{
    "status": "OK",
    "results": {
        "docsMatched": 110,
        "docsExported": 110,
        "docs": [
            {
                "index": "1",
                "publicationKey": "WO_2015_057966_A2",
                "lensId": "022-760-401-941-857",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2015/057966 A2",
                "publicationDate": "2015-04-23",
                "filingNumber": "US 2014/0060906 W",
                "filingDate": "2014-10-16",
                "priorityFilingKeysActive": [
                    "US 201361891677 P 20131016",
                    "US 201461993332 P 20140515"
                ],
                "earliestPriorityDate": "2013-10-16",
                "title": "Therapies, Vaccines, And Predictive Methods For Middle East Respiratory Syndrome Virus (mers Cov)",
                "applicants": [
                    "BOGOCH SAMUEL",
                    "BOGOCH ELENORE S",
                    "BORSANYI ANNE-ELENORE BOGOCH",
                    "BOGOCH SAMUEL WINSTON"
                ],
                "inventors": [
                    "BOGOCH SAMUEL",
                    "BOGOCH ELENORE S",
                    "BORSANYI ANNE-ELENORE BOGOCH",
                    "BOGOCH SAMUEL WINSTON"
                ],
                "owners": [],
                "url": "https://lens.org/022-760-401-941-857",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 239,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/70",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2317/34",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "G01N33/56983",
                    "G01N2333/165"
                ],
                "ipcrClassifications": [
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "2",
                "publicationKey": "WO_2015_161908_A1",
                "lensId": "024-553-140-872-320",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/161908 A1",
                "publicationDate": "2015-10-29",
                "filingNumber": "EP 2015000543 W",
                "filingDate": "2015-03-11",
                "priorityFilingKeysActive": [
                    "US 201461951106 P 20140311",
                    "US 201461951742 P 20140312"
                ],
                "earliestPriorityDate": "2014-03-11",
                "title": "Non-immunosuppressive Cyclophilin Inhibitors For The Treatment Of Coronavirus Infections",
                "applicants": [
                    "LUDWIG MAXIMILIANS UNIVERSIT\u00c4T M\u00dcNCHEN"
                ],
                "inventors": [
                    "NAOUMOV NIKOLAI",
                    "VON BRUNN ALBRECHT"
                ],
                "owners": [],
                "url": "https://lens.org/024-553-140-872-320",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 10,
                "cpcClassifications": [
                    "A61K38/13",
                    "A61K31/7056",
                    "A61K38/12",
                    "A61K45/06",
                    "A61K2300/00"
                ],
                "ipcrClassifications": [
                    "A61K38/12",
                    "A61K31/7056",
                    "A61K38/13",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "JAVIER CARBAJO-LOZOYA ET AL: \"Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir\", VIRUS RESEARCH, vol. 184, 22 February 2014 (2014-02-22), pages 44 - 53, XP055206009, ISSN: 0168-1702, DOI: 10.1016/j.virusres.2014.02.010",
                    "TAN E L C ET AL: \"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs\", EMERGING INFECTIOUS DISEASES, EID, ATLANTA, GA, US, vol. 10, no. 4, 1 April 2004 (2004-04-01), pages 581 - 586, XP008102827, ISSN: 1080-6040, Retrieved from the Internet <URL:http://www.cdc.gov/ncidod/EID/vol10no4/03-0458.htm> [retrieved on 20150803]",
                    "MORGENSTERN B ET AL: \"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines\", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 326, no. 4, 28 January 2005 (2005-01-28), pages 905 - 908, XP004682899, ISSN: 0006-291X, DOI: 10.1016/J.BBRC.2004.11.128"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "074-960-744-959-701",
                    "064-999-125-102-982",
                    "129-401-973-660-415"
                ],
                "nplResolvedExternalIDs": [
                    "10.3201/eid1004.030458",
                    "24566223",
                    "pmc3323075",
                    "10.1016/j.virusres.2014.02.010",
                    "15607755",
                    "15200845",
                    "10.1016/j.bbrc.2004.11.128"
                ]
            },
            {
                "index": "3",
                "publicationKey": "US_9266844_B2",
                "lensId": "114-859-966-167-438",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9266844 B2",
                "publicationDate": "2016-02-23",
                "filingNumber": "US 201313919951 A",
                "filingDate": "2013-06-17",
                "priorityFilingKeysActive": [
                    "US 201261689952 P 20120615"
                ],
                "earliestPriorityDate": "2012-06-15",
                "title": "Suppression Of Sars Replication By Sars Helicase Inhibitors",
                "applicants": [
                    "UNIV MISSOURI"
                ],
                "inventors": [
                    "SARAFIANOS STEFAN G",
                    "ADEDEJI ADEYEMI O",
                    "SINGH KAMLENDRA"
                ],
                "owners": [
                    {
                        "name": "THE CURATORS OF THE UNIVERSITY OF MISSOURI",
                        "executionDate": "2013-08-22"
                    }
                ],
                "url": "https://lens.org/114-859-966-167-438",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 16,
                "cpcClassifications": [
                    "C07D249/12",
                    "A61K31/4196",
                    "C12Q1/18",
                    "G01N2333/165"
                ],
                "ipcrClassifications": [
                    "A61K31/4196",
                    "C07D249/12",
                    "C12Q1/18"
                ],
                "usClassifications": [],
                "nplCitationCount": 19,
                "nplCitations": [
                    "Talawar et al., Indian Journal of Heterocyclic Chemistry, vol. 5, Jan.-Mar. 1996, pp. 215-218.",
                    "CAS RN 675104-49-1, Indexed in STN Registry database, Entered STN Apr. 14, 2004. Accessed Jun. 15, 2015.",
                    "Ito et al. In Cancer Science 94(1), 3-8 (2003).",
                    "Adedeji et al., \"Identification of a Novel Inhibitor That Prevents SARS-CoV Replication by Interfering with the Unwinding Mechanism of the Viral Helicase,\" 12th Annual Symposium on Antiviral Drug Resistance, Nov. 2011.",
                    "Adedeji et al., \"Severe Acute Respiratory Syndrome Coronavirus Replication Inhibitor That Interferes with the Nucleic Acid Unwinding of the Viral Helicase,\" Antimicrobial Agents and Chemotherapy 56(9):4718-4728, Sep. 2012.",
                    "Adedeji et al., \"Mechanism of nucleic acid unwinding by SARS-CoV Helicase,\" PLoS One 7(5):e36521, May 2012.",
                    "Adedeji et al., \"SARS-CoV Replication Inhibitor that Interferes with the Nucleic Acid Unwinding of the Viral Helicase,\" Antimicrob Agents Chemother 56:4718-28, 2012.",
                    "Adedeji et al., \"Structural and biochemical basis for the difference in the helicase activity of two different constructs of sars-cov helicase,\" Cell Mol Biol 58:114-121, 2012.",
                    "Alasdair et al., \"Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites,\" Oxford Journals 21:1906-1908, 2005.",
                    "Almazan et al., \"Construction of a severe acute respiratory syndrome coronavirus infections cDNA clone and a replicon to study coronavirus RNA synthesis,\" J Virol 80:10900-10906, 2006.",
                    "Durk et al., \"Inhibitors of foot and mouth disease virus targeting a novel pocket of the RNA-dependent RNA polymerase,\" PLoS One 5:e15049, 2010.",
                    "International Search Report and Written Opinion issued in PCT/US2013/0461999, dated Nov. 5, 2013.",
                    "Ivanov et al., \"Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase,\" J Virol 78:5619-5632, 2004.",
                    "Kleymann, \"New antiviral drugs that target herpesvirus helicase primase enzymes,\" Herpes 10(2):46-52, 2003.",
                    "Kwong et al., \"Viral and Cellular RNA Helicases as Antiviral Targets,\" Nature Reviews Drug Discovery 4:845-853, Oct. 2005.",
                    "Sarafianos et al., \"Mechanism of polyoxometalate-mediated inactivation of DNA polymerases: an analysis with HIV-1 reverse transcriptase indicates specificity for the DNA-binding cleft,\" Biochem J 319(Pt 2):619-626, 1996.",
                    "Sharma et al., \"DNA helicases as targets for anti-cancer drugs,\" Curr Med Chem Anticancer Agents 5(3):183-99, 2005.",
                    "Tanner et al., \"The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases,\" J Biol Chem 278:39578-39582, 2003.",
                    "Zhang et al., \"A simple statistical parameter for use in evaluation and validation of high throughput screening assays,\" J Biomol Screen 4:67-73, 1999."
                ],
                "nplResolvedCount": 15,
                "nplResolvedLensIDs": [
                    "003-518-463-670-939",
                    "028-450-139-890-891",
                    "069-366-695-251-949",
                    "031-350-975-474-711",
                    "004-001-811-739-459",
                    "044-313-524-523-851",
                    "059-862-174-165-412",
                    "064-753-583-450-482",
                    "004-336-171-565-212",
                    "013-102-099-846-742",
                    "052-044-410-776-241",
                    "040-448-762-727-406",
                    "145-098-152-895-779",
                    "035-017-401-933-161",
                    "132-910-657-022-562"
                ],
                "nplResolvedExternalIDs": [
                    "10.1074/jbc.c300328200",
                    "15701681",
                    "10838414",
                    "15992349",
                    "10.1038/nrd1853",
                    "16928748",
                    "10.1128/aac.00957-12",
                    "10.1042/bj3190619",
                    "10.1128/jvi.00385-06",
                    "10.1371/journal.pone.0015049",
                    "10.1177/108705719900400206",
                    "12708466",
                    "10.1128/jvi.78.11.5619-5632.2004",
                    "10.1371/journal.pone.0036521",
                    "22615777",
                    "21203539",
                    "15140959",
                    "pmc3421890",
                    "pmc415832",
                    "pmc1217812",
                    "14577954",
                    "22733076",
                    "23273200",
                    "pmc3006429",
                    "8912703",
                    "pmc1641757",
                    "12917423",
                    "16184083",
                    "10.1111/j.1349-7006.2003.tb01343.x",
                    "10.2174/1568011053765985",
                    "pmc3352918",
                    "10.1093/bioinformatics/bti315",
                    "12708475"
                ]
            },
            {
                "index": "4",
                "publicationKey": "US_2016_0082074_A1",
                "lensId": "025-205-095-624-576",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2016/0082074 A1",
                "publicationDate": "2016-03-24",
                "filingNumber": "US 201514707356 A",
                "filingDate": "2015-05-08",
                "priorityFilingKeysActive": [
                    "US 201461951106 P 20140311",
                    "US 201461951742 P 20140312"
                ],
                "earliestPriorityDate": "2014-03-11",
                "title": "Compositions And Methods For Treating Coronavirus Infection",
                "applicants": [
                    "UNIV MUENCHEN L MAXIMILIANS"
                ],
                "inventors": [
                    "NAOUMOV NIKOLAI",
                    "VON BRUNN ALBRECHT"
                ],
                "owners": [
                    {
                        "name": "LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN",
                        "executionDate": "2016-05-30"
                    },
                    {
                        "name": "NOVARTIS AG",
                        "executionDate": "2015-03-09"
                    },
                    {
                        "name": "NOVARTIS PHARMA AG",
                        "executionDate": "2015-03-09"
                    }
                ],
                "url": "https://lens.org/025-205-095-624-576",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 10,
                "cpcClassifications": [
                    "A61K38/13",
                    "A61K31/7056",
                    "A61K38/12",
                    "A61K45/06",
                    "A61K2300/00"
                ],
                "ipcrClassifications": [
                    "A61K38/13",
                    "A61K31/7056",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "5",
                "publicationKey": "US_9415087_B2",
                "lensId": "032-435-067-652-921",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9415087 B2",
                "publicationDate": "2016-08-16",
                "filingNumber": "US 201514707356 A",
                "filingDate": "2015-05-08",
                "priorityFilingKeysActive": [
                    "US 201461951106 P 20140311",
                    "US 201461951742 P 20140312"
                ],
                "earliestPriorityDate": "2014-03-11",
                "title": "Compositions And Methods For Treating Coronavirus Infection",
                "applicants": [
                    "LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN"
                ],
                "inventors": [
                    "NAOUMOV NIKOLAI",
                    "VON BRUNN ALBRECHT"
                ],
                "owners": [
                    {
                        "name": "LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN",
                        "executionDate": "2016-05-30"
                    },
                    {
                        "name": "NOVARTIS AG",
                        "executionDate": "2015-03-09"
                    },
                    {
                        "name": "NOVARTIS PHARMA AG",
                        "executionDate": "2015-03-09"
                    }
                ],
                "url": "https://lens.org/032-435-067-652-921",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 10,
                "cpcClassifications": [
                    "A61K38/13",
                    "A61K31/7056",
                    "A61K38/12",
                    "A61K45/06",
                    "A61K2300/00"
                ],
                "ipcrClassifications": [
                    "A61K38/13",
                    "A61K31/7056",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 65,
                "nplCitations": [
                    "Carbajo-Lozoya et al. Virus Research. 184, 44-53. 2014.",
                    "Medical Xpress. MedicalXpress.com. \"Derivatives of a known drug inhibity the replication of a pathogenic coronavirus.\" Mar. 18, 2014.",
                    "Koren et al. JAMC. 168(10). 1289-1292. 2003.",
                    "Adedeji, et al., \"Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses\", Antimicrobial Agents and Chemotherapy, 58(8):4894, May 2014.",
                    "An, et al., \"Regulatory Polymorphisms in the Cyclophilin Gene, PPIA, Accelerate Progression to AIDS\", PLoS Pathog, 3(6):e88 Jun. 2007.",
                    "Arbour, et al., \"Neuroinvasion by Human Respiratory Coronaviruses\", Journal of Virology, 74(19):8913-8921, Oct. 2000.",
                    "Arevalo-Rodriguez, et al., \"Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase\", The EMBO Journal, 19(14):3739-3749, 2000.",
                    "Bartenschlager, et al., \"Efficient hepatitis C virus cell Culture system: What a difference the host cell makes\", PNAS, 102(28):9739-9740, Jul. 12, 2005.",
                    "Bigham, et al., \"Variants in Host Viral Replication Cycle Genes are Associated with Heterosexual HIV-1 Acquisition in Africa\", J. Acquir Immune Defic Syndr, 66(2):127-134, Jun. 2014.",
                    "Blight, et al., \"Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication\" Journal of Virology, 76(24):13001-13014, Dec. 2002.",
                    "Carbajo-Lozoya, et al., \"Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506\", Virus Research 165:112-117, Jan. 2012.",
                    "Carbajo-Lozoya, et al., \"Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosupressive cyclosporine A-derivatives including Alisporivir\", Virus Research, 184:44-53, Jan. 2014.",
                    "Cervantes-Barragan, et al., \"Dendritic Cell-Specific Antigen Delivery by Coronavirus Vaccine Vectors Induces Long-Lasting Protective Antiviral and Antitumor Immunity\", mBio, 1(4):e00171-10, Sep./Oct. 2010.",
                    "Collins, \"In Vitro Detection of Apoptosis in Monocytes/Macrophages Infected with Human Coronavirus\", Clinical and Diagnostic Laboratory Immunology, 9(6):1392-1395, Nov. 2002.",
                    "De Paulis, et al., \"Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine\", J. Allergy Clin. Immunol, 98(1):153-164, Jul. 1996.",
                    "Desforges, et al., \"HCoV-229E Infects and Activates Monocytes\", Adv. Exp. Med. Biol., 581:511-514. 2006.",
                    "De Wilde, et al., \"Cyclosporin A inhibits the replication of diverse coronaviruses\", Journal of General Virology, 92:2542-2548, Jun. 2011.",
                    "De Wilde, et al., \"Cyclosphilin Inhibitors Block Arterivirus Replication by Interfering with Viral RNA Synthesis\", J. Virol., 87(3):1454, Nov. 2012.",
                    "De Wilde, et al., \"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporine A or interferon-alpha treatment\", Journal of General Virology, 94:1749-1760, Mar. 2013.",
                    "De Wilde, et al., \"Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture\", Antimicrob. Agents Chemother. 58(8):4875, May 2014.",
                    "Dijkman, et al., \"Human Coronavirus NL63 and 229E Seroconversion in Children\", Journal of Clinical Microbiology, 46(7):2368-2373, Jul. 2008.",
                    "Dijkman, et al., \"The dominance of human coronavirus OC43 and NL63 infections in infants\", Journal of Clinical Virology, 53:135-139, Nov. 2011.",
                    "Dyall, et al., \"Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection\", Antimicrobial Agents and Chemotherapy, 58(8):4885, May 2014.",
                    "Feigelstock, et al., \"Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I\", Virology Journal, 7:10, Feb. 2010.",
                    "Friebe, et al., \"Kissing-Loop Interaction in the 3' End of the Hepatitis C Virus Genome Essential for RNA Replication\", Journal of Virology, 79(1):380-392, Jan. 2005.",
                    "Gallay, et al., \"Profile of alisporivir and its potential in the treatment of hepatitis C\", Drug Design, Development and Therapy, 7:105-115, 2013.",
                    "Gaunt, et al., \"Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method\", Journal of Clinical Microbiology, 48(8):2940, Jun. 2010.",
                    "Ge, et al., \"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor\", Nature, 503:535-538, Nov. 2013.",
                    "Gemmill, et al., \"Vanishingly Low Levels of Ess1 Prolyl-isomerase Activity Are Sufficient for Growth in Saccharomyces cerevisiae\", The Journal of Biological Chemistry, 280(16):15510-15517, Apr. 2005.",
                    "Hemida, et al., \"Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013\", Euro Surveill., 18(50):pii=20659, Dec. 2013.",
                    "Hopkins, et al., \"SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA Replication In Vitro\", Antimicrobial Agents and Chemotherapy, 54(2):660-672, Feb. 2010.",
                    "Huang, et al., \"Rapamycins-Mechanism of Action and Cellular Resistance\", Cancer Biology & Therapy, 2(3):222-232, May/Jun. 2003.",
                    "Huynh, et al., \"Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63\", Journal of Virology, 86(23):12816, Sep. 2012.",
                    "Koren, et al., \"Ribavirin in the treatment of SARS: A new trick for an old drug?\", Canadian Medical Association or its licensors, 168(10):1289-1292, May 2003.",
                    "Koutsoudakis, et al., \"The Level of CD81 Cell Surface Expression is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells\", Journal of Virology, 81(2):588-598, Jan. 2007.",
                    "Lafemina, \"Alternative Screening Approaches for Discovery of MERS Coronavirus Inhibitors\", Antimicrob. Agents Chemother. doi:10.1128/AAC.03406-14, American Society for Microbiology, Jun. 2014.",
                    "Lang, et al., \"Catalysis of protein folding by prolyl isomerase\", Letters to Nature, 329:268-270, Sep. 1987.",
                    "Legrue, et al., \"Does the Binding of Cyclosporine to Calmodulin Result in Immunosuppression\", Science, 234:68-71, Oct. 1986.",
                    "Lin, \"Curing a viral infection by targeting the host: The example of cyclophilin inhibitors\", Antiviral Research, 99:68-77, Jan. 2013.",
                    "Ludwig Maximilian University of Munich, \"Derivatives of a known drug inhibit the replication of a pathogenic coronavirus\", MedicalXpress, http://medicalxpress.com/news/2014-03-derivatives-drug-inhibit-replication-pathogenic.html , Mar. 18, 2014.",
                    "Lundin, et al., \"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus\", PLOS, 10(5):e1004166, May 2014.",
                    "Luo, et al., \"Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A\", Biochemical and Biophysical Research Communications, 321:557-565, Jun. 2004.",
                    "Malesevic, et al., \"Anti-inflammatory Effects of Extracellular Cyclosporins are Exclusively Mediated by CD147\", Journal of Medicinal Chemistry, 56:7302-7311, May 2013.",
                    "Membreno, et al., \"Cyclophilin Inhibitors for Hepatitis C Therapy\", Clin Liver Dis, 17:129-139, 2013.",
                    "Mesel-Lemoine, et al., \"A Human Coronavirus Responsible for the Common Cold Massively Kills Dendritic Cells but Not Monocytes\", Journal of Virology, 86(14):7577-7587, Jul. 2012.",
                    "Naoumov, \"Cyclophilin inhibition as potential therapy for liver disease\", Journal of Hepatology, 61:1166-1174, Nov. 2014.",
                    "Neuman, et al., \"Proteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3\", Journal of Virology, 82(11):5279-5294, Jun. 2008.",
                    "Nigro, et al., \"Cyclophilin A: a key player for human disease\", Cell Death and Disease, 4, e888, doi:10.1038/cddis.2013.410, Oct. 2013.",
                    "Perlman, et al., \"Coronaviruses post-SARS: update on replication and pathogenesis\", Nature Reviews Microbiology, 7:439-450, Jun. 2009.",
                    "Pfefferle, et al., \"Distant Relatives of Severe Acute Respiratory Syndrome Coronavirus and Close Relatives of Human Coronavirus 229E in Bats, Ghana\", Emerging Infectious Diseases, 15(9):1377-1384, Sep. 2009.",
                    "Pfefferle, et al., \"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors\", PLoS, 7(10):e1002331 Oct. 2011.",
                    "Prell, et al., \"Fine Tuning the Inhibition Profile of Cyclosporine A by Derivatization of the MeBmt Residue\", ChemBioChem, 14:63-65 2013.",
                    "Raj, et al., \"Dipeptidyl peptisdase 4 is a functional receptor for the emerging human coronavirus-EMC\", Letter, 495:251-256, Mar. 2013.",
                    "Reusken, et al., \"Middle East respiratory syndrome coronavirus neutralizing serum antibodies in dromedary camels: a comparative serological study\", LancetInfect Dis, 13:859-866 Oct. 2013.",
                    "Riva, et al., Hepatitis C virus and interferon type III (interferon lambda 3/interleukin 28B and interferon lambda 4): genetic basis of susceptibility to infection and response to antiviral treatment, Clinical Microbiology and Infection (Impact Factor: 5.77), doi: 10.1111/1469-0691.12797, Oct. 2014.",
                    "Sanglier, et al., \"Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110\", The Journal of Antibiotics, 52(5):466-473, May 1999.",
                    "Sastre, \"Differentiation between Human Coronaviruses NL63 and 229E Using a Novel Double-Antibody Sandwich Enzyme-Linked Immunosorbent Assay Based on Specific Monoclonal Antibodies\", Clin. Vaccine Immunol., 18(1):113, Nov. 2010.",
                    "Sims, et al., \"SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium\", ScienceDirect, 133:33-44, Apr. 2007.",
                    "Stadler, et al., \"SARS-Beginning to Understand a New Virus\", Nature Reviews Microbiology, 1:209-218, Dec. 2003.",
                    "Van Der Hoek, et al., \"Identification of a new human coronavirus\", Nature Medicine, published online, doi:10.1038.nm1024, Mar. 2004.",
                    "Van Hemert, et al., The inVitro RNA Synthesizing Activity of the Isolated ARterivirus Replication/Transcription Complex is Dependent on a Host Factor, The Journal of Biological Chemistry, 283(24):16525-16536, Jun. 2008.",
                    "Vijgen, et al., \"Complete Genomic Sequence of Human Cornoavirus OC43: Molecular Clock Analysis Suggests a Relatively Recent Zoonotic Coronavirus Transmission Event\", Journal of Virology, 79(3):1595-1604, Feb. 2005.",
                    "Von Hahn, et al., \"Hepatocytes that Express Variants of Cyclophilin A are Resistant to HCV Infection and Replication\", Gastroenterology, 143(2):439-447, Oct. 2011.",
                    "Woo, et al., \"Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia\", Journal of Virology, 79(2):884-895, Jan. 2005.",
                    "Zhou, et al., \"Cyclophilin A and viral infections\", Biochemical and Biophysical Research Communications, 424:647-650 Jun. 2012."
                ],
                "nplResolvedCount": 62,
                "nplResolvedLensIDs": [
                    "022-404-814-149-218",
                    "010-366-466-549-230",
                    "069-503-293-645-943",
                    "013-724-125-892-168",
                    "034-180-651-577-351",
                    "075-322-231-917-450",
                    "023-111-442-014-271",
                    "071-228-272-039-774",
                    "079-193-165-875-201",
                    "056-950-079-112-567",
                    "103-927-858-988-784",
                    "011-438-250-833-909",
                    "170-734-804-561-178",
                    "005-483-816-218-442",
                    "046-508-989-530-587",
                    "033-514-299-309-606",
                    "050-487-825-790-264",
                    "133-972-307-208-56X",
                    "084-383-272-528-908",
                    "064-999-125-102-982",
                    "011-379-100-989-88X",
                    "009-000-123-209-750",
                    "085-642-156-816-769",
                    "004-534-339-587-19X",
                    "094-971-760-491-845",
                    "034-987-129-287-957",
                    "069-221-292-019-080",
                    "142-004-422-588-420",
                    "138-840-356-153-97X",
                    "009-038-449-146-60X",
                    "114-615-248-574-417",
                    "039-053-666-913-127",
                    "088-764-625-204-541",
                    "017-353-572-975-921",
                    "064-672-615-629-942",
                    "038-278-863-521-49X",
                    "032-660-874-366-359",
                    "016-680-514-013-427",
                    "134-508-343-769-601",
                    "071-582-679-256-924",
                    "052-375-350-750-096",
                    "006-985-494-194-594",
                    "012-852-742-797-721",
                    "108-229-899-337-383",
                    "081-307-021-537-929",
                    "020-009-029-407-493",
                    "093-074-771-307-71X",
                    "033-737-476-374-790",
                    "084-893-855-384-248",
                    "073-038-408-550-957",
                    "055-961-145-484-279",
                    "088-862-562-214-599",
                    "019-231-459-111-141",
                    "020-132-199-967-470",
                    "006-981-427-811-70X",
                    "002-186-688-852-050",
                    "073-682-937-516-081",
                    "013-333-138-079-426",
                    "056-936-059-383-537",
                    "086-963-615-655-137",
                    "026-518-238-956-425",
                    "012-232-117-412-374"
                ],
                "nplResolvedExternalIDs": [
                    "10.1371/journal.ppat.1002331",
                    "10.3201/eid1509.090224",
                    "pmc3554155",
                    "pmc2831881",
                    "10.1038/nature12711",
                    "10.1128/mbio.00171-10",
                    "pmc4136071",
                    "24172901",
                    "10.1016/j.jhep.2014.07.008",
                    "pmc3352363",
                    "24874215",
                    "10.1128/jvi.00906-12",
                    "15596831",
                    "17451829",
                    "10.1128/aac.02994-14",
                    "pmc3920964",
                    "18495857",
                    "24841268",
                    "10.1099/vir.0.034983-0",
                    "23440335",
                    "24841269",
                    "10.1128/jvi.74.19.8913-8921.2000",
                    "pmc3203193",
                    "10.1073/pnas.0504296102",
                    "10.1016/j.virusres.2007.03.013",
                    "10.1038/329268a0",
                    "22580540",
                    "10.1128/aac.03036-14",
                    "10.1128/jvi.79.1.380-392.2005",
                    "10.2807/1560-7917.es2013.18.50.20659",
                    "10480570",
                    "pmc130109",
                    "24463784",
                    "24841273",
                    "pmc3497669",
                    "23486063",
                    "10.1074/jbc.m708136200",
                    "10.1128/jvi.79.3.1595-1604.2005",
                    "10.1128/jvi.76.24.13001-13014.2002",
                    "19933795",
                    "pmc2830095",
                    "pmc3578503",
                    "10.7164/antibiotics.52.466",
                    "10.1053/j.gastro.2012.04.053",
                    "15728580",
                    "22349148",
                    "10.1016/j.cld.2012.09.008",
                    "10.1128/jvi.01534-06",
                    "22046132",
                    "15613317",
                    "23177289",
                    "10982334",
                    "23964991",
                    "15035025",
                    "25273834",
                    "pmc3416289",
                    "12743076",
                    "24867994",
                    "10.1128/cvi.00355-10",
                    "18411274",
                    "pmc4038610",
                    "17079281",
                    "3749892",
                    "21084464",
                    "pmc313981",
                    "pmc4136000",
                    "pmc1797465",
                    "10.4161/cbt.2.3.360",
                    "10.1097/qai.0000000000000113",
                    "15358143",
                    "20844609",
                    "10.1016/j.virusres.2012.02.002",
                    "10.1038/nrmicro775",
                    "pmc136668",
                    "10.1128/cdli.9.6.1392-1395.2002",
                    "23933067",
                    "10.2147/dddt.s30946",
                    "pmc2395186",
                    "17590083",
                    "12414783",
                    "10.1128/jvi.00269-12",
                    "8765829",
                    "10.1128/aac.00660-09",
                    "pmc154189",
                    "10.1038/cddis.2013.410",
                    "10.1128/jvi.02631-07",
                    "pmc2384224",
                    "12438626",
                    "10.1128/jvi.02078-12",
                    "10.1038/nrmicro2147",
                    "20554810",
                    "pmc2916580",
                    "10.1016/s1473-3099(13)70164-6",
                    "10.1128/jcm.00533-08",
                    "10.1371/journal.ppat.0030088",
                    "24566223",
                    "pmc3019789",
                    "15998731",
                    "10.1016/j.virusres.2014.02.010",
                    "10.1016/j.bbrc.2012.07.024",
                    "10.1128/aac.03406-14",
                    "10.1128/jcm.00636-10",
                    "10.1093/emboj/19.14.3739",
                    "10.1021/jm4007577",
                    "10899127",
                    "10.1016/j.bbrc.2004.07.003",
                    "10.1016/j.jcv.2011.11.011",
                    "22993147",
                    "22814107",
                    "3306408",
                    "10.1002/cbic.201200621",
                    "23620378",
                    "10.1128/aac.03011-14",
                    "10.1126/science.3749892",
                    "19430490",
                    "12878853",
                    "10.1371/journal.ppat.1004166",
                    "pmc1894826",
                    "23578729",
                    "pmc538593",
                    "10.1074/jbc.m412172200",
                    "15650185",
                    "pmc2446899",
                    "pmc2812147",
                    "pmc4025588",
                    "24176846",
                    "pmc102086",
                    "10.1016/s0091-6749(96)70237-3",
                    "10.1111/1469-0691.12797",
                    "10.1007/978-0-387-33012-9_91",
                    "pmc544107",
                    "22188723",
                    "10.1128/jvi.79.2.884-895.2005",
                    "10.1038/nature12005",
                    "25048953",
                    "20170495",
                    "pmc4136041",
                    "22553325",
                    "10.1016/j.antiviral.2013.03.020",
                    "17037587",
                    "10.1099/vir.0.052910-0",
                    "pmc1175013",
                    "19788804",
                    "10.1186/1743-422x-7-44",
                    "23225707",
                    "pmc3749523",
                    "pmc4135998",
                    "pmc2819850",
                    "pmc4332838",
                    "pmc538730",
                    "24342517",
                    "21752960",
                    "18367524",
                    "23152531"
                ]
            },
            {
                "index": "6",
                "publicationKey": "US_2016_0235837_A1",
                "lensId": "185-808-559-387-025",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2016/0235837 A1",
                "publicationDate": "2016-08-18",
                "filingNumber": "US 201415029169 A",
                "filingDate": "2014-10-16",
                "priorityFilingKeysActive": [
                    "US 201361891677 P 20131016",
                    "US 201461993332 P 20140515"
                ],
                "earliestPriorityDate": "2013-10-16",
                "title": "Therapies, Vaccines, And Predictive Methods For Middle East Respiratory Syndrome Virus (mers Cov)",
                "applicants": [
                    "BOGOCH SAMUEL",
                    "BOGOCH ELENORE S",
                    "BORSANYI ANNE-ELENORE BOGOCH",
                    "BOGOCH SAMUEL WINSTON"
                ],
                "inventors": [
                    "BOGOCH SAMUEL",
                    "BOGOCH ELENORE S",
                    "BORSANYI ANNE-ELENORE BOGOCH",
                    "BOGOCH SAMUEL WINSTON"
                ],
                "owners": [],
                "url": "https://lens.org/185-808-559-387-025",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 239,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/70",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2317/34",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "G01N33/56983",
                    "G01N2333/165"
                ],
                "ipcrClassifications": [
                    "A61K39/215",
                    "C07K14/005",
                    "C07K16/10",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "de Groot et al. \"Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group\u201d J. Virol. 2013; 87(14): 7790-7792"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "083-152-458-546-878"
                ],
                "nplResolvedExternalIDs": [
                    "23678167",
                    "pmc3700179",
                    "10.1128/jvi.01244-13"
                ]
            },
            {
                "index": "7",
                "publicationKey": "WO_2017_196847_A1",
                "lensId": "072-933-474-452-559",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/196847 A1",
                "publicationDate": "2017-11-16",
                "filingNumber": "US 2017/0031758 W",
                "filingDate": "2017-05-09",
                "priorityFilingKeysActive": [
                    "US 201662334194 P 20160510"
                ],
                "earliestPriorityDate": "2016-05-10",
                "title": "Variable New Antigen Receptor (vnar) Antibodies And Antibody Conjugates Targeting Tumor And Viral Antigens",
                "applicants": [
                    "US HEALTH",
                    "UNIV MARYLAND"
                ],
                "inventors": [
                    "HO MITCHELL",
                    "FENG MINGQIAN",
                    "FLAJNIK MARTIN F"
                ],
                "owners": [],
                "url": "https://lens.org/072-933-474-452-559",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 97,
                "cpcClassifications": [
                    "C07K16/28",
                    "C07K16/10",
                    "C07K16/2896",
                    "C07K16/32",
                    "C07K2317/20",
                    "C07K2317/33",
                    "C07K2317/569",
                    "C07K2317/73",
                    "C07K2317/76",
                    "C07K2317/92"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "C07K16/28",
                    "C07K16/32"
                ],
                "usClassifications": [],
                "nplCitationCount": 105,
                "nplCitations": [
                    "YEN PHUNG ET AL: \"High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening\", MABS, vol. 4, no. 5, 1 September 2012 (2012-09-01), pages 592 - 599, XP055084048, ISSN: 1942-0862, DOI: 10.4161/mabs.20933",
                    "M. FENG ET AL: \"Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 110, no. 12, 19 March 2013 (2013-03-19), pages E1083 - E1091, XP055083878, ISSN: 0027-8424, DOI: 10.1073/pnas.1217868110",
                    "STEFAN ZIELONKA ET AL: \"Structural insights and biomedical potential of IgNAR scaffolds from sharks\", MABS, vol. 7, no. 1, 18 December 2014 (2014-12-18), US, pages 15 - 25, XP055235550, ISSN: 1942-0862, DOI: 10.4161/19420862.2015.989032",
                    "CAROLINE BARELLE ET AL: \"VNARs: An Ancient and Unique Repertoire of Molecules That Deliver Small, Soluble, Stable and High Affinity Binders of Proteins\", ANTIBODIES, vol. 4, no. 3, 1 September 2015 (2015-09-01), pages 240 - 258, XP055389558, DOI: 10.3390/antib4030240",
                    "WESOLOWSKI ET AL., MED MICROBIOL IMMUNOL, vol. 198, 2009, pages 157 - 174",
                    "RUMFELT ET AL., BMC IMMUNOL, vol. 5, 2004, pages 8",
                    "RUMFELT ET AL., J IMMUNOL, vol. 173, 2004, pages 1129 - 1139",
                    "FEIGE ET AL., PROC NATL ACAD SCI USA, vol. 111, 2014, pages 8155 - 8160",
                    "IRVING ET AL., J IMMUNOL METHODS, vol. 248, 2001, pages 31 - 45",
                    "STANFIELD ET AL., SCIENCE, vol. 305, 2004, pages 1770 - 1773",
                    "SIMMONS ET AL., J IMMUNOL METHODS, vol. 315, 2006, pages 171 - 184",
                    "FENNELL ET AL., J MOL BIOL, vol. 400, 2010, pages 155 - 170",
                    "BENJAMIN LEWIN: \"Genes V\", 1994, OXFORD UNIVERSITY PRESS, ISBN: 0-19-854287-9",
                    "KENDREW ET AL.: \"The Encyclopedia of Molecular Biology\", 1994, BLACKWELL SCIENCE LTD., ISBN: 0-632-02182-9",
                    "ROBERT A. MEYERS: \"Molecular Biology and Biotechnology: a Comprehensive Desk Reference\", 1995, VCH PUBLISHERS, INC., ISBN: 1-56081-569-8",
                    "KABAT ET AL.: \"Sequences of Proteins of Immunological Interest\", 1991, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                    "CHOTHIA; LESK, J MOL BIOL, vol. 196, 1987, pages 901 - 917",
                    "CHOTHIA ET AL., NATURE, vol. 342, 1989, pages 877",
                    "AL-LAZIKANI ET AL., JMB, vol. 273, 1997, pages 927 - 948",
                    "LEFRANC, NUCLEIC ACIDS RES, vol. 29, 2001, pages 207 - 9",
                    "KOVALENKO ET AL., J BIOL CHEM, vol. 288, no. 24, 2013, pages 17408 - 17419",
                    "FRANKEL ET AL., MOL. IMMUNOL., vol. 16, 1979, pages 101 - 106",
                    "\"Harrison's Principles of Internal Medicine, 14th edition\", article SLAPAK AND KUFE: \"Principles of Cancer Therapy, Chapter 86\"",
                    "\"Harrison's Principles of Internal Medicine\"",
                    "ABELOFF: \"Clinical Oncology, 2nd ed.\", 2000, CHURCHILL LIVINGSTONE, INC, article PERRY ET AL.: \"Chemotherapy (Ch. 17)\"",
                    "BALTZER, L., BERKERY, R.: \"Oncology Pocket Guide to Chemotherapy, 2nd ed.\", 1995, MOSBY-YEAR BOOK",
                    "FISCHER, D.S., KNOBF, M.F., DURIVAGE, H.J.: \"The Cancer Chemotherapy Handbook, 4th ed.\", 1993, MOSBY-YEAR BOOK",
                    "CONNOR ET AL., PHARM THER, vol. 28, 1985, pages 341 - 365",
                    "FILMUS; SELLECK, J CLIN INVEST, vol. 108, 2001, pages 497 - 501",
                    "HO; KIM, EUR J CANCER, vol. 47, no. 3, 2011, pages 333 - 338",
                    "ROUX ET AL., PROC NATL ACAD SCI USA, vol. 95, 1998, pages 11804 - 11809",
                    "HORTON ET AL., BIOTECHNIQUES, vol. 54, no. 3, 2013, pages 129 - 133",
                    "E.W. MARTIN: \"Remington's Pharmaceutical Sciences, 15th ed.\", 1975, MACK PUBLISHING CO.",
                    "GERRATANA, MED RES REV, vol. 32, no. 2, 2012, pages 254 - 293",
                    "SMITH; WATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482",
                    "NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443",
                    "PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. U.S.A., vol. 85, 1988, pages 2444",
                    "HIGGINS; SHARP, GENE, vol. 73, 1988, pages 237",
                    "HIGGINS; SHARP, CABIOS, vol. 5, 1989, pages 151",
                    "CORPET ET AL., NUCLEIC ACIDS RESEARCH, vol. 16, 1988, pages 10881",
                    "ALTSCHUL ET AL., NATURE GENET., vol. 6, 1994, pages 119",
                    "ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403",
                    "BARELLE ET AL., ADV EXP MED BIOL, vol. 655, 2009, pages 49 - 62",
                    "NUTTALL; WALSH, CURR OPIN PHARMACOL, vol. 8, 2008, pages 609 - 615",
                    "DIAZ ET AL., IMMUNOGENETICS, vol. 54, 2002, pages 501 - 512",
                    "MORDENTI ET AL., TOXICOL PATHOL, vol. 27, 1999, pages 536 - 544",
                    "LIU ET AL., MOL IMMUNOL, vol. 44, 2007, pages 1775 - 1783",
                    "STANFIELD ET AL., J MOL BIOL, vol. 367, 2007, pages 358 - 372",
                    "DOOLEY ET AL., MOL IMMUNOL, vol. 40, 2003, pages 25 - 33",
                    "DOOLEY; FLAJNIK, EUR J IMMUNOL, vol. 35, 2005, pages 936 - 945",
                    "DOOLEY ET AL., PROC NATL ACAD SCI USA, vol. 103, 2006, pages 1846 - 1851",
                    "SHAO ET AL., MOL IMMUNOL, vol. 44, 2007, pages 656 - 665",
                    "LIU ET AL., BMC BIOTECHNOL, vol. 7, 2007, pages 78",
                    "NUTTALL ET AL., MOL IMMUNOL, vol. 38, 2001, pages 313 - 326",
                    "NUTTALL ET AL., EUR J BIOCHEM, vol. 270, 2003, pages 3543 - 3554",
                    "NUTTALL ET AL., PROTEINS, vol. 55, 2004, pages 187 - 197",
                    "FAY; SCOTT, IMMUNOTHERAPY, vol. 3, no. 3, 2011, pages 381 - 394",
                    "BANDER, CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, vol. 10, no. 8, 2012, pages 3 - 7",
                    "QASBA ET AL., BIOTECHNOL PROG, vol. 24, 2008, pages 520 - 526",
                    "LEIMGRUBER ET AL., J AM CHEM SOC, vol. 87, 1965, pages 5793 - 5795",
                    "LEIMGRUBER ET AL., JAM CHEM SOC, vol. 87, 1965, pages 5791 - 5793",
                    "WOYKE ET AL., ANTIMICROB AGENTS AND CHEMOTHER, vol. 45, no. 12, 2001, pages 3580 - 3584",
                    "PETTIT ET AL., ANTIMICROB AGENTS CHEMOTHER, vol. 42, 1998, pages 2961 - 2965",
                    "HINMAN ET AL., CANCER RES, vol. 53, 1993, pages 3336 - 3342",
                    "LODE ET AL., CANCER RES, vol. 58, 1998, pages 2925 - 2928",
                    "QUINTIERI ET AL., CLIN CANCER RES, vol. 11, no. 4, 2005, pages 1608 - 1617",
                    "GRANDI ET AL., CANCER TREAT REV, vol. 17, 1990, pages 133",
                    "RIPAMONTI ET AL., BR J CANCER, vol. 65, 1992, pages 703 - 707",
                    "CHARI ET AL., CANCER RES, vol. 52, 1992, pages 127 - 131",
                    "CARTELLIERI ET AL., J BIOMED BIOTECHNOL, 2010, pages 956304",
                    "PARK ET AL., MOL THER, vol. 15, no. 4, 2007, pages 825 - 833",
                    "SIEGALL ET AL., J. BIOL. CHEM., vol. 264, 1989, pages 14256 - 14261",
                    "PAI ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 3358 - 3362",
                    "KONDO ET AL., J. BIOL. CHEM., vol. 263, 1988, pages 9470 - 9475",
                    "PASTAN ET AL., BIOCHIM. BIOPHYS. ACTA, vol. 1333, 1997, pages C1 - C6",
                    "WELDON ET AL., BLOOD, vol. 113, no. 16, 2009, pages 3792 - 3800",
                    "ONDA ET AL., PROC NATL ACAD SCI USA, vol. 105, no. 32, 2008, pages 11311 - 11316",
                    "CONNOR ET AL., PHARM. THER., vol. 28, 1985, pages 341 - 365",
                    "PASZKO; SENGE, CURR MED CHEM, vol. 19, no. 31, 2012, pages 5239 - 5277",
                    "IMMORDINO ET AL., INT J NANOMEDICINE, vol. 1, no. 3, 2006, pages 297 - 315",
                    "\"Remington's Pharmaceutical Science, 19th ed.\", 1995, MACK PUBLISHING COMPANY",
                    "BANGA, A.J.: \"Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems\", 1995, TECHNOMIC PUBLISHING COMPANY, INC.",
                    "KREUTER, J.: \"Colloidal Drug Delivery Systems\", 1994, MARCEL DEKKER, INC., pages: 219 - 342",
                    "TICE; TABIBI: \"Treatise on Controlled Drug Delivery\", 1992, MARCEL DEKKER, INC, pages: 315 - 339",
                    "LANGER, ACCOUNTS CHEM. RES, vol. 26, 1993, pages 537 - 542",
                    "JOHNSTON ET AL., PHARM. RES., vol. 9, 1992, pages 425 - 434",
                    "PEC ET AL., J. PARENT. SCI. TECH., vol. 44, no. 2, 1990, pages 58 - 65",
                    "IJNTEMA ET AL., INT. J. PHARM., vol. 112, 1994, pages 215 - 224",
                    "M\u00dcLLER ET AL., MABS, vol. 4, 2012, pages 673 - 685",
                    "OHTANI ET AL., MAR BIOTECHNOL, vol. 15, 2013, pages 56 - 62",
                    "OHTANI ET AL., FISH SHELLFISH IMMUNOL, vol. 34, 2013, pages 724 - 728",
                    "ZIELONKA ET AL., J BIOTECHNOL, vol. 191, 2014, pages 236 - 245",
                    "KOPSIDAS ET AL., IMMUNOL LETT, vol. 107, 2006, pages 163 - 168",
                    "PHUNG ET AL., MABS, vol. 4, 2012, pages 592 - 599",
                    "GAO ET AL., NAT COMMUN, vol. 6, 2015, pages 6536",
                    "FENG ET AL., PROC NATL ACAD SCI USA, vol. 110, 2013, pages E1083 - E1091",
                    "FENG; HO, FEBS LETT, vol. 588, 2014, pages 377 - 382",
                    "LIU ET AL., PROC NATL ACAD SCI USA, vol. 109, 2012, pages 11782 - 11787",
                    "ALEWINE ET AL., MOL CANCER THER, vol. 13, 2014, pages 2653 - 2661",
                    "KOVALEVA ET AL., EXPERT OPIN BIOL THER, vol. 14, 2014, pages 1527 - 1539",
                    "CAMACHO-VILLEGAS ET AL., MABS, vol. 5, 2013, pages 80 - 85",
                    "MULLER ET AL., MABS, vol. 4, 2012, pages 673 - 685",
                    "WALSH ET AL., VIROLOGY, vol. 411, 2011, pages 132 - 141",
                    "GOODCHILD ET AL., MOL IMMUNOL, vol. 48, 2011, pages 2027 - 2037",
                    "NUTTALL ET AL., FEBS LETT, vol. 516, 2002, pages 80 - 6"
                ],
                "nplResolvedCount": 89,
                "nplResolvedLensIDs": [
                    "031-891-811-637-90X",
                    "125-887-305-963-629",
                    "126-670-872-645-263",
                    "060-391-827-069-40X",
                    "022-695-199-813-430",
                    "002-495-630-767-098",
                    "099-415-168-216-03X",
                    "138-792-006-137-992",
                    "123-559-100-031-929",
                    "027-670-963-287-976",
                    "032-749-455-659-553",
                    "048-389-769-784-036",
                    "065-684-269-783-203",
                    "049-955-273-394-333",
                    "004-694-440-872-537",
                    "109-664-639-230-056",
                    "048-853-055-063-524",
                    "016-155-290-797-107",
                    "083-672-921-972-481",
                    "004-056-961-843-815",
                    "140-686-709-284-617",
                    "052-724-213-786-191",
                    "049-134-753-209-354",
                    "054-257-655-602-057",
                    "093-576-263-928-739",
                    "081-177-071-539-997",
                    "005-813-390-127-218",
                    "044-695-786-434-628",
                    "114-264-767-617-683",
                    "123-452-046-644-23X",
                    "031-429-862-517-588",
                    "056-460-395-736-329",
                    "049-645-318-851-478",
                    "097-694-869-419-018",
                    "085-764-009-624-439",
                    "154-738-795-445-041",
                    "031-230-174-713-712",
                    "003-525-643-875-478",
                    "053-410-183-185-380",
                    "012-258-343-712-880",
                    "012-887-746-280-711",
                    "105-024-621-755-777",
                    "010-734-451-880-891",
                    "044-559-151-383-437",
                    "001-752-680-214-246",
                    "043-271-014-136-772",
                    "027-688-746-910-536",
                    "014-454-617-643-60X",
                    "015-796-443-867-043",
                    "101-914-796-586-505",
                    "109-354-311-139-255",
                    "117-416-919-237-41X",
                    "056-201-471-905-934",
                    "162-450-410-656-890",
                    "037-739-438-733-451",
                    "076-295-340-200-024",
                    "039-943-722-485-724",
                    "030-134-218-546-041",
                    "046-099-948-978-735",
                    "088-125-732-406-009",
                    "047-294-403-699-699",
                    "032-728-154-591-070",
                    "024-995-475-936-443",
                    "071-328-232-469-698",
                    "121-926-711-462-17X",
                    "100-041-294-232-313",
                    "101-693-241-437-665",
                    "023-693-113-014-951",
                    "128-112-305-146-026",
                    "016-617-627-772-41X",
                    "026-068-595-051-389",
                    "093-183-016-210-781",
                    "038-383-743-124-048",
                    "023-875-640-152-798",
                    "151-614-122-349-22X",
                    "003-280-353-877-595",
                    "119-624-955-614-365",
                    "050-268-426-304-10X",
                    "001-229-324-200-781",
                    "017-184-999-837-662",
                    "148-029-633-567-717",
                    "048-691-666-475-879",
                    "003-131-309-414-13X",
                    "071-273-910-767-454",
                    "011-012-284-651-080",
                    "032-720-983-972-675",
                    "014-423-782-126-065",
                    "038-994-369-651-86X",
                    "091-571-308-998-082"
                ],
                "nplResolvedExternalIDs": [
                    "9847182",
                    "17716160",
                    "10.1021/ar00034a004",
                    "10.1002/eji.200425760",
                    "pmc1977399",
                    "10.1016/0161-5890(79)90051-8",
                    "23599925",
                    "10.1177/019262339902700507",
                    "10.1093/nar/29.1.207",
                    "2272029",
                    "2231712",
                    "pmc2714450",
                    "11125093",
                    "12919318",
                    "16500706",
                    "pmc2435414",
                    "23471984",
                    "pmc2670794",
                    "10.1016/j.ejca.2010.10.024",
                    "23632026",
                    "11959108",
                    "10.1016/s0304-419x(97)00021-8",
                    "10.1128/aac.42.11.2961",
                    "10.1023/a:1015815624334",
                    "pmc4050542",
                    "10.1016/0022-2836(70)90057-4",
                    "21239030",
                    "21395380",
                    "10.1046/j.1432-1033.2003.03737.x",
                    "10.1002/prot.20005",
                    "10.1016/s0022-1759(00)00341-0",
                    "5420325",
                    "10.1016/s0014-5793(02)02506-1",
                    "10.1016/j.molimm.2006.07.299",
                    "10.1074/jbc.m112.435289",
                    "23257206",
                    "10528633",
                    "10.1007/s00430-009-0116-7",
                    "8162065",
                    "pmc4221527",
                    "17007931",
                    "10.1172/jci200113712",
                    "10.1073/pnas.1217868110",
                    "pmc3947105",
                    "pmc102442",
                    "10.1016/j.jbiotec.2014.04.023",
                    "pmc1413636",
                    "9751746",
                    "24140348",
                    "10.1128/aac.45.12.3580-3584.2001",
                    "pmc3682541",
                    "2720464",
                    "10.1073/pnas.1209292109",
                    "11223067",
                    "10.1021/bp0704034",
                    "pmc420240",
                    "15319492",
                    "22552958",
                    "10.1073/pnas.85.8.2444",
                    "10.1155/2010/956304",
                    "pmc3031711",
                    "10.1016/j.jim.2006.07.019",
                    "10.1073/pnas.88.11.5066-d",
                    "10.1038/sj.mt.6300104",
                    "10.2174/092986712803833362",
                    "2014255",
                    "10.1016/j.molimm.2006.01.010",
                    "10.4161/mabs.22242",
                    "10.1016/j.virol.2010.12.034",
                    "447371",
                    "10.1016/j.fsi.2012.11.041",
                    "10.1016/0163-7258(85)90058-0",
                    "pmc3502234",
                    "17717971",
                    "10.1038/342877a0",
                    "22753489",
                    "pmc105973",
                    "18426242",
                    "18678888",
                    "2849754",
                    "10.1111/1467-6486.00238",
                    "10.1126/science.1101148",
                    "23676205",
                    "19529959",
                    "10.1201/9781498710565",
                    "pmc165532",
                    "10.1182/blood-2008-08-173195",
                    "15240702",
                    "18988862",
                    "25239937",
                    "16962608",
                    "10.1006/jmbi.1997.1354",
                    "10.1093/bioinformatics/5.2.151",
                    "24830426",
                    "10.1002/med.20212",
                    "20047035",
                    "pmc280013",
                    "5845428",
                    "5845427",
                    "10.1016/0305-7372(90)90037-g",
                    "15688348",
                    "9395287",
                    "pmc2213646",
                    "3911220",
                    "22820551",
                    "10.3390/antib4030240",
                    "10.1021/ja00952a050",
                    "10.2144/000114017",
                    "10.1021/ja00952a051",
                    "pmc209407",
                    "10.1016/s0022-2836(05)80360-2",
                    "25523873",
                    "pmc146384",
                    "10592230",
                    "18021450",
                    "10.4049/jimmunol.173.2.1129",
                    "10.1016/j.jmb.2006.12.045",
                    "pmc3406843",
                    "10.1007/s10126-012-9456-1",
                    "10.1186/1472-6750-7-78",
                    "10.1073/pnas.1321502111",
                    "pmc2426795",
                    "pmc338945",
                    "10.1006/jmbi.1990.9999",
                    "pmc90872",
                    "10.4161/mabs.22593",
                    "pmc147225",
                    "10.1073/pnas.0508341103",
                    "17299405",
                    "15746066",
                    "10.1016/j.jmb.2010.04.061",
                    "10.1007/978-1-4419-1132-2_6",
                    "12389098",
                    "16446445",
                    "pmc3499300",
                    "10.1016/0022-2836(87)90412-8",
                    "2687698",
                    "1586598",
                    "10.1158/1535-7163.mct-14-0132",
                    "24862193",
                    "pmc2516223",
                    "pmc4127195",
                    "pmc51446",
                    "pmc148137",
                    "10.1038/bjc.1992.148",
                    "10.1007/s00251-002-0479-z",
                    "10.1093/nar/16.22.10881",
                    "10.1016/j.coph.2008.06.007",
                    "1727373",
                    "12909128",
                    "20450918",
                    "10.2217/17435889.1.3.297",
                    "11518720",
                    "25090369",
                    "10.1073/pnas.0804851105",
                    "11709343",
                    "10.1073/pnas.95.20.11804",
                    "10.1093/nar/27.1.209",
                    "23221782",
                    "20467460",
                    "8324745",
                    "10.1517/14712598.2014.937701",
                    "10.1073/pnas.88.8.3358",
                    "pmc3564889",
                    "9367782",
                    "10.4161/mabs.20933",
                    "21112773",
                    "10.2217/imt.11.5",
                    "10.1186/1472-6750-7-23",
                    "10.1158/1078-0432.ccr-04-1845",
                    "pmc21721",
                    "20544978",
                    "18619558",
                    "10.1016/j.febslet.2013.10.002",
                    "9797233",
                    "10.1186/1471-2172-5-8",
                    "17258766",
                    "21752470",
                    "pmc3607002",
                    "3243435",
                    "14997552",
                    "pmc2864912",
                    "17511866",
                    "17069896",
                    "15132758",
                    "10.1172/jci13712",
                    "10.1016/s0161-5890(01)00057-8",
                    "11566324",
                    "10.1016/0378-1119(88)90330-7",
                    "10.1016/0378-5173(94)90357-3",
                    "2357375",
                    "1614979",
                    "9679947",
                    "10.4161/19420862.2015.989032",
                    "22934774",
                    "10.1016/j.imlet.2006.09.004",
                    "10.1016/j.molimm.2011.06.437",
                    "10.1016/s0161-5890(03)00084-1",
                    "2503515",
                    "3132465",
                    "3681981",
                    "10.1097/00007611-195101000-00027",
                    "3162770",
                    "pmc29797",
                    "10.1038/ng0294-119"
                ]
            },
            {
                "index": "8",
                "publicationKey": "WO_2017_212422_A1",
                "lensId": "188-372-610-856-777",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/212422 A1",
                "publicationDate": "2017-12-14",
                "filingNumber": "IB 2017053367 W",
                "filingDate": "2017-06-07",
                "priorityFilingKeysActive": [
                    "US 201662347387 P 20160608"
                ],
                "earliestPriorityDate": "2016-06-08",
                "title": "Topical Compositions Comprising Carbomer For The Treatment And Prevention Of Viral Infections And Allergic Conditions",
                "applicants": [
                    "NOVARTIS CONSUMER HEALTH SA"
                ],
                "inventors": [
                    "CHURCH DENNIS JOSEPH",
                    "NICHOLS ANTHONY"
                ],
                "owners": [],
                "url": "https://lens.org/188-372-610-856-777",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/78",
                    "A61K9/0043",
                    "A61P31/16"
                ],
                "ipcrClassifications": [
                    "A61K31/78",
                    "A61K9/00",
                    "A61P11/02",
                    "A61P27/14",
                    "A61P31/16"
                ],
                "usClassifications": [],
                "nplCitationCount": 40,
                "nplCitations": [
                    "LUCZAK: \"Antiviral and anineoplastic effect of Carbopol\", 1 January 1979 (1979-01-01), pages 815 - 821, XP055396901, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pubmed/233349> [retrieved on 20170808]",
                    "CLERCQ ET AL: \"Antiviral activity of carbopol, a cross-linked polycarboxylate\", 1 January 1976 (1976-01-01), pages 151 - 158, XP055396905, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pubmed/187146> [retrieved on 20170808]",
                    "BLOEMERS H P J ET AL: \"Inhibition of RNA-dependent DNA polymerase of oncorna viruses by Carbopol 934\", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 52, no. 1, 15 March 1975 (1975-03-15), pages 141 - 144, XP025602906, ISSN: 0014-5793, [retrieved on 19750315], DOI: 10.1016/0014-5793(75)80657-0",
                    "K.H. MAIR ET AL: \"Carbopol improves the early cellular immune responses induced by the modified-life vaccine Ingelvac PRRS MLV\", VETERINARY MICROBIOLOGY, vol. 176, no. 3-4, 1 April 2015 (2015-04-01), NL, pages 352 - 357, XP055308822, ISSN: 0378-1135, DOI: 10.1016/j.vetmic.2015.02.001",
                    "\"Final report on the safety assessment of carbomers - 934, -910, -934P, -940, -941 and -962\", INT. J. TOXICOLOGY, vol. 1, 1982, pages 109 - 141",
                    "BARRETT B.: \"Medicinal properties of Echinacea: a critical review\", PHYTOMEDICINE, vol. 10, 2003, pages 66 - 86, XP004957204, DOI: doi:10.1078/094471103321648692",
                    "BERTINO JS.: \"Cost burden of viral respiratory infections: issues for formulary decision makers\", AM. J. MED., vol. 112, 2002, pages 42S - 49S",
                    "\"Carbopol. Water soluble resins.\", SERVICE BULL. GC-36, 1962",
                    "BLOEMERS HPJ; VAN DER HORST A.: \"Inhibition of RNA-dependent DNA polymerase of oncorna viruses by Carbapol 934\", FEBS LET., vol. 52, no. 1, 1975, pages 141 - 144, XP025602906, DOI: doi:10.1016/0014-5793(75)80657-0",
                    "CHOULIS N.: \"Timed-release tablets containing quinine sulfate\", J. PHORM. SCI., vol. 64, no. 6, 1976, pages 1033 - 1035, XP009014686, DOI: doi:10.1002/jps.2600640634",
                    "\"Final Report on the Safety Assessment of Carbomers-934, -910, -934P, -940, -941, and - 962\", JOURNAL OF THE AMERICAN COLLEGE OF TOXICOLOGY, vol. 1, 1982, pages 109 - 141",
                    "DE CLERCQ; LUCZAK M.: \"Antiviral activity of carpobol, a cross-linked polycarboxylate\", ARCH. VIROL, vol. 52, no. 1, 1976, pages 151 - 158, XP055396905",
                    "ELGINDY NA.: \"Molecular entrapment of cationic drugs by Carbopol 934\", CAN. J. PHARM. SCI., vol. 11, no. 1, 1976, pages 32 - 4",
                    "FENDRICK AM; MONTO AS; NIGHTENGALE B; SARNES M.: \"The economic burden of non-influenza-related viral respiratory tract infection in the United States\", ARCH. INTERN. MED., vol. 163, 2003, pages 487 - 494",
                    "GERN JE; MOSSER AG; SWENSON CA; RENNIE PJ; ENGLAND RJ; SHAFFER J; MIZOGUCHI H.: \"Inhibition of rhinovirus replication in vitro and in vivo by acid-buffered saline.\", J. INF. DIS, vol. 195, 2007, pages 1137 - 1143",
                    "GIRANDA VL; HEINZ BA; OLIVIERA MA.: \"Acid-induced structural changes in human rinovirus-14 and possible role in uncoating\", PROC. NAT'I ACAD. SCI. USA, vol. 89, 1992, pages 10213 - 10217",
                    "HAYDEN FG; GWALTNEY JM.: \"Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds infection\", J. INFECT. DIS, vol. 150, 1984, pages 174 - 180",
                    "HAYDEN FG; KAISER DL; ALBRECHT JK.: \"Intranasal recombinant alpha-2b interferon treatment of naturally occurring common colds.\", ANTIMICROB. AGENTS CHEMOTHER., vol. 32, 1988, pages 224 - 230",
                    "HAYDEN FG; ANDRIES K; JANSSEN PA.: \"Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection.\", ANTIMICROB. AGENTS CHEMOTHER, vol. 36, 1992, pages 727 - 732",
                    "HAYDEN FG; HIPSKIND GJ; WOERNER DH; EISEN GF; JANSSENS M; JANSSEN PA; ANDRIES K.: \"Intranasal pirodavir (R77975) treatment of rhinovirus colds.\", ANTIMICROB. AGENTS CHEMOTHER, vol. 39, 1995, pages 290 - 294, XP002474491",
                    "HAYDEN FG; HERRINGTON DT; COATS TL; KIM K; COOPER EC; VILLANO SA; LIU S; HUDSON S; PEVEAR DC; COLLETT M: \"Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of two double-blind, randomized, placebo-controlled trials.\", CLIN. INFECT. DIS., vol. 36, 2003, pages 1523 - 1532, XP002392816, DOI: doi:10.1086/375069",
                    "HAYDEN FG; TURNER RB; GWALTNEY JM; CHI-BURRIS K; GERSTEN M; HSYU P; PATICK AK; SMITH GJ; ZALMAN LS: \"Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray two-percent suspension for prevention and treatment of experimentally-induced rhinovirus colds in healthy volunteers.\", ANTIMICROB. AGENTS CHEMOTHER, vol. 47, 2003, pages 3907 - 3916",
                    "HULL D; RENNIE P; NORONHA A; POORE C; HARRINGTON N; FEARNLEY V; PASSALI D.: \"Effects of creating a non-specific, virus hostile environment in the nasopharanx on symptoms and duration of the common cold\", ACTA OTORHIN. ITAL., vol. 27, 2007, pages 73 - 77",
                    "JACOBS SE; LAMSON DM; ST. GEORGE K; WALSH TJ., CLIN. MICROBIOL. REV., vol. 26, no. 1, 2013, pages 135 - 162",
                    "JULLAPHANT T: \"Colloidal properties of montelukast sodium nasal spray. Paper presented at: 5th Thailand International Nanotechnology Conference (NanoThailand\", NANOTECHNOLOGY ASSOCIATION OF THAILAND., 2016",
                    "KENNEDY JL; TURNER RB; BRACIALE, T; HEYMANN, P; BORISH, L: \"Pathogenesis of rhinovirus infection\", CURRENT OPINION IN VIROLOGY, vol. 2, 2012, pages 287 - 293, XP055311472, DOI: doi:10.1016/j.coviro.2012.03.008",
                    "KUMAR BV.: \"Inhibition of reverse transcriptase and r-DNA polymerase by Carbapol 934\", MICROBIOS. LETT., vol. 2, no. 7, 1976, pages 219 - 223",
                    "LAZE L; BARENE I; NESTEROVA Z ET AL.: \"Formulation of product for topical delivery of heparin\", PAPER PRESENTED AT: INTERNATIONAL STUDENT CONFERENCE OF THE RIGAS STRADINA UNIVERSITY: HEALTH AND SOCIAL SCIENCES., 2017",
                    "NICHOL KL; D'HEILLY S; EHLINGER E.: \"Colds and influenza-like illnesses in university students: impact on health, academic and work performance, and health care use\", CLIN. INFECT. DIS., vol. 40, 2005, pages 1263 - 1270",
                    "PALMENBERG AC; SPIRO D; KUZMICKAS R; WANG S; DJIKENG A; RATHE JA; FRASER-LIGGETT CM; LIGGETT SB.: \"Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution.\", SCIENCE, vol. 324, 2009, pages 55 - 59, XP055118758, DOI: doi:10.1126/science.1165557",
                    "PALMENBERG AC; RATHE JA; LIGGETT SB.: \"Analysis of the complete genome sequences of human rhinovirus\", J. ALLERGY CLIN. IMMUNOL, vol. 125, 2010, pages 1190 - 1201",
                    "PATICK AK; BROTHERS MA; MALDONADO F; BINFORD S; MALDONADO O; FUHRMAN S; PETERSEN A; SMITH GJ; ZALMAN LS.: \"In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease\", ANTIMICROB. AGENTS CHEMOTHER, vol. 49, 2005, pages 2267 - 2275",
                    "PEVEAR DC; HAYDEN FG; DEMENCZUK TM; BARONE LR; MCKINLAY MA; COLLETT MS.: \"Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses\", ANTIMICROB. AGENTS CHEMOTHER, vol. 49, 2005, pages 4492 - 4499",
                    "RAJNIK M; TOLAN RW., RHINOVIRUS INFECTION, 2014, Retrieved from the Internet <URL:http://emedicine.medscape.com/ article/ 227820-overview#a0101>",
                    "RENNIE P; BOWTELL P; HULL D; CHARBONNEAU D; LAMBKIN-WILLIAMS R; OXFORD J.: \"Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection.\", RESPIR RES., vol. 8, no. 1, 2007, pages 38, XP021027435, DOI: doi:10.1186/1465-9921-8-38",
                    "ROELEN CAM; KOOPMANS PC; NOTENBOMER A; GROOTHOFF JW.: \"Job satisfaction and short sickness absence due to the common cold\", WORK, vol. 39, 2011, pages 305 - 313",
                    "SIMASEK M; BLANDINO DA.: \"Treatment of the common cold.\", AMER. FAM. PHYSICIAN, vol. 75, no. 4, 2007, pages 515 - 20",
                    "WINE TM; ALPER CM.: \"Cytokine responses in the common cold and otitis media.\", CURR ALLERGY ASTHMA REP., vol. 12, no. 6, 2012, pages 574 - 581, XP035135439, DOI: doi:10.1007/s11882-012-0306-z",
                    "WINDHOLZ M: \"The Merck Index, 9th ed.\", 1976, MERCK & CO",
                    "ZUCKERMAN AJ: \"Principles and Practice of Clinical Virology, 6th Edition,\", 2007, WILEY, pages: 496"
                ],
                "nplResolvedCount": 30,
                "nplResolvedLensIDs": [
                    "005-996-056-579-539",
                    "148-466-068-286-589",
                    "143-637-150-196-867",
                    "108-399-414-820-791",
                    "009-376-281-904-316",
                    "062-932-095-932-045",
                    "131-810-466-111-189",
                    "087-688-064-471-878",
                    "070-220-415-942-520",
                    "114-241-417-127-826",
                    "029-688-779-635-174",
                    "004-967-144-049-264",
                    "085-545-351-952-964",
                    "015-809-327-934-499",
                    "059-551-862-842-845",
                    "088-913-492-821-445",
                    "041-173-432-545-34X",
                    "132-658-871-904-61X",
                    "043-201-732-321-119",
                    "124-388-869-608-013",
                    "029-245-145-707-356",
                    "049-684-187-282-165",
                    "081-433-204-269-872",
                    "015-256-782-039-712",
                    "085-944-451-004-791",
                    "004-027-037-663-680",
                    "041-826-502-904-308",
                    "059-527-995-517-165",
                    "091-219-132-750-354",
                    "114-426-980-780-286"
                ],
                "nplResolvedExternalIDs": [
                    "pmc172139",
                    "pmc189373",
                    "10.1128/aac.49.6.2267-2275.2005",
                    "1332036",
                    "15917520",
                    "pmc296196",
                    "17608134",
                    "23054624",
                    "pmc1885256",
                    "pmc1280128",
                    "10.1093/infdis/150.2.174",
                    "10.1086/429237",
                    "10.1128/aac.47.12.3907-3916.2003",
                    "10.1007/bf01317874",
                    "15825028",
                    "21709366",
                    "47299",
                    "20471068",
                    "pmc2640010",
                    "10.1128/cmr.00077-12",
                    "1133722",
                    "10.1078/094471103321648692",
                    "12802751",
                    "10.1007/s11882-012-0306-z",
                    "7726484",
                    "12588210",
                    "12622467",
                    "10.1016/0016-0032(62)90965-1",
                    "pmc1140523",
                    "1503435",
                    "14638501",
                    "pmc2893015",
                    "10.1016/j.jaci.2010.04.010",
                    "10.1001/archinte.163.4.487",
                    "17357049",
                    "10.1016/j.coviro.2012.03.008",
                    "10.1073/pnas.89.21.10213",
                    "10.3233/wor-2011-1178",
                    "pmc50308",
                    "10.1128/aac.49.11.4492-4499.2005",
                    "23297263",
                    "11955459",
                    "187146",
                    "pmc3378761",
                    "10.1016/j.vetmic.2015.02.001",
                    "10.1128/aac.39.2.290",
                    "10.1126/science.1165557",
                    "10.1086/512858",
                    "10.1016/0014-5793(75)80657-0",
                    "6381610",
                    "17509128",
                    "10.1067/mda.2003.22",
                    "2834996",
                    "pmc3553670",
                    "10.3109/10915818209013151",
                    "25707990",
                    "10.1002/jps.2600640634",
                    "22542099",
                    "10.1186/1465-9921-8-38",
                    "pmc162529",
                    "16251287",
                    "10.1128/aac.36.4.727",
                    "10.1086/375069",
                    "17323712",
                    "pmc3923423",
                    "19213880",
                    "10.1128/aac.32.2.224"
                ]
            },
            {
                "index": "9",
                "publicationKey": "WO_2015_143335_A1",
                "lensId": "044-568-385-301-945",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/143335 A1",
                "publicationDate": "2015-09-24",
                "filingNumber": "US 2015/0021773 W",
                "filingDate": "2015-03-20",
                "priorityFilingKeysActive": [
                    "US 201461968279 P 20140320"
                ],
                "earliestPriorityDate": "2014-03-20",
                "title": "Methods And Compositions For Chimeric Coronavirus Spike Proteins",
                "applicants": [
                    "UNIV NORTH CAROLINA"
                ],
                "inventors": [
                    "BARIC RALPH",
                    "AGNIHOTHRAM SUDHAKAR",
                    "YOUNT BOYD"
                ],
                "owners": [],
                "url": "https://lens.org/044-568-385-301-945",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "A61K2039/5256",
                    "A61K2039/5258",
                    "A61K2039/70",
                    "C07K16/10",
                    "C07K2317/34",
                    "C07K2317/76",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "C12N2770/36123",
                    "C12N2770/36143",
                    "C12N2770/36144"
                ],
                "ipcrClassifications": [
                    "C07K14/165",
                    "A61K39/215",
                    "A61P31/12",
                    "C12N15/50"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "AGNIHOTHRAM S ET AL.: \"Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses\", J INFECT DIS., vol. 209, no. 7, 18 November 2013 (2013-11-18), pages 995 - 1006, XP055227760, [retrieved on 20140401]"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "089-209-533-057-090"
                ],
                "nplResolvedExternalIDs": [
                    "24253287",
                    "pmc3952667",
                    "10.1093/infdis/jit609"
                ]
            },
            {
                "index": "10",
                "publicationKey": "US_9884895_B2",
                "lensId": "131-058-428-999-313",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9884895 B2",
                "publicationDate": "2018-02-06",
                "filingNumber": "US 201515124992 A",
                "filingDate": "2015-03-20",
                "priorityFilingKeysActive": [
                    "US 201461968279 P 20140320"
                ],
                "earliestPriorityDate": "2014-03-20",
                "title": "Methods And Compositions For Chimeric Coronavirus Spike Proteins",
                "applicants": [
                    "UNIV NORTH CAROLINA CHAPEL HILL"
                ],
                "inventors": [
                    "BARIC RALPH",
                    "AGNIHOTHRAM SUDHAKAR",
                    "YOUNT BOYD"
                ],
                "owners": [
                    {
                        "name": "THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL",
                        "executionDate": "2016-10-05"
                    }
                ],
                "url": "https://lens.org/131-058-428-999-313",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 8,
                "cpcClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "A61K2039/5256",
                    "A61K2039/5258",
                    "A61K2039/70",
                    "C07K16/10",
                    "C07K2317/34",
                    "C07K2317/76",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "C12N2770/36123",
                    "C12N2770/36143",
                    "C12N2770/36144"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/00",
                    "A61K39/12",
                    "A61K39/215",
                    "A61K39/395",
                    "A61K45/06",
                    "C07K14/005",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 292,
                "nplCitations": [
                    "Agnihothram et al. \u201cEvaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses\u201d The Journal of Infectious Diseases 209:995-1006 (2014).",
                    "International Search Report and the Written Opinion of the International Searching Authority corresponding to International Patent Application No. PCT/US2015/021773 (12 pages) (dated Jun. 10, 2015).",
                    "GenBank Accession No. ACJ60694.1, \u201cSpike glycoprotein [recombinant coronavirus]\u201d, NCBI, 2 pages, Jul. 26, 2016.",
                    "GenBank Accession No. AAP13441.1, \u201cS protein [SARS coronavirus Urbani]\u201d, NCBI, 2 pages, Jul. 25, 2016.",
                    "GenBank Accession No. ABG47069, \u201cSpike protein [Bat CoV 279/2005]\u201d, NCBI, 2 pages, Jul. 19, 2006.",
                    "GenBank Accession No. ABN10848.1, \u201cSpike glycoprotein [Bat coronavirus HKU4-2]\u201d, NCBI, 2 pages, Feb. 7, 2007.",
                    "GenBank Accession No. AFS88936.1, \u201cS protein [Human betacoronavirus 2c EMC/2012]\u201d, NCBI, 2 pages, Dec. 4, 2012.",
                    "GenBank Accession No. ABN10902.1, \u201cSpike glycoprotein [Bat coronavirus HKU5-5]\u201d, NCBI, 2 pages, Feb. 7, 2007.",
                    "GenBank Accession No. FJ211859, \u201cRecombinant coronavirus clone Bat SARS-CoV, complete sequence\u201d, NCBI, 11 pages, Jul. 26, 2016.",
                    "GenBank Accession No. FJ211860, \u201cRecombinant coronavirus clone Bat-SRBD spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Dec. 31, 2008.",
                    "GenBank Accession No. DQ022305, \u201cBat SARS coronavirus HKU3-1, complete genome\u201d, NCBI, 12 pages, Oct. 25, 2005.",
                    "GenBank Accession No. DQ084199, \u201cBat SARS coronavirus HKU3-2, complete genome\u201d, NCBI, 12 pages, Sep. 28, 2005.",
                    "GenBank Accession No. DQ084200, \u201cBat SARS coronavirus HKU3-3, complete genome\u201d, NCBI, 12 pages, Sep. 28, 2005.",
                    "GenBank Accession No. DQ412043, \u201cBat SARS coronavirus Rm1, complete genome\u201d, NCBI, 12 pages, Jul. 13, 2006.",
                    "GenBank Accession No. DQ648857, \u201cBat coronavirus (BtCoV/279/2005), complete genome\u201d, NCBI, 11 pages, Jul. 19, 2006.",
                    "GenBank Accession No. DQ412042, \u201cBat SARS coronavirus Rf1, complete genome\u201d, NCBI, 12 pages, Jul. 13, 2016.",
                    "GenBank Accession No. DQ648856, \u201cBat coronavirus (BtCoV/273/2005), complete genome\u201d, NCBI, 11 pages, Jul. 19, 2006.",
                    "GenBank Accession No. DQ071615, \u201cBat SARS coronavirus Rp3, complete genome\u201d, NCBI, 12 pages, Jan. 25, 2006.",
                    "GenBank Accession No. AY686863, \u201cSARS coronavirus A022, complete genome\u201d, NCBI, 12 pages, Jul. 21, 2006.",
                    "GenBank Accession No. AY278554, \u201cSARS coronavirus CUHK-W1, complete genome\u201d, NCBI, 14 pages, Jul. 31, 2003.",
                    "GenBank Accession No. AY278489, \u201cSARS coronavirus GD01, complete genome\u201d, NCBI, 13 pages, Sep. 1, 2009.",
                    "GenBank Accession No. AY515512, \u201cSARS coronavirus HC/SZ/61/03, complete genome\u201d, NCBI, 8 pages, Jan. 1, 2005.",
                    "Genbank accession No. AY304488, \u201cSARS coronavirus SZ16, complete genome\u201d, NCBI 8 pages, Nov. 5, 2003.",
                    "GenBank Accession No. AY278741, \u201cSARS coronavirus Urbani, complete genome\u201d, NCBI 14 pages, Jul. 25, 2016.",
                    "GenBank Accession No. AY572035, \u201cSARS coronavirus civet010, complete genome\u201d, NCBI, 12 pages, Dec. 1, 2005.",
                    "GenBank Accession No. DQ497008, \u201cSARS coronavirus strain MA-15, complete genome\u201d, NCBI, 13 pages, Mar. 20, 2007.",
                    "GenBank Accession No. KC881005, \u201cBat SARS-like coronavirus RsSHC014, complete genome\u201d, NCBI, 13 pages, Nov. 22, 2013.",
                    "GenBank Accession No. KC881006, Bat SARS-like coronavirus Rs3367, complete genome, NCBI, 13 pages, Nov. 22, 2013.",
                    "GenBank Accession No. KC881007, \u201cBat SARS-like coronavirus WIV1 spike protein (S) gene, complete cds\u201d, NCBI, 3 pages, Nov. 22, 2013.",
                    "GenBank Accession No. KF600652.1, \u201cMiddle East respiratory syndrome coronavirus isolate Riyadh\u20142\u20142012, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600651.1, \u201cMiddle East respiratory syndrome coronavirus isolate\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600647.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201417\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600645.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201415\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600644.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201416\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600634, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201421\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600632, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201419\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600630.1, \u201cMiddle East respiratory syndrome coronavirus isolate Buraidah\u20141\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600628.1, \u201cMiddle East respiratory syndrome coronavirus isolate Hafr-Al-Batin\u20141\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600627.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201412\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600620.1, \u201cMiddle East respiratory syndrome coronavirus isolate Bisha\u20141\u20142012, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600613.1, \u201cMiddle East respiratory syndrome coronavirus isolate Riyadh\u20143\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600612.1, \u201cMiddle East respiratory syndrome coronavirus isolate Riyadh\u20141\u20142012, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF186565.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20143\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF186567.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20141\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF186566.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20142\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF186564.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20144\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF192507.1, \u201cMiddle East respiratory syndrome coronavirus, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. NC\u2014019843, \u201cMiddle East respiratory syndrome coronavirus, complete genome\u201d, NCBI, 16 pages, Sep. 9, 2014.",
                    "GenBank Accession No. KC667074, \u201cHuman betacoronavirus 2c England-Qatar/2012, complete genome\u201d, NCBI, 13 pages, Apr. 30, 2013.",
                    "GenBank Accession No. KF600656.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201413d\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600655.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20147a\u20142013, partial genome\u201d, NCBI, 8 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600654.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20149b\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600649.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20149c\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600648.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20149a\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600646.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201411b\u20142013, partial genome\u201d, NCBI, 4 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600643.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201414b\u20142013, partial genome\u201d, NCBI, 7 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600642.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201410b\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600640.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201413e\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600639.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20149e\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600638.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20148b\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600637.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201413c\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600636.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201411c\u20142013, partial genome\u201d, NCBI, 7 pages, Jul. 24, 2014.",
                    "GenBank Accession No, KF600635.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20148d\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600631.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422e\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600626.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20148c\u20142013, partial genome\u201d, NCBI, 5 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600625.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422b\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600624.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201410c\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600623.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20147b\u20142013, partial genome\u201d, NCBI, 5 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600622.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20149d\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600621.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422f\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600619.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422d\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600618.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20148a\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600616.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201413b\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600615.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201414a\u20142013, partial genome\u201d, NCBI, 4 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600614.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201410e\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600641.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201410d\u20142013, partial genome\u201d, NCBI, 1 page, Jul. 24, 2014.",
                    "GenBank Accession No. KF600633.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422c\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600629.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201411a\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600617.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422a\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KC869678.2, \u201cCoronavirus Neoromicia/PML-PHE1/RSA/2011 RNA-dependent RNA polymerase (ORF1b) gene, partial cds\u201d, NCBI, 2 pages, Aug. 27, 2013.",
                    "GenBank Accession No. KF493885.1, \u201cBat Coronavirus Taper/CII\u2014KDS\u2014287/Bisha/Saudi Arabia/2012 RNA-directed RNA polymerase gene, partial cds\u201d, NCBI, 1 page, Nov. 14, 2013.",
                    "GenBank Accession No. KF493888.1, \u201cBat coronavirus Rhhar/CII\u2014KSA\u2014003/Bisha/Saudi Arabia/2013 RNA-directed RNA polymerase gene, partial cds\u201d, NCBI, 1 page, Nov. 14, 2013.",
                    "GenBank Accession No. KF493887.1, \u201cBat coronavirus Pikuh/CII\u2014KSA\u2014001/Riyadh/Saudi Arabia/2013 RNA-directed RNA polymerase gene, partial cds\u201d, NCBI, 1 page, Nov. 14, 2013.",
                    "GenBank Accession No. KF493886.1, \u201cBat coronavirus Rhhar/CII\u2014KSA\u2014002/Bisha/Saudi Arabia/2013 RNA-directed RNA polymerase gene, partial cds\u201d, NCBI, 1 page, Nov. 14, 2013.",
                    "GenBank Accession No. KF493884.1, \u201cBat coronavirus Rhhar/CII\u2014KSA\u2014004/Bisha/Saudi Arabia/2013 RNA-directed RNA polymerase gene, partial cds\u201d, NCBI, 1 page, Nov. 14, 2013.",
                    "GenBank Accession No. EF065506, \u201cBat coronavirus HKU4-2, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. NC\u2014009019, \u201cBat coronavirus HKU4-1, complete genome\u201d, NCBI, 13 pages, Mar. 28, 2016.",
                    "GenBank Accession No. EF065507, \u201cBat coronavirus HKU4-3, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. EF065508, \u201cBat coronavirus HKU4-4, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. NC\u2014008315, \u201cBat coronavirus (BtCoV/133/2005), complete genome\u201d, NCBI, 12 pages, May 22, 2007.",
                    "GenBank Accession No. EF065512, \u201cBat coronavirus HKU5-5, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. NC\u2014009020, \u201cBat coronavirus HKU5-1, complete genome\u201d, NCBI, 13 pages, Mar. 28, 2016.",
                    "GenBank Accession No. EF065510, \u201cBat coronavirus HKU5-2, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. EF065511, \u201cBat coronavirus HKU5-3, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. KC776174.1, \u201cHuman betacoronavirus 2c Jordan-N3/2012, complete genome\u201d, NCBI, 13 pages, Mar. 25, 2013.",
                    "GenBank Accession No. JX869059.2, \u201cHuman betacoronavirus 2c EMC/2012, complete genome\u201d, NCBI, 13 pages, Dec. 4, 2012.",
                    "GenBank Accession No. KC522089.1, \u201cPipistrellus bat coronavirus HKU5 isolate 33R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522088.1, \u201cPipistrellus bat coronavirus HKU5 isolate 32R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522087.1, \u201cPipistrellus bat coronavirus HKU5 isolate 31R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522086.1, \u201cPipistrellus bat coronavirus HKU5 isolate 30R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522085.1, \u201cPipistrellus bat coronavirus HKU5 isolate 28R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522084.1, \u201cPipistrellus bat coronavirus HKU5 isolate 27R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522083.1, \u201cPipistrellus bat coronavirus HKU5 isolate 26R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522082.1, \u201cPipistrellus bat coronavirus HKU5 isolate 24R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522081.1, \u201cPipistrellus bat coronavirus HKU5 isolate 22R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522080.1, \u201cPipistrellus bat coronavirus HKU5 isolate 21R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522079.1, \u201cPipistrellus bat coronavirus HKU5 isolate 20R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522078.1, \u201cPipistrellus bat coronavirus HKU5 isolate 19R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522077.1, \u201cPipistrellus bat coronavirus HKU5 isolate 18R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522076.1, \u201cPipistrellus bat coronavirus HKU5 isolate 17R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522075.1, \u201cPipistrellus bat coronavirus HKU5 isolate 16R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522104.1, \u201cPipistrellus bat coronavirus HKU5 isolate 33S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522103.1, \u201cPipistrellus bat coronavirus HKU5 isolate 32S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522102.1, \u201cPipistrellus bat coronavirus HKU5 isolate 31S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522101.1, \u201cPipistrellus bat coronavirus HKU5 isolate 30S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522100.1, \u201cPipistrellus bat coronavirus HKU5 isolate 28S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522099.1, \u201cPipistrellus bat coronavirus HKU5 isolate 27S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522098.1, \u201cPipistrellus bat coronavirus HKU5 isolate 26S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522097.1, \u201cPipistrellus bat coronavirus HKU5 isolate 24S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522096.1, \u201cPipistrellus bat coronavirus HKU5 isolate 22S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522095.1, \u201cPipistrellus bat coronavirus HKU5 isolate 21S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522094.1, \u201cPipistrellus bat coronavirus HKU5 isolate 20S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522093.1, \u201cPipistrellus bat coronavirus HKU5 isolate 19S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522092.1, \u201cPipistrellus bat coronavirus HKU5 isolate 18S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522091.1, \u201cPipistrellus bat coronavirus HKU5 isolate 17S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522090.1, \u201cPipistrellus bat coronavirus HKU5 isolate 16S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522119.1, \u201cPipistrellus bat coronavirus HKU5 isolate 33N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522118.1, \u201cPipistrellus bat coronavirus HKU5 isolate 32N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522117.1, \u201cPipistrellus bat coronavirus HKU5 isolate 31N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522116.1, \u201cPipistrellus bat coronavirus HKU5 isolate 30N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522115.1, \u201cPipistrellus bat coronavirus HKU5 isolate 28N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522114.1, \u201cPipistrellus bat coronavirus HKU5 isolate 27N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522113.1, \u201cPipistrellus bat coronavirus HKU5 isolate 26N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522112.1, \u201cPipistrellus bat coronavirus HKU5 isolate 24N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522111.1, \u201cPipistrellus bat coronavirus HKU5 isolate 22N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522110.1, \u201cPipistrellus bat coronavirus HKU5 isolate 21N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522109.1, \u201cPipistrellus bat coronavirus HKU5 isolate 20N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522108.1, \u201cPipistrellus bat coronavirus HKU5 isolate 19N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522107.1, \u201cPipistrellus bat coronavirus HKU5 isolate 18N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522106.1, \u201cPipistrellus bat coronavirus HKU5 isolate 17N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522105.1, \u201cPipistrellus bat coronavirus HKU5 isolate 16N nucleocapsid protein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522048.1, \u201cTylonycteris bat coronavirus HKU4 isolate 15R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522047.1, \u201cTylonycteris bat coronavirus HKU4 isolate 14R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522046.1, \u201cTylonycteris bat coronavirus HKU4 isolate 12R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522045.1, \u201cTylonycteris bat coronavirus HKU4 isolate 11R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522044.1, \u201cTylonycteris bat coronavirus HKU4 isolate 10R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522043.1, \u201cTylonycteris bat coronavirus HKU4 isolate 9R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522042.1, \u201cTylonycteris bat coronavirus HKU4 isolate 8R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522041.1, \u201cTylonycteris bat coronavirus HKU4 isolate 7R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522040.1, \u201cTylonycteris bat coronavirus HKU4 isolate 6R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522039.1, \u201cTylonycteris bat coronavirus HKU4 isolate 5R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522038.1, \u201cTylonycteris bat coronavirus HKU4 isolate 4R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522037.1, \u201cTylonycteris bat coronavirus HKU4 isolate 3R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522036.1, \u201cTylonycteris bat coronavirus HKU4 isolate 2R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522061.1, \u201cTylonycteris bat coronavirus HKU4 isolate 15S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522060.1, \u201cTylonycteris bat coronavirus HKU4 isolate 14S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522059.1, \u201cTylonycteris bat coronavirus HKU4 isolate 12S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522058.1, \u201cTylonycteris bat coronavirus HKU4 isolate 11S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522057.1, \u201cTylonycteris bat coronavirus HKU4 isolate 10S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522056.1, \u201cTylonycteris bat coronavirus HKU4 isolate 9S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522055.1, \u201cTylonycteris bat coronavirus HKU4 isolate 8S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522054.1, \u201cTylonycteris bat coronavirus HKU4 isolate 7S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522053.1, \u201cTylonycteris bat coronavirus HKU4 isolate 6S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522052.1, \u201cTylonycteris bat coronavirus HKU4 isolate 5S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522051.1, \u201cTylonycteris bat coronavirus HKU4 isolate 4S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522050.1, \u201cTylonycteris bat coronavirus HKU4 isolate 3S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522049.1, \u201cTylonycteris bat coronavirus HKU4 isolate 2S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522074.1, \u201cTylonycteris bat coronavirus HKU4 isolate 15N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522073.1, \u201cTylonycteris bat coronavirus HKU4 isolate 14N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522072.1, \u201cTylonycteris bat coronavirus HKU4 isolate 12N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522071.1, \u201cTylonycteris bat coronavirus HKU4 isolate 11N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522070.1, \u201cTylonycteris bat coronavirus HKU4 isolate 10N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522069.1, \u201cTylonycteris bat coronavirus HKU4 isolate 9N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522068.1, \u201cTylonycteris bat coronavirus HKU4 isolate 8N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522067.1, \u201cTylonycteris bat coronavirus HKU4 isolate 7N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522066.1, \u201cTylonycteris bat coronavirus HKU4 isolate 6N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522065.1, \u201cTylonycteris bat coronavirus HKU4 isolate 5N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522064.1, \u201cTylonycteris bat coronavirus HKU4 isolate 4N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15 2013.",
                    "GenBank Accession No. KC522063.1, \u201cTylonycteris bat coronavirus HKU4 isolate 3N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522062.1, \u201cTylonycteris bat coronavirus HKU4 isolate 2N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. NC\u2014007025, \u201cFeline coronavirus, complete genome\u201d, NCBI, 13 pages, Dec. 1, 2009.",
                    "GenBank Accession No. NC\u2014002306, \u201cFeline infectious peritonitis virus, complete genome\u201d, NCBI, 12 pages, Dec. 13, 2013.",
                    "GenBank Accession No. DQ811789.2, \u201cTGEV virulent Purdue, complete genome\u201d, NCBI, 12 pages, Apr. 29, 2011.",
                    "GenBank Accession No. DQ811786.2, \u201cTGEV Miller M60, complete genome\u201d, NCBI, 12 pages, Apr. 29, 2011.",
                    "GenBank Accession No. DQ811788.1, \u201cTGEV Purdue P115, complete genome\u201d, NCBI, 11 pages, Jul. 14, 2016.",
                    "GenBank Accession No. DQ811785.1, \u201cTGEV Miller M6, complete genome\u201d, NCBI, 11 pages, Jul. 14, 2016.",
                    "GenBank Accession No. X52157.1, \u201cCoronavirus TGEV mRNA for nucleoprotein, 5\u2032 region\u201d, NCBI, 1 pages, Jul. 26, 2016.",
                    "GenBank Accession No. AJ011482.1, \u201cPorcine transmissible gastroenteritis virus minigenome\u201d, NCBI, 5 pages, Nov. 14, 2006.",
                    "GenBank Accession No. KC962433.1, \u201cTransmissible gastroenteritis virus isolate TGEV-HX, complete genome\u201d, NCBI, 11 pages, Apr. 1, 2015.",
                    "GenBank Accession No. AJ271965.2, \u201cTransmissible gastroenteritis virus complete genome, genomic RNA\u201d, NCBI, 13 pages, Apr. 15, 2005.",
                    "GenBank Accession No. JQ693060.1, \u201cTransmissible gastroenteritis virus isolate KT3 nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Mar. 22, 2013.",
                    "GenBank Accession No. KC609371.1, \u201cTransmissible gastroenteritis virus isolate ZH spike protein mRNA, complete cds\u201d, NCBI, 3 pages, May 21, 2013.",
                    "GenBank Accession No. JQ693059.1, \u201cTransmissible gastroenteritis virus isolate KT2 nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Mar. 22, 2013.",
                    "GenBank Accession No. JQ693058.1, \u201cTransmissible gastroenteritis virus isolate DAE nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Mar. 22, 2013.",
                    "GenBank Accession No. JQ693057.1, \u201cTransmissible gastroenteritis virus isolate 133 nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Mar. 22, 2013.",
                    "GenBank Accession No. JQ693052.1, \u201cTransmissible gastroenteritis virus isolate KT3 spike glycoprotein (S) gene, complete cds\u201d, NCBI, 3 pages, Mar. 22, 2013.",
                    "GenBank Accession No. JQ693051.1, \u201cTransmissible gastroenteritis virus isolate KT2 spike glycoprotein (S) gene, complete cds\u201d, NCBI, 3 pages, Mar. 22, 2013.",
                    "GenBank Accession No. JQ693050.1, \u201cTransmissible gastroenteritis virus isolate DAE spike glycoprotein (S) gene, complete cds\u201d, NCBI, 3 pages, Mar. 22, 2013.",
                    "GenBank Accession No. NC\u2014001961.1, \u201cPorcine respiratory and reproductive syndrome virus, complete genome\u201d, NCBI, 11 pages, Nov. 2, 2012.",
                    "GenBank Accession No. DQ811787, \u201cPRCV ISU-1, complete genome\u201d, NCBI, 11 pages, Jul. 14, 2016.",
                    "GenBank Accession No. NC\u2014010437, \u201cBat coronavirus 1A, complete genome\u201d, NCBI, 12 pages, Mar. 28, 2016.",
                    "GenBank Accession No. NC\u2014010436, \u201cBat coronavirus 1B, complete genome\u201d, NCBI, 13 pages, Apr. 23, 2008.",
                    "GenBank Accession No. NC\u2014010438, \u201cBat coronavirus HKU8, complete genome\u201d, NCBI, 13 pages, Mar. 28, 2016.",
                    "GenBank Accession No. DQ648858, \u201cBat coronavirus (BtCoV/512/2005) ORF1, spike protein, putative ORF3, envelope protein, matrix protein, and nucleocapsid protein genes, complete cds\u201d, NCBI, 11 pages, Jul. 19, 2006.",
                    "GenBank Accession No. NC\u2014003436, \u201cPorcine epidemic diarrhea virus, complete genome\u201d, NCBI, 12 pages, Feb. 10, 2015.",
                    "GenBank Accession No. DQ355224.1, \u201cPorcine epidemic diarrhea virus strain CH/S nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Feb. 1, 2006.",
                    "GenBank Accession No. DQ355223.1, \u201cPorcine epidemic diarrhea virus strain S nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Feb. 1, 2006.",
                    "GenBank Accession No. DQ355221.1, \u201cPorcine epidemic diarrhea virus strain CV777 nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Feb. 1, 2006.",
                    "GenBank Accession No. JN601062.1, \u201cPorcine epidemic diarrhea virus strain CH/GXNN/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601061.1, \u201cPorcine epidemic diarrhea virus strain CH/SDRZ-2/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601060.1, \u201cPorcine epidemic diarrhea virus strain CH/SDRZ-1/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601059.1, \u201cPorcine epidemic diarrhea virus strain CH/HLJHG/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601058.1, \u201cPorcine epidemic diarrhea virus strain CH/GDQY-3/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601057.1, \u201cPorcine epidemic diarrhea virus strain CH/GDQY-1/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601056.1, \u201cPorcine epidemic diarrhea virus strain CH/GDQY-1/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601055.1, \u201cPorcine epidemic diarrhea virus strain CH/FJND/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601054.1, \u201cPorcine epidemic diarrhea virus strain CH/BJYQ-2/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601053.1, \u201cPorcine epidemic diarrhea virus strain CH/BJYQ-1/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601052.1, \u201cPorcine epidemic diarrhea virus strain CH/HNZZ/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN400902.1, \u201cPorcine epidemic diarrhea virus strain CH/HBQX/10 membrane glycoprotein (M) gene, complete cds\u201d, NCBI, 3 pages, Apr. 3, 2013.",
                    "GenBank Accession No. JN547395.1, \u201cPorcine epidemic diarrhea virus strain CH/HBQX/10 non-structural protein gene, complete cds\u201d, NCBI, 2 pages, Apr. 3, 2013.",
                    "GenBank Accession No. FJ687473.1, \u201cPorcine epidemic diarrhea virus isolate CPF1074 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687472.1, \u201cPorcine epidemic diarrhea virus isolate PFF1051 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687471.1, \u201cPorcine epidemic diarrhea virus isolate CPF531 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687470.1, \u201cPorcine epidemic diarrhea virus isolate PFF514 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687469.1, \u201cPorcine epidemic diarrhea virus isolate PFF513 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687468.1, \u201cPorcine epidemic diarrhea virus isolate PFF381 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687467.1, \u201cPorcine epidemic diarrhea virus isolate CPF299 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687466.1, \u201cPorcine epidemic diarrhea virus isolate PFF285 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687465.1, \u201cPorcine epidemic diarrhea virus isolate CPF259 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687464.1, \u201cPorcine epidemic diarrhea virus isolate BIF256 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687463.1, \u201cPorcine epidemic diarrhea virus isolate CPF193 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687462.1, \u201cPorcine epidemic diarrhea virus isolate PFF188 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687461.1, \u201cPorcine epidemic diarrhea virus isolate VF131 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687460.1, \u201cPorcine epidemic diarrhea virus isolate BIF118 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687459.1, \u201cPorcine epidemic diarrhea virus isolate MF78 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687458.1, \u201cPorcine epidemic diarrhea virus isolate V25010 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687457.1, \u201cPorcine epidemic diarrhea virus isolate M2366 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687456.1, \u201cPorcine epidemic diarrhea virus isolate M2227 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687455.1, \u201cPorcine epidemic diarrhea virus isolate M1763 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687454.1, \u201cPorcine epidemic diarrhea virus isolate e1697 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687453, \u201cPorcine epidemic diarrhea virus isolate e1642 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687452.1, \u201cPorcine epidemic diarrhea virus isolate M1595 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687451.1, \u201cPorcine epidemic diarrhea virus isolate BI1108 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687450.1, \u201cPorcine epidemic diarrhea virus isolate BI981 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687449.1, \u201cPorcine epidemic diarrhea virus isolate BI976 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. AF500215.1, \u201cPorcine epidemic diarrhea virus spike protein (Spk1) gene, complete cds\u201d, NCBI, 3 pages, Aug. 23, 2005.",
                    "GenBank Accession No. KF476061.1, \u201cPorcine epidemic diarrhea virus isolate CHHEB ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476060.1, \u201cPorcine epidemic diarrhea virus isolate CHZHZ-04 putative ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476059.1, \u201cPorcine epidemic diarrhea virus isolate CHJCH ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476058.1, \u201cPorcine epidemic diarrhea virus isolate CHXIP-03 putative ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476057.1, \u201cPorcine epidemic diarrhea virus isolate CHLSHAN ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476056.1, \u201cPorcine epidemic diarrhea virus isolate CHFH putative ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476055.1, \u201cPorcine epidemic diarrhea virus isolate CHLH ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476054.1, \u201cPorcine epidemic diarrhea virus isolate CHFCH-01 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476053.1, \u201cPorcine epidemic diarrhea virus isolate CHLY-09 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476052.1, \u201cPorcine epidemic diarrhea virus isolate CHXIP-01 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476051.1, \u201cPorcine epidemic diarrhea virus isolate CHKF-01 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476050.1, \u201cPorcine epidemic diarrhea virus isolate CHQX-02 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476049.1, \u201cPorcine epidemic diarrhea virus isolate CHXY-02 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476048.1, \u201cPorcine epidemic diarrhea virus isolate CHYF-01 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF177258.1, \u201cPorcine epidemic diarrhea virus isolate YJ7C spike protein (S) gene, complete cds\u201d, NCBI, 3 pages, Sep. 18, 2013.",
                    "GenBank Accession No. KF177257.1, \u201cPorcine epidemic diarrhea virus isolate YJ3F spike protein (S) gene, complete cds\u201d, NCBI, 3 pages, Sep. 18, 2013.",
                    "GenBank Accession No. KF177256.1, \u201cPorcine epidemic diarrhea virus isolate JY7C spike protein (S) gene, complete cds\u201d, NCBI, 3 pages, Sep. 18, 2013.",
                    "GenBank Accession No. KF177255.1, \u201cPorcine epidemic diarrhea virus isolate JY6C spike protein (S) gene, complete cds\u201d, NCBI, 3 pages, Sep. 18, 2013.",
                    "GenBank Accession No. NC\u2014002645, \u201cHuman coronavirus 229E, complete genome\u201d, NCBI, 12 pages, Apr. 28, 20710.",
                    "GenBank Accession No. NC\u2014005831, \u201cHuman coronavirus NL63, complete genome\u201d, NCBI, 11 pages, Mar. 29, 2016.",
                    "GenBank Accession No. EF203066, \u201cBat coronavirus HKU2 strain HKU2/HK/298/2006, complete genome\u201d, NCBI, 12 pages, Oct. 9, 2007.",
                    "GenBank Accession No. EF203067.1, \u201cBat coronavirus HKU2 strain HKU2/HK/33/2006, complete genome\u201d, NCBI, 12 pages, Oct. 9, 2007.",
                    "GenBank Accession No. EF203065, \u201cBat coronavirus HKU2 strain HKU2/HK/46/2006, complete genome\u201d, NCBI, 12 pages, Oct. 9, 2007.",
                    "GenBank Accession No. EF203064, \u201cBat coronavirus HKU2 strain HKU2/GD/430/2006, complete genome\u201d, NCBI, 12 pages, Oct. 9, 2007.",
                    "GenBank Accession No. DQ339101, \u201cHuman coronavirus HKU1 strain N5P8 genotype A/B recombinant, complete genome\u201d, NCBI, 12 pages, Jun. 30, 2006.",
                    "GenBank Accession No. NC\u2014001846, \u201cMouse hepatitis virus strain MHV-A59 C12 mutant, complete genome\u201d, NCBI, 12 pages, Mar. 29, 2016.",
                    "GenBank Accession No. NC\u2014007732, \u201cPorcine hemagglutinating encephalomyelitis virus, complete genome\u201d, NCBI, 13 pages, Dec. 1, 2009.",
                    "GenBank Accession No. NC\u2014005147, \u201cHuman coronavirus OC43, complete genome\u201d, NCBI, 13 pages, Dec. 13, 2013.",
                    "GenBank Accession No. NC\u2014003045, \u201cBovine coronavirus, complete genome\u201d, NCBI, 16 pages, Feb. 10, 2015.",
                    "GenBank Accession No. EF065514, \u201cBat coronavirus HKU9-2, complete genome\u201d, NCBI, 11 pages, Feb. 7, 2007.",
                    "GenBank Accession No. NC\u2014009021, \u201cBat coronavirus HKU9-1, complete genome\u201d, NCBI, 12 pages, Dec. 8, 2008.",
                    "GenBank Accession No. EF065515, \u201cBat coronavirus HKU9-3, complete genome\u201d, NCBI, 11 pages, Feb. 7, 2007.",
                    "GenBank Accession No. EF065516, \u201cBat coronavirus HKU9-4, complete genome\u201d, NCBI, 11 pages, Feb. 7, 2007.",
                    "GenBank Accession No. DQ001339, \u201cAvian infectious bronchitis virus isolate IBV-p65, complete genome\u201d, NCBI, 11 pages, Oct. 17, 2005.",
                    "Akerstr\u00f6m et al. \u201cProtein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies\u201d, J Immunol 1985; 135:2589-2592.",
                    "Chen et al. \u201cBoosting with recombinant vacccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines\u201d, Vaccine, 18(19):2015-2022, Apr. 3, 2000 (Abstract Only).",
                    "Gonzalo et al. \u201cEnhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants\u201d, Vaccine, 17(7-8):887-892, Feb. 26, 1999 (Abstract Only).",
                    "Hanke et al. \u201cEnhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime\u201d, Vaccine, 16(5):439-445, Mar. 1998 (Abstract Only).",
                    "Huse et al. \u201cGeneration of a large combinatorial library of the immunoglobulin repertoire in phage lambda\u201d, Science, Dec. 8, 1989, vol. 246, Issue 4935, pp. 1275-1281 (Abstract Only).",
                    "Kohler and Milstein, \u201cContinuous cultures of fused cells secreting antibody of predefined specificity\u201d, Nature, vol. 256:494-497, Aug. 7, 1975.",
                    "Kronvall et al. \u201cA Surface Component in Group A, C, and G Streptococci with Non-Immune Reactivity for Immunoglobulin G\u201d, J. Immunol. 111:1401-1406 (1973).",
                    "Maddox et al. \u201cElevated Serum Levels in Human Pregnancy of a Molecule Immunochemically Similar to Eosinophil Granule Major Basic Protein\u201d, J. Exp. Med. 158:1211-1226 (Oct. 1983).",
                    "Pancholi et al. \u201cDNA Prime-Canarypox Boost with Polycistronic Hepatitis C Virus (HCV) Genes Generates Potent Immune Responses to HCV Structural and Nonstructural Proteins\u201d, J. Infect. Dis. 182:18-27, 2000.",
                    "Walker et al. \u201cInteraction of human IgG chimeric antibodies with the human FcRI and FcRII receptors: requirements for antibody-mediated host cell-target cell interaction\u201d, Molec. Immunol. Apr. 1989; 26(4):403-411 (Abstract Only).",
                    "International Preliminary Report on Patentability Corresponding to International Application No. PCT/US2015/021773; dated Sep. 29, 2016; 8 pages."
                ],
                "nplResolvedCount": 11,
                "nplResolvedLensIDs": [
                    "031-691-266-250-26X",
                    "106-695-963-997-796",
                    "111-704-019-488-289",
                    "091-415-113-195-947",
                    "006-138-564-118-46X",
                    "033-797-614-829-293",
                    "112-863-452-534-981",
                    "151-516-877-883-106",
                    "089-209-533-057-090",
                    "079-069-238-514-186",
                    "106-753-778-592-300"
                ],
                "nplResolvedExternalIDs": [
                    "10067695",
                    "10882577",
                    "1172191",
                    "4031496",
                    "10706963",
                    "10.1016/0161-5890(89)90129-6",
                    "10.1084/jem.158.4.1211",
                    "4744924",
                    "10.1093/infdis/jit609",
                    "10.1086/315646",
                    "24253287",
                    "10.1016/s0264-410x(99)00528-9",
                    "6619734",
                    "2716734",
                    "pmc3952667",
                    "10.1126/science.2531466",
                    "10.1016/s0264-410x(98)00274-6",
                    "10.1038/256495a0",
                    "9491498",
                    "10.1016/s0264-410x(97)00226-0",
                    "2531466"
                ]
            },
            {
                "index": "11",
                "publicationKey": "US_9919034_B2",
                "lensId": "167-192-947-618-782",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9919034 B2",
                "publicationDate": "2018-03-20",
                "filingNumber": "US 201514736170 A",
                "filingDate": "2015-06-10",
                "priorityFilingKeysActive": [
                    "US 201514736170 A 20150610",
                    "US 201514667282 A 20150324",
                    "US 201414316893 A 20140627",
                    "US 201414247723 A 20140408",
                    "US 201562147209 P 20150414",
                    "US 201562102671 P 20150113",
                    "US 201462063551 P 20141014",
                    "US 201462040885 P 20140822"
                ],
                "earliestPriorityDate": "2014-04-08",
                "title": "Methods Of Treating And Prophylactically Protecting Mammalian Patients Infected By Viruses Classified In Baltimore Group V",
                "applicants": [
                    "TAMIR BIOTECHNOLOGY INC"
                ],
                "inventors": [
                    "HODGE III THOMAS W"
                ],
                "owners": [
                    {
                        "name": "TAMIR BIOTECHNOLOGY INC",
                        "executionDate": "2015-06-08"
                    }
                ],
                "url": "https://lens.org/167-192-947-618-782",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K38/465",
                    "A01N63/00",
                    "C12N9/22",
                    "C12Y301/27",
                    "C12Y301/27005"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A01N63/00",
                    "A61K38/46",
                    "C07H21/04",
                    "C07K7/00",
                    "C12N9/22"
                ],
                "usClassifications": [],
                "nplCitationCount": 73,
                "nplCitations": [
                    "Tamir Reports Positive Effect Against SARS Virus (Jul. 21, 2010).",
                    "Tamir's Compounds Show Remarkable Results Against Dengue Virus (Jul. 19, 2010).",
                    "Investor Village\u2014Form 10-Q for Tamir Biotechnology, Inc. (Aug. 15, 2011).",
                    "Baltimore, Bacteriological Reviews, vol. 35, No. 3, p. 235-241 (Sep. 1971).",
                    "Wikipedia: Baltimore classification (Mar. 6, 2013).",
                    "Ilinskaya et al, Molecular Biology, vol. 48, No. 5, pp. 615-623 (2014).",
                    "Qiao et al, Cell Research 22:1199-1202 (2012).",
                    "Lin et al, Biochemical and Biophysical Research Communications, vol. 204, No. 1, pp. 156-162 (Oct. 14, 1994).",
                    "Moreau et al, Antiviral Research 59, pp. 181-191 (2003).",
                    "Domachowske et al, Nucleic Acids Research, vol. 26, No. 14, pp. 3358-3363 (1998).",
                    "GlobeNewswire, Jul. 21, 2010, Tamir Reports Positive Effect Against SARS Virus.",
                    "GlobeNewswire, Jul. 19, 2010, Tamirs Compounds Show Remarkable Results Against Dengue Virus.",
                    "InvestorVillage.com, May 15, 2011, ACEL / Message Board/ Thread View.",
                    "Baltimore, Expression of Animal Virus Genomes, Bacteriological Reviews, Sep. 1971, vol. 35, No. 3, pp. 235-241.",
                    "Wikipedia, Baltimore classification, Mar. 6, 2013.",
                    "Ilinskaya, Ribonucleases as Antiviral Agents, Molecular Biology, 2014, vol. 48, No. 5, pp. 615-623.",
                    "Qiao, Onconase downregulates microRNA expression through targeting microRNA precursors, Cell Research, 2012, 22:1199-1202.",
                    "Lin et al., Biochemical and Biophysical Research Communications 201 (1), 156-162 (1994).",
                    "Ardelt et al, Onconase and Amphinase, the Antitumor Ribonucleases from Rana pipiens Oocytes Curr Pharm Biotechnol. Jun. 2008; 9(3): 215-225.",
                    "Saxena et al, Effect of Onconase on Double-stranded RNA in Vitr Anticancer Research 29: 1067-1072 (2009).",
                    "UniProtKB\u2014Amphinase-2 entry (2007).",
                    "PCT/US1999/030799, International Search Report and Written Opinion dated May 30, 2000, 7 pages.",
                    "PCT/US2000/023426, International Search Report dated Nov. 27, 2000, 3 pages.",
                    "PCT/US2004/014844, International Search Report and Written Opinion, dated May 10, 2006, 8 pages.",
                    "PCT/US2004/014844, International Preliminary Report on Patentability, dated Feb. 15, 2007, 5 pages.",
                    "PCT/US2015/022670, International Search Report and Written Opinion, dated Nov. 18, 2015, 29 pages.",
                    "PCT/US2015/022670, International Preliminary Report on Patentability, dated Oct. 4, 2016, 21 pages.",
                    "PCT/US2015/045272, International Search Report and Written Opinion, dated Dec. 1, 2015, 9 pages.",
                    "PCT/US2015/045272, International Preliminary Report on Patentability, dated Feb. 21, 2017, 6 pages.",
                    "PCT/US2016/037174, International Search Report and Written Opinion, dated Oct. 12, 2016, 14 pages.",
                    "Adinolfi, B.S., et al., \u201cFull antitumor action of recombinant seminal ribonuclease depends on the removal of its N-terminal methionine.\u201d Biochem Biophys Res Commun. (1995); 213(2): 525-532.",
                    "Ardelt, W., et al., \u201cAmino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases.\u201d J Biol Chem. (1991); 266(1): 245-251.",
                    "Boix, E., et al., \u201cRole of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.\u201d J Mol Biol. (1996); 257(5): 992-1007.",
                    "Branden et al., Introduction to Protein Structure, Garland Publishing Inc., New York, p. 247, 1991, 24 pages.",
                    "Bucher, M.H., et al., \u201cDifferential effects of short affinity tags on the crystallization of Pyrococcus furiosus maltodextrin-binding protein.\u201d Acta Crystallogr D Biol Crystallogr. (2002);58(Pt 3): 392-397. Epub Feb. 21, 2002.",
                    "Chao, Q., et al., \u201cExpression and partial characterization of Dolichos biflorus seed lectin in Escherichia coli.\u201d Arch Biochem Biophys. (1994); 313(2): 346-350.",
                    "Chaudhuri, T.K., et al., \u201cEffect of the extra n-terminal methionine residue on the stability and folding of recombinant a-lactalbumin expressed in Escherichia coli.\u201d J Mol Biol. (1999); 285(3): 1179-1194.",
                    "Chen, C-Y., et al., \u201cCloning, sequencing and expression of a cDNA encoding bovine pancreatic deoxyribonuclease I in Escherichia coli: purification and characterization of the recombinant enzyme.\u201d Gene (1998); 206(2): 181-184.",
                    "Durmazlar, K., et al., \u201cCantharidin treatment for recalcitrant facial flat warts: a preliminary study.\u201d J. Dermatol. Treatment (2009); 20(2): 114-119.",
                    "Dyer and Rosenberg, \u201cThe RNase a superfamily: generation of diversity and innate host defense.\u201d Mol Divers. (2006); 10(4): 585-597.",
                    "Fonda, I., et al., \u201cAttachment of histidine tags to recombinant tumor necrosis factor-alpha drastically changes its properties.\u201d ScientificWorldJournal (2002); 2: 1312-1325.",
                    "Geurrero, S.A., et al., \u201cHis-tagged tryparedoxin peroxidase of Trypanosoma cruzi as a tool for drug screening.\u201d Appl Microbiol Biotechnol. (2000); 53(4): 410-414.",
                    "Goda, S., et al., \u201cEffect of extra N-terminal residues on the stability and folding of human lysozyme expressed in Pichia pastoris.\u201d Protein Engineering (2000); 13(4): 299-307.",
                    "Gupta, P.K., et al., \u201cRole of N-Terminal Amino Acids in the Potency of Anthrax Lethal Factor.\u201d PLoS ONE (2008); 3(9): e3130.",
                    "Hariri, S., et al., \u201cHuman Papillomavirus.\u201d Centers for Disease Control VPD Surveillance Manual, 5th edition, Chapter 5, pp. 1 -11 (2011).",
                    "Hirel, P.H., et al., \u201cExtent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid.\u201d PNAS USA (1989); 86(21): 8247-8251.",
                    "Ho, S.N., et al., \u201cSite-directed mutagenesis by overlap extension using the polymerase chain reaction.\u201d Gene (1989); 77(1): 51-59.",
                    "Huang, H-C., et al., \u201cThe Rana catesbeiana rcr Gene Encoding a Cytotoxic Ribonuclease. Tissue Distribution, Cloning, Purification, Cytotoxicity, and Active Residues for RNase Activity.\u201d J. Biol. Chem. (1998); 273(11): 6395-6401.",
                    "Ishikiwa, N., et al., \u201cRemarkable destabilization of recombinant alpha-lactalbumin by an extraneous N-terminal methionyl residue.\u201d Protein Eng. (1998); 11(5): 333-335.",
                    "Kamiya, Y., et al., \u201cAmino acid sequence of a lectin from Japanese frog (Rana japonica) eggs.\u201d J Biochem. (1990); 108(1): 139-143.",
                    "Lehninger, A.L. (1975) Biochemistry, Second Edition, p. 962, 5 pages.",
                    "Liao, Y.D., et al., \u201cRemoval of N-terminal methionine from recombinant proteins by engineered E. coli methionine aminopeptidase.\u201d Protein Sci. (2004); 13(7): 1802-1810.",
                    "Moore, J.A., et al., \u201cEquivalent Potency and Pharmacokinetics of Recombinant Human Growth Hormones with or without an N-Terminal Methionine.\u201d Endocrinology (1988); 122(6): 2920-2926.",
                    "Mosimann, S.C., et al., \u201cComparative molecular modeling and crystallization of P-30 protein: A novel antitumor protein of Rana pipiens oocytes and early embryos.\u201d Proteins (1992); 14(3): 392-400.",
                    "Notomista, E., et al., \u201cEffective expression and purification of recombinant onconase, an antitumor protein.\u201d FEBS Letters (1999); 463(3): 211-215.",
                    "Park, K.S., et al., \u201cBiologic and biochemic properties of recombinant platelet factor 4 demonstrate identity with the native protein.\u201d Blood (1990); 75: 1290-1295.",
                    "Porta, C., et al., \u201cRanpirnase and its potential for the treatment of unresectable malignant mesothelioma.\u201d Biologics (2008); 2(4): 601-609.",
                    "Saxena, S.K., et al., \u201cInhibition of HIV-1 production and selective degradation of viral RNA by an amphibian ribonuclease.\u201d J Biol Chem. (1996); 271(34): 20783-20788.",
                    "Saxena, S.K., et al., \u201cOnconase\u00ae and its Therapeutic Potential.\u201d Lab Medicine (2003); 34(5): 380-387.",
                    "Seffernick, J.L., et al., \u201cMelamine Deaminase and Atrazine Chlorohydrolase: 98 Percent Identical but Functionally Different.\u201d Journal of Bacteriology (2001); 183(8): 2405-2410.",
                    "Studier, F.W., et al., \u201cUse of T7 RNA polymerase to direct expression of cloned genes.\u201d Methods Enzymol. (1990); 185: 60-89.",
                    "Suhasini and Sirdeshmukh, \u201cTransfer RNA cleavages by onconase reveal unusual cleavage sites.\u201d J Biol Chem. (2006); 281(18): 12201-12209. Epub Feb. 23, 2006.",
                    "Supplementary European Search Report in European application No. EP 04751988.9, dated May 30, 2007 and dated Jun. 6, 2007, 6 pages.",
                    "Suzuki, M., et al., \u201cEngineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction.\u201d Nat Biotechnol. (1999); 17(3): 265-270.",
                    "Takano, K., et al., \u201cEffect of foreign N-terminal residues on the conformational stability of human lysozyme.\u201d The FEBS Journal (1999); 266(2): 675-682.",
                    "Trimble and Frazer, \u201cDevelopment of therapeutic HPV vaccines.\u201d Lancet Oncol. (2009); 10(10): 975-980.",
                    "Turcotte and Raines, \u201cDesign and Characterization of an HIV-Specific Ribonuclease Zymogen.\u201d AIDS Res Hum Retroviruses (2008); 24(11): 1357-1363.",
                    "Witkowski, A., et al., \u201cConversion of a \u03b2-Ketoacyl Synthase to a Malonyl Decarboxylase by Replacement of the Active-Site Cysteine with Glutamine.\u201d Biochemistry, (1999); 38(36): 11643-11650.",
                    "Wu and Filutowicz, \u201cHexahistidine (His6)-tag dependent protein dimerization: a cautionary tale.\u201d Acta Biochim Pol. (1999); 46(3): 591-599.",
                    "Wu, Y., et al., \u201cA cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.\u201d The Journal of Biological Chemistry (1993); 268(14): 10686-10693.",
                    "PCT/US2016/037174, International Preliminary Report on Patentability, dated Dec. 19, 2017, 9 pages.",
                    "PCT/US2017/043984, International Search Report and Written Opinion, dated Oct. 10, 2017, 15 pages.",
                    "Langston, \u201cHerpes Simplex Virus in the Eye\u201d, Digital Journal of Ophthalmology, Oct. 15, 2002, 3 pages."
                ],
                "nplResolvedCount": 45,
                "nplResolvedLensIDs": [
                    "183-199-955-821-58X",
                    "081-975-240-328-194",
                    "028-781-143-330-295",
                    "014-962-893-502-724",
                    "058-565-045-538-561",
                    "074-019-691-989-836",
                    "049-790-593-893-868",
                    "029-908-654-731-041",
                    "050-615-121-045-702",
                    "045-046-217-858-486",
                    "065-407-674-006-488",
                    "157-939-838-575-373",
                    "089-876-823-876-974",
                    "040-463-542-748-18X",
                    "033-673-240-985-077",
                    "012-664-898-846-608",
                    "068-350-979-903-088",
                    "081-606-351-847-620",
                    "019-318-201-447-272",
                    "128-620-645-455-459",
                    "179-052-482-657-722",
                    "069-538-319-620-681",
                    "067-045-038-523-385",
                    "129-892-405-589-373",
                    "000-429-842-178-350",
                    "009-620-258-695-693",
                    "027-493-429-522-118",
                    "063-918-616-263-074",
                    "034-784-012-662-936",
                    "020-130-144-194-934",
                    "023-973-012-067-612",
                    "039-290-617-350-793",
                    "051-335-014-275-668",
                    "056-331-009-417-186",
                    "044-705-117-387-162",
                    "053-960-716-570-131",
                    "056-171-629-693-587",
                    "079-736-607-266-605",
                    "054-547-223-876-922",
                    "012-361-686-036-568",
                    "046-926-645-516-900",
                    "034-122-884-140-729",
                    "002-018-167-726-726",
                    "023-481-904-534-57X",
                    "050-180-531-862-30X"
                ],
                "nplResolvedExternalIDs": [
                    "18769623",
                    "10.1134/s0026893314040050",
                    "pmc298257",
                    "10.1073/pnas.86.21.8247",
                    "19414347",
                    "10.1016/0076-6879(90)85008-c",
                    "pmc2888699",
                    "10.1128/mmbr.35.3.235-241.1971",
                    "10.1038/cr.2012.67",
                    "10803896",
                    "10.1093/nar/26.14.3358",
                    "10.1016/s0378-1119(97)00582-9",
                    "10.1089/aid.2008.0146",
                    "9497370",
                    "1985896",
                    "10.1371/journal.pone.0003130",
                    "4329869",
                    "10.1074/jbc.271.34.20783",
                    "10.1038/7010",
                    "10.18388/abp.1999_4131",
                    "10.1100/tsw.2002.215",
                    "10.1046/j.1432-1327.1999.00918.x",
                    "pmc95154",
                    "10.2147/btt.s2383",
                    "10.1016/s0014-5793(99)01623-3",
                    "10.1006/bbrc.1995.2163",
                    "11856823",
                    "8486718",
                    "15215523",
                    "10.1006/abbi.1994.1397",
                    "pmc378387",
                    "10.1128/jb.183.8.2405-2410.2001",
                    "10.2174/138920108784567245",
                    "10.1074/jbc.m504488200",
                    "2178704",
                    "7646508",
                    "10.1110/ps.04679104",
                    "19025416",
                    "10.1006/bbrc.1994.2439",
                    "10.1093/protein/11.5.333",
                    "10.1006/jmbi.1996.0218",
                    "10.1080/09546630802287546",
                    "10.1309/3td2-6gxn-65ge-c1bg",
                    "10.1002/prot.340140308",
                    "1438177",
                    "pmc147714",
                    "10561612",
                    "pmc3090037",
                    "8702832",
                    "10.1182/blood.v75.6.1290.1290",
                    "2199796",
                    "pmc2518864",
                    "pmc2586917",
                    "10810162",
                    "10.1210/endo-122-6-2920",
                    "16497678",
                    "2744487",
                    "10.1016/0378-1119(89)90358-2",
                    "8080282",
                    "10096294",
                    "8632481",
                    "9649619",
                    "10.1007/s002530051634",
                    "10.1093/oxfordjournals.jbchem.a123153",
                    "pmc2727885",
                    "10.1007/s11030-006-9028-2",
                    "22525336",
                    "16969722",
                    "19796749",
                    "11274097",
                    "10.1016/s0166-3542(03)00111-6",
                    "pmc2279930",
                    "pmc3391012",
                    "9469931",
                    "2229005",
                    "10.1074/jbc.273.11.6395",
                    "19707441",
                    "9887272",
                    "12927308",
                    "10606723",
                    "10.1006/jmbi.1998.2362",
                    "10.1016/j.jmb.2003.12.051",
                    "9681864",
                    "18821118",
                    "10.1093/protein/13.4.299",
                    "10.1107/s0907444901021187",
                    "10.1016/s1470-2045(09)70227-x",
                    "10698267",
                    "3371267",
                    "12805914",
                    "18673287",
                    "2682640",
                    "7945354"
                ]
            },
            {
                "index": "12",
                "publicationKey": "US_2015_0376584_A1",
                "lensId": "119-830-198-720-431",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2015/0376584 A1",
                "publicationDate": "2016-12-31",
                "filingNumber": "US 201514736170 A",
                "filingDate": "2015-06-10",
                "priorityFilingKeysActive": [
                    "US 201514736170 A 20150610",
                    "US 201514667282 A 20150324",
                    "US 201414316893 A 20140627",
                    "US 201414247723 A 20140408",
                    "US 201562147209 P 20150414",
                    "US 201562102671 P 20150113",
                    "US 201462063551 P 20141014",
                    "US 201462040885 P 20140822"
                ],
                "earliestPriorityDate": "2014-04-08",
                "title": "Methods Of Treating Viral Infections, Particularly Rabies, Mers-cov, Influenza, Ebola, Chikungunya, Venezuelan Equine Encephalitus, Canine Parvovirus, Adenovirus, Respiratory Syncytial Virus, Rhinovirus, And Poxvirus In Mammalian Patients",
                "applicants": [
                    "TAMIR BIOTECHNOLOGY INC"
                ],
                "inventors": [
                    "HODGE III THOMAS W"
                ],
                "owners": [
                    {
                        "name": "TAMIR BIOTECHNOLOGY INC",
                        "executionDate": "2015-06-08"
                    }
                ],
                "url": "https://lens.org/119-830-198-720-431",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 2,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K38/465",
                    "A01N63/00",
                    "C12N9/22",
                    "C12Y301/27",
                    "C12Y301/27005"
                ],
                "ipcrClassifications": [
                    "C12N9/22"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "13",
                "publicationKey": "US_2017_0096455_A1",
                "lensId": "186-435-322-275-495",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0096455 A1",
                "publicationDate": "2017-04-06",
                "filingNumber": "US 201515124992 A",
                "filingDate": "2015-03-20",
                "priorityFilingKeysActive": [
                    "US 201461968279 P 20140320"
                ],
                "earliestPriorityDate": "2014-03-20",
                "title": "Methods And Compositions For Chimeric Coronavirus Spike Proteins",
                "applicants": [
                    "UNIV NORTH CAROLINA CHAPEL HILL"
                ],
                "inventors": [
                    "BARIC RALPH",
                    "AGNIHOTHRAM SUDHAKAR",
                    "YOUNT BOYD"
                ],
                "owners": [
                    {
                        "name": "THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL",
                        "executionDate": "2016-10-05"
                    }
                ],
                "url": "https://lens.org/186-435-322-275-495",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 8,
                "cpcClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "A61K2039/5256",
                    "A61K2039/5258",
                    "A61K2039/70",
                    "C07K16/10",
                    "C07K2317/34",
                    "C07K2317/76",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "C12N2770/36123",
                    "C12N2770/36143",
                    "C12N2770/36144"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "C07K16/10",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "14",
                "publicationKey": "WO_2015_184356_A1",
                "lensId": "027-137-895-934-354",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/184356 A1",
                "publicationDate": "2015-12-03",
                "filingNumber": "US 2015/0033331 W",
                "filingDate": "2015-05-29",
                "priorityFilingKeysActive": [
                    "US 201462005817 P 20140530"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Treatment Of Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "ANSUN BIOPHARMA INC"
                ],
                "inventors": [
                    "MOSS RONALD D"
                ],
                "owners": [],
                "url": "https://lens.org/027-137-895-934-354",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 3,
                "seqCount": 14,
                "cpcClassifications": [
                    "A61K38/47",
                    "A61K9/0019",
                    "A61K9/0048",
                    "A61K9/007",
                    "A61K39/12",
                    "A61K47/183",
                    "A61K47/26",
                    "C07K14/485",
                    "C07K2319/20",
                    "C12N9/2402",
                    "C12N2770/20034",
                    "C12Y302/01018"
                ],
                "ipcrClassifications": [
                    "A61K39/00",
                    "A61K9/50",
                    "A61K38/00",
                    "A61K38/16"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "HAYDEN: \"Advances in antivirals for non-influenza respiratory virus infections.\", INFLUENZA OTHER RESPIR VIRUSES., vol. 7, no. 3, 2013, pages 36 - 43, XP055228651",
                    "WIT ET AL.: \"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques.\", PROC NATL ACAD SCI USA., vol. 110, no. 41, 2013, pages 16598 - 603, XP055239202"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "084-664-258-959-729",
                    "050-671-752-937-471",
                    "076-701-180-458-616"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3799368",
                    "pmc6492651",
                    "10.1073/pnas.1310744110",
                    "24215380",
                    "24062443",
                    "10.1111/irv.12173"
                ]
            },
            {
                "index": "15",
                "publicationKey": "WO_2016_007653_A2",
                "lensId": "097-791-400-877-497",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2016/007653 A2",
                "publicationDate": "2016-01-14",
                "filingNumber": "US 2015/0039586 W",
                "filingDate": "2015-07-08",
                "priorityFilingKeysActive": [
                    "US 201462022191 P 20140708"
                ],
                "earliestPriorityDate": "2014-07-08",
                "title": "Psgl-1 Modulators And Uses Thereof",
                "applicants": [
                    "SANFORD BURNHAM MED RES INST"
                ],
                "inventors": [
                    "BRADLEY LINDA M",
                    "TINOCO ROBERTO"
                ],
                "owners": [],
                "url": "https://lens.org/097-791-400-877-497",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 8,
                "familySize": 8,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07K16/2854",
                    "A61K48/00",
                    "A61K2039/505",
                    "C07K14/70596",
                    "C07K16/2896",
                    "C07K2317/76"
                ],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K39/40"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "16",
                "publicationKey": "US_2017_0119859_A1",
                "lensId": "036-482-691-255-724",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0119859 A1",
                "publicationDate": "2017-05-04",
                "filingNumber": "US 201515314782 A",
                "filingDate": "2015-05-29",
                "priorityFilingKeysActive": [
                    "US 201462005817 P 20140530"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Treatment Of Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "ANSUN BIOPHARMA INC"
                ],
                "inventors": [
                    "MOSS RONALD D"
                ],
                "owners": [
                    {
                        "name": "ANSUN BIOPHARMA INC",
                        "executionDate": "2014-06-16"
                    }
                ],
                "url": "https://lens.org/036-482-691-255-724",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 3,
                "seqCount": 14,
                "cpcClassifications": [
                    "A61K38/47",
                    "A61K9/0019",
                    "A61K9/0048",
                    "A61K9/007",
                    "A61K39/12",
                    "A61K47/183",
                    "A61K47/26",
                    "C07K14/485",
                    "C07K2319/20",
                    "C12N9/2402",
                    "C12N2770/20034",
                    "C12Y302/01018"
                ],
                "ipcrClassifications": [
                    "A61K38/47",
                    "A61K9/00",
                    "C07K14/485",
                    "C12N9/24"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "17",
                "publicationKey": "US_2017_0198047_A1",
                "lensId": "113-597-190-477-864",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0198047 A1",
                "publicationDate": "2017-07-13",
                "filingNumber": "US 201515324262 A",
                "filingDate": "2015-07-08",
                "priorityFilingKeysActive": [
                    "US 201462022191 P 20140708"
                ],
                "earliestPriorityDate": "2014-07-08",
                "title": "Psgl-1 Modulators And Uses Thereof",
                "applicants": [
                    "SANFORD-BURNHAM MEDICAL RES INST"
                ],
                "inventors": [
                    "BRADLEY LINDA M",
                    "TINOCO ROBERTO"
                ],
                "owners": [
                    {
                        "name": "SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE",
                        "executionDate": "2017-03-13"
                    },
                    {
                        "name": "SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE",
                        "executionDate": "2015-06-24"
                    }
                ],
                "url": "https://lens.org/113-597-190-477-864",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 8,
                "familySize": 8,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07K16/2854",
                    "A61K48/00",
                    "A61K2039/505",
                    "C07K14/70596",
                    "C07K16/2896",
                    "C07K2317/76"
                ],
                "ipcrClassifications": [
                    "C07K16/28"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "18",
                "publicationKey": "WO_2016_123318_A2",
                "lensId": "001-776-747-524-561",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2016/123318 A2",
                "publicationDate": "2016-08-04",
                "filingNumber": "US 2016/0015327 W",
                "filingDate": "2016-01-28",
                "priorityFilingKeysActive": [
                    "US 201562109667 P 20150130",
                    "US 201562195968 P 20150723"
                ],
                "earliestPriorityDate": "2015-01-30",
                "title": "Design Synthesis And Methods Of Use Of Acyclic Fleximer Nucleoside Analogues Having Anti-coronavirus Activity",
                "applicants": [
                    "UNIV MARYLAND",
                    "KATHOLIEK UNIVERSITEIT LEUVEN",
                    "LIEDEN UNIVERSITY MEDICAL CT"
                ],
                "inventors": [
                    "RADTKE KATHERINE L",
                    "PETERS HANNAH L",
                    "NEYTS JOHAN",
                    "JOCHMANS DIRK",
                    "SNIJDER ERIC J"
                ],
                "owners": [],
                "url": "https://lens.org/001-776-747-524-561",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "A61K2300/00",
                    "C07D403/04",
                    "Y02P20/582"
                ],
                "ipcrClassifications": [
                    "C07D403/04",
                    "A61K31/506",
                    "A61P31/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "19",
                "publicationKey": "US_2018_0303768_A1",
                "lensId": "181-913-390-114-177",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0303768 A1",
                "publicationDate": "2018-10-25",
                "filingNumber": "US 201816025284 A",
                "filingDate": "2018-07-02",
                "priorityFilingKeysActive": [
                    "US 201562109667 P 20150130",
                    "US 201562195968 P 20150723"
                ],
                "earliestPriorityDate": "2015-01-30",
                "title": "Design, Synthesis And Methods Of Use Of Acyclic Flexmier Nucleoside Analogues Having Anti-coronavirus Activity",
                "applicants": [
                    "UNIV MARYLAND"
                ],
                "inventors": [
                    "RADTKE KATHERINE L",
                    "PETERS HANNAH",
                    "NEYTS JOHAN",
                    "JOCHMANS DIRK",
                    "SNIJDER ERIC J"
                ],
                "owners": [],
                "url": "https://lens.org/181-913-390-114-177",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "A61K2300/00",
                    "C07D403/04",
                    "Y02P20/582"
                ],
                "ipcrClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "C07D403/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "20",
                "publicationKey": "WO_2018_164573_A1",
                "lensId": "074-479-815-323-575",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/164573 A1",
                "publicationDate": "2018-09-13",
                "filingNumber": "NL 2018050137 W",
                "filingDate": "2018-03-06",
                "priorityFilingKeysActive": [
                    "EP 17159420 A 20170306"
                ],
                "earliestPriorityDate": "2017-03-06",
                "title": "Viral Polypeptide Inhibitors",
                "applicants": [
                    "ACADEMISCH ZIEKENHUIS LEIDEN",
                    "GOVERNING COUNCIL UNIV TORONTO",
                    "UNIV OF MANITOBA"
                ],
                "inventors": [
                    "KIKKERT MARJOLEIN",
                    "KNAAP ROBERT CORNELLS MARTINUS",
                    "SIDHU SACHDEV SINGH",
                    "ZHANG WEI",
                    "MARK BRIAN LEONARD",
                    "BAILEY-ELKIN BEN ALLAN"
                ],
                "owners": [],
                "url": "https://lens.org/074-479-815-323-575",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 22,
                "cpcClassifications": [
                    "A61K38/55"
                ],
                "ipcrClassifications": [
                    "A61K38/55",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 65,
                "nplCitations": [
                    "\"PROGRESS IN MEDICINAL CHEMISTRY.\", vol. 55, 1 January 2016, ELSEVIER, AMSTERDAM., NL, ISSN: 0079-6468, article MARK KEMP ET AL: \"Recent Advances in the Discovery of Deubiquitinating Enzyme Inhibitors\", pages: 149 - 192, XP055333853, DOI: 10.1016/bs.pmch.2015.10.002",
                    "BURROUGHS ET AL.: \"Methods in Molecular Biology\", vol. 832, 2012",
                    "VAN HOOIJDONK BMC NEUROSCIENCE, vol. 10, 2009, pages 2",
                    "DZAU ET AL., TRENDS IN BIOTECHNOLOGY, vol. 11, 1993, pages 205 - 210",
                    "ERNST ET AL., SCIENCE, vol. 339, 2013, pages 590 - 595",
                    "WIMMER; SCHREINER, VIRUSES, vol. 7, 2015, pages 4854 - 4872",
                    "ZHANG, W.; BAILEY-ELKIN, B. A.; KNAAP, R. C. M.; KHARE, B.; DALEBOUT, T. J.; JOHNSON, G. G.; VAN KASTEREN, P. B.; MCLEISH, N. J.;: \"Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants\", PLOS PATHOGENS, vol. 13, 2017, pages el006372",
                    "CHEN, P. Y.; GOPALACUSHINA, B. G.; YANG, C. C.; CHAN, S. I.; EVANS, P. A.: \"The role of a beta-bulge in the folding of the beta-hairpin structure in ubiquitin\", PROTEIN SCI., vol. 10, 2001, pages 2063 - 2074",
                    "PIANA, S.; LINDORFF-LARSEN, K.; SHAW, D. E.: \"Atomic-level description of ubiquitin folding\", vol. 110, 2013, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, pages: 5915 - 5920",
                    "PANTOLIANO, M. W.; PETRELLA, E. C.; KWASNOSKI, J. D.; LOBANOV, V. S.; MYSLIK, J.; GRAF, E.; CARVER, T.; ASEL, E.; SPRINGER, B. A.;: \"High-density miniaturized thermal shift assays as a general strategy for drug discovery\", J BIOMOL SCREEN, vol. 6, 2001, pages 429 - 440, XP055027496, DOI: doi:10.1177/108705710100600609",
                    "KOMANDER D; RAPE M, THE UBIQUITIN CODE. ANNUAL REVIEW OF BIOCHEMISTRY, vol. 81, 2012, pages 203 - 29",
                    "YAU R; RAPE M: \"The increasing complexity of the ubiquitin code\", NAT CELL BIOL., vol. 18, no. 6, 2016, pages 579 - 86",
                    "JIANG X; CHEN ZJ: \"The role of ubiquitylation in immune defence and pathogen evasion\", NATURE REVIEWS IMMUNOLOGY, vol. 12, no. 1, 2012, pages 35 - 48",
                    "MIELECH AM; CHEN Y; MESECAR AD; BAKER SC: \"Nidovirus papain-like proteases: multifunctional enzymes with protease, deubiquitinating and deISGylating activities\", VIRUS RES., vol. 194, 2014, pages 184 - 90, XP029105621, DOI: doi:10.1016/j.virusres.2014.01.025",
                    "MORALES DJ; LENSCHOW DJ: \"The antiviral activities of ISG15\", JOURNAL OF MOLECULAR BIOLOGY, vol. 425, no. 24, 2013, pages 4995 - 5008, XP028775405, DOI: doi:10.1016/j.jmb.2013.09.041",
                    "CHENON M; CAMBORDE L; CHEMINANT S; JUPIN I: \"A viral deubiquitylating enzyme targets viral RNA-dependent RNA polymerase and affects viral infectivity\", THE EMBO JOURNAL, vol. 31, no. 3, 2012, pages 741 - 53",
                    "ISAACSON MK; PLOEGH HL: \"Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection\", CELL HOST & MICROBE, vol. 5, no. 6, 2009, pages 559 - 70",
                    "DE WIT E; VAN DOREMALEN N; FALZARANO D; MUNSTER VJ: \"SARS and MERS: recent insights into emerging coronaviruses\", NATURE REVIEWS MICROBIOLOGY, vol. 14, 2016, pages 523 - 34, XP055369190, DOI: doi:10.1038/nrmicro.2016.81",
                    "BAILEY-ELKIN BA; KNAAP RC; JOHNSON GG; DALEBOUT TJ; NINABER DK; VAN KASTEREN PB ET AL.: \"Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression\", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 289, no. 50, 2014, pages 34667 - 82",
                    "MIELECH AM; KILIANSKI A; BAEZ-SANTOS YM; MESECAR AD; BAKER SC: \"MERS-CoV papain-like protease has deISGylating and deubiquitinating activities\", VIROLOGY, vol. 450-451, 2014, pages 64 - 70",
                    "CLEMENTZ MA; CHEN Z; BANACH BS; WANG Y; SUN L; RATIA K ET AL.: \"Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases\", J VIROL., vol. 84, no. 9, 2010, pages 4619 - 29",
                    "XING Y; CHEN J; TU J; ZHANG B; CHEN X; SHI H ET AL.: \"The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase\", THE JOURNAL OF GENERAL VIROLOGY, vol. 94, no. 7, 2013, pages 1554 - 67",
                    "DEVARAJ SG; WANG N; CHEN Z; CHEN Z; TSENG M; BARRETTO N ET AL.: \"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus\", J BIOL CHEM., vol. 282, no. 44, 2007, pages 32208 - 21",
                    "ZHENG D; CHEN G; GUO B; CHENG G; TANG H: \"PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production\", CELL RES., vol. 18, no. 11, 2008, pages 1105 - 13",
                    "BAEZ-SANTOS YM; ST JOHN SE; MESECAR AD: \"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds\", ANTIVIRAL RES., vol. 115, 2015, pages 21 - 38, XP029136855, DOI: doi:10.1016/j.antiviral.2014.12.015",
                    "HILGENFELD R: \"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design\", FEBS J., vol. 281, no. 18, 2014, pages 4085 - 96",
                    "FRIAS-STAHELI N; GIANNAKOPOULOS NV; KIKKERT M; TAYLOR SL; BRIDGEN A; PARAGAS J ET AL.: \"Ovarian tumor domain-containing viral proteases evade ubiquitin-and ISG15-dependent innate immune responses\", CELL HOST MICROBE, vol. 2, no. 6, 2007, pages 404 - 16, XP055049785, DOI: doi:10.1016/j.chom.2007.09.014",
                    "LEI J; MESTERS JR; DROSTEN C; ANEMULLER S; MA Q; HILGENFELD R: \"Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features\", ANTIVIRAL RESEARCH., vol. 109, 2014, pages 72 - 82, XP029045736, DOI: doi:10.1016/j.antiviral.2014.06.011",
                    "RATIA K; SAIKATENDU KS; SANTARSIERO BD; BARRETTO N; BAKER SC; STEVENS RC ET AL.: \"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 103, 2006, pages 5717 - 22",
                    "JAMES TW; FRIAS-STAHELI N; BACIK JP; LEVINGSTON MACLEOD JM; KHAJEHPOUR M; GARCIA-SASTRE A ET AL.: \"Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 108, 2011, pages 2222 - 7, XP055049784, DOI: doi:10.1073/pnas.1013388108",
                    "AKUTSU M; YE Y; VIRDEE S; CHIN JW; KOMANDER D: \"Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 108, 2011, pages 2228 - 33, XP055249441, DOI: doi:10.1073/pnas.1015287108",
                    "CALISTRI A; MUNEGATO D; CARLI I; PAROLIN C; PALU G: \"The ubiquitin-conjugating system: multiple roles in viral replication and infection\", CELLS, vol. 3, no. 2, 2014, pages 386 - 417",
                    "HEIDEKER J; WERTZ IE: \"DUBs, the regulation of cell identity and disease\", BIOCHEM J., vol. 465, no. 1, 2015, pages 1 - 26",
                    "KEMP M.: \"Recent Advances in the Discovery of Deubiquitinating Enzyme Inhibitors\", PROG MED CHEM., vol. 55, 2016, pages 149 - 92, XP055333853, DOI: doi:10.1016/bs.pmch.2015.10.002",
                    "ERNST A; AVVAKUMOV G; TONG J; FAN Y; ZHAO Y; ALBERTS P ET AL.: \"A strategy for modulation of enzymes in the ubiquitin system\", SCIENCE, vol. 339, no. 6119, 2013, pages 590 - 5",
                    "ZHANG W; WU KP; SARTORI MA; KAMADURAI HB; ORDUREAU A; JIANG C ET AL.: \"System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes\", MOLECULAR CELL, vol. 62, no. 1, 2016, pages 121 - 36, XP029496716, DOI: doi:10.1016/j.molcel.2016.02.005",
                    "KRISSINEL E; HENRICK K: \"Inference of macromolecular assemblies from crystalline state\", JOURNAL OF MOLECULAR BIOLOGY, vol. 372, no. 3, 2007, pages 774 - 97, XP022220069, DOI: doi:10.1016/j.jmb.2007.05.022",
                    "HAAGMANS BL; VAN DEN BRAND JM; RAJ VS; VOLZ A; WOHLSEIN P; SMITS SL ET AL.: \"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels\", SCIENCE, vol. 351, no. 6268, 2016, pages 77 - 81, XP055265765, DOI: doi:10.1126/science.aad1283",
                    "INN KS; LEE SH; RATHBUN JY; WONG LY; TOTH Z; MACHIDA K ET AL.: \"Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64\", J VIROL., vol. 85, no. 20, 2011, pages 10899 - 904",
                    "WANG S; WANG K; LI J; ZHENG C: \"Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3\", J VIROL., vol. 87, no. 21, 2013, pages 11851 - 60",
                    "BARRETTO N; JUKNELIENE D; RATIA K; CHEN Z; MESECAR AD; BAKER SC: \"The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity\", J VIROL., vol. 79, no. 24, 2005, pages 15189 - 98",
                    "CHEN Z; WANG Y; RATIA K; MESECAR AD; WILKINSON KD; BAKER SC: \"Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63\", J VIROL., vol. 81, no. 11, 2007, pages 6007 - 18",
                    "LINDNER HA; FOTOUHI-ARDAKANI N; LYTVYN V; LACHANCE P; SULEA T; MENARD R: \"The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme\", J VIROL., vol. 79, no. 24, 2005, pages 15199 - 208",
                    "ZIEBUHR J; SCHELLE B; KARL N; MINSKAIA E; BAYER S; SIDDELL SG ET AL.: \"Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication\", J VIROL., vol. 81, no. 8, 2007, pages 3922 - 32",
                    "BERGERON E; ALBARINO CG; KHRISTOVA ML; NICHOL ST: \"Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function\", J VIROL., vol. 84, no. 1, 2010, pages 216 - 26, XP055249446, DOI: doi:10.1128/JVI.01859-09",
                    "LOMBARDI C; AYACH M; BEAUREPAIRE L; CHENON M; ANDREANI J; GUEROIS R ET AL.: \"A compact viral processing proteinase/ubiquitin hydrolase from the OTU family\", PLOS PATHOG., vol. 9, no. 8, 2013, pages elO03560",
                    "MIAO X.: \"Recent advances in the development of new transgenic animal technology\", CELLULAR AND MOLECULAR LIFE SCIENCES : CMLS, vol. 70, no. 5, 2013, pages 815 - 28, XP055073911, DOI: doi:10.1007/s00018-012-1081-7",
                    "AUGER A; PARK M; NITSCHKE F; MINASSIAN LM; BEILHARTZ GL; MINASSIAN BA ET AL.: \"Efficient Delivery of Structurally Diverse Protein Cargo into Mammalian Cells by a Bacterial Toxin\", MOL PHARM., vol. 12, no. 8, 2015, pages 2962 - 71, XP055332136, DOI: doi:10.1021/acs.molpharmaceut.5b00233",
                    "D'ASTOLFO DS; PAGLIERO RJ; PRAS A; KARTHAUS WR; CLEVERS H; PRASAD V ET AL.: \"Efficient intracellular delivery of native proteins\", CELL, vol. 161, no. 3, 2015, pages 674 - 90, XP055338589, DOI: doi:10.1016/j.cell.2015.03.028",
                    "GAJ T; LIU J; ANDERSON KE; SIRK SJ; BARBAS CF: \"3rd. Protein delivery using Cys2-His2 zinc-finger domains\", ACS CHEM BIOL., vol. 9, no. 8, 2014, pages 1662 - 7",
                    "SCHOTT JW; MORGAN M; GALLA M; SCHAMBACH A: \"Viral and Synthetic RNA Vector Technologies and Applications\", MOL THER., 2016",
                    "WADIA JS; STAN RV; DOWDY SF: \"Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis\", NAT MED., vol. 10, no. 3, 2004, pages 310 - 5, XP002477563, DOI: doi:10.1038/nm996",
                    "VAN DOREMALEN N; MUNSTER VJ: \"Animal models of Middle East respiratory syndrome coronavirus infection\", ANTIVIRAL RES., vol. 122, 2015, pages 28 - 38, XP029262472, DOI: doi:10.1016/j.antiviral.2015.07.005",
                    "COCKRELL AS; YOUNT BL; SCOBEY T; JENSEN K; DOUGLAS M; BEALL A ET AL.: \"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome\", NAT MICROBIOL, vol. 2, 2016, pages 16226",
                    "TONIKIAN R; ZHANG Y; BOONE C; SIDHU SS: \"Identifying specificity profiles for peptide recognition modules from phage-displayed peptide libraries\", NATURE PROTOCOLS, vol. 2, no. 6, 2007, pages 1368 - 86, XP008167972, DOI: doi:10.1038/nprot.2007.151",
                    "D'ARCY A; VILLARD F; MARSH M: \"An automated microseed matrix-screening method for protein crystallization\", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, vol. 63, no. 4, 2007, pages 550 - 4",
                    "IRETON GC; STODDARD BL: \"Microseed matrix screening to improve crystals of yeast cytosine deaminase\", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, vol. 60, no. 3, 2004, pages 601 - 5",
                    "GEORGIEVA DG; KUIL ME; OOSTERKAMP TH; ZANDBERGEN HW; ABRAHAMS JP: \"Heterogeneous nucleation of three-dimensional protein nanocrystals\", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR., vol. 63, no. 5, 2007, pages 564 - 70",
                    "CARLOTTI F; BAZUINE M; KEKARAINEN T; SEPPEN J; POGNONEC P; MAASSEN JA ET AL.: \"Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes\", MOL THER., vol. 9, no. 2, 2004, pages 209 - 17",
                    "VAN DEN WORM SH; ERIKSSON KK; ZEVENHOVEN JC; WEBER F; ZUST R; KURI T ET AL.: \"Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination\", PLOS ONE, vol. 7, no. 3, 2012, pages e32857",
                    "SCHRODINGER, LLC, THE PYMOL MOLECULAR GRAPHICS SYSTEM, 2015",
                    "HEMSLEY A; ARNHEIM N, TONEY MD; CORTOPASSI G; GALAS DJ: \"A simple method for site-directed mutagenesis using the polymerase chain reaction\", NUCLEIC ACIDS RES., vol. 17, 1989, pages 6545 - 51, XP002027312",
                    "GRAHAM FL; VAN DER EB AJ: \"A new technique for the assay of infectivity of human adenovirus 5 DNA\", VIROLOGY, vol. 52, 1973, pages 456 - 67, XP023052128, DOI: doi:10.1016/0042-6822(73)90341-3",
                    "SCHNEIDER CA; RASBAND WS; ELICEIRI KW: \"NIH Image to ImageJ: 25 years of image analysis\", NATURE METHODS, vol. 9, 2012, pages 671 - 5, XP055403257",
                    "CANCER RESEARCH, vol. 64, 2004, pages 5245 - 50"
                ],
                "nplResolvedCount": 66,
                "nplResolvedLensIDs": [
                    "114-964-897-022-095",
                    "024-318-224-229-965",
                    "005-298-110-675-698",
                    "052-726-708-480-011",
                    "101-743-503-932-627",
                    "072-366-322-919-406",
                    "036-868-925-283-835",
                    "059-583-354-909-122",
                    "126-564-848-863-317",
                    "051-310-823-539-220",
                    "066-811-889-923-241",
                    "078-259-908-118-109",
                    "118-587-590-089-222",
                    "123-880-690-838-255",
                    "014-189-817-974-441",
                    "131-153-593-230-765",
                    "029-188-012-110-005",
                    "049-744-366-450-584",
                    "051-035-066-702-786",
                    "062-247-380-633-444",
                    "152-789-448-284-148",
                    "030-820-278-374-034",
                    "078-104-784-735-44X",
                    "036-782-618-845-511",
                    "000-567-989-523-118",
                    "071-412-051-150-727",
                    "056-432-502-904-052",
                    "172-171-664-790-660",
                    "010-219-024-639-095",
                    "093-321-245-747-876",
                    "026-486-758-058-334",
                    "044-480-578-761-351",
                    "017-102-792-005-162",
                    "048-110-934-943-336",
                    "039-999-294-190-112",
                    "012-227-133-222-574",
                    "004-985-510-220-56X",
                    "020-441-798-387-741",
                    "098-589-983-993-779",
                    "008-868-281-317-271",
                    "091-518-359-484-580",
                    "005-697-684-554-770",
                    "017-606-259-428-289",
                    "056-385-580-015-163",
                    "105-695-255-226-679",
                    "008-100-412-815-097",
                    "159-329-767-442-147",
                    "107-516-982-192-993",
                    "000-689-120-517-809",
                    "014-995-358-199-891",
                    "038-318-025-421-071",
                    "021-986-748-450-702",
                    "033-427-366-787-582",
                    "022-644-269-040-219",
                    "038-023-187-031-246",
                    "025-250-299-448-570",
                    "002-309-125-864-020",
                    "036-237-551-499-058",
                    "066-741-088-563-900",
                    "031-005-301-131-571",
                    "083-381-538-598-781",
                    "057-960-261-636-194",
                    "048-396-769-070-290",
                    "051-768-949-935-987",
                    "023-053-797-481-28X",
                    "011-658-930-551-029"
                ],
                "nplResolvedExternalIDs": [
                    "11788061",
                    "pmc4092849",
                    "10.1128/jvi.02747-06",
                    "19864393",
                    "pmc3807349",
                    "10.1038/nrmicro.2016.81",
                    "10.1099/vir.0.051169-0",
                    "26343706",
                    "pmc318348",
                    "17681537",
                    "pmc4584293",
                    "22158412",
                    "10.1038/nm996",
                    "10.1371/journal.ppat.1006372",
                    "pmc2863753",
                    "10.1016/j.chom.2009.05.012",
                    "10.1158/0008-5472.can-04-0496",
                    "27344959",
                    "15289330",
                    "10.1128/jvi.02406-09",
                    "pmc4519095",
                    "10.1177/108705710100600609",
                    "10.1021/acs.molpharmaceut.5b00233",
                    "pmc3187500",
                    "pmc4263872",
                    "14993707",
                    "22833168",
                    "24095857",
                    "17392370",
                    "23966860",
                    "16306591",
                    "16306590",
                    "21835791",
                    "10.1073/pnas.1218321110",
                    "10.1371/journal.pone.0032857",
                    "10.1016/j.virusres.2014.01.025",
                    "pmc3957432",
                    "pmc3038727",
                    "10.1126/science.aad1283",
                    "23596270",
                    "pmc2647928",
                    "23503848",
                    "10.1093/nar/17.16.6545",
                    "10.1007/s00018-012-1081-7",
                    "25554382",
                    "pmc4811637",
                    "10.1128/jvi.01859-09",
                    "19527883",
                    "pmc2798392",
                    "pmc3744425",
                    "10.1016/j.molcel.2016.02.005",
                    "pmc1866161",
                    "23986588",
                    "11567097",
                    "24503068",
                    "10.3390/cells3020386",
                    "26949039",
                    "10.1016/j.antiviral.2014.12.015",
                    "10.1371/journal.ppat.1003560",
                    "22412934",
                    "10.1128/jvi.79.24.15199-15208.2005",
                    "25320088",
                    "19144149",
                    "10.1110/ps.07101",
                    "10.1016/j.virol.2013.11.040",
                    "10.1038/nmicrobiol.2016.226",
                    "10.1073/pnas.1015287108",
                    "10.1042/bj20140496",
                    "24936957",
                    "10.1038/emboj.2011.424",
                    "10.1128/jvi.00690-11",
                    "26192750",
                    "17372361",
                    "10.1111/febs.12936",
                    "25910214",
                    "22350875",
                    "10.1016/j.ymthe.2003.11.021",
                    "18957937",
                    "24992731",
                    "10.1038/nmeth.2089",
                    "10.1016/j.antiviral.2015.07.005",
                    "22524316",
                    "24805990",
                    "pmc3038750",
                    "10.1016/j.jmb.2007.05.022",
                    "18078692",
                    "10.1146/annurev-biochem-060310-170328",
                    "16581910",
                    "pmc1900296",
                    "10.1186/1471-2202-10-2",
                    "21245344",
                    "20181693",
                    "10.1038/nri3111",
                    "28542609",
                    "10.3390/v7092849",
                    "10.1073/pnas.0510851103",
                    "10.1016/0042-6822(73)90341-3",
                    "25793419",
                    "23287719",
                    "14759805",
                    "pmc3815447",
                    "10.1016/j.cell.2015.03.028",
                    "27377044",
                    "pmc1316033",
                    "17251282",
                    "10.1128/jvi.01211-13",
                    "pmc4090058",
                    "pmc3864900",
                    "pmc2756044",
                    "2674899",
                    "25631680",
                    "10.2210/pdb5hpl/pdb",
                    "14770178",
                    "17545975",
                    "17761676",
                    "021266548",
                    "26678878",
                    "10.1107/s0907444903029664",
                    "10.1016/j.antiviral.2014.06.011",
                    "21266548",
                    "26852935",
                    "10.1038/mt.2016.143",
                    "10.1016/0167-7799(93)90116-q",
                    "pmc1316023",
                    "10.1038/ncb3358",
                    "10.1126/science.1230161",
                    "pmc3625349",
                    "pmc1458639",
                    "pmc4125544",
                    "10.1016/j.jmb.2013.09.041",
                    "pmc3273391",
                    "10.1107/s0907444907007810",
                    "10.1038/nprot.2007.151",
                    "10.1038/cr.2008.294",
                    "pmc2184509",
                    "26103531",
                    "10.1107/s0907444907007652",
                    "24512893",
                    "10.1074/jbc.m114.609644",
                    "10.1074/jbc.m704870200",
                    "25039866",
                    "10.1021/cb500282g",
                    "pmc3296753",
                    "10.1073/pnas.1013388108",
                    "22930834",
                    "10.1089/108705701753364922",
                    "10.1016/j.chom.2007.09.014",
                    "10.1007/978-1-61779-474-2_2",
                    "22117220",
                    "27230526",
                    "17452781",
                    "27892925",
                    "10.1128/jvi.02091-06",
                    "10.1016/bs.pmch.2015.10.002",
                    "10.1128/jvi.79.24.15189-15198.2005",
                    "pmc2374220",
                    "4705382",
                    "7763813"
                ]
            },
            {
                "index": "21",
                "publicationKey": "US_10058516_B2",
                "lensId": "076-507-655-389-388",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10058516 B2",
                "publicationDate": "2018-08-28",
                "filingNumber": "US 201615546818 A",
                "filingDate": "2016-01-28",
                "priorityFilingKeysActive": [
                    "US 201562109667 P 20150130",
                    "US 201562195968 P 20150723"
                ],
                "earliestPriorityDate": "2015-01-30",
                "title": "Design, Synthesis And Methods Of Use Of Acyclic Fleximer Nucleoside Analogues Having Anti-coronavirus Activity",
                "applicants": [
                    "UNIV MARYLAND",
                    "UNIV LEUVEN KATH",
                    "LEIDEN UNIV MEDICAL CENTER"
                ],
                "inventors": [
                    "RADTKE KATHERINE L",
                    "PETERS HANNAH L",
                    "NEYTS JOHAN",
                    "JOCHMANS DIRK",
                    "SNIJDER ERIC J"
                ],
                "owners": [],
                "url": "https://lens.org/076-507-655-389-388",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "A61K2300/00",
                    "C07D403/04",
                    "Y02P20/582"
                ],
                "ipcrClassifications": [
                    "C07D403/04",
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 38,
                "nplCitations": [
                    "Peters et al., Bioorganic & Medicinal Chemistry Letters, published online May 23, 2015, 25(15), pp. 2923-2926.",
                    "Chemical Abstracts Registry No. 550-33-4, Nov. 16, 1984.",
                    "Chemical Abstracts Registry No. 19186-33-5, Nov. 16, 1984.",
                    "Grant, R., Grant, C. (1987). Grant & Hackh's Chemical Dictionary (5th ed.). New York, NY: McGraw-Hill, p. 313.",
                    "Al-Hazmi, Saudi Journal of Biological Sciences, 2016, 23, 507-511.",
                    "Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An Overview of Their Replication and Pathogenesis. Methods in Molecular Biology (Clifton, N.J.), 1282, 1-23.",
                    "Niedzwicki et al., Biochemical Pharmacology, 1991, 41(11), pp. 1615-1624.",
                    "In Global alert and response. Middle East Respiratory syndrome coronavirus (MERS-CoV); World Health Organization: 2015; vol. 2014.",
                    "In Zovirax Prescribing Information; U.S. Food and Drug Administration: 2003; NDA 18-603/5-027.",
                    "Al-Tawfiq, J.A. et al. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study, Int. J. Infect. Dis., 20 (2014), pp. 42-46.",
                    "Boncel, A. et al. Novel 5-(N-Alkylaminouracil) Acyclic Nucleosides, Synthesis-Stuttgart (2011), pp. 603-610.",
                    "Chen, F. et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds, J. Clin. Virol., 31 (2004), pp. 69-75.",
                    "de Wilde, A.H. et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment, J. Gen. Virol., 94 (2013), pp. 1749-1760.",
                    "de Wilde, A.H. et al. Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture, Antimicrob. Agents Chemother, 58 (2014), pp. 4875-4884.",
                    "Falzarano, D. et al. Treatment with interferon-alpha 2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques Nat. Med., 19 (2013), pp. 1313-1317.",
                    "Fouchier, R. A. et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A 101 (2004), pp. 6212-6216.",
                    "Furman, P.A. et al. Acyclovir Triphosphate is a Suicide Inactivator of the Herpes-Simplex Virus DNA Polymerase, J. Biol. Chem., 259 (1984), pp. 9575-9579.",
                    "Jochmans, D. et al. A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE. J Virol Methods 183 (2012), pp. 176-179.",
                    "Kuiken, T. et al. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol, 164 (2004), pp. 1893-1900.",
                    "McGuigan, C. et al. Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus Bioorg. Med. Chem. Lett., 20 (2010), pp. 4850-4854.",
                    "McGuirt, P.V. et al. Acyclovir Inhibition of Viral DNA Chain Elongation in Herpes Simplex Virus-Infected Cells, Am. J. Med., 73 (1982), pp. 67-71.",
                    "Mee, S.P. et al. Significant enhancement of the Stille reaction with a new combination of reagents-copper(I) iodide with cesium fluoride, Chem. Eur. J., 11 (2005), pp. 3294-3308.",
                    "Momattin, H. et al. Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)\u2014possible lessons from a systematic review of SARS-CoV therapy, Int. J. Infect. Dis., 17 (2013), pp. e792-e798.",
                    "Morgenstern, B. et al. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines, Biochem. Biophys. Res. Commun., 326 (2005), pp. 905-908.",
                    "Peiris, J.S.M. et al. Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet, 361 (2003), pp. 1319-1325.",
                    "Pyrc, K. et al. Identification of new human coronaviruses, Expert Rev. Anti-infect. Ther., 5 (2007), pp. 245-253.",
                    "Quirk, S. et al. Substrate discrimination by the human GTP fucose pyrophosphorylase, Biochemistry, 44 (2005), pp. 10854-10863.",
                    "Quirk, S. et al. Identification of catalytic amino acids in the human GTP fucose pyrophosphorylase active site, Biochemistry, 44 (2005), pp. 13172-13178.",
                    "Salim, S. Molecular chameleons: design and synthesis of a second series of flexible nucleosides, Doctoral dissertation, Georgia Institute of Technology, 2004, pp. 1-149.",
                    "Schinazi, R. Synthesis of 5-(Dihydroxyboryl)-2\u2032deoxyuridine and Related Boron-Containing Pyrimidines, J. Org. Chem., 50 (1985), pp. 841-847.",
                    "Seley, K.L. et al. \u201cFleximers\u201d. Design and Synthesis of Two Novel Split Nucleosides, Org. Lett., 3 (2001), p. 3209-3210.",
                    "Seley, K.L. et al. \u201cFleximers\u201d. Design and Synthesis of a New Class of Novel Shape-Modified Nucleosies, 67 (2002), p. 3365, J. Org. Chem.",
                    "Seley, K. L. et al. Unexpected inhibition of S-adenosyl-L-homocysteine hydrolase by a guanosine nucleoside, Bioorg. Med. Chem. Lett., 13, (2003) pp. 1985-1988.",
                    "Seley, K. L. et al. \u201cMolecular chameleons\u201d. Design and synthesis of C-4-substituted imidazole fleximers, Org. Lett., 7 (2005), pp. 63-66.",
                    "Smith, E.C. et al. Coronavirus Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics, PLoS Pathog., 9 (2013), p. e1003565, 1-11.",
                    "Tan, E.L. et al. Inhibition of SARS Coronavirus Infection in Vitro with Clinically Approved Antiviral Drugs, Emerg. Infect. Dis., 10 (2004), pp. 581-586.",
                    "Vanpouille, C. et al. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2, J. Infect. Dis., 201 (2010), pp. 635-643.",
                    "Wauchope, O.R. et al. Synthetic Routes to a Series of Proximal and Distal 2\u2032-Deoxy Fleximers, Synthesis, 44 (2012), pp. 3496-3504."
                ],
                "nplResolvedCount": 35,
                "nplResolvedLensIDs": [
                    "057-617-477-665-56X",
                    "032-735-667-143-965",
                    "055-817-993-936-104",
                    "074-919-683-245-507",
                    "059-550-034-399-273",
                    "099-339-512-037-70X",
                    "043-175-443-728-67X",
                    "007-805-109-951-284",
                    "074-960-744-959-701",
                    "018-702-914-707-986",
                    "073-663-856-907-01X",
                    "057-080-756-583-519",
                    "062-192-092-753-972",
                    "016-754-916-865-234",
                    "094-485-484-823-984",
                    "054-117-964-555-982",
                    "017-883-043-691-040",
                    "052-650-110-852-468",
                    "009-403-958-653-100",
                    "002-808-749-577-966",
                    "020-090-218-931-826",
                    "025-992-623-190-843",
                    "108-229-899-337-383",
                    "081-307-021-537-929",
                    "084-893-855-384-248",
                    "102-808-548-863-662",
                    "071-349-856-440-802",
                    "002-163-468-775-047",
                    "080-897-630-292-177",
                    "185-700-349-724-543",
                    "127-574-272-971-002",
                    "062-634-123-022-634",
                    "035-834-171-631-191",
                    "017-689-034-509-674",
                    "129-401-973-660-415"
                ],
                "nplResolvedExternalIDs": [
                    "15161626",
                    "27298584",
                    "pmc4136071",
                    "pmc395948",
                    "10.1038/nm.3362",
                    "6285735",
                    "10.3201/eid1004.030458",
                    "16185085",
                    "pmc3323075",
                    "10.1016/j.bmcl.2015.05.039",
                    "10.1016/j.jviromet.2012.04.011",
                    "20637609",
                    "10.1016/s0002-9440(10)63750-9",
                    "24406736",
                    "10.1002/chem.200401162",
                    "pmc1615765",
                    "23993766",
                    "pmc4093902",
                    "10.1055/s-0032-1316791",
                    "10.1021/ol047895v",
                    "10.1021/bi051288d",
                    "24841269",
                    "10.1016/j.sjbs.2016.02.019",
                    "11574032",
                    "15073334",
                    "16086588",
                    "pmc4890194",
                    "10.1016/j.bbrc.2004.11.128",
                    "10.1021/jo00206a024",
                    "10.1016/0006-2952(91)90162-x",
                    "10.1016/s0960-894x(03)00331-7",
                    "10.1016/s1386-6532(04)00055-1",
                    "23966862",
                    "23620378",
                    "10.1128/aac.03011-14",
                    "15200845",
                    "26048809",
                    "10.1073/pnas.0400762101",
                    "10.1055/s-0030-1258397",
                    "10.1371/journal.ppat.1003565",
                    "10.1016/s0140-6736(03)13077-2",
                    "15624978",
                    "17402839",
                    "pmc4466200",
                    "pmc2811219",
                    "10.1016/j.bmcl.2010.06.094",
                    "15288617",
                    "15786503",
                    "24465059",
                    "10.1007/978-1-4939-2438-7_1",
                    "10.1586/14787210.5.2.245",
                    "12781179",
                    "10.1016/j.jcv.2004.03.003",
                    "24013700",
                    "22575574",
                    "6086640",
                    "pmc4369385",
                    "10.1021/bi0503605",
                    "10.1002/chin.201052201",
                    "2043151",
                    "12711465",
                    "10.1099/vir.0.052910-0",
                    "10.1016/0002-9343(82)90066-3",
                    "pmc3898542",
                    "pmc3744431",
                    "10.1016/j.ijid.2013.07.002",
                    "pmc3749523",
                    "12003548",
                    "25720466",
                    "10.1016/j.ijid.2013.12.003",
                    "10.1021/jo0255476",
                    "15607755",
                    "10.1086/650343",
                    "10.1021/ol0165443",
                    "20085496"
                ]
            },
            {
                "index": "22",
                "publicationKey": "US_2018_0015052_A1",
                "lensId": "071-023-173-107-488",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0015052 A1",
                "publicationDate": "2018-01-18",
                "filingNumber": "US 201615546818 A",
                "filingDate": "2016-01-28",
                "priorityFilingKeysActive": [
                    "US 201562109667 P 20150130",
                    "US 201562195968 P 20150723"
                ],
                "earliestPriorityDate": "2015-01-30",
                "title": "Design, Synthesis And Methods Of Use Of Acyclic Flexmier Nucleoside Analogues Having Anti-coronavirus Activity",
                "applicants": [
                    "UNIV MARYLAND",
                    "UNIV LEUVEN KATH",
                    "LEIDEN UNIV MEDICAL CENTER"
                ],
                "inventors": [
                    "RADTKE KATHERINE L",
                    "PETERS HANNAH L",
                    "NEYTS JOHAN",
                    "JOCHMANS DIRK",
                    "SNIJDER ERIC J"
                ],
                "owners": [],
                "url": "https://lens.org/071-023-173-107-488",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "A61K2300/00",
                    "C07D403/04",
                    "Y02P20/582"
                ],
                "ipcrClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "C07D403/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 7,
                "nplCitations": [
                    "Peters et al., Bioorganic & Medicinal Chemistry Letters, published online May 23, 2015, 25(15), pages 2923-2926.",
                    "Chemical Abstracts Registry Number 550-33-4, November 16, 1984.",
                    "Chemical Abstracts Registry Number 19186-33-5, November 16, 1984.",
                    "Grant, R., Grant, C. (1987). Grant & Hackh's Chemical Dictionary (5th ed.). New York, NY: McGraw-Hill, page 313.",
                    "Al-Hazmi, Saudi Journal of Biological Sciences, 2016, 23, 507-511.",
                    "Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An Overview of Their Replication and Pathogenesis. Methods in Molecular Biology (Clifton, N.J.), 1282, 1\u201323.",
                    "Niedzwicki et al., Biochemical Pharmacology, 1991, 41(11), pages 1615-1624."
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "057-617-477-665-56X",
                    "032-735-667-143-965",
                    "009-403-958-653-100",
                    "080-897-630-292-177"
                ],
                "nplResolvedExternalIDs": [
                    "10.1007/978-1-4939-2438-7_1",
                    "10.1016/0006-2952(91)90162-x",
                    "25720466",
                    "2043151",
                    "10.1016/j.sjbs.2016.02.019",
                    "27298584",
                    "10.1016/j.bmcl.2015.05.039",
                    "pmc4466200",
                    "26048809",
                    "pmc4890194",
                    "pmc4369385"
                ]
            },
            {
                "index": "23",
                "publicationKey": "WO_2017_040316_A1",
                "lensId": "186-083-318-857-488",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/040316 A1",
                "publicationDate": "2017-03-09",
                "filingNumber": "US 2016/0049071 W",
                "filingDate": "2016-08-26",
                "priorityFilingKeysActive": [
                    "US 201562211541 P 20150828"
                ],
                "earliestPriorityDate": "2015-08-28",
                "title": "Sample Analysis, Presence Determination Of A Target Sequence",
                "applicants": [
                    "BROAD INST INC",
                    "MASSACHUSETTS INST TECHNOLOGY",
                    "SABETI PARDIS"
                ],
                "inventors": [
                    "SABETI PARDIS",
                    "METSKY HAYDEN",
                    "GNIRKE ANDREAS",
                    "MATRANGA CHRISTIAN",
                    "PARK DANIEL"
                ],
                "owners": [],
                "url": "https://lens.org/186-083-318-857-488",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 452330,
                "cpcClassifications": [
                    "C12Q1/686",
                    "C07H21/04",
                    "C12Q1/6806",
                    "C12Q1/6809",
                    "C12Q1/6816",
                    "C12Q1/701",
                    "Y02A50/51",
                    "Y02A50/53",
                    "Y02A50/54",
                    "Y02A50/60"
                ],
                "ipcrClassifications": [
                    "C40B30/04",
                    "C12Q1/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "JABADO ET AL.: \"Comprehensive viral oligonucleotide probe design using conserved protein regions\", NUCLEIC ACIDS RESEARCH, vol. 36, no. 1, 2008, pages 1 - 10, XP055366340",
                    "TAGHIPOUR ET AL.: \"Applying surface-based DNA computing for solving the dominating set problem\", AMERICAN JOURNAL OF MOLECULAR BIOLOGY, vol. 2, no. 3, July 2012 (2012-07-01), pages 286 - 290, XP055366355"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "178-230-553-419-469",
                    "001-544-300-732-126"
                ],
                "nplResolvedExternalIDs": [
                    "pmc2248741",
                    "18079152",
                    "10.1093/nar/gkm1106",
                    "10.4236/ajmb.2012.23030"
                ]
            },
            {
                "index": "24",
                "publicationKey": "US_10086063_B2",
                "lensId": "179-929-644-817-02X",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10086063 B2",
                "publicationDate": "2018-10-02",
                "filingNumber": "US 201615274491 A",
                "filingDate": "2016-09-23",
                "priorityFilingKeysActive": [
                    "US 201562222322 P 20150923"
                ],
                "earliestPriorityDate": "2015-09-23",
                "title": "Methods Of Making And Using Live Attenuated Viruses",
                "applicants": [
                    "UNIV MINNESOTA"
                ],
                "inventors": [
                    "LANGLOIS RYAN ANDREW",
                    "FIEGE JESSICA KAREN",
                    "SJAASTAD LOUISA ELIZABETH",
                    "WARING BARBARA MAE"
                ],
                "owners": [
                    {
                        "name": "REGENTS OF THE UNIVERSITY OF MINNESOTA",
                        "executionDate": "2019-04-26"
                    }
                ],
                "url": "https://lens.org/179-929-644-817-02X",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 4,
                "seqCount": 2,
                "cpcClassifications": [
                    "C12N7/00",
                    "C12N15/111",
                    "C12N2310/113",
                    "C12N2330/50",
                    "C12N2760/16034",
                    "C12N2760/16051",
                    "C12N2760/16062",
                    "Y02A50/51"
                ],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K31/7088",
                    "A61K39/00",
                    "A61K39/145",
                    "C07H21/02",
                    "C07H21/04",
                    "C12N5/00",
                    "C12N7/00",
                    "C12N15/85"
                ],
                "usClassifications": [],
                "nplCitationCount": 12,
                "nplCitations": [
                    "Barnes et al., \u201cHarnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virusvaccines,\u201d Cell Host Microbe., 4(3):239-48, Sep. 11, 2008.",
                    "Bartel, \u201cMicroRNA Target Recognition and Regulatory Functions,\u201d Cell., 136(2):215-233, Jan. 23, 2009.",
                    "Chenna et al., \u201cMultiple sequence alignment with the Clustal series of program,\u201d Nucleic Acids Res., 31(13):3497-3500, 2003.",
                    "Fodor et al., \u201cRescue of Influenza A Virus from Recombinant DNA,\u201d J Virol., 73(11):9679-9682, Nov. 1999.",
                    "Kelly et al, \u201cEngineering microRNA responsiveness to decrease virus pathogenicity,\u201d Nature Medicine., 14(11):1278-1283, Nov. 2008.",
                    "Langlois et al., \u201cIn vivo delivery of cytoplasmic RNA virus-derived miRNAs,\u201d Mol.Therapy., 20(2):367-375, Feb. 2012.",
                    "Langlois et al., \u201cHematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses,\u201d PNAS., 109(30): 12117-12122, Jul. 24, 2012.",
                    "Langlois et al., \u201cMicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies,\u201d Nature Biotechnology 31(9):844-847, Aug. 11, 2013.",
                    "Perez et al., \u201cMicroRNA-mediated species-specific attenuation of influenza A virus,\u201d Nature Biotechnology 27:572-576, 2009.",
                    "Pfeffer et al., \u201cIdentification of microRNAs of the herpesvirus family,\u201d Nat Methods., 2(4):269-276, 2005.",
                    "Pham et al., \u201cReplication in Cells of Hematopoietic Origin Is Necessary for Dengue Virus Dissemination,\u201d PLoS Pathogens., 8(1):e1002465, 10 pages, Jan. 5, 2012.",
                    "Shapiro et al., \u201cNoncanonical cytoplasmic processing of viral microRNAs,\u201d RNA. 16(11):2068-2074, Nov. 2010."
                ],
                "nplResolvedCount": 12,
                "nplResolvedLensIDs": [
                    "026-956-603-588-975",
                    "062-926-743-070-156",
                    "057-727-756-782-512",
                    "144-376-770-423-358",
                    "040-649-149-362-761",
                    "014-462-529-725-525",
                    "089-587-704-837-170",
                    "014-993-888-050-374",
                    "090-174-138-652-509",
                    "067-288-941-479-970",
                    "092-203-218-432-170",
                    "057-124-103-401-53X"
                ],
                "nplResolvedExternalIDs": [
                    "19483680",
                    "10.1261/rna.2303610",
                    "pmc3808852",
                    "18779050",
                    "12824352",
                    "22778433",
                    "pmc3277236",
                    "10.1038/nbt.1542",
                    "pmc2045542",
                    "19167326",
                    "10.1371/journal.ppat.1002465",
                    "pmc113010",
                    "15782219",
                    "10.1038/nmeth746",
                    "10.1073/pnas.1206039109",
                    "pmc2605097",
                    "10.1038/mt.2011.244",
                    "22086233",
                    "10.1016/j.chom.2008.08.003",
                    "10516084",
                    "20841420",
                    "23934176",
                    "pmc3409765",
                    "10.1016/j.cell.2009.01.002",
                    "10.1093/nar/gkg500",
                    "pmc3252368",
                    "10.1038/nm.1776",
                    "pmc168907",
                    "22241991",
                    "18953352",
                    "10.1038/nbt.2666",
                    "pmc2957047",
                    "pmc3794896"
                ]
            },
            {
                "index": "25",
                "publicationKey": "US_2017_0080079_A1",
                "lensId": "130-719-068-655-806",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0080079 A1",
                "publicationDate": "2017-03-23",
                "filingNumber": "US 201615274491 A",
                "filingDate": "2016-09-23",
                "priorityFilingKeysActive": [
                    "US 201562222322 P 20150923"
                ],
                "earliestPriorityDate": "2015-09-23",
                "title": "Methods Of Making And Using Live Attenuated Viruses",
                "applicants": [
                    "UNIV MINNESOTA"
                ],
                "inventors": [
                    "LANGLOIS RYAN ANDREW"
                ],
                "owners": [
                    {
                        "name": "REGENTS OF THE UNIVERSITY OF MINNESOTA",
                        "executionDate": "2019-04-26"
                    }
                ],
                "url": "https://lens.org/130-719-068-655-806",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 4,
                "seqCount": 2,
                "cpcClassifications": [
                    "C12N7/00",
                    "C12N15/111",
                    "C12N2310/113",
                    "C12N2330/50",
                    "C12N2760/16034",
                    "C12N2760/16051",
                    "C12N2760/16062",
                    "Y02A50/51"
                ],
                "ipcrClassifications": [
                    "A61K39/145",
                    "C12N5/00",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "26",
                "publicationKey": "WO_2017_044507_A2",
                "lensId": "092-874-904-147-131",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2017/044507 A2",
                "publicationDate": "2017-03-16",
                "filingNumber": "US 2016/0050590 W",
                "filingDate": "2016-09-07",
                "priorityFilingKeysActive": [
                    "US 201562215565 P 20150908"
                ],
                "earliestPriorityDate": "2015-09-08",
                "title": "Sirna/nanoparticle Formulations For Treatment Of Middle-east Respiratory Syndrome Coronaviral Infection",
                "applicants": [
                    "SIRNAOMICS INC"
                ],
                "inventors": [
                    "LU PATRICK Y",
                    "SIMONENKO VERA",
                    "CAI YIBIN",
                    "XU JOHN",
                    "EVANS DAVID"
                ],
                "owners": [],
                "url": "https://lens.org/092-874-904-147-131",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K48/0066",
                    "A61K9/127",
                    "A61K9/5153",
                    "A61K47/28",
                    "A61K47/543",
                    "A61K48/0008",
                    "A61P31/14",
                    "B82Y5/00",
                    "C12N15/1131",
                    "C12N15/88",
                    "C12N2310/14",
                    "C12N2320/31",
                    "C12N2320/32"
                ],
                "ipcrClassifications": [
                    "A61K48/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "27",
                "publicationKey": "WO_2015_192077_A1",
                "lensId": "008-342-999-301-854",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/192077 A1",
                "publicationDate": "2015-12-17",
                "filingNumber": "US 2015/0035658 W",
                "filingDate": "2015-06-12",
                "priorityFilingKeysActive": [
                    "US 201462011462 P 20140612"
                ],
                "earliestPriorityDate": "2014-06-12",
                "title": "Heterocyclic Compounds And Methods Of Use Thereof",
                "applicants": [
                    "US HEALTH",
                    "UNIV KANSAS"
                ],
                "inventors": [
                    "LIANG TSANYANG",
                    "HU ZONGYI",
                    "MARUGAN JUAN JOSE",
                    "SOUTHALL NOEL TERRENCE",
                    "HE SHANSHAN",
                    "HU XIN",
                    "XIAO JINGBO",
                    "FERRER MARC",
                    "ZHENG WEI",
                    "FRANKOWSKI KEVIN J",
                    "SCHOENEN FRANK J",
                    "LI KELIN"
                ],
                "owners": [],
                "url": "https://lens.org/008-342-999-301-854",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 10,
                "familySize": 10,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07D413/06",
                    "A61K31/4178",
                    "A61K31/454",
                    "A61K31/4545",
                    "A61K31/496",
                    "A61K31/5377",
                    "A61K31/7056",
                    "A61K31/7068",
                    "A61K38/07",
                    "A61K38/13",
                    "A61K38/212",
                    "C07D413/14",
                    "C07D417/14",
                    "C07D471/08",
                    "Y02A50/385"
                ],
                "ipcrClassifications": [
                    "C07D413/14",
                    "A61K31/553",
                    "A61P31/14",
                    "C07D471/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "28",
                "publicationKey": "US_2019_0030187_A1",
                "lensId": "027-117-701-172-454",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0030187 A1",
                "publicationDate": "2019-01-31",
                "filingNumber": "US 201615758312 A",
                "filingDate": "2016-09-07",
                "priorityFilingKeysActive": [
                    "US 201562215565 P 20150908"
                ],
                "earliestPriorityDate": "2015-09-08",
                "title": "Sirna/nanoparticle Formulations For Treatment Of Middle-east Respiratory Syndrome Coronaviral Infection",
                "applicants": [
                    "SIRNAOMICS INC"
                ],
                "inventors": [
                    "LU PATRICK Y",
                    "SIMONENKO VERA",
                    "CAI YIBIN",
                    "XU JOHN",
                    "EVANS DAVID"
                ],
                "owners": [
                    {
                        "name": "SIRNAOMICS INC",
                        "executionDate": "2017-02-28"
                    }
                ],
                "url": "https://lens.org/027-117-701-172-454",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 1059,
                "cpcClassifications": [
                    "A61K48/0066",
                    "A61K9/127",
                    "A61K9/5153",
                    "A61K47/28",
                    "A61K47/543",
                    "A61K48/0008",
                    "A61P31/14",
                    "B82Y5/00",
                    "C12N15/1131",
                    "C12N15/88",
                    "C12N2310/14",
                    "C12N2320/31",
                    "C12N2320/32"
                ],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K47/28",
                    "A61K47/54",
                    "A61P31/14",
                    "C12N15/113"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "29",
                "publicationKey": "US_2017_0114053_A1",
                "lensId": "194-597-687-028-253",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0114053 A1",
                "publicationDate": "2017-04-27",
                "filingNumber": "US 201515317864 A",
                "filingDate": "2015-06-12",
                "priorityFilingKeysActive": [
                    "US 201462011462 P 20140612"
                ],
                "earliestPriorityDate": "2014-06-12",
                "title": "Heterocyclic Compounds And Methods Of Use Thereof",
                "applicants": [
                    "US HEALTH",
                    "UNIV OF KANSAS"
                ],
                "inventors": [
                    "LIANG TSANYANG",
                    "HU ZONGYI",
                    "MARUGAN JUAN JOSE",
                    "SOUTHALL NOEL TERRENCE",
                    "HE SHANSHAN",
                    "HU XIN",
                    "XIAO JINGBO",
                    "FERRER MARC",
                    "ZHENG WEI",
                    "FRANKOWSKI KEVIN J",
                    "SCHOENEN FRANK J",
                    "LI KELIN"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                        "executionDate": "2017-07-24"
                    },
                    {
                        "name": "UNIVERSITY OF KANSAS",
                        "executionDate": "2017-07-24"
                    }
                ],
                "url": "https://lens.org/194-597-687-028-253",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 10,
                "familySize": 10,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07D413/06",
                    "A61K31/4178",
                    "A61K31/454",
                    "A61K31/4545",
                    "A61K31/496",
                    "A61K31/5377",
                    "A61K31/7056",
                    "A61K31/7068",
                    "A61K38/07",
                    "A61K38/13",
                    "A61K38/212",
                    "C07D413/14",
                    "C07D417/14",
                    "C07D471/08",
                    "Y02A50/385"
                ],
                "ipcrClassifications": [
                    "C07D413/06",
                    "A61K31/4178",
                    "A61K31/454",
                    "A61K31/4545",
                    "A61K31/496",
                    "A61K31/5377",
                    "A61K31/7056",
                    "A61K31/7068",
                    "A61K38/07",
                    "A61K38/13",
                    "A61K38/21",
                    "C07D413/14",
                    "C07D417/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "CA registry No.902500-07-6, entered into CA registry File on 8/17/06,supplied by Aurora Fine Chemicals.",
                    "Aurora Fine Chemicals Product Guide.1 page, retrieved from the Internet at http://www.aurorafinechemicals.com/abouthtml on 4/28/15.",
                    "Goldfarb I, Chemical Abstracts vol.151. No.92849 and 92847, abstracts for US 2009/0163545 (2009).",
                    "Goldfarb II, Chemical Abstracts vol.151. No.92845,92840,70320, abstracts for US 2009/0163545 (2009)."
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "30",
                "publicationKey": "US_2019_0062785_A1",
                "lensId": "115-286-759-285-758",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0062785 A1",
                "publicationDate": "2019-02-28",
                "filingNumber": "US 201716091005 A",
                "filingDate": "2017-03-31",
                "priorityFilingKeysActive": [
                    "US 201662318087 P 20160404"
                ],
                "earliestPriorityDate": "2016-04-04",
                "title": "Multivalent Vaccines For Rabies Virus And Coronoviruses",
                "applicants": [
                    "THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVIC",
                    "UNIV JEFFERSON",
                    "UNIV MARYLAND"
                ],
                "inventors": [
                    "JOHNSON REED F",
                    "SCHNELL MATTHIAS",
                    "HENSLEY LISA E",
                    "WIRBLICH CHRISTOPH",
                    "COLEMAN CHRISTOPHER M",
                    "FRIEMAN MATTHEW B"
                ],
                "owners": [
                    {
                        "name": "UNIVERSITY OF MARYLAND BALTIMORE",
                        "executionDate": "2017-04-26"
                    }
                ],
                "url": "https://lens.org/115-286-759-285-758",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 24,
                "cpcClassifications": [
                    "C12N15/86",
                    "A61K39/12",
                    "A61K39/205",
                    "A61K39/215",
                    "A61K2039/5254",
                    "A61K2039/5256",
                    "C12N2760/20034",
                    "C12N2760/20043",
                    "C12N2760/20134",
                    "C12N2760/20143",
                    "C12N2770/20022",
                    "C12N2770/20034"
                ],
                "ipcrClassifications": [
                    "C12N15/86",
                    "A61K39/205",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "31",
                "publicationKey": "WO_2019_046316_A1",
                "lensId": "190-724-549-141-163",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/046316 A1",
                "publicationDate": "2019-03-07",
                "filingNumber": "US 2018/0048369 W",
                "filingDate": "2018-08-28",
                "priorityFilingKeysActive": [
                    "US 201762551047 P 20170828"
                ],
                "earliestPriorityDate": "2017-08-28",
                "title": "Pikfyve Kinase Inhibitors",
                "applicants": [
                    "ACURASTEM INC"
                ],
                "inventors": [
                    "SMRCINA MARTIN",
                    "LI RONGHUA",
                    "NAIR ANIL",
                    "AUGUST PAUL",
                    "BJERGARDE KIRSTEN"
                ],
                "owners": [],
                "url": "https://lens.org/190-724-549-141-163",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07D403/04",
                    "C07D407/14",
                    "C07D413/14",
                    "C07D417/14",
                    "C07D491/048"
                ],
                "ipcrClassifications": [
                    "C07D413/14",
                    "A61K31/506",
                    "A61P25/14",
                    "A61P25/16",
                    "A61P25/28",
                    "A61P31/12",
                    "A61P31/22",
                    "C07D403/04",
                    "C07D407/14",
                    "C07D417/14",
                    "C07D491/048"
                ],
                "usClassifications": [],
                "nplCitationCount": 6,
                "nplCitations": [
                    "WADA ET AL., BLOOD, vol. 109, 2007, pages 1156 - 1164",
                    "CAI ET AL., CHEMISTRY AND BIOL., vol. 20, 2013, pages 912 - 921",
                    "BAIRD ET AL., FRONTIERS IN ONCOLOGY, vol. 3, no. 1, 2013",
                    "T. W. GREENE: \"Protective Groups in Organic Synthesis\", 1991, JOHN WILEY & SONS",
                    "HARDMA, ET AL.: \"Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed.,\", 1996, pages: 11 - 16",
                    "HIGUCHI ET AL.: \"Prodrugs as Novel Delivery Systems\", vol. 14, 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS, article \"Bioreversible Carriers in Drug Design\""
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "025-530-111-636-673",
                    "100-440-307-757-089"
                ],
                "nplResolvedExternalIDs": [
                    "10.3410/f.718050843.793481348",
                    "10.1016/j.chembiol.2013.05.010",
                    "pmc4878021",
                    "23890009",
                    "10.1182/blood-2006-04-019398",
                    "17053051"
                ]
            },
            {
                "index": "32",
                "publicationKey": "US_10226434_B2",
                "lensId": "084-877-761-320-438",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10226434 B2",
                "publicationDate": "2019-03-12",
                "filingNumber": "US 201816025284 A",
                "filingDate": "2018-07-02",
                "priorityFilingKeysActive": [
                    "US 201562109667 P 20150130",
                    "US 201562195968 P 20150723"
                ],
                "earliestPriorityDate": "2015-01-30",
                "title": "Design, Synthesis And Methods Of Use Of Acyclic Fleximer Nucleoside Analogues Having Anti-coronavirus Activity",
                "applicants": [
                    "UNIV MARYLAND",
                    "KATHOLIEKE UNIV LEUVEN/LIEDEN UNIV MEDICAL CENTER RC LEIDEN"
                ],
                "inventors": [
                    "RADTKE KATHERINE L",
                    "PETERS HANNAH",
                    "NEYTS JOHAN",
                    "JOCHMANS DIRK",
                    "SNIJDER ERIC J"
                ],
                "owners": [],
                "url": "https://lens.org/084-877-761-320-438",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "A61K2300/00",
                    "C07D403/04",
                    "Y02P20/582"
                ],
                "ipcrClassifications": [
                    "C07D403/04",
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 38,
                "nplCitations": [
                    "Chemical Abstracts Registry No. 550-33-4, Nov. 16, 1984.",
                    "Chemical Abstracts Registry No. 19186-33-5, Nov. 16, 1984.",
                    "In Global alert and response. Middle East Respiratory syndrome coronavirus (MERS-CoV); World Health Organization: 2015; vol. 2014.",
                    "In Zovirax Prescribing Information; U.S. Food and Drug Administration: 2003; NDA 18-603/5-027.",
                    "Al-Hazmi, A. Challenges presented by MERS corona virus, and SARS corona virus to global health, Saudi Journal of Biological Sciences, 23 (2016), pp. 507-511.",
                    "Al-Tawfiq, J.A. et al. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study, Int. J. Infect. Dis., 20 (2014), pp. 42-46.",
                    "Boncel, A. et al. Novel 5-(N-Alkylaminouracil) Acyclic Nucleosides, Synthesis-Stuttgart (2011), pp. 603-610.",
                    "Chen, F. et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds, J. Clin. Virol., 31 (2004), pp. 69-75.",
                    "De Wilde, A.H. et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment, J. Gen. Virol., 94 (2013), pp. 1749-1760.",
                    "De Wilde, A.H. et al. Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture, Antimicrob. Agents Chemother, 58 (2014), pp. 4875-4884.",
                    "Falzarano, D. et al. Treatment with interferon-alpha 2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques Nat. Med., 19 (2013), pp. 1313-1317.",
                    "Fehr, A.R. et al. Coronaviruses: An Overview of Their Replication and Pathogensis, Methods Mol. Biol. 1282 (2015) pp. 1-23.",
                    "Fouchier, R. A. et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A 101 (2004), pp. 6212-6216.",
                    "Furman, P.A. et al. Acyclovir Triphosphate is a Suicide Inactivator of the Herpes-Simplex Virus DNA Polymerase, J. Biol. Chem., 259 (1984), pp. 9575-9579.",
                    "Grant, R. et al. Grant & Hackh's Chemical Dictionary, 1987 (5th ed.) New York, NY; McGraw-Hill, p. 313.",
                    "Jochmans, D. et al. A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE. J Virol Methods 183 (2012), pp. 176-179.",
                    "Kuiken, T. et al. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol, 164 (2004), pp. 1893-1900.",
                    "McGuigan, C. et al. Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus Bioorg. Med. Chem. Lett., 20 (2010), pp. 4850-4854.",
                    "McGuirt, P.V. et al. Acyclovir Inhibition of Viral DNA Chain Elongation in Herpes Simplex Virus-Infected Cells, Am. J. Med., 73 (1982), pp. 67-71.",
                    "Mee, S.P. et al. Significant enhancement of the Stille reaction with a new combination of reagents-copper(I) iodide with cesium fluoride, Chem. Eur. J., 11 (2005), pp. 3294-3308.",
                    "Momattin, H. et al. Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)\u2014possible lessons from a systematic review of SARS-CoV therapy, Int. J. Infect. Dis., 17 (2013), pp. e792-e798.",
                    "Morgenstern, B. et al. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines, Biochem. Biophys. Res. Commun., 326 (2005), pp. 905-908.",
                    "Niedzwicki, J.G. et al. Structure-Activity Relationship of Ligands of Human Plasma Adenosine Deaminase2, Biochemical Pharmacology, 41 (1991) pp. 1615-1624.",
                    "Peiris, J.S.M. et al. Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet, 361 (2003), pp. 1319-1325.",
                    "Peters, H.L. Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronaviurs activity, Bioorganic & Medical Chemistry Letters, 25 (2015) pp. 2923-2926.",
                    "Pyrc, K. et al. Identification of new human coronaviruses, Expert Rev. Anti-infect. Ther., 5 (2007), pp. 245-253.",
                    "Quirk, S. et al. Substrate discrimination by the human GTP fucose pyrophosphorylase, Biochemistry, 44 (2005), pp. 10854-10863.",
                    "Quirk, S. et al. Identification of catalytic amino acids in the human GTP fucose pyrophosphorylase active site, Biochemistry, 44 (2005), pp. 13172-13178.",
                    "Salim, S. Molecular chameleons: design and synthesis of a second series of flexible nucleosides, Doctoral dissertation, Georgia Institute of Technology, 2004, pp. 1-149.",
                    "Schinazi, R. Synthesis of 5-(Dihydroxyboryl)-2\u2032 deoxyuridine and Related Boron-Containing Pyrimidines, J. Org. Chem., 50 (1985), pp. 841-847.",
                    "Seley, K.L. et al. \u201cFleximers\u201d. Design and Synthesis of Two Novel Split Nucleosides, Org. Lett., 3 (2001), p. 3209-3210.",
                    "Seley, K.L. et al. \u201cFleximers\u201d. Design and Synthesis of a New Class of Novel Shape-Modified Nucleosies, Org. Chem., 67 (2002), p. 3365.",
                    "Seley, K. L. et al. Unexpected inhibition of S-adenosyl-L-homocysteine hydrolase by a guanosine nucleoside, Bioorg. Med. Chem. Lett., 13, (2003) pp. 1985-1988.",
                    "Seley, K. L. et al. \u201cMolecular chameleons\u201d. Design and synthesis of C-4-substituted imidazole fleximers, Org. Lett., 7 (2005), pp. 63-66.",
                    "Smith, E.C. et al. Coronavirus Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics, PLoS Pathog., 9 (2013), p. e1003565, 1-11.",
                    "Tan, E.L. et al. Inhibition of SARS Coronavirus Infection in Vitro with Clinically Approved Antiviral Drugs, Emerg. Infect. Dis., 10 (2004), pp. 581-586.",
                    "Vanpouille, C. et al. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2, J. Infect. Dis., 201 (2010), pp. 635-643.",
                    "Wauchope, O.R. et al. Synthetic Routes to a Series of Proximal and Distal 2\u2032-Deoxy Fleximers, Synthesis, 44 (2012), pp. 3496-3504."
                ],
                "nplResolvedCount": 35,
                "nplResolvedLensIDs": [
                    "057-617-477-665-56X",
                    "032-735-667-143-965",
                    "055-817-993-936-104",
                    "074-919-683-245-507",
                    "059-550-034-399-273",
                    "099-339-512-037-70X",
                    "043-175-443-728-67X",
                    "007-805-109-951-284",
                    "074-960-744-959-701",
                    "018-702-914-707-986",
                    "073-663-856-907-01X",
                    "057-080-756-583-519",
                    "062-192-092-753-972",
                    "016-754-916-865-234",
                    "094-485-484-823-984",
                    "054-117-964-555-982",
                    "017-883-043-691-040",
                    "052-650-110-852-468",
                    "009-403-958-653-100",
                    "002-808-749-577-966",
                    "020-090-218-931-826",
                    "025-992-623-190-843",
                    "108-229-899-337-383",
                    "081-307-021-537-929",
                    "084-893-855-384-248",
                    "102-808-548-863-662",
                    "071-349-856-440-802",
                    "002-163-468-775-047",
                    "080-897-630-292-177",
                    "185-700-349-724-543",
                    "127-574-272-971-002",
                    "062-634-123-022-634",
                    "035-834-171-631-191",
                    "017-689-034-509-674",
                    "129-401-973-660-415"
                ],
                "nplResolvedExternalIDs": [
                    "15161626",
                    "27298584",
                    "pmc4136071",
                    "pmc395948",
                    "10.1038/nm.3362",
                    "6285735",
                    "10.3201/eid1004.030458",
                    "16185085",
                    "pmc3323075",
                    "10.1016/j.bmcl.2015.05.039",
                    "10.1016/j.jviromet.2012.04.011",
                    "20637609",
                    "10.1016/s0002-9440(10)63750-9",
                    "24406736",
                    "10.1002/chem.200401162",
                    "pmc1615765",
                    "23993766",
                    "pmc4093902",
                    "10.1055/s-0032-1316791",
                    "10.1021/ol047895v",
                    "10.1021/bi051288d",
                    "24841269",
                    "10.1016/j.sjbs.2016.02.019",
                    "11574032",
                    "15073334",
                    "16086588",
                    "pmc4890194",
                    "10.1016/j.bbrc.2004.11.128",
                    "10.1021/jo00206a024",
                    "10.1016/0006-2952(91)90162-x",
                    "10.1016/s0960-894x(03)00331-7",
                    "10.1016/s1386-6532(04)00055-1",
                    "23966862",
                    "23620378",
                    "10.1128/aac.03011-14",
                    "15200845",
                    "26048809",
                    "10.1073/pnas.0400762101",
                    "10.1055/s-0030-1258397",
                    "10.1371/journal.ppat.1003565",
                    "10.1016/s0140-6736(03)13077-2",
                    "15624978",
                    "17402839",
                    "pmc4466200",
                    "pmc2811219",
                    "10.1016/j.bmcl.2010.06.094",
                    "15288617",
                    "15786503",
                    "24465059",
                    "10.1007/978-1-4939-2438-7_1",
                    "10.1586/14787210.5.2.245",
                    "12781179",
                    "10.1016/j.jcv.2004.03.003",
                    "24013700",
                    "22575574",
                    "6086640",
                    "pmc4369385",
                    "10.1021/bi0503605",
                    "10.1002/chin.201052201",
                    "2043151",
                    "12711465",
                    "10.1099/vir.0.052910-0",
                    "10.1016/0002-9343(82)90066-3",
                    "pmc3898542",
                    "pmc3744431",
                    "10.1016/j.ijid.2013.07.002",
                    "pmc3749523",
                    "12003548",
                    "25720466",
                    "10.1016/j.ijid.2013.12.003",
                    "10.1021/jo0255476",
                    "15607755",
                    "10.1086/650343",
                    "10.1021/ol0165443",
                    "20085496"
                ]
            },
            {
                "index": "33",
                "publicationKey": "WO_2019_027501_A1",
                "lensId": "013-969-913-582-81X",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/027501 A1",
                "publicationDate": "2019-02-07",
                "filingNumber": "US 2018/0015352 W",
                "filingDate": "2018-01-26",
                "priorityFilingKeysActive": [
                    "US 201762539034 P 20170731"
                ],
                "earliestPriorityDate": "2017-07-31",
                "title": "Flex-nucleoside Analogues, Novel Therapeutics Against Filoviruses And Flaviviruses",
                "applicants": [
                    "UNIV MARYLAND"
                ],
                "inventors": [
                    "RADTKE KATHERINE"
                ],
                "owners": [],
                "url": "https://lens.org/013-969-913-582-81X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 1,
                "cpcClassifications": [
                    "A61K45/06",
                    "A61K31/506",
                    "A61K31/675",
                    "A61K31/683",
                    "A61P31/12"
                ],
                "ipcrClassifications": [
                    "A61K31/506",
                    "A61K31/66",
                    "A61P31/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "PETERS, H. L. ET AL.: \"Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity\", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 25, no. 15, 2015, pages 2923 - 2926, XP029160589",
                    "SELEY, K. L. ET AL.: \"Molecular chameleons ''. Design and synthesis of a second series of flexible nucleosides\", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 70, no. 5, 2005, pages 1612 - 1619, XP055572460",
                    "TAN, E. L. C. ET AL.: \"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs\", EMERGING INFECTIOUS DISEASES, vol. 10, no. 4, 2004, pages 581 - 586, XP055572465"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "032-735-667-143-965",
                    "016-532-239-841-388",
                    "129-401-973-660-415"
                ],
                "nplResolvedExternalIDs": [
                    "10.3201/eid1004.030458",
                    "pmc3323075",
                    "10.1021/jo048218h",
                    "10.1016/j.bmcl.2015.05.039",
                    "pmc4466200",
                    "15730279",
                    "15200845",
                    "26048809"
                ]
            },
            {
                "index": "34",
                "publicationKey": "WO_2019_067671_A1",
                "lensId": "098-388-076-635-213",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/067671 A1",
                "publicationDate": "2019-04-04",
                "filingNumber": "US 2018/0053044 W",
                "filingDate": "2018-09-27",
                "priorityFilingKeysActive": [
                    "US 201762564177 P 20170927"
                ],
                "earliestPriorityDate": "2017-09-27",
                "title": "Dna Antibody Constructs For Use Against Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "WEINER DAVID",
                    "SMITH TREVOR RF"
                ],
                "inventors": [
                    "WEINER DAVID",
                    "SMITH TREVOR"
                ],
                "owners": [],
                "url": "https://lens.org/098-388-076-635-213",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 7,
                "cpcClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61K2039/53",
                    "C12N15/63"
                ],
                "ipcrClassifications": [
                    "A61K39/42",
                    "C07K16/10",
                    "C12N15/63"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "LI, Y ET AL.: \"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein\", CELL RESEARCH, vol. 25, no. 11, 22 September 2015 (2015-09-22), pages 1237 - 1249, XP055587421"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "008-237-414-214-209"
                ],
                "nplResolvedExternalIDs": [
                    "26391698",
                    "10.1038/cr.2015.113"
                ]
            },
            {
                "index": "35",
                "publicationKey": "US_10143709_B2",
                "lensId": "037-143-268-651-498",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10143709 B2",
                "publicationDate": "2018-12-04",
                "filingNumber": "US 201514705895 A",
                "filingDate": "2015-05-06",
                "priorityFilingKeysActive": [
                    "US 201461989459 P 20140506",
                    "US 201462077824 P 20141110"
                ],
                "earliestPriorityDate": "2014-05-06",
                "title": "Use Of Asc And Asc-cm To Treat Ards, Sars, And Mers",
                "applicants": [
                    "INDIANA UNIV RESEARCH AND TECHNOLOGY CORP",
                    "UNIV INDIANA RES & TECH CORP",
                    "THE UNITED STATES OF AMERICA DEPARTMENT OF VETERAN AFFAIRS AS REPRESENTED BY THE TECH TRANSFER PROGR"
                ],
                "inventors": [
                    "MARCH KEITH",
                    "BOGATCHEVA NATALIA"
                ],
                "owners": [
                    {
                        "name": "INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION",
                        "executionDate": "2018-09-15"
                    },
                    {
                        "name": "UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS",
                        "executionDate": "2018-09-15"
                    },
                    {
                        "name": "U.S. DEPARTMENT OF VETERAN AFFAIRS AS REPRESENTED BY THE TECHNOLOGY TRANSFER PROGRAM",
                        "executionDate": "2018-09-15"
                    },
                    {
                        "name": "INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION",
                        "executionDate": "2015-09-03"
                    }
                ],
                "url": "https://lens.org/037-143-268-651-498",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K35/28"
                ],
                "ipcrClassifications": [
                    "A61K35/28"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "dos Santos et al., Cell Therapy in Acute Lung Injury, Pulmao RJ 2011; 20(1): 64-68.",
                    "Ionescu et al., Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action, NCBI (2012).",
                    "Zheng et al., Treatment of acute respiratory distress syndrom with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study, Respiratory Research 2014, 15:39."
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "074-645-906-971-341",
                    "063-822-209-142-48X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1152/ajplung.00144.2011",
                    "pmc3532523",
                    "24708472",
                    "10.1186/1465-9921-15-39",
                    "pmc3994204",
                    "23023971"
                ]
            },
            {
                "index": "36",
                "publicationKey": "US_2018_0334480_A1",
                "lensId": "030-828-546-807-446",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0334480 A1",
                "publicationDate": "2018-11-22",
                "filingNumber": "US 201615760878 A",
                "filingDate": "2016-09-15",
                "priorityFilingKeysActive": [
                    "US 201562219926 P 20150917"
                ],
                "earliestPriorityDate": "2015-09-17",
                "title": "Coronaviruses Epitope-based Vaccines",
                "applicants": [
                    "UNIV RAMOT"
                ],
                "inventors": [
                    "GERSHONI JONATHAN"
                ],
                "owners": [
                    {
                        "name": "RAMOT AT TEL-AVIV UNIVERSITY LTD",
                        "executionDate": "2017-01-02"
                    }
                ],
                "url": "https://lens.org/030-828-546-807-446",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 110,
                "cpcClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "A61K39/215",
                    "A61P31/14",
                    "C07K2319/735",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "C12N2770/20051"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/215",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "37",
                "publicationKey": "US_2019_0085024_A1",
                "lensId": "149-867-692-101-537",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0085024 A1",
                "publicationDate": "2019-03-21",
                "filingNumber": "US 201816132794 A",
                "filingDate": "2018-09-17",
                "priorityFilingKeysActive": [
                    "US 201762559200 P 20170915"
                ],
                "earliestPriorityDate": "2017-09-15",
                "title": "Alpha-ketoamide Inhibitors Of Cysteine Proteases",
                "applicants": [
                    "PHELIX THERAPEUTICS"
                ],
                "inventors": [
                    "GREENBAUM DORON",
                    "ADDIS RUSS",
                    "GABOURY JANET",
                    "KULKAMI SWAPNIL",
                    "MEINHARDT NATALINE"
                ],
                "owners": [],
                "url": "https://lens.org/149-867-692-101-537",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07K5/06052",
                    "C07B2200/07",
                    "C07C237/22",
                    "C07C255/29",
                    "C07C255/60",
                    "C07C271/18",
                    "C07C271/22",
                    "C07C275/16",
                    "C07C275/24",
                    "C07C279/12",
                    "C07C279/14",
                    "C07C2601/02",
                    "C07C2601/08",
                    "C07D205/04",
                    "C07D209/20",
                    "C07D211/62",
                    "C07D213/56",
                    "C07D233/64",
                    "C07D403/12",
                    "C07K5/0202",
                    "C07K5/0205",
                    "C07K5/06165"
                ],
                "ipcrClassifications": [
                    "C07K5/062",
                    "C07C237/22",
                    "C07C271/18",
                    "C07C275/24",
                    "C07C279/12",
                    "C07D205/04",
                    "C07D209/20",
                    "C07D211/62",
                    "C07D213/56",
                    "C07D233/64",
                    "C07D403/12",
                    "C07K5/078"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "38",
                "publicationKey": "WO_2017_046801_A1",
                "lensId": "089-741-935-592-222",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/046801 A1",
                "publicationDate": "2017-03-23",
                "filingNumber": "IL 2016051029 W",
                "filingDate": "2016-09-15",
                "priorityFilingKeysActive": [
                    "US 201562219926 P 20150917"
                ],
                "earliestPriorityDate": "2015-09-17",
                "title": "Coronaviruses Epitope-based Vaccines",
                "applicants": [
                    "RAMOT AT TEL-AVIV UNIV LTD"
                ],
                "inventors": [
                    "GERSHONI JONATHAN"
                ],
                "owners": [],
                "url": "https://lens.org/089-741-935-592-222",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 110,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/16",
                    "A61K39/215",
                    "C07K14/165",
                    "C12N15/50",
                    "C40B30/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "FREUND, N. T. ET AL.: \"Reconstitution of the receptor-binding motif of the SARS coronavirus.\", PROTEIN ENGINEERING DESIGN AND SELECTION, vol. 28, no. 12, 20 October 2015 (2015-10-20), pages 567 - 575, XP055370532, Retrieved from the Internet <URL:http://peds.oxfordjournalsorg/content/28/12/567.short>",
                    "LIN, S. C. ET AL., BIOTECHNOLOGY PROGRESS, vol. 26, no. 6, 31 August 2010 (2010-08-31), pages 1733 - 1740, Retrieved from the Internet <URL:https://www.researchgate.net/profile/Suh-Chin_Wu/publication/46109219_Generating_Stable_Chinese_Hamster_Ovary_Cell_Clones_to_Produce_a_Truncated_SARS-CoV_Spike_Protein_for_Vaccine_Development/links/56c1200a08ae44da37fc207d.pdf>",
                    "DU, L. ET AL.: \"A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS- CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines.\", PLOS ONE, vol. 8, no. 12, 4 December 2013 (2013-12-04), pages e81587, XP009182022, Retrieved from the Internet <URL:http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081587>",
                    "DU, L. ET AL.: \"Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.\", VIROLOGY, vol. 393, no. 1, 15 August 2009 (2009-08-15), pages 144 - 150, XP026641695, Retrieved from the Internet <URL:http://www.sciencedirect.com/science/article/pii/S0042682209004516>"
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "031-376-558-706-943",
                    "062-391-440-922-675",
                    "003-376-346-248-551",
                    "023-661-639-958-635"
                ],
                "nplResolvedExternalIDs": [
                    "10.1371/journal.pone.0081587",
                    "24324708",
                    "pmc3852489",
                    "10.1002/btpr.480",
                    "20809484",
                    "10.1016/j.virol.2009.07.018",
                    "10.1093/protein/gzv052",
                    "26487711",
                    "pmc2753736",
                    "19683779"
                ]
            },
            {
                "index": "39",
                "publicationKey": "US_2015_0017207_A1",
                "lensId": "085-537-359-212-944",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2015/0017207 A1",
                "publicationDate": "2015-01-15",
                "filingNumber": "US 201414327439 A",
                "filingDate": "2014-07-09",
                "priorityFilingKeysActive": [
                    "US 201361844022 P 20130709"
                ],
                "earliestPriorityDate": "2013-07-09",
                "title": "Methods And Compositions For Activation Of Innate Immune Responses Through Rig-i Like Receptor Signaling",
                "applicants": [
                    "UNIV WASHINGTON CT COMMERCIALI"
                ],
                "inventors": [
                    "GALE JR MICHAEL J",
                    "SCHNELL GRETJA",
                    "LOO YUEH-MING"
                ],
                "owners": [
                    {
                        "name": "UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION",
                        "executionDate": "2014-08-18"
                    }
                ],
                "url": "https://lens.org/085-537-359-212-944",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 99,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/39",
                    "A61K39/12",
                    "A61K39/155",
                    "A61K39/205",
                    "A61K39/29",
                    "C07H21/04",
                    "C12N7/00"
                ],
                "usClassifications": [
                    "424/211.1",
                    "536/23.1",
                    "424/281.1",
                    "424/218.1",
                    "424/228.1",
                    "424/224.1"
                ],
                "nplCitationCount": 2,
                "nplCitations": [
                    "Kishine et al., Biochemical and Biophysical Research Communications, 2002, 293(3):993-999.",
                    "GenBank Accession Number AB080299.1, submitted 2002."
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "054-259-000-032-929"
                ],
                "nplResolvedExternalIDs": [
                    "12051758",
                    "10.1016/s0006-291x(02)00342-x"
                ]
            },
            {
                "index": "40",
                "publicationKey": "US_2018_0104325_A1",
                "lensId": "037-247-957-520-06X",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0104325 A1",
                "publicationDate": "2018-04-19",
                "filingNumber": "US 201715711934 A",
                "filingDate": "2017-09-21",
                "priorityFilingKeysActive": [
                    "US 201361844022 P 20130709"
                ],
                "earliestPriorityDate": "2013-07-09",
                "title": "Methods And Compositions For Activation Of Innate Immune Responses Through Rig-i Like Receptor Signaling",
                "applicants": [
                    "UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION"
                ],
                "inventors": [
                    "GALE JR MICHAEL J",
                    "SCHNELL GRETJA",
                    "LOO YUEH-MING"
                ],
                "owners": [],
                "url": "https://lens.org/037-247-957-520-06X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 99,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K31/00",
                    "A61K39/00",
                    "A61K39/39",
                    "A61K45/06",
                    "C07H21/04",
                    "C12N15/117"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "41",
                "publicationKey": "WO_2016_138160_A1",
                "lensId": "100-132-660-706-843",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2016/138160 A1",
                "publicationDate": "2016-09-01",
                "filingNumber": "US 2016/0019395 W",
                "filingDate": "2016-02-24",
                "priorityFilingKeysActive": [
                    "US 201562120353 P 20150224"
                ],
                "earliestPriorityDate": "2015-02-24",
                "title": "Middle East Respiratory Syndrome Coronavirus Immunogens, Antibodies, And Their Use",
                "applicants": [
                    "US HEALTH"
                ],
                "inventors": [
                    "GRAHAM BARNEY",
                    "KONG WING-PUI",
                    "MODJARRAD KAYVON",
                    "WANG LINGSHU",
                    "SHI WEI",
                    "JOYCE MICHAEL GORDON",
                    "KANEKIYO MASARU",
                    "MASCOLA JOHN"
                ],
                "owners": [],
                "url": "https://lens.org/100-132-660-706-843",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 8,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 154,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "C07K14/165",
                    "C07K16/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 246,
                "nplCitations": [
                    "ZHANG NARU ET AL: \"Current advancements and potential strategies in the development of MERS-CoV vaccines\", EXPERT REVIEW OF VACCINES, EXPERT REVIEWS LTD, GB, vol. 13, no. 6, 1 June 2014 (2014-06-01), pages 761 - 774, XP009181616, ISSN: 1744-8395, DOI: 10.1586/14760584.2014.912134",
                    "JIAMING LAN ET AL: \"Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen\", PLOS ONE, vol. 9, no. 11, 18 November 2014 (2014-11-18), pages e112602, XP055272022, DOI: 10.1371/journal.pone.0112602",
                    "COLEMAN CHRISTOPHER M ET AL: \"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice\", VACCINE, vol. 32, no. 26, 13 April 2014 (2014-04-13), pages 3169 - 3174, XP028654166, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2014.04.016",
                    "CHEN YI-NING ET AL: \"A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge\", VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, ELSEVIER BV, AMSTERDAM, NL, vol. 152, no. 3, 1 February 2013 (2013-02-01), pages 359 - 369, XP028990055, ISSN: 0165-2427, DOI: 10.1016/J.VETIMM.2013.01.009",
                    "WOO P C Y ET AL: \"SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus\", VACCINE, ELSEVIER LTD, GB, vol. 23, no. 42, 10 October 2005 (2005-10-10), pages 4959 - 4968, XP027652024, ISSN: 0264-410X, [retrieved on 20051010]",
                    "JIANG SHIBO ET AL: \"Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome\", EXPERT REVIEW OF VACCINES, EXPERT REVIEWS LTD, GB, vol. 11, no. 12, 1 December 2012 (2012-12-01), pages 1405 - 1403, XP009189955, ISSN: 1744-8395, DOI: 10.1586/ERV.12.126",
                    "L. DU ET AL: \"A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein\", JOURNAL OF VIROLOGY, vol. 88, no. 12, 9 April 2014 (2014-04-09), pages 7045 - 7053, XP055162783, ISSN: 0022-538X, DOI: 10.1128/JVI.00433-14",
                    "YING TIANLEI ET AL: \"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies\", JOURNAL OF VIROLOGYUNITED STATES1 MAY 2016,, vol. 88, no. 14, 1 July 2014 (2014-07-01), pages 7796 - 7805, XP009181617, ISSN: 1098-5514, DOI: 10.1128/JVI.00912-14",
                    "JIANG LIWEI ET AL: \"Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein\", SCIENCE TRANSLATIONAL MEDICINE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC, vol. 6, no. 234, 30 April 2014 (2014-04-30), pages - 9, XP009182042, ISSN: 1946-6234",
                    "X.-C. TANG ET AL: \"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 111, no. 19, 13 May 2014 (2014-05-13), pages E2018 - E2026, XP055162782, ISSN: 0027-8424, DOI: 10.1073/pnas.1402074111",
                    "TIANLEI YING ET AL: \"Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections\", MICROBES AND INFECTION, vol. 17, no. 2, 29 November 2014 (2014-11-29), FR, pages 142 - 148, XP055272026, ISSN: 1286-4579, DOI: 10.1016/j.micinf.2014.11.008",
                    "WEIXU MENG ET AL: \"Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases\", PLOS ONE, vol. 8, no. 6, 18 June 2013 (2013-06-18), pages e66276, XP055271629, DOI: 10.1371/journal.pone.0066276",
                    "LINGSHU WANG ET AL: \"Evaluation of candidate vaccine approaches for MERS-CoV\", NATURE COMMUNICATIONS, vol. 6, 28 July 2015 (2015-07-28), United Kingdom, pages 7712, XP055271251, ISSN: 2041-1723, DOI: 10.1038/ncomms8712",
                    "PRABAKARAN ET AL., J BIOL CHEM, vol. 281, 2006, pages 15829",
                    "ZHU ET AL., PNAS, vol. 104, 2007, pages 12123",
                    "PAK ET AL., J MOL BIOL, vol. 388, 2009, pages 815",
                    "HWANG ET AL., J BIOL CHEM, vol. 281, 2006, pages 34610",
                    "GRAHAM ET AL., NATURE REVIEWS. MICROBIOLOGY, vol. 11, 2013, pages 836",
                    "BENJAMIN LEWIN: \"Genes X\", 2009, JONES & BARTLETT PUBLISHERS",
                    "MEYERS ET AL.: \"The Encyclopedia of Cell Biology and Molecular Medicine\", vol. 16, 2008, WILEY-VCH",
                    "SINGH: \"Vaccine Adjuvants and Delivery Systems\", 2007, WILEY-INTERSCIENCE",
                    "HARLOW; LANE: \"Antibodies, A Laboratory Manual, 2nd ed.\", 2013, COLD SPRING HARBOR PUBLICATIONS",
                    "KINDT ET AL.: \"Kuby Immunology, 6.sup.th ed.,\", 2007, W.H. FREEMAN AND CO., pages: 91",
                    "HAMERS-CASTERMAN ET AL., NATURE, vol. 363, 1993, pages 446 - 448",
                    "SHERIFF ET AL., NAT. STRUCT. BIOT., vol. 3, 1996, pages 733 - 736",
                    "KABAT ET AL.: \"Sequences of Proteins of Immunological Interest\", 1991",
                    "KABAT ET AL.: \"Sequences of Proteins of Immunological Interest 5th Ed.\", 1991, NATIONAL INSTITUTES OF HEALTH",
                    "AL-LAZIKANI ET AL., JMB, vol. 273, 1997, pages 927 - 948",
                    "LEFRANC ET AL.: \"IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains\", DEV. COMP. IMMUNOL., vol. 27, 2003, pages 55 - 77, XP055144492, DOI: doi:10.1016/S0145-305X(02)00039-3",
                    "KONTERMANN AND DUBEL: \"Antibody Engineering, 2nd Ed.,\", vol. 1-2, 2010, SPRINGER PRESS",
                    "BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426",
                    "HUSTON ET AL., PROC. NATL. ACAD. SCI., vol. 85, 1988, pages 5879 - 5883",
                    "AHMAD ET AL., CLIU. DEV. 1NNNNNOL., 2012",
                    "MARBRY, IDRUGS, vol. 13, 2010, pages 543 - 549",
                    "HOLLIGER ET AL., PROC. NATL. ACAD. SCI., vol. 90, 1993, pages 6444 - 6448",
                    "POLJAK ET AL., STRUCTURE, vol. 2, 1994, pages 1121 - 1123",
                    "\"Pierce Catalog and Handbook\", 1994, PIERCE CHEMICAL CO.",
                    "KUBY, J.: \"Immunology\", 1997, W.H. FREEMAN & CO.",
                    "HUSE ET AL., SCIENCE, vol. 246, 1989, pages 1275 - 1281",
                    "WINTER; HARRIS, IMMUNOL. TODAY, vol. 14, 1993, pages 243 - 246",
                    "WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546",
                    "HILYARD ET AL.: \"Protein Engineering: A practical approach\", 1992, IRL PRESS",
                    "BORRABECK: \"Antibody Engineering, 2d ed.\", 1995, OXFORD UNIVERSITY PRESS",
                    "BARBAS ET AL.: \"Phage display: A Laboratory Manuel\", 2004, COLD SPRING HARBOR LABORATORY PRESS",
                    "LONBERG, NAT. BIOTECH., vol. 23, 2005, pages 1117 - 1125",
                    "LONENBERG, CURR. OPIN. IMMUNOL., vol. 20, 2008, pages 450 - 459",
                    "SAMBROOK ET AL.: \"Molecular Cloning: A Laboratory Manual, 4th ed,\", 2012, COLD SPRING HARBOR",
                    "AUSUBEL ET AL.: \"Current Protocols in Molecular Biology\", vol. 104, 2013, JOHN WILEY & SONS",
                    "BITTER ET AL., METHODS IN ENZYMOLOGY, vol. 153, 1987, pages 516 - 544",
                    "SAMPATHKUMAR P, MAYO CLIN PROC., vol. 89, no. 8, August 2014 (2014-08-01), pages 1153 - 8",
                    "E. W. MARTIN: \"Remington's Pharmaceutical Sciences, 19th Edition,\", 1995, MACK PUBLISHING CO.",
                    "SPATOLA: \"Chemistry and Biochemistry of Amino Acids, Peptides, and Proteins\", 1983, MARCEL DEKKER, pages: 267",
                    "SPATOLA, A. F.: \"Vega Data\", PEPTIDE BACKBONE MODIFICATIONS, vol. 1, no. 3, March 1983 (1983-03-01)",
                    "MORLEY, TRENDS PHARM SCI, 1980, pages 463 - 468",
                    "HUDSON ET AL., INT J PEPT PROT RES, vol. 14, 1979, pages 177 - 185",
                    "SPATOLA ET AL., LIFE SCI, vol. 38, 1986, pages 1243 - 1249",
                    "HARM J., CHEM. SOC PERKIN TRANS., 1982, pages 1307 - 314",
                    "ALMQUIST ET AL., J. MED. CHEM., vol. 23, 1980, pages 1392 - 1398",
                    "JENNINGS-WHITE E, TETRAHEDRON LETT, vol. 23, 1982, pages 2533",
                    "HOLLADAY ET AL., TETRAHEDRON. LETT, vol. 24, 1983, pages 4401 - 4404",
                    "HRUBY, LIFE SCI, vol. 31, 1982, pages 189 - 199",
                    "ZHANG, Y, INT. J. MOL. SCI., vol. 12, 2011, pages 5406 - 5421",
                    "SUTTER ET AL., NATURE STRUCT. AND MOL. BIOL., vol. 15, 2008, pages 939 - 947",
                    "SCIENCE, vol. 311, 2006, pages 996 - 1000",
                    "ZHANG ET AL., J. MOL. BIOL., vol. 306, 2001, pages 1099 - 1114",
                    "IZARD ET AL., PNAS, vol. 96, 1999, pages 1240 - 1245",
                    "SMITH; WATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482",
                    "NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443",
                    "PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444",
                    "HIGGINS; SHARP, GENE, vol. 73, 1988, pages 237 - 44",
                    "HIGGINS; SHARP, CABIOS, vol. 5, 1989, pages 151 - 3",
                    "CORPET, NUC. ACIDS RES., vol. 16, 1988, pages 10881 - 90",
                    "HUANG ET AL., COMPUTER APPLS. IN THE BIOSCIENCES, vol. 8, 1992, pages 155 - 65",
                    "PEARSON ET AL., METH. MOL. BIO., vol. 24, 1994, pages 307 - 31",
                    "ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10",
                    "PEARSON; LIPMAN, PROC. NAT'L. ACAD. SCI. USA, vol. 85, 1988, pages 2444",
                    "FENG; DOOLITTLE, J. MOL. EVOL., vol. 35, 1987, pages 351 - 360",
                    "HIGGINS; SHARP, CABIOS, vol. 5, 1989, pages 151 - 153",
                    "DEVEREAUX ET AL., NUC. ACIDS RES., vol. 12, 1984, pages 387 - 395",
                    "ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410",
                    "ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1977, pages 3389 - 3402",
                    "HENIKOFF; HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1989, pages 10915",
                    "BAKER ET AL., BIOPHYS. J., vol. 60, 1991, pages 1445 - 1456",
                    "HAGENSEE ET AL., J. VIROL., vol. 68, 1994, pages 4503 - 4505",
                    "VINCENTE, J INVERTEBR PATHOL., 2011",
                    "SCHNEIDER-OHRUM; ROSS, CURR. TOP. MICROBIOL. IMMUNOL., vol. 354, 2012, pages 53073",
                    "JONES ET AL., NATURE, vol. 321, 1986, pages 522",
                    "RIECHMANN ET AL., NATURE, vol. 332, 1988, pages 323",
                    "VERHOEYEN ET AL., SCIENCE, vol. 239, 1988, pages 1534",
                    "CARTER ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 89, 1992, pages 4285",
                    "SANDHU, CRIT. REV. BIOTECH., vol. 12, 1992, pages 437",
                    "CHEN ET AL., J. MOL. BIOL., vol. 293, 1999, pages 865 - 881",
                    "PRESTA ET AL., CANCER RES., vol. 57, 1997, pages 4593 - 4599",
                    "MACK, J. IMMUNOL., vol. 158, 1997, pages 3965 - 3970",
                    "MACK, PNAS, vol. 92, 1995, pages 7021 - 7025",
                    "KUFER, CANCER IMMUNOL. IMMUNOTHER., vol. 45, 1997, pages 193 - 197",
                    "LOFFLER, BLOOD, vol. 95, 2000, pages 2098 - 2103",
                    "BRUHL, J. IMMUNOL., vol. 166, 2001, pages 2420 - 2426",
                    "J. IMMUNOL., vol. 165, 2000, pages 7050 - 57",
                    "WILLEMS ET AL., J CHROMATOGR B ANALYT TECHNOL BIOMED LIFE SCI., vol. 786, 2003, pages 161 - 76",
                    "AHMAD ET AL., CLIN. DEV. IMMUNOL., 2012",
                    "HARLOW; LANE: \"Antibodies: A Laboratory Manual, 2nd ed .,\", 2013, COLD SPRING HARBOR LABORATORY",
                    "NISONHOFF ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 89, 1960, pages 230",
                    "PORTER, BIOCHEM. J., vol. 73, 1959, pages 119",
                    "EDELMAN ET AL.: \"Methods in Enzymology\", vol. 1, 1967, ACADEMIC PRESS, pages: 422",
                    "LIU ET AL., J. VIROLOGY, vol. 85, no. 17, 2011, pages 8467 - 8476",
                    "STIJLEMANS, B. ET AL., J BIOL CHEM, vol. 279, 2004, pages 1256 - 1261",
                    "DUMOULIN, M. ET AL., NATURE, vol. 424, 2003, pages 783 - 788",
                    "PLESCHBERGER, M. ET AL., BIOCONJUGATE CHEM, vol. 14, 2003, pages 440 - 448",
                    "CORTEZ-RETAMOZO, V ET AL., INT J CANCER, vol. 89, 2002, pages 456 - 62",
                    "LAUWEREYS, M. ET AL., EMBO J, vol. 17, 1998, pages 3512 - 3520",
                    "CHOWDHURY, METHODS MOL. BIOL., vol. 207, 2008, pages 179 - 196",
                    "HOOGENBOOM ET AL.: \"Methods in Molecular Biology\", vol. 178, 2001, HUMAN PRESS, pages: 1 - 37",
                    "CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085",
                    "WRIGHT ET AL., TIBTECH, vol. 15, 1997, pages 26 - 32",
                    "OKAZAKI ET AL., J. MOL. BIOL., vol. 336, 2004, pages 1239 - 1249",
                    "YAMANE-OHNUKI ET AL., BIOTECH. BIOENG., vol. 87, 2004, pages 614",
                    "RIPKA ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 249, 1986, pages 533 - 545",
                    "KANDA, Y. ET AL., BIOTECHNOL. BIOENG., vol. 94, no. 4, 2006, pages 680 - 688",
                    "HINTON ET AL., J IMMUNOL., vol. 176, 2006, pages 346 - 356",
                    "ZALEVSKY ET AL., NATURE BIOTECHNOLOGY, vol. 28, 2010, pages 157 - 159",
                    "PETKOVA ET AL., INT. IMMUNOL., vol. 18, 2006, pages 1759 - 1769",
                    "DALL'ACQUA ET AL., J. BIOL. CHEM., vol. 281, 2006, pages 23514 - 23524",
                    "LAZAR ET AL., PROC. NATL., ACAD. SCI. U.S.A., vol. 103, 2006, pages 4005 - 4010",
                    "HUNIG ET AL., CHEM. BER., vol. 100, 1974, pages 3039 - 3044",
                    "BASAK, BIOCONJUG. CHEM., vol. 5, 1994, pages 301 - 305",
                    "KANEKIYO ET AL., NATURE, vol. 499, 2013, pages 102 - 106",
                    "ZHANG, INT. J. MOL. SCI., vol. 12, 2011, pages 5406 - 5421",
                    "SUTTER, NATURE STRUCT. AND MOL. BIOL., vol. 15, 2008, pages 939 - 947",
                    "URICH, SCIENCE, vol. 311, 2006, pages 996 - 1000",
                    "KANG ET AL., BIOL. CHEM., vol. 380, 1999, pages 353 - 64",
                    "NOTKA ET AL., BIOL. CHEM., vol. 380, 1999, pages 341 - 52",
                    "AKAHATA, NAT. MED., vol. 16, 2010, pages 334 - 338",
                    "GOLDMANN, J. VIROL., vol. 73, 1999, pages 4465 - 9",
                    "JIANG ET AL., VACCINE, vol. 17, 1999, pages 1005 - 13",
                    "CASAL, BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, vol. 29, 1999, pages 141 - 150",
                    "HURTADO ET AL., J. VIROL., vol. 70, 1996, pages 5422 - 9",
                    "LI ET AL., J. VIROL., vol. 71, 1997, pages 7207 - 13",
                    "MADZAK ET AL., J. GEN. VIROL., vol. 73, 1992, pages 1533 - 1536",
                    "BERKNER, CUR. TOP. MICROBIOL. IMMUNOL., vol. 158, 1992, pages 39 - 6",
                    "BERLINER ET AL., BIO TECHNIQUES, vol. 6, 1988, pages 616 - 629",
                    "GORZIGLIA ET AL., J. VIROL., vol. 66, 1992, pages 4407 - 4412",
                    "QUANTIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 2581 - 2584",
                    "ROSENFELD ET AL., CELL, vol. 68, 1992, pages 143 - 155",
                    "WILKINSON ET AL., NUCL. ACIDS RES., vol. 20, 1992, pages 2233 - 2239",
                    "STRATFORD-PERRICAUDET ET AL., HUM. GENE THER., vol. 1, 1990, pages 241 - 256",
                    "MACKETT, BIOTECHNOLOGY, vol. 24, 1992, pages 495 - 499",
                    "MUZYCZKA, CURR. TOP. MICROBIOL. IMMUNOL., vol. 158, 1992, pages 91 - 123",
                    "ON ET AL., GENE, vol. 89, 1990, pages 279 - 282",
                    "MARGOLSKEE, CURR. TOP. MICROBIOL. IMMUNOL., vol. 158, 1992, pages 67 - 90",
                    "JOHNSON, J. VIROL., vol. 66, 1992, pages 2952 - 2965",
                    "FINK, HUM. GENE THER, vol. 3, 1992, pages 11 - 19",
                    "BREAKFIELD, MOL. NEUROBIOL., vol. 1, 1987, pages 337 - 371",
                    "FRESSE ET AL., BIOCHEM. PHARMACOL., vol. 40, 1990, pages 2189 - 2199",
                    "H. HERWEIJER, HUMAN GENE THERAPY, vol. 6, 1995, pages 1161 - 1167",
                    "S. SCHLESINGER, TRENDS BIOTECHNOL., vol. 11, 1993, pages 18 - 22",
                    "1. FROLOV ET AL., PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 11371 - 11377",
                    "BRANDYOPADHYAY ET AL., MOL. CELL BIOL., vol. 4, 1984, pages 749 - 754",
                    "PETROPOUPLOS ET AL., J. VIROL., vol. 66, 1992, pages 3391 - 3397",
                    "MILLER, CURR. TOP. MICROBIOL. IMMUNOL., vol. 158, 1992, pages 1 - 24",
                    "MILLER, MOL. CELL BIOL., vol. 5, 1985, pages 431 - 437",
                    "SORGE, MOL. CELL BIOL., vol. 4, 1984, pages 1730 - 1737",
                    "MANN ET AL., J. VIROL., vol. 54, 1985, pages 401 - 407",
                    "PAGE ET AL., J. VIROL., vol. 64, 1990, pages 5370 - 5276",
                    "BUCHSCHALCHER, J. VIROL., vol. 66, 1992, pages 2731 - 2739",
                    "JOHNSON ET AL., MOL THER., vol. 22, no. 1, January 2014 (2014-01-01), pages 196 - 205",
                    "PERUZZI ET AL., VACCINE, vol. 27, 2009, pages 1293 - 1300",
                    "\"Remingtons Pharmaceutical Sciences, 19th Ed.,\", 1995, MACK PUBLISHING COMPANY",
                    "MOWAT; DONACHIE, IMMUNOL. TODAY, vol. 12, 1991, pages 383",
                    "TAKAHASHI ET AL., NATURE, vol. 344, 1990, pages 873",
                    "LUNDSTROM, VIRUSES, vol. 7, no. 5, 2015, pages 2321 - 2333",
                    "STOVER, NATURE, vol. 351, 1991, pages 456 - 460",
                    "NARANG ET AL., METH. ENZYMOL., vol. 68, 1979, pages 90 - 99",
                    "BROWN ET AL., METH. ENZYMOL., vol. 68, 1979, pages 109 - 151",
                    "BEAUCAGE ET AL., TETRA. LETT., vol. 22, 1981, pages 1859 - 1862",
                    "BEAUCAGE; CARUTHERS, TETRA. LETTS., vol. 22, no. 20, 1981, pages 1859 - 1862",
                    "NEEDHAM-VANDEVANTER ET AL., NUCL. ACIDS RES., vol. 12, 1984, pages 6159 - 6168",
                    "AUSUBEL ET AL.: \"Current Protocols in Molecular Biology\", JOHN WILEY & SONS",
                    "HELGASON AND MILLER: \"Basic Cell Culture Protocols (Methods in Molecular Biology, 4th Ed.,\", 2012, HUMANA PRESS",
                    "MUZYCZKA: \"Viral Expression Vectors\", 2011, SPRINGER PRESS",
                    "AL-RUBEAI: \"Antibody Expression and Production\", 2011, SPRINGER PRESS",
                    "HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883",
                    "MCCAFFERTY ET AL., NATURE, vol. 348, 1990, pages 552 - 554",
                    "SIMPSON: \"Basic methods in Protein Purification and Analysis: A laboratory Manual\", 2008, COLD HARBOR PRESS",
                    "WARD, NATURE, vol. 341, 1989, pages 544",
                    "BAROUCH ET AL., J. VIROL, vol. 79, 2005, pages 8828 - 8834",
                    "BIOCHEMISTRY, vol. 9, 1970, pages 5015 - 5021",
                    "BARANY; MERRIFIELD, THE PEPTIDES: ANALYSIS, SYNTHESIS, BIOLOGY, vol. 2, pages 3 - 284",
                    "MERRIFIELD ET AL., J. AM CHEM. SOC., vol. 85, 1963, pages 2149 - 2156",
                    "STEWART ET AL.: \"Solid Phase Peptide Synthesis, 2nd ed.,\", 1984, PIERCE CHEM. CO.",
                    "\"Remington's Pharmaceutical Science, 19th ed.,\", 1995, MACK PUBLISHING COMPANY",
                    "POWELL AND NEWMAN,: \"Pharmaceutical Biotechnology\", vol. 61, 1995, PLENUM PRESS",
                    "VOLLER ET AL.: \"New Trends and Developments in Vaccines\", 1978, UNIVERSITY PARK PRESS",
                    "BANGA, A.J.: \"Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems\", 1995, TECHNOMIC PUBLISHING COMPANY, INC.",
                    "KREUTER, J.: \"Colloidal Drug Delivery Systems\", 1994, MARCEL DEKKER, INC., pages: 219 - 342",
                    "TICE; TABIBI: \"Treatise on Controlled Drug Delivery\", 1992, MARCEL DEKKER, INC, pages: 315 - 339",
                    "LANGER, ACCOUNTS CHEM. RES., vol. 26, 1993, pages 537 - 542",
                    "JOHNSTON ET AL., PHARM. RES., vol. 9, 1992, pages 425 - 434",
                    "PEC ET AL., J. PARENT. SCI. TECH., vol. 44, no. 2, 1990, pages 58 - 65",
                    "IJNTEMA ET AL., INT. J. P/ 7M., vol. 112, 1994, pages 215 - 224",
                    "BETAGERI ET AL.: \"Liposome Drug Delivery Systems\", 1993, TECHNOMIC PUBLISHING CO., INC.",
                    "CAVANAGH, J GENERAL VIROLOGY, vol. 64, 1983, pages 2577",
                    "BUCHHOLZ ET AL., PNAS, vol. 101, 2004, pages 9804",
                    "COLEMAN ET AL., VACCINE, vol. 32, 2014, pages 3169",
                    "DU ET AL., PLOS ONE, vol. 8, 2013, pages E81587",
                    "MA ET AL., VACCINE, vol. 32, 2014, pages 2100",
                    "MOU ET AL., J VIROLOGY, vol. 87, 2013, pages 9379",
                    "DU ET AL., J VIROLOGY, vol. 88, 2014, pages 7045",
                    "OHNUMA ET AL., J VIROLOGY, vol. 87, 2013, pages 13892",
                    "YING ET AL., J VIROLOGY, vol. 88, 2014, pages 7796",
                    "JIANG ET AL., SCIENCE TRANSLATIONAL MEDICINE, vol. 6, 2014, pages 234RA59",
                    "BRIESE ET AL., MBIO, vol. 5, 2014, pages E01146",
                    "MARTIN ET AL., VACCINE, vol. 26, 2008, pages 6338",
                    "YANG ET AL., NATURE, vol. 428, 2004, pages 561",
                    "NALDINI ET AL., PNAS, vol. 93, 1996, pages 11382",
                    "YANG ET AL., PNAS, vol. 102, 2005, pages 797",
                    "STEVENS ET AL., NATURE, vol. 334, 1988, pages 255",
                    "DAVIS ET AL., HUMAN GENE THERAPY, vol. 6, 1995, pages 1447",
                    "SHEDLOCK ET AL., J LEUKOCYTE BIOLOGY, vol. 68, 2000, pages 793",
                    "CARGNELUTTI, THE NEW MICROBIOLOGICA, vol. 36, 2013, pages 145",
                    "CHAITRA ET AL., VACCINE, vol. 25, 2007, pages 7168",
                    "DU, J VIROLOGY, vol. 88, 2014, pages 7045",
                    "OHNUMA, J VIROLOGY, vol. 87, 2013, pages 13892",
                    "NATURE, vol. 500, 2013, pages 227 - 231",
                    "MANSOOR ET AL., IEEE TRANSACTIONS ON MEDICAL IMAGING, vol. 33, 2014, pages 2293 - 2310",
                    "TANG ET AL., PNAS, vol. 111, 2014, pages E2018 - 2026",
                    "CAULFIELD ET AL., J VIROLOGY, vol. 76, 2002, pages 10038",
                    "LEDGERWOOD ET AL., LANCET INFECTIOUS DISEASES, vol. 11, 2011, pages 916",
                    "LEDGERWOOD ET AL., J INFECTIOUS DISEASES, vol. 208, 2013, pages 418",
                    "KHURANA ET AL., J OF INFECTIOUS DISEASES, vol. 208, 2013, pages 413",
                    "YANG ET AL., J VIROL., vol. 78, 2004, pages 5642 - 5650",
                    "BAROUCH ET AL., J VIROLOGY, vol. 79, 2005, pages 8828",
                    "CATANZARO ET AL., VACCINE, vol. 25, 2007, pages 4085",
                    "ZHU ET AL., PNAS, vol. 104, 2007, pages 12123 - 12128",
                    "TOMARAS ET AL., PNAS, vol. 110, 2013, pages 9019 - 9024",
                    "KONG ET AL., J. VIROL., vol. 86, 2012, pages 12115 - 12128",
                    "OTWINOWSKI ET AL., METHODS ENZYMOL., vol. 276, 1997, pages 307",
                    "MCCOY ET AL., J APPLIED CRYSTALLOGRAPHY, vol. 40, 2007, pages 658",
                    "EMSLEY ET AL., ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY, vol. 66, 2010, pages 486",
                    "BLANC ET AL., ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY, vol. 60, 2004, pages 2210",
                    "NATURE, vol. 500, 2013, pages 227",
                    "FAN ET AL., J MOL BIOL, vol. 228, 1992, pages 188",
                    "ADAMS ET AL., ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY, vol. 66, 2010, pages 213",
                    "CHEN, ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY, vol. 66, 2010, pages 12",
                    "SCOBEY ET AL., PNAS, vol. 110, 2013, pages 16157",
                    "WU ET AL., SCIENCE, 2010"
                ],
                "nplResolvedCount": 174,
                "nplResolvedLensIDs": [
                    "130-870-309-662-129",
                    "045-500-830-356-334",
                    "126-670-872-645-263",
                    "031-729-641-207-089",
                    "019-037-168-645-793",
                    "034-345-578-106-977",
                    "035-887-489-355-317",
                    "067-968-492-468-107",
                    "082-259-797-755-133",
                    "116-767-209-544-755",
                    "034-328-650-978-645",
                    "015-467-638-461-61X",
                    "105-105-580-970-036",
                    "141-031-108-222-217",
                    "048-389-769-784-036",
                    "042-064-861-703-426",
                    "069-637-253-856-619",
                    "010-884-480-301-434",
                    "035-890-080-496-015",
                    "072-468-307-701-916",
                    "099-900-812-708-588",
                    "022-385-630-807-414",
                    "041-965-729-467-130",
                    "051-537-585-472-863",
                    "082-210-673-349-152",
                    "129-743-827-740-708",
                    "062-679-649-579-866",
                    "012-264-220-259-845",
                    "104-132-094-161-775",
                    "035-723-147-584-661",
                    "113-143-308-281-79X",
                    "045-094-249-115-990",
                    "001-779-867-387-972",
                    "026-634-789-611-309",
                    "007-426-700-052-93X",
                    "082-700-502-354-717",
                    "056-382-008-571-392",
                    "012-268-510-926-843",
                    "003-393-487-467-621",
                    "040-307-220-582-194",
                    "037-600-511-600-799",
                    "111-602-669-712-02X",
                    "152-978-735-478-562",
                    "002-911-689-401-496",
                    "050-246-204-785-836",
                    "036-746-145-798-090",
                    "009-732-181-810-150",
                    "123-474-152-390-023",
                    "081-177-071-539-997",
                    "005-354-868-074-208",
                    "042-458-651-550-70X",
                    "078-135-961-116-992",
                    "035-362-670-138-614",
                    "078-432-639-041-575",
                    "074-235-844-036-582",
                    "066-749-017-721-197",
                    "078-081-741-547-36X",
                    "006-035-768-214-419",
                    "058-313-617-778-309",
                    "089-353-071-323-759",
                    "009-483-512-107-343",
                    "023-968-952-017-264",
                    "063-786-591-916-259",
                    "017-150-654-990-340",
                    "115-789-063-931-955",
                    "066-141-497-990-023",
                    "097-694-869-419-018",
                    "044-876-143-907-404",
                    "078-227-590-332-589",
                    "085-764-009-624-439",
                    "006-819-881-646-075",
                    "032-496-293-605-153",
                    "001-171-324-377-852",
                    "046-168-955-011-967",
                    "088-851-255-233-972",
                    "109-175-133-197-204",
                    "030-088-151-483-183",
                    "060-928-640-668-012",
                    "042-204-626-457-327",
                    "003-663-667-600-837",
                    "129-588-069-141-396",
                    "022-899-518-024-071",
                    "043-271-014-136-772",
                    "003-434-920-063-133",
                    "023-485-474-759-717",
                    "058-124-894-825-860",
                    "129-273-407-931-838",
                    "018-694-084-068-187",
                    "020-924-696-164-172",
                    "010-953-281-569-514",
                    "056-201-471-905-934",
                    "058-522-492-925-838",
                    "053-333-370-639-425",
                    "062-118-852-464-802",
                    "033-797-614-829-293",
                    "064-968-246-716-831",
                    "011-174-345-245-142",
                    "123-244-124-088-579",
                    "016-525-147-386-650",
                    "032-728-154-591-070",
                    "004-828-255-207-755",
                    "006-574-964-805-278",
                    "134-030-034-621-902",
                    "009-841-837-271-501",
                    "001-147-941-858-547",
                    "039-515-794-348-090",
                    "050-086-153-406-428",
                    "047-448-941-251-436",
                    "046-628-575-045-641",
                    "001-467-559-709-949",
                    "043-968-156-521-588",
                    "014-686-084-244-632",
                    "060-690-417-053-376",
                    "037-445-639-149-821",
                    "158-261-806-420-924",
                    "074-817-300-512-106",
                    "027-043-089-978-283",
                    "016-617-627-772-41X",
                    "073-622-562-721-761",
                    "057-659-314-168-759",
                    "050-959-366-576-084",
                    "133-937-184-150-076",
                    "040-834-970-282-128",
                    "071-152-541-652-393",
                    "075-426-376-647-072",
                    "055-005-586-964-518",
                    "038-383-743-124-048",
                    "048-315-448-162-242",
                    "120-113-979-825-387",
                    "033-588-559-144-185",
                    "052-507-092-115-672",
                    "003-376-346-248-551",
                    "020-126-213-879-311",
                    "017-980-004-624-253",
                    "145-146-407-738-040",
                    "011-604-339-472-637",
                    "009-275-403-380-31X",
                    "070-296-445-348-347",
                    "106-138-575-366-798",
                    "082-151-267-963-934",
                    "041-144-393-062-157",
                    "013-836-730-694-422",
                    "063-469-288-339-138",
                    "006-772-167-939-860",
                    "033-542-963-142-911",
                    "023-907-179-348-058",
                    "076-774-944-138-418",
                    "035-746-725-150-104",
                    "027-150-334-287-405",
                    "009-253-604-595-037",
                    "143-306-732-579-95X",
                    "034-994-634-633-262",
                    "056-681-930-672-283",
                    "044-522-255-085-902",
                    "180-914-023-267-719",
                    "119-678-450-376-625",
                    "002-264-966-090-625",
                    "043-148-481-331-661",
                    "028-862-168-091-90X",
                    "030-630-100-818-462",
                    "019-967-851-030-751",
                    "009-507-053-935-564",
                    "040-363-636-264-022",
                    "117-552-761-069-626",
                    "010-537-288-097-385",
                    "064-799-052-071-305",
                    "079-080-784-051-77X",
                    "100-876-606-929-853",
                    "076-921-778-471-668",
                    "026-944-353-804-488",
                    "028-835-710-133-898",
                    "041-548-559-329-087",
                    "032-720-983-972-675",
                    "029-627-399-633-530"
                ],
                "nplResolvedExternalIDs": [
                    "10.2210/pdb1igm/pdb",
                    "2428310",
                    "pmc46948",
                    "1447781",
                    "24766432",
                    "25405618",
                    "10.1126/science.1120306",
                    "23831647",
                    "10.1107/s0021889807021206",
                    "10.1023/a:1015815624334",
                    "10.1038/nature02463",
                    "10.1371/journal.pone.0081587",
                    "8207824",
                    "10.1128/jvi.00912-14",
                    "10.1128/jvi.66.5.2731-2739.1992",
                    "10.1016/j.vaccine.2014.02.004",
                    "2531466",
                    "10.1073/pnas.96.4.1240",
                    "10.1007/s002620050431",
                    "10.1038/nrmicro3143",
                    "16597622",
                    "pmc38064",
                    "5420325",
                    "pmc38066",
                    "10.1042/bj0730119",
                    "8573617",
                    "pmc3586247",
                    "14434282",
                    "10.3390/v7052321",
                    "pmc4054355",
                    "24719424",
                    "pmc41463",
                    "10.1128/jvi.66.7.4407-4412.1992",
                    "21715497",
                    "19162112",
                    "15993989",
                    "24789777",
                    "16609957",
                    "10.1073/pnas.85.8.2444",
                    "pmc3838260",
                    "pmc49066",
                    "pmc4236105",
                    "10.1016/s0145-305x(02)00039-3",
                    "24778414",
                    "16537476",
                    "10.4049/jimmunol.176.1.346",
                    "pmc2855492",
                    "3989912",
                    "2471267",
                    "1423650",
                    "10.1128/jvi.01277-13",
                    "10.1073/pnas.0701000104",
                    "10223338",
                    "10223337",
                    "10.1126/science.3140379",
                    "10067709",
                    "10.1007/978-94-011-6630-0",
                    "10.1038/nsb0996-733",
                    "10.1021/ja00897a025",
                    "10.1073/pnas.0403492101",
                    "23428360",
                    "10.1073/pnas.1311542110",
                    "1316260",
                    "15994776",
                    "pmc415834",
                    "10.1016/s0040-4039(01)90461-7",
                    "10.1107/s0907444904016427",
                    "10.1006/jmbi.2000.4435",
                    "10.1007/bf02603120",
                    "pmc3670311",
                    "16365427",
                    "10.1006/jmbi.1997.1354",
                    "16151405",
                    "pmc366734",
                    "24067970",
                    "9254694",
                    "pmc470755",
                    "10.1016/j.vaccine.2007.02.050",
                    "10.1016/s0022-2836(05)80360-2",
                    "1370653",
                    "10.1038/ncomms8712",
                    "24043791",
                    "10.1016/j.micinf.2014.11.008",
                    "10.1016/s0264-410x(98)00317-x",
                    "3127726",
                    "10.1089/hum.1995.6.9-1161",
                    "10.1089/hum.1990.1.3-241",
                    "8764053",
                    "25961488",
                    "1582242",
                    "1560523",
                    "1318411",
                    "10.1128/jvi.78.11.5642-5650.2004",
                    "pmc241119",
                    "10.1385/1-59259-240-6:001",
                    "10.1074/jbc.m603275200",
                    "10.3410/f.1020100.229441",
                    "7948095",
                    "2184369",
                    "2451287",
                    "10.3109/07388559209114235",
                    "10.1016/0006-2952(90)90711-s",
                    "10.1128/jvi.00520-11",
                    "12477501",
                    "1557362",
                    "20111039",
                    "pmc241248",
                    "pmc4024880",
                    "10.1093/nar/16.22.10881",
                    "pmc3165811",
                    "10.1002/9780470134931",
                    "pmc2815670",
                    "15642942",
                    "8876142",
                    "8876144",
                    "10.1073/pnas.92.15.7021",
                    "10.1128/jvi.02448-13",
                    "pmc48705",
                    "10.1016/0024-3205(82)90578-1",
                    "10.1016/s0006-3495(91)82181-6",
                    "521205",
                    "2828848",
                    "1317548",
                    "pmc2483472",
                    "pmc136497",
                    "7624362",
                    "10.1038/nature12202",
                    "10.1038/nature12328",
                    "25456101",
                    "9103467",
                    "23752342",
                    "9367782",
                    "26218507",
                    "pmc241028",
                    "10.1126/science.2451287",
                    "pmc1170688",
                    "9377574",
                    "10.1038/348552a0",
                    "12208982",
                    "11920600",
                    "10.1016/j.vaccine.2014.04.016",
                    "9311793",
                    "10.1007/978-3-642-01147-4",
                    "5593847",
                    "pmc192060",
                    "6092935",
                    "10.1111/j.1399-3011.1979.tb01923.x",
                    "3243435",
                    "24217413",
                    "6546423",
                    "19461840",
                    "10.1016/0076-6879(79)68010-2",
                    "10.1182/blood.v95.6.2098",
                    "10.1038/351456a0",
                    "23785207",
                    "10.1073/pnas.89.22.10915",
                    "pmc281868",
                    "15037082",
                    "9649422",
                    "10.1016/0378-1119(88)90330-7",
                    "10.1016/0378-5173(94)90357-3",
                    "12917687",
                    "pmc104235",
                    "10.1038/363446a0",
                    "15210961",
                    "10.1586/14760584.2014.912134",
                    "10.1128/mcb.5.3.431",
                    "1438297",
                    "pmc3179174",
                    "10.1073/pnas.85.16.5879",
                    "10.1016/0022-2836(92)90500-j",
                    "10.1128/jvi.73.5.4465-4469.1999",
                    "10.1016/0076-6879(87)53076-2",
                    "pmc3978801",
                    "3713831",
                    "1786069",
                    "10.1016/j.vaccine.2008.12.051",
                    "pmc241054",
                    "11160301",
                    "10.1093/nar/12.15.6159",
                    "10.1007/978-3-642-75608-5_1",
                    "10.1007/978-3-642-75608-5_4",
                    "6325895",
                    "10.1089/hum.1995.6.11-1447",
                    "10.1007/bf02388594",
                    "1314100",
                    "10.1038/nature01870",
                    "24324708",
                    "6126794",
                    "6473105",
                    "1663794",
                    "10.1128/jvi.66.6.3391-3397.1992",
                    "3162770",
                    "10.1021/ar00034a004",
                    "10.1038/334255a0",
                    "2456466",
                    "16484493",
                    "2231712",
                    "10.1128/jvi.54.2.401-407.1985",
                    "20721825",
                    "10.1016/0092-8674(92)90213-v",
                    "15140961",
                    "pmc4194189",
                    "19324051",
                    "10.1089/hum.1992.3.1-11",
                    "7764041",
                    "10.1038/341544a0",
                    "10.1073/pnas.89.10.4285",
                    "10.1016/0022-2836(70)90057-4",
                    "23824680",
                    "10.1128/jvi.79.14.8828-8834.2005",
                    "10.1093/nar/12.1part1.387",
                    "pmc146917",
                    "10.1038/344873a0",
                    "10.1099/0022-1317-64-12-2577",
                    "17391815",
                    "pmc3688872",
                    "10.1126/science.2471267",
                    "2247164",
                    "16954221",
                    "23661056",
                    "23686120",
                    "pmc4241375",
                    "10.1371/journal.pone.0112602",
                    "10.1586/erv.12.126",
                    "24736006",
                    "10.1073/pnas.0409065102",
                    "pmc4525294",
                    "2720464",
                    "pmc2612543",
                    "2677748",
                    "10.1002/bit.20880",
                    "pmc2852313",
                    "1637416",
                    "10.1038/mt.2013.142",
                    "10.1038/nbt1135",
                    "pmc3791741",
                    "10.1093/nar/25.17.3389",
                    "10.1016/0167-5699(93)90039-n",
                    "17620608",
                    "10.1093/intimm/dxl110",
                    "10.1016/j.jmb.2004.01.007",
                    "11129646",
                    "pmc15447",
                    "10.1007/82_2011_135",
                    "pmc320064",
                    "2849754",
                    "10.1016/0024-3205(86)90416-9",
                    "10.1073/pnas.1301456110",
                    "10.1201/9781498710565",
                    "10.1016/j.mayocp.2014.06.008",
                    "1591611",
                    "pmc545557",
                    "10.1016/s0040-4039(00)85908-0",
                    "10.1021/bc025603+",
                    "10.1016/s1570-0232(02)00813-9",
                    "10.1021/jm00186a020",
                    "10.1093/bioinformatics/8.2.155",
                    "10.1074/jbc.m600697200",
                    "10.1007/978-94-007-1257-7",
                    "10.1073/pnas.90.14.6444",
                    "8784342",
                    "2173924",
                    "10.1093/bioinformatics/5.2.151",
                    "20124702",
                    "pmc280013",
                    "10.1093/nar/20.9.2233",
                    "10.1128/jvi.70.8.5422-5429.1996",
                    "27754618",
                    "10.1128/mcb.4.4.749",
                    "10.1021/bc00028a003",
                    "22933274",
                    "10.1016/0167-5699(91)90133-e",
                    "19172747",
                    "10.1073/pnas.1402074111",
                    "10.1128/mcb.4.9.1730",
                    "20081867",
                    "3140379",
                    "10.1515/bc.1999.047",
                    "10.1515/bc.1999.046",
                    "pmc338945",
                    "10.1006/jmbi.1990.9999",
                    "pmc312336",
                    "10.1128/jvi.76.19.10038-10043.2002",
                    "pmc4097770",
                    "6256550",
                    "10.1126/science.2531466",
                    "21744306",
                    "23698367",
                    "10.1038/332323a0",
                    "pmc4058772",
                    "12643755",
                    "27799103",
                    "10.1038/nsmb.1473",
                    "10.1016/s0076-6879(97)76066-x",
                    "10196348",
                    "10.1073/pnas.89.7.2581",
                    "11968478",
                    "12651012",
                    "17077181",
                    "10.3390/ijms12085406",
                    "pmc4452908",
                    "10.1128/jvi.68.7.4503-4505.1994",
                    "10.1002/ijc.10212",
                    "14527957",
                    "10.1128/mbio.01146-14",
                    "pmc3486499",
                    "pmc368793",
                    "25034307",
                    "8502296",
                    "16793771",
                    "10.1074/jbc.m604292200",
                    "10.1038/321522a0",
                    "396436",
                    "10.1128/jvi.66.5.2952-2965.1992",
                    "10.1128/jvi.00433-14",
                    "10.1107/s0907444910007493",
                    "10.1016/j.vaccine.2005.05.023",
                    "10.1016/j.jmb.2009.03.042",
                    "11237620",
                    "pmc321012",
                    "3045807",
                    "pmc3754068",
                    "9990008",
                    "pmc190499",
                    "10.1074/jbc.m307341200",
                    "10075910",
                    "8527474",
                    "10.1006/jmbi.1999.3192",
                    "10543973",
                    "3959753",
                    "10.1016/s0969-2126(94)00113-8",
                    "pmc50453",
                    "23252385",
                    "15024391",
                    "10.1016/j.vetimm.2013.01.009",
                    "10.4049/jimmunol.166.4.2420",
                    "10.1002/cber.19671000929",
                    "10.1371/journal.pone.0066276",
                    "24781747",
                    "10.1073/pnas.93.21.11382",
                    "pmc1389705",
                    "10.1093/emboj/17.13.3512",
                    "10.1016/0167-7799(93)90070-p",
                    "20383002",
                    "10.1109/tmi.2014.2337057",
                    "10.1016/j.vaccine.2008.09.026",
                    "10.1128/jvi.71.10.7207-7213.1997",
                    "10.1016/0378-1119(90)90018-m",
                    "8397764",
                    "pmc3852489",
                    "pmc1924550",
                    "10.1073/pnas.93.21.11371",
                    "25020069",
                    "10706880",
                    "pmc236376",
                    "24560617",
                    "10.1016/j.vaccine.2007.07.026",
                    "pmc1260204",
                    "10.1016/0003-9861(86)90031-7",
                    "1422060",
                    "10.1038/nbt.1601",
                    "pmc254810",
                    "21954367",
                    "18824060",
                    "1350088",
                    "8341653",
                    "9435872",
                    "1614979",
                    "6319549",
                    "pmc4308519",
                    "2165023",
                    "pmc368980",
                    "3118049",
                    "7704521",
                    "24778221",
                    "1373198",
                    "pmc2834826",
                    "10.1073/pnas.0508123103",
                    "10.1126/scitranslmed.3008140",
                    "pmc1197021",
                    "pmc1168733",
                    "10.1038/nm.2105",
                    "17709160",
                    "1904554",
                    "2985952",
                    "15572774",
                    "10.1128/jvi.01632-12",
                    "2081192"
                ]
            },
            {
                "index": "42",
                "publicationKey": "US_10301377_B2",
                "lensId": "188-765-157-754-859",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10301377 B2",
                "publicationDate": "2019-05-28",
                "filingNumber": "US 201615553466 A",
                "filingDate": "2016-02-24",
                "priorityFilingKeysActive": [
                    "US 201562120353 P 20150224"
                ],
                "earliestPriorityDate": "2015-02-24",
                "title": "Middle East Respiratory Syndrome Coronavirus Immunogens, Antibodies, And Their Use",
                "applicants": [
                    "US HEALTH"
                ],
                "inventors": [
                    "GRAHAM BARNEY",
                    "KONG WING-PUI",
                    "MODJARRAD KAYVON",
                    "WANG LINGSHU",
                    "SHI WEI",
                    "JOYCE MICHAEL GORDON",
                    "KANEKIYO MASARU",
                    "MASCOLA JOHN"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                        "executionDate": "2016-03-22"
                    }
                ],
                "url": "https://lens.org/188-765-157-754-859",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 155,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/00",
                    "A61K39/215",
                    "C07K14/005",
                    "C07K14/165",
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 17,
                "nplCitations": [
                    "Chen, et al. \u201cA DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge.\u201d Veterinary Immunology and Immunopathology 152, No. 3 (2013): 359-369.",
                    "Coleman, et al. \u201cPurified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.\u201d Vaccine 32, No. 26 (2014): 3169-3174.",
                    "Du, et al. \u201cA conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East raspiratory syndrome coronavirus spike protein.\u201d Journal of Virology 88, No. 12, (2014): 7045-7053.",
                    "Du, et al. A truncated receptor-binding domain of MERS-CoV spike protein 515 potently inhibits MERS-CoV infection and induces strong neutralizing antibody 516 responses: implication for developing therapeutics and vaccines. PloS One 8 (2013): e81587.",
                    "Jiang, et al. \u201cPotent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.\u201d Science Translational Medicine 6, No. 234 (2014): 2334ra59-234ra59.",
                    "Jiang, et al. \u201cRoadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome.\u201d Expert Review of Vaccines 11, No. 12 (2012): 1405-1413.",
                    "Lan, et al. \u201cTailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.\u201d PLoS One 9, No. 11 (2014): e112602.",
                    "Ma, et al. \u201cIntranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines.\u201d Vaccine 32, No. 18 (2014): 2100-2108.",
                    "Meng, et al. \u201cRapid generation of human-like neutralizing monoclonal antibodies in urgent preparedness for influenza pandemics and virulent infectious diseases.\u201d PloS One 8, No. 6 (2013): e66276.",
                    "Ohnuma, et al. \u201cInhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody.\u201d Journal of Virology 87, No. 24 (2013): 13892-13899.",
                    "Song, et al. \u201cMiddle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.\u201d Journal of Virology 87, No. 21 (2013): 11950-11954.",
                    "Tang, et al. \u201cIdentification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.\u201d Proceedings of the National Academy of Sciences 111, No. 19 (2014): E2018-E2026.",
                    "Wang, et al. \u201cEvaluation of candidate vaccine approaches for MERS-CoV.\u201d Nature Communications 6 (2015): 7712.",
                    "Woo, et al. \u201cSARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.\u201d Vaccine 23, No. 42 (2005): 4959-4968.",
                    "Ying, et al. \u201cDevelopment of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.\u201d Microbes and Infection 17, No. 2 (2015): 142-148.",
                    "Ying, et al. \u201cExceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.\u201d Journal of Virology 88, No. 14 (2014): 7796-7805.",
                    "Zhang, et al. \u201cCuirent advancements and potential strategies in the development of MERS-CoV vaccines.\u201d Expert Review of Vaccines 13, No. 6 (2014): 761-774."
                ],
                "nplResolvedCount": 17,
                "nplResolvedLensIDs": [
                    "009-732-181-810-150",
                    "078-081-741-547-36X",
                    "006-819-881-646-075",
                    "030-088-151-483-183",
                    "003-663-667-600-837",
                    "022-899-518-024-071",
                    "134-030-034-621-902",
                    "047-448-941-251-436",
                    "114-114-185-080-165",
                    "055-005-586-964-518",
                    "003-376-346-248-551",
                    "033-542-963-142-911",
                    "034-994-634-633-262",
                    "043-148-481-331-661",
                    "010-537-288-097-385",
                    "079-080-784-051-77X",
                    "076-921-778-471-668"
                ],
                "nplResolvedExternalIDs": [
                    "10.1128/jvi.02448-13",
                    "pmc3688872",
                    "pmc4058772",
                    "10.1371/journal.pone.0066276",
                    "10.1128/jvi.00433-14",
                    "10.1016/j.vaccine.2005.05.023",
                    "10.1073/pnas.1402074111",
                    "pmc4308519",
                    "pmc4241375",
                    "24766432",
                    "23986586",
                    "10.1038/ncomms8712",
                    "pmc3586247",
                    "25405618",
                    "10.1371/journal.pone.0112602",
                    "pmc4054355",
                    "23428360",
                    "10.1586/erv.12.126",
                    "10.1016/j.micinf.2014.11.008",
                    "24719424",
                    "24736006",
                    "24778221",
                    "pmc4194189",
                    "pmc3807317",
                    "pmc4525294",
                    "pmc3852489",
                    "25456101",
                    "15993989",
                    "24789777",
                    "10.1126/scitranslmed.3008140",
                    "26218507",
                    "23252385",
                    "24560617",
                    "pmc4097770",
                    "pmc4024880",
                    "10.1371/journal.pone.0081587",
                    "24324708",
                    "pmc3838260",
                    "23824680",
                    "10.1128/jvi.00912-14",
                    "10.1016/j.vaccine.2014.02.004",
                    "10.1016/j.vetimm.2013.01.009",
                    "pmc4236105",
                    "10.1586/14760584.2014.912134",
                    "24067970",
                    "10.1128/jvi.01672-13",
                    "24778414",
                    "10.1016/j.vaccine.2014.04.016"
                ]
            },
            {
                "index": "43",
                "publicationKey": "US_10383844_B2",
                "lensId": "143-305-057-238-363",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10383844 B2",
                "publicationDate": "2019-08-20",
                "filingNumber": "US 201815986033 A",
                "filingDate": "2018-05-22",
                "priorityFilingKeysActive": [
                    "KR 20170063643 A 20170523"
                ],
                "earliestPriorityDate": "2017-05-23",
                "title": "Methods For Treating Pulmonary Fibrosis Using Chromenone Derivatives",
                "applicants": [
                    "COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY\u2014ACADEMIC COOPERATION FOUNDATION",
                    "EWHA UNIVERSITY\u2014INDUSTRY COLLABORATION FOUND",
                    "INDUSTRY\u2014ACADEMIC COOPERATION FOUNDATION YONSEI UNIV",
                    "COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY\u2014ACADEMIC COOPERATION",
                    "UNIV YONSEI IACF"
                ],
                "inventors": [
                    "NA YOUNGHWA",
                    "LEE YUN-SIL",
                    "CHO JAE HO"
                ],
                "owners": [
                    {
                        "name": "EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION",
                        "executionDate": "2018-06-28"
                    },
                    {
                        "name": "COLL MEDICINE POCHON CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION",
                        "executionDate": "2018-06-19"
                    },
                    {
                        "name": "INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY",
                        "executionDate": "2018-06-19"
                    }
                ],
                "url": "https://lens.org/143-305-057-238-363",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/353",
                    "A61K31/38",
                    "A61P11/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "CN1493571A, Abstract English translation (2004) (Year: 2004)."
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "44",
                "publicationKey": "US_2018_0244756_A1",
                "lensId": "171-622-821-892-796",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0244756 A1",
                "publicationDate": "2018-08-30",
                "filingNumber": "US 201615553466 A",
                "filingDate": "2016-02-24",
                "priorityFilingKeysActive": [
                    "US 201562120353 P 20150224"
                ],
                "earliestPriorityDate": "2015-02-24",
                "title": "Middle East Respiratory Syndrome Coronavirus Immunogens, Antibodies, And Their Use",
                "applicants": [
                    "US HEALTH"
                ],
                "inventors": [
                    "GRAHAM BARNEY",
                    "KONG WING-PUI",
                    "MODJARRAD KAYVON",
                    "WANG LINGSHU",
                    "SHI WEI",
                    "JOYCE MICHAEL GORDON",
                    "KANEKIYO MASARU",
                    "MASCOLA JOHN"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                        "executionDate": "2016-03-22"
                    }
                ],
                "url": "https://lens.org/171-622-821-892-796",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 155,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/215",
                    "C07K14/005",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "45",
                "publicationKey": "US_2018_0338948_A1",
                "lensId": "054-692-127-518-966",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0338948 A1",
                "publicationDate": "2018-11-29",
                "filingNumber": "US 201815986033 A",
                "filingDate": "2018-05-22",
                "priorityFilingKeysActive": [
                    "KR 20170063643 A 20170523"
                ],
                "earliestPriorityDate": "2017-05-23",
                "title": "Methods For Treating Pulmonary Fibrosis Using Chromenone Derivatives",
                "applicants": [
                    "COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION",
                    "EWHA UNIV INDUSTRY COLLABORATION FOUNDATION",
                    "UNIV YONSEI IACF"
                ],
                "inventors": [
                    "NA YOUNGHWA",
                    "LEE YUN-SIL",
                    "CHO JAE HO"
                ],
                "owners": [
                    {
                        "name": "EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION",
                        "executionDate": "2018-06-28"
                    },
                    {
                        "name": "COLL MEDICINE POCHON CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION",
                        "executionDate": "2018-06-19"
                    },
                    {
                        "name": "INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY",
                        "executionDate": "2018-06-19"
                    }
                ],
                "url": "https://lens.org/054-692-127-518-966",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/353",
                    "A61K31/38",
                    "A61P11/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "46",
                "publicationKey": "US_2019_0262432_A1",
                "lensId": "192-142-722-311-81X",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0262432 A1",
                "publicationDate": "2019-08-29",
                "filingNumber": "US 201916293589 A",
                "filingDate": "2019-03-05",
                "priorityFilingKeysActive": [
                    "US 201615314782 A 20161129",
                    "US 201462005817 P 20140530"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Treatment Of Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "ANSUN BIOPHARMA INC"
                ],
                "inventors": [
                    "MOSS RONALD B"
                ],
                "owners": [
                    {
                        "name": "ANSUN BIOPHARMA INC",
                        "executionDate": "2014-06-16"
                    }
                ],
                "url": "https://lens.org/192-142-722-311-81X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 3,
                "seqCount": 14,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/47",
                    "A61K9/00",
                    "A61K38/18",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "47",
                "publicationKey": "US_2019_0285632_A1",
                "lensId": "046-071-737-251-283",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0285632 A1",
                "publicationDate": "2019-09-19",
                "filingNumber": "US 201716300654 A",
                "filingDate": "2017-05-24",
                "priorityFilingKeysActive": [
                    "US 201662340624 P 20160524"
                ],
                "earliestPriorityDate": "2016-05-24",
                "title": "Metabalomics And Viral Diagnostics Suite",
                "applicants": [
                    "EXCISION BIOTHERAPEUTICS INC"
                ],
                "inventors": [
                    "MALCOLM THOMAS"
                ],
                "owners": [
                    {
                        "name": "EXCISION BIOTHERAPEUTICS INC",
                        "executionDate": "2016-06-19"
                    }
                ],
                "url": "https://lens.org/046-071-737-251-283",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 7,
                "familySize": 7,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "48",
                "publicationKey": "WO_2018_112648_A1",
                "lensId": "113-044-931-681-169",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/112648 A1",
                "publicationDate": "2018-06-28",
                "filingNumber": "CA 2017051575 W",
                "filingDate": "2017-12-21",
                "priorityFilingKeysActive": [
                    "CA 2953159 A 20161223",
                    "CA 2953166 A 20161223",
                    "CA 2953168 A 20161223"
                ],
                "earliestPriorityDate": "2016-12-23",
                "title": "Matriptase Inhibitors And Uses Thereof",
                "applicants": [
                    "NEOMED INST"
                ],
                "inventors": [
                    "BOUDREAULT PIERRE-LUC",
                    "COLOMBO \u00c9LO\u00cfC",
                    "LEDUC RICHARD",
                    "MARSAULT ERIC",
                    "PLANCQ BAPTISTE",
                    "RICHTER MARTIN"
                ],
                "owners": [],
                "url": "https://lens.org/113-044-931-681-169",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K5/083",
                    "A61K38/06",
                    "A61K38/55",
                    "A61P31/12",
                    "A61P31/16",
                    "A61P35/00",
                    "C07K5/03",
                    "C07K5/08",
                    "C12N9/64"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "DUCHENE ET AL.: \"Analysis of Sub pocket Selectivity and identification of potent selective inhibitors for matriptase and matriptase-2\", JOURNAL OF MEDICINAL CHEMISTRY, vol. 57, 11 November 2014 (2014-11-11), pages 10198 - 10204, XP055429365",
                    "ZORATTI ET AL.: \"Targeting matriptase in breast cancer abrogates tumor progression via impairment of stromal-epithelial growth factor signalling\", NATURE COMMUNICATIONS, vol. 6, no. 6776, 15 April 2015 (2015-04-15), pages 1 - 13, XP055509519",
                    "MILNER ET AL.: \"Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis\", ARTHRITIS & RHEUMATISM, vol. 62, no. 7, 7 July 2010 (2010-07-07), pages 1955 - 1966, XP002608337",
                    "BARDOU ET AL.: \"Membrane-anchored serine protease matriptase is a trigger of pulmonary fibrogenesis\", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 193, no. 8, 15 April 2016 (2016-04-15), pages 847 - 860, XP055509527"
                ],
                "nplResolvedCount": 5,
                "nplResolvedLensIDs": [
                    "054-164-583-801-723",
                    "077-768-186-082-245",
                    "015-187-643-449-264",
                    "069-030-472-021-098",
                    "019-642-134-486-056"
                ],
                "nplResolvedExternalIDs": [
                    "10.1002/art.27476",
                    "26599507",
                    "10.1021/jm5015633",
                    "10.1038/ncomms7776",
                    "pmc4749267",
                    "20506309",
                    "10.1164/rccm.201502-0299oc",
                    "25873032",
                    "25387268"
                ]
            },
            {
                "index": "49",
                "publicationKey": "US_2019_0337981_A1",
                "lensId": "179-166-719-695-539",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0337981 A1",
                "publicationDate": "2019-11-07",
                "filingNumber": "US 201716471979 A",
                "filingDate": "2017-12-21",
                "priorityFilingKeysActive": [
                    "CA 2953159 A 20161223",
                    "CA 2953166 A 20161223",
                    "CA 2953168 A 20161223"
                ],
                "earliestPriorityDate": "2016-12-23",
                "title": "Matriptase Inhibitors And Uses Thereof",
                "applicants": [
                    "NEOMED INST"
                ],
                "inventors": [
                    "BOUDREAULT PIERRE-LUC",
                    "COLOMBO \u00c9LO\u00cfC",
                    "LEDUC RICHARD",
                    "MARSAULT ERIC",
                    "PLANCQ BAPTISTE",
                    "RICHTER MARTIN"
                ],
                "owners": [],
                "url": "https://lens.org/179-166-719-695-539",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K5/09",
                    "A61P11/00",
                    "A61P19/02",
                    "A61P31/16",
                    "C07K5/083"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "50",
                "publicationKey": "WO_2015_179535_A1",
                "lensId": "057-128-608-970-373",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/179535 A1",
                "publicationDate": "2015-11-26",
                "filingNumber": "US 2015/0031800 W",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome -coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [],
                "url": "https://lens.org/057-128-608-970-373",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 4,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "C07K16/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 44,
                "nplCitations": [
                    "X.-C. TANG ET AL: \"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 111, no. 19, 13 May 2014 (2014-05-13), pages E2018 - E2026, XP055162782, ISSN: 0027-8424, DOI: 10.1073/pnas.1402074111",
                    "YING TIANLEI ET AL: \"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies\", JOURNAL OF VIROLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 88, no. 14, 30 April 2014 (2014-04-30), pages 7796 - 7805, XP009181617, ISSN: 1098-5514, DOI: 10.1128/JVI.00912-14",
                    "JIANG LIWEI ET AL: \"Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein\", SCIENCE TRANSLATIONAL MEDICINE,, vol. 6, no. 234, 30 April 2014 (2014-04-30), pages - 9, XP009182042, ISSN: 1946-6234",
                    "ZAKI ET AL., NEJM, vol. 367, 2012, pages 1814 - 1820",
                    "RAJ ET AL., NATURE, vol. 495, 2013, pages 251 - 256",
                    "LU ET AL., NATURE, vol. 500, 2013, pages 227 - 231",
                    "DU ET AL., J. VIROL., 2014",
                    "YING ET AL., J. VIROL., 2014",
                    "TANG ET AL., PNAS, 2014",
                    "JIANG ET AL., SCI. TRANSL. MED., vol. 6, 2014, pages 234RA59",
                    "REDDY ET AL., J. IMMUNOL., vol. 164, 2000, pages 1925 - 1933",
                    "KABAT, SEQUENCES OF PROTEINS OF IMMUNOLOGICAL INTEREST, 1991",
                    "AL-LAZIKANI ET AL., J. MOL. BIOL., vol. 273, 1997, pages 927 - 948",
                    "MARTIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 9268 - 9272",
                    "SHIELD ET AL., JBC, vol. 277, 2002, pages 26733",
                    "RAJ ET AL., NATURE, vol. 495, 2013, pages 251 - 254",
                    "MOU ET AL., J. VIROLOGY, vol. 87, 2013, pages 9379 - 9383",
                    "PADLAN ET AL., FASEB J., vol. 9, 1995, pages 133 - 139",
                    "VAJDOS ET AL., J MOL BIOL, vol. 320, 2002, pages 415 - 428",
                    "PEARSON, METHODS MOL. BIOL., vol. 24, 1994, pages 307 - 331",
                    "GONNET ET AL., SCIENCE, vol. 256, 1992, pages 1443 - 45",
                    "ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410",
                    "NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402",
                    "LLOYD, THE ART, SCIENCE AND TECHNOLOGY OF PHARMACEUTICAL COMPOUNDING, 1999",
                    "GOOD ET AL., CANCER, vol. 68, 1991, pages 1415 - 1421",
                    "MARASCO ET AL., NATURE BIOTECHNOLOGY, vol. 25, 2007, pages 1421 - 1434",
                    "HARLOW; LANE: \"Antibodies\", COLD SPRING HARBOR PRESS",
                    "REINEKE, METHODS MOL. BIOL., vol. 248, 2004, pages 443 - 63",
                    "TOMER, PROT. SCI., vol. 9, 2000, pages 487 - 496",
                    "EHRING, ANALYTICAL BIOCHEMISTRY, vol. 267, 1999, pages 252 - 259",
                    "ENGEN; SMITH, ANAL. CHEM., vol. 73, 2001, pages 256A - 265A",
                    "JUNGHANS ET AL., CANCER RES., vol. 50, 1990, pages 1495 - 1502",
                    "TUTT ET AL., J. IMMUNOL., vol. 147, 1991, pages 60 - 69",
                    "KUFER ET AL., TRENDS BIOTECHNOL., vol. 22, 2004, pages 238 - 244",
                    "KAZANE ET AL., J. AM. CHEM. SOC., 4 December 2012 (2012-12-04)",
                    "\"Remington's Pharmaceutical Sciences\", MACK PUBLISHING COMPANY",
                    "POWELL ET AL.: \"Compendium of excipients for parenteral formulations\", J PHARM SCI TECHNOL, vol. 52, 1998, pages 238 - 311, XP009119027",
                    "WU ET AL., J. BIOL. CHEM., vol. 262, 1987, pages 4429 - 4432",
                    "LANGER, SCIENCE, vol. 249, 1990, pages 1527 - 1533",
                    "ARRUEBO, M. ET AL.: \"Antibody-conjugated nanoparticles for biomedical applications\", J. NANOMAT., vol. 2009, 2009, pages 24",
                    "MALPICA ET AL., GENETICS, vol. 162, 2002, pages 1505 - 1511",
                    "JIANG ET AL., SCI. TRANSL. MED., 2014",
                    "VALENZUELA ET AL., NAT. BIOTECHNOL., vol. 21, 2003, pages 652 - 659",
                    "POUEYMIROU, NATURE BIOTECHNOLOGY, vol. 25, 2007, pages 91 - 99"
                ],
                "nplResolvedCount": 31,
                "nplResolvedLensIDs": [
                    "048-623-783-675-63X",
                    "108-511-801-833-75X",
                    "004-701-796-869-470",
                    "022-375-749-274-329",
                    "113-446-080-346-814",
                    "052-664-611-823-937",
                    "007-875-147-167-216",
                    "007-047-414-654-825",
                    "051-707-000-800-833",
                    "059-212-558-154-670",
                    "016-034-870-606-687",
                    "085-122-255-782-470",
                    "007-845-004-248-599",
                    "046-419-902-381-810",
                    "142-265-334-235-532",
                    "174-067-461-309-323",
                    "056-201-471-905-934",
                    "023-868-377-007-810",
                    "055-005-586-964-518",
                    "034-892-502-452-681",
                    "020-009-029-407-493",
                    "145-146-407-738-040",
                    "043-148-481-331-661",
                    "028-862-168-091-90X",
                    "009-507-053-935-564",
                    "045-149-256-448-908",
                    "023-671-383-084-282",
                    "026-221-045-144-327",
                    "079-080-784-051-77X",
                    "010-655-350-435-62X",
                    "032-720-983-972-675"
                ],
                "nplResolvedExternalIDs": [
                    "12079396",
                    "10.1128/jvi.01277-13",
                    "10.1006/abio.1998.3000",
                    "10.1073/pnas.86.23.9268",
                    "2231712",
                    "10.1038/nbt1263",
                    "1878838",
                    "3558345",
                    "2218494",
                    "10.1096/fasebj.9.1.7821752",
                    "23785207",
                    "23831647",
                    "10.4049/jimmunol.164.4.1925",
                    "10.1126/science.1604319",
                    "pmc4024880",
                    "10.1006/jmbi.1997.1354",
                    "10.1128/jvi.00912-14",
                    "10036128",
                    "8205202",
                    "pmc1462378",
                    "23486063",
                    "pmc146917",
                    "9254694",
                    "23075143",
                    "9846074",
                    "10.1021/ac012452f",
                    "10.1002/1097-0142(19910915)68:6+<1415::aid-cncr2820681402>3.0.co;2-0",
                    "10.1016/j.tibtech.2004.03.006",
                    "pmc298475",
                    "10.1016/s0022-2836(05)80360-2",
                    "10.1073/pnas.1402074111",
                    "10.1056/nejmoa1211721",
                    "10657642",
                    "12730667",
                    "10.1038/nbt1363",
                    "17187059",
                    "14970513",
                    "12524327",
                    "10.1016/s0022-2836(02)00264-4",
                    "10.1016/s0167-7799(04)00080-0",
                    "pmc3754068",
                    "10.1038/nbt822",
                    "15109810",
                    "1604319",
                    "10.1038/nature12005",
                    "24778221",
                    "10.1006/jmbi.1990.9999",
                    "10.1126/science.2218494",
                    "1675655",
                    "10.1038/nature12328",
                    "24789777",
                    "7821752",
                    "10.1126/scitranslmed.3008140",
                    "9367782",
                    "10.1385/1-59259-666-5:443",
                    "pmc4097770",
                    "10.1093/nar/25.17.3389",
                    "10.1385/0-89603-246-9:307",
                    "2406013",
                    "24778414",
                    "18066039",
                    "2594766",
                    "11354508"
                ]
            },
            {
                "index": "51",
                "publicationKey": "WO_2017_010835_A1",
                "lensId": "045-313-279-230-815",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/010835 A1",
                "publicationDate": "2017-01-19",
                "filingNumber": "KR 2016007719 W",
                "filingDate": "2016-07-15",
                "priorityFilingKeysActive": [
                    "KR 20150101046 A 20150716"
                ],
                "earliestPriorityDate": "2015-07-16",
                "title": "Use Of Radotinib For Prevention Or Treatment Of Viral Respiratory Disease",
                "applicants": [
                    "IL-YANG PHARM CO LTD"
                ],
                "inventors": [
                    "KIM DONG YEON",
                    "PARK MAN SEONG",
                    "CHO DAE JIN",
                    "LEE GONG YEAL",
                    "KIM HONG YOUB",
                    "LEE HEA UN",
                    "AHN CHOONG AM",
                    "BANG HYE JIN",
                    "SONG SONG EI",
                    "PARK JONG SEONG"
                ],
                "owners": [],
                "url": "https://lens.org/045-313-279-230-815",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/506",
                    "A61K31/4178",
                    "A61K31/497"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "DYALL, J. ET AL.: \"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.\", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 58, no. 8, 2014, pages 4885 - 4893, XP055321806",
                    "KIM, S.-H. ET AL.: \"Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors.\", HAEMATOLOGICA, vol. 99, no. 7, 2014, pages 1191 - 1196, XP055346578",
                    "KIM, D.-W.: \"Recent advances of management for chronic myeloid leukemia.\", THE KOREAN JOURNAL OF MEDICINE, vol. 83, no. 6, 2012, pages 718 - 723, XP055346584",
                    "HEO, S.-K. ET AL.: \"Radotinib induces apoptosis of CDllb+ cells differentiated from acute myeloid leukemia cells.\", PLOS ONE, vol. 10, no. 6, June 2015 (2015-06-01), pages 1 - 18, XP055346586"
                ],
                "nplResolvedCount": 5,
                "nplResolvedLensIDs": [
                    "084-056-283-121-611",
                    "060-128-920-862-316",
                    "034-799-376-806-357",
                    "078-927-472-648-096",
                    "026-518-238-956-425"
                ],
                "nplResolvedExternalIDs": [
                    "10.1371/journal.pone.0129853",
                    "10.3904/kjm.2012.83.6.718",
                    "pmc4077080",
                    "24705186",
                    "pmc4466365",
                    "pmc4136000",
                    "10.1128/aac.03036-14",
                    "26065685",
                    "10.3324/haematol.2014.123232",
                    "25740109",
                    "24841273",
                    "pmc4349295",
                    "10.3324/haematol.2013.096776"
                ]
            },
            {
                "index": "52",
                "publicationKey": "WO_2017_176596_A1",
                "lensId": "138-661-899-573-600",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/176596 A1",
                "publicationDate": "2017-10-12",
                "filingNumber": "US 2017/0025623 W",
                "filingDate": "2017-03-31",
                "priorityFilingKeysActive": [
                    "US 201662318087 P 20160404"
                ],
                "earliestPriorityDate": "2016-04-04",
                "title": "Multivalent Vaccines For Rabies Virus And Coronaviruses",
                "applicants": [
                    "THE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES",
                    "THE UNIV OF MARYLAND",
                    "UNIV JEFFERSON"
                ],
                "inventors": [
                    "JOHNSON REED F PH D",
                    "SCHNELL MATTHIAS",
                    "HENSLEY LISA E",
                    "WIRBLICH CHRISTOPH",
                    "COLEMAN CHRISTOPHER M",
                    "FRIEMAN MATTHEW B"
                ],
                "owners": [],
                "url": "https://lens.org/138-661-899-573-600",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 24,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/205",
                    "A61K39/215",
                    "C12N7/04",
                    "C12N15/86"
                ],
                "usClassifications": [],
                "nplCitationCount": 80,
                "nplCitations": [
                    "M. FABER: \"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies\", JOURNAL OF GENERAL VIROLOGY., vol. 86, no. 5, 1 May 2005 (2005-05-01), GB, pages 1435 - 1440, XP055380471, ISSN: 0022-1317, DOI: 10.1099/vir.0.80844-0",
                    "J. P. MCGETTIGAN ET AL: \"Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic\", JOURNAL OF VIROLOGY, vol. 77, no. 1, 1 January 2003 (2003-01-01), pages 237 - 244, XP055028019, ISSN: 0022-538X, DOI: 10.1128/JVI.77.1.237-244.2003",
                    "ANNA H. MALCZYK ET AL: \"A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform ABSTRACT\", JOURNAL OF VIROLOGY., vol. 89, no. 22, 9 September 2015 (2015-09-09), US, pages 11654 - 11667, XP055257597, ISSN: 0022-538X, DOI: 10.1128/JVI.01815-15",
                    "DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; January 2017 (2017-01-01), WIRBLICH CHRISTOPH ET AL: \"One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus\", XP009194667, Database accession no. PREV201700240013",
                    "\"Remington's Pharmaceutical Sciences\", MACK PUBLISHING COL, article \"Chapter 43\"",
                    "A. GENNARO: \"Remington: The Science and Practice of Pharmacy\", 2000, LIPPINCOTT, WILLIAMS, & WILKINS",
                    "\"Pharmaceutical Dosage Forms and Drug Delivery Systems\", 1999, LIPPINCOTT, WILLIAMS, & WILKINS",
                    "\"Handbook of Pharmaceutical Excipients\", 2000, AMER. PHARMACEUTICAL ASSOC.",
                    "BARRETT PN ET AL., EXPERT REV VACCINES, vol. 8, no. 5, May 2009 (2009-05-01), pages 607 - 618",
                    "TORDO N ET AL., DEV BIOL (BASEL, vol. 131, 2008, pages 467 - 476",
                    "TOOVEY S. ET AL., TRAVEL MED INFECT DIS., vol. 5, no. 6, November 2007 (2007-11-01), pages 327 - 348",
                    "CHELBI-ALIX MK, J INTERFERON CYTOKINE RES., vol. 26, no. 5, May 2006 (2006-05-01), pages 271 - 280",
                    "MORENWEISER R. ET AL., GENE THER., vol. 12, no. 1, October 2005 (2005-10-01), pages 103 - 110",
                    "MORIMOTO K ET AL., VIRUS RES., vol. 111, no. 1, 11 April 2005 (2005-04-11), pages 61 - 67",
                    "FINKE S ET AL., VIRUS RES., vol. 111, no. 2, August 2005 (2005-08-01), pages 120 - 131",
                    "HALDER M., ALTERN LAB ANIM., vol. 30, no. 1, January 2002 (2002-01-01), pages 93 - 108",
                    "MONTAGNON BJ ET AL., DEV BIOL STAND, vol. 93, 1998, pages 119 - 123",
                    "\"Current Protocols in Molecular Biology\", JOHN WILEY AND SONS, INC",
                    "MIYAO ET AL., DSRNA RES. DEV., vol. 5, 1995, pages 115 - 121",
                    "TAKAKURA ET AL., DSRNA & NUCL. ACID DRUG DEV., vol. 6, 1996, pages 177 - 183",
                    "\"The Merck Manual of Diagnosis and Therapy\", 1987, pages: 1206 - 1228",
                    "\"The Merck Manual of Diagnosis and Therapy\", 1987, pages: 2499 - 2506,46-",
                    "ZHANG ET AL., J. CONTROL RELEASE, vol. 100, 2004, pages 165 - 180",
                    "MILNE-PRICE S; MIAZGOWICZ KL; MUNSTER VJ.: \"The emergence of the Middle East respiratory syndrome coronavirus\", PATHOG DIS, vol. 71, 2014, pages 121 - 136",
                    "ZAKI AM ET AL: \"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.\", N ENGL J MED, vol. 367, 2012, pages 1814 - 1820, XP055274765, DOI: doi:10.1056/NEJMoa1211721",
                    "\"WHO Statement on the third meeting of the IHR Emergency committee concerning Middle East respiratory syndrome coronavirus (MERS-CoV\", WKLY EPIDEMIOL REC, vol. 88, 2013, pages 435 - 436",
                    "MEMISH ZA; ZUMLA AI; ASSIRI A.: \"Middle East respiratory syndrome coronavirus infections in health care workers\", N ENGL J MED, vol. 369, 2013, pages 884 - 886",
                    "DROSTEN C; KELLAM P; MEMISH ZA: \"Evidence for camel-to-human transmission of MERS coronavirus\", N ENGL J MED, vol. 371, 2014, pages 1359 - 1360",
                    "MADANI TA; AZHAR EI; HASHEM AM: \"Evidence for camel-to-human transmission of MERS coronavirus\", N ENGL J MED, vol. 371, 2014, pages 1360",
                    "AZHAR ET AL: \"Evidence for camel-to-human transmission of MERS coronavirus\", N ENGL J MED, vol. 370, 2014, pages 2499 - 2505",
                    "KHAN A; FAROOQUI A; GUAN Y; KELVIN DJ.: \"Lessons to learn from MERS-CoV outbreak in South Korea\", J INFECT DEV CTRIES, vol. 9, 2015, pages 543 - 546",
                    "PARK HY ET AL: \"Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea\", EURO SURVEILL, vol. 20, May 2015 (2015-05-01), pages 1 - 6",
                    "PETERSEN E; POLLACK MM; MADOFF LC.: \"Health-care associate transmission of Middle East Respiratory Syndrome Corona virus, MERS-CoV, in the Kingdom of Saudi Arabia\", INT J INFECT DIS, vol. 29, 2014, pages 299 - 300",
                    "CAUCHEMEZ S. ET AL: \"Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart.\", EURO SURVEILL, 2013, pages 18",
                    "CHAN PK; MA S; NGAI SM.: \"Identification of T-cell epitopes of SARS-coronavirus for development of peptide-based vaccines and cellular immunity assessment methods\", HONG KONG MED J, vol. 17, no. 6, 2011, pages 26 - 30",
                    "ROPER RL; REHM KE: \"SARS vaccines: where are we?\", EXPERT REV VACCINES, vol. 8, 2009, pages 887 - 898",
                    "ZHU X. ET AL: \"Receptor-binding domain as a target for developing SARS vaccines.\", J THORAC DIS, vol. 5, no. 2, 2013, pages 142 - 148",
                    "DU L; JIANG S.: \"Middle East respiratory syndrome: current status and future prospects for vaccine development.\", EXPERT OPIN BIOL THER, vol. 15, 2015, pages 1647 - 1651",
                    "VOLZ A. ET AL: \"Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein\", J VIROL, vol. 89, 2015, pages 8651 - 8656, XP055257600, DOI: doi:10.1128/JVI.00614-15",
                    "MA C. ET AL: \"Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design\", VACCINE, vol. 32, 2014, pages 6170 - 6176, XP029049168, DOI: doi:10.1016/j.vaccine.2014.08.086",
                    "MA C.ET AL: \"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines\", VACCINE, vol. 32, 2014, pages 2100 - 2108, XP028838491, DOI: doi:10.1016/j.vaccine.2014.02.004",
                    "MUTHUMANI K. ET AL: \"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates.\", SCI TRANSL MED, vol. 7, 2015, pages 301RA132",
                    "COLEMAN CM ET AL: \"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.\", VACCINE, vol. 32, 2014, pages 3169 - 3174, XP028654166, DOI: doi:10.1016/j.vaccine.2014.04.016",
                    "MOU H. ET AL: \"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies\", J VIROL, vol. 87, 2013, pages 9379 - 9383, XP055162922, DOI: doi:10.1128/JVI.01277-13",
                    "DU L. ET AL: \"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development\", J VIROL, vol. 87, 2013, pages 9939 - 9942, XP055157122, DOI: doi:10.1128/JVI.01048-13",
                    "ZHANG N. ET AL: \"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus\", CELL MOL IMMUNOL, 2015",
                    "YANG Y. ET AL: \"The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents\", VIRAL IMMUNOL, vol. 27, 2014, pages 543 - 550",
                    "KIM E. ET AL: \"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice\", VACCINE, vol. 32, 2014, pages 5975 - 5982, XP029069689, DOI: doi:10.1016/j.vaccine.2014.08.058",
                    "GUO X. ET AL: \"Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus\", IMMUNOLOGY, vol. 145, 2015, pages 476 - 484",
                    "PFALLER CK; CATTANEO R; SCHNELL MJ.: \"Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics\", VIROLOGY, 2015",
                    "WILLET M. ET AL: \"Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses\", J INFECT DIS, 2015",
                    "HUTTNER A. ET AL: \"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial\", LANCET INFECT DIS, vol. 15, 2015, pages 1156 - 1166",
                    "BLANEY JE ET AL: \"Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine\", PLOS PATHOG, vol. 9, 2013, pages E1003389",
                    "BLANEY JE ET AL: \"Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses\", J VIROL, vol. 85, 2011, pages 10605 - 10616, XP055027816, DOI: doi:10.1128/JVI.00558-11",
                    "PAPANERI AB ET AL: \"A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence\", VIROLOGY, vol. 434, 2012, pages 18 - 26",
                    "PAPANERI AB ET AL: \"Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein\", VACCINE, vol. 30, 2012, pages 6136 - 6141",
                    "CLIQUET F; AUBERT M.: \"Elimination of terrestrial rabies in Western European countries\", DEV BIOL (BASEL, vol. 119, 2004, pages 185 - 204",
                    "RABIES, FACT SHEET, 2015, pages 99",
                    "MCGETTIGAN JP; POMERANTZ RJ; SILER CA; MCKENNA PM; FOLEY HD; DIETZSCHOLD B; SCHNELL MJ.: \"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic\", J VIROL, vol. 77, 2003, pages 237 - 244, XP055028019, DOI: doi:10.1128/JVI.77.1.237-244.2003",
                    "PAPANERI AB; WIRBLICH C; MARISSEN WE; SCHNELL MJ.: \"Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment.\", VACCINE, vol. 31, 2013, pages 5897 - 5902, XP028776495, DOI: doi:10.1016/j.vaccine.2013.09.038",
                    "KURUP D; WIRBLICH C; FELDMANN H; MARZI A; SCHNELL MJ.: \"Rhabdoviral-Based Vaccine Platforms against Henipaviruses\", J VIROL, 2014",
                    "ZHAO J. ET AL: \"Rapid generation of a mouse model for Middle East respiratory syndrome\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 111, 2014, pages 4970 - 4975, XP055212024, DOI: doi:10.1073/pnas.1323279111",
                    "PASCAL KE E AL: \"Pre-and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 112, 2015, pages 8738 - 8743",
                    "COLEMAN CM; FRIEMAN MB.: \"Growth and Quantification of MERS-CoV Infection\", CURRENT PROTOCOLS IN MICROBIOLOGY, vol. 37, no. 15E 12, 2015, pages 11 - 19",
                    "CONZELMANN KK ET AL: \"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19\", VIROLOGY, vol. 175, 1990, pages 485 - 499, XP023056033, DOI: doi:10.1016/0042-6822(90)90433-R",
                    "HUDACEK AW ET AL: \"Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo\", MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2014, pages 1",
                    "MCGETTIGAN JP ET AL: \"Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome\", J VIROL, vol. 77, 2003, pages 10889 - 10899, XP055028016, DOI: doi:10.1128/JVI.77.20.10889-10899.2003",
                    "LONTOK E; CORSE E; MACHAMER CE.: \"Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site\", J VIROL, vol. 78, 2004, pages 5913 - 5922",
                    "SCHWEGMANN-WESSELS C. ET AL: \"Comparison of vesicular stomatitis virus pseudotyped with the S proteins from a porcine and a human coronavirus\", J GEN VIROL, vol. 90, 2009, pages 1724 - 1729",
                    "FUKUSHI S. ET AL: \"Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein\", J GEN VIROL, vol. 86, 2005, pages 2269 - 2274, XP055006010, DOI: doi:10.1099/vir.0.80955-0",
                    "SMITH ME ET AL: \"Rabies virus glycoprotein as a carrier for anthrax protective antigen\", VIROLOGY, vol. 353, 2006, pages 344 - 356, XP005654110, DOI: doi:10.1016/j.virol.2006.05.010",
                    "MCKENNA PM ET AL: \"Covalently linked human immunodeficiency virus type 1 gpl20/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes\", J VIROL, vol. 77, 2003, pages 12782 - 12794, XP003015642, DOI: doi:10.1128/JVI.77.23.12782-12794.2003",
                    "SILER CA ET AL: \"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.\", VIROLOGY, vol. 292, 2002, pages 24 - 34",
                    "SCHNELL MJ ET AL: \"Recombinant rabies virus as potential live-viral vaccines for HIV-1\", PROC NATL ACAD SCI U S A, vol. 97, 2000, pages 3544 - 3549, XP002313400, DOI: doi:10.1073/pnas.050589197",
                    "WINTER C. ET AL: \"The spike protein of infectious bronchitis virus is retained intracellularly by a tyrosine motif\", J VIROL, vol. 82, 2008, pages 2765 - 2771",
                    "SCHWEGMANN-WESSELS C; REN X; HERRLER G.: \"Intracellular transport of the S proteins of coronaviruses\", ADV EXP MED BIOL, vol. 581, 2006, pages 271 - 275",
                    "SCHWEGMANN-WESSELS C ET AL: \"A novel sorting signal for intracellular localization is present in the S protein of a porcine coronavirus but absent from severe acute respiratory syndrome-associated coronavirus.\", J BIOL CHEM, vol. 279, 2004, pages 43661 - 43666",
                    "COLEMAN CM; MATTHEWS KL; GOICOCHEA L; FRIEMAN MB.: \"Wild type and innate immune deficient mice are not susceptible to the Middle East Respiratory Syndrome Coronavirus\", J GEN VIROL, 2013",
                    "\"Pneumonia from Human Coronavirus in a Macaque Model\", N ENGL J MED, vol. 368, 18 May 2013 (2013-05-18), pages 1560 - 1562, Retrieved from the Internet <URL:http://www.nejm.org/doi/abs/10.1056/NEJMcl215691>",
                    "WANG L. ET AL: \"Evaluation of candidate vaccine approaches for MERS-CoV\", NAT COMMUN, vol. 6, 2015, pages 7712, XP055271251, DOI: doi:10.1038/ncomms8712"
                ],
                "nplResolvedCount": 73,
                "nplResolvedLensIDs": [
                    "186-131-706-503-300",
                    "014-222-463-869-012",
                    "006-187-565-187-783",
                    "018-858-508-332-649",
                    "082-704-325-838-62X",
                    "100-328-832-278-211",
                    "030-812-431-486-64X",
                    "032-514-877-351-077",
                    "073-670-783-767-946",
                    "005-378-015-489-66X",
                    "014-259-866-982-422",
                    "035-760-912-363-624",
                    "048-932-226-325-353",
                    "055-844-457-938-708",
                    "005-156-329-511-387",
                    "111-186-753-527-695",
                    "083-386-037-387-452",
                    "003-252-406-340-268",
                    "144-348-691-534-756",
                    "078-081-741-547-36X",
                    "011-161-347-459-213",
                    "017-277-733-543-918",
                    "001-460-168-050-735",
                    "118-660-215-665-839",
                    "113-247-817-446-456",
                    "071-691-773-181-474",
                    "067-884-443-627-767",
                    "094-008-083-779-263",
                    "022-899-518-024-071",
                    "001-859-682-521-346",
                    "007-882-357-040-729",
                    "032-556-517-411-211",
                    "122-907-742-543-047",
                    "048-463-665-735-216",
                    "024-304-505-069-69X",
                    "022-578-530-537-710",
                    "036-021-099-803-216",
                    "054-391-011-603-49X",
                    "018-103-960-238-098",
                    "078-710-383-444-481",
                    "080-249-086-891-460",
                    "025-804-338-184-099",
                    "015-744-293-104-440",
                    "014-894-183-227-316",
                    "075-104-348-923-162",
                    "044-658-427-636-241",
                    "020-600-994-448-068",
                    "141-683-074-439-656",
                    "034-461-427-208-00X",
                    "013-621-572-895-916",
                    "018-385-072-135-339",
                    "120-822-127-937-671",
                    "017-640-080-650-989",
                    "095-622-383-143-992",
                    "092-050-659-074-634",
                    "002-010-068-713-43X",
                    "022-590-916-692-360",
                    "009-507-053-935-564",
                    "023-671-383-084-282",
                    "073-007-095-991-601",
                    "035-596-626-535-729",
                    "017-696-574-305-547",
                    "017-009-482-039-774",
                    "076-921-778-471-668",
                    "002-608-926-300-030",
                    "047-651-486-067-322",
                    "055-833-259-904-765",
                    "005-857-892-715-452",
                    "084-660-300-366-33X",
                    "035-522-277-138-087",
                    "091-916-363-696-037",
                    "007-306-206-076-93X",
                    "083-071-859-057-528"
                ],
                "nplResolvedExternalIDs": [
                    "10.3410/f.725599658.793535757",
                    "10.1371/journal.ppat.1003389",
                    "10.1002/9780471729259.mc15e02s37",
                    "17983973",
                    "pmc4058772",
                    "26355094",
                    "16820183",
                    "10.1177/026119290203000109",
                    "10.1016/j.virol.2015.01.029",
                    "2139267",
                    "pmc4735735",
                    "10.1016/j.vaccine.2012.07.073",
                    "19538115",
                    "pmc4645655",
                    "pmc4301098",
                    "10.1093/infdis/jiv251",
                    "10.1016/j.tmaid.2007.07.004",
                    "23787162",
                    "26018172",
                    "pmc4194190",
                    "pmc3667758",
                    "10.3855/jidc.7278",
                    "25702088",
                    "24896817",
                    "pmc4194189",
                    "26290414",
                    "26132766",
                    "10.1128/jvi.77.23.12782-12794.2003",
                    "9737386",
                    "10.1099/vir.0.80844-0",
                    "pmc224996",
                    "10.1016/s1473-3099(15)00154-1",
                    "10.1016/j.virusres.2005.03.011",
                    "24197535",
                    "24585737",
                    "10.1016/j.vaccine.2014.02.004",
                    "pmc4573558",
                    "pmc3807362",
                    "10.1128/jvi.02308-14",
                    "10.1111/imm.12462",
                    "pmc4557643",
                    "10.1073/pnas.1510830112",
                    "pmc16276",
                    "23824801",
                    "10.1007/978-0-387-33012-9_45",
                    "10.1126/scitranslmed.aac7462",
                    "10.1016/j.jconrel.2004.08.019",
                    "10.1056/nejmc1308698",
                    "19264610",
                    "22884661",
                    "pmc3187516",
                    "10.1111/2049-632x.12166",
                    "pmc4106996",
                    "26015984",
                    "16689655",
                    "25640653",
                    "23737747",
                    "pmc3754068",
                    "15831955",
                    "10.1016/j.virol.2012.07.020",
                    "24736006",
                    "pmc4259179",
                    "10.1056/nejmc1215691",
                    "pmc4525294",
                    "10.1016/j.vaccine.2014.08.086",
                    "17037541",
                    "10.1038/mtm.2014.46",
                    "10.1517/14712598.2015.1092518",
                    "21849459",
                    "15896403",
                    "14610200",
                    "pmc140592",
                    "26218507",
                    "14512539",
                    "10.1128/jvi.00614-15",
                    "10.2807/1560-7917.es2015.20.25.21169",
                    "pmc262580",
                    "10.1128/jvi.77.1.237-244.2003",
                    "26124093",
                    "10.1586/erv.09.19",
                    "10.1056/nejmoa1401505",
                    "pmc3754113",
                    "pmc3977243",
                    "10.1128/jvi.02064-07",
                    "10.1016/j.vaccine.2014.04.016",
                    "10.1016/j.vaccine.2013.09.038",
                    "10.1074/jbc.m407233200",
                    "pmc415842",
                    "pmc2258963",
                    "10.1089/vim.2014.0080",
                    "10.1006/viro.2001.1212",
                    "10.1128/jvi.01277-13",
                    "22889613",
                    "26414077",
                    "pmc3434297",
                    "10.1016/j.virusres.2005.04.004",
                    "pmc3484205",
                    "10.1128/jvi.00558-11",
                    "10.1128/jvi.78.11.5913-5922.2004",
                    "8915502",
                    "pmc4088931",
                    "12477829",
                    "pmc6624136",
                    "25387086",
                    "10.1089/jir.2006.26.271",
                    "10.1128/jvi.01815-15",
                    "23785207",
                    "pmc4507189",
                    "25320306",
                    "10706640",
                    "27807241",
                    "pmc4524222",
                    "26063224",
                    "15544865",
                    "24560617",
                    "pmc4515128",
                    "26248510",
                    "25461234",
                    "10.1016/j.vaccine.2014.08.058",
                    "11878905",
                    "pmc4362357",
                    "11827574",
                    "23075143",
                    "25271615",
                    "15140989",
                    "25271614",
                    "10.1128/jvi.77.20.10889-10899.2003",
                    "10.1016/0042-6822(90)90433-r",
                    "25240756",
                    "15747421",
                    "10.1128/jvi.01048-13",
                    "26344219",
                    "pmc1361274",
                    "pmc3815470",
                    "10.1073/pnas.050589197",
                    "18094153",
                    "16033974",
                    "10.1056/nejmoa1211721",
                    "10.1586/erv.09.43",
                    "10.1038/ncomms8712",
                    "10.1099/vir.0.009704-0",
                    "10.1089/ard.1995.5.115",
                    "pmc3917065",
                    "pmc1576297",
                    "15304515",
                    "10.1016/j.virol.2006.05.010",
                    "10.1016/j.ijid.2014.10.001",
                    "24159666",
                    "10.1073/pnas.97.7.3544",
                    "23550601",
                    "10.1056/nejmc1409847",
                    "22147356",
                    "10.1089/oli.1.1996.6.177",
                    "15885837",
                    "23923992",
                    "7580115",
                    "18634509",
                    "25192975",
                    "10.1038/cmi.2015.03",
                    "10.1099/vir.0.060640-0",
                    "19397417",
                    "pmc4564550",
                    "pmc4786625",
                    "24599590",
                    "24120673",
                    "25762305",
                    "10.1073/pnas.1323279111",
                    "26142661",
                    "10.1128/jvi.02040-16",
                    "10.1099/vir.0.80955-0"
                ]
            },
            {
                "index": "53",
                "publicationKey": "WO_2019_183362_A1",
                "lensId": "032-308-638-643-219",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/183362 A1",
                "publicationDate": "2019-09-26",
                "filingNumber": "US 2019/0023382 W",
                "filingDate": "2019-03-21",
                "priorityFilingKeysActive": [
                    "US 201862646053 P 20180321"
                ],
                "earliestPriorityDate": "2018-03-21",
                "title": "Fc Variant Compositions And Methods Of Use Thereof",
                "applicants": [
                    "DANA FARBER CANCER INST INC"
                ],
                "inventors": [
                    "MARASCO WAYNE A",
                    "ZHU QUAN KAREN",
                    "CHANG MATTHEW R"
                ],
                "owners": [],
                "url": "https://lens.org/032-308-638-643-219",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/395",
                    "A61K45/06",
                    "C07K16/28"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "54",
                "publicationKey": "US_10406222_B2",
                "lensId": "158-487-103-147-986",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10406222 B2",
                "publicationDate": "2019-09-10",
                "filingNumber": "US 201715633589 A",
                "filingDate": "2017-06-26",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome\u2014coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2016-04-11"
                    }
                ],
                "url": "https://lens.org/158-487-103-147-986",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K38/00",
                    "A61K39/00",
                    "A61K39/12",
                    "A61K45/06",
                    "C07K14/165",
                    "C07K16/10",
                    "C12N7/00",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 27,
                "nplCitations": [
                    "Kyratsous CA, Olson W, Stahl N. Reply to Dimitrov et al.: VelociSuite technologies are a foundation for rapid therapeutic antibody development. Proc Natl Acad Sci U S A. Sep. 15, 2015;112(37):E5116. Epub Aug. 28, 2015.",
                    "Dimitrov DS, Jiang S, Ying T, Tseng CT, Zhang L, Yuen KY. No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses. Proc Natl Acad Sci U S A. Sep. 15, 2015;112(37):E5115. doi: 10.1073/pnas.1513441112. Epub Aug. 28, 2015.",
                    "Bowie et al. (1990) Science 247(4948):1306-10 \u201cDeciphering the message in protein sequences: tolerance to amino acid substitutions\u201d.",
                    "Chan et al. (2012) J Infect 65(6):477-489 \u201cIs the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?\u201d",
                    "Corman et al. (2012) Eurosurveillance 17(49) \u201cAssays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections\u201d.",
                    "Corti et al. (2015) PNAS \u201cProphylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus\u201d.",
                    "Coughlin and Prabhakar (2012) Reviews in Medical Virology 22(1):2-17. Epub Sep. 8, 2011. \u201cNeutralizing human momoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential\u201d http://onlinelibrary.wiley.com/doi/10.1002/rmv.706/pdf.",
                    "Du et al. (2013) Journal of Virology 87(17):9939-9942 \u201cIdentification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Develolpment\u201d.",
                    "Du et al. (2013) PLOS ONE 8(12) \u201cA Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits Mers-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines\u201d.",
                    "Gierer et al. (2013) Journal of Virology 87(10):5502-5511 \u201cThe Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies\u201d.",
                    "Jiang et al. (2014) Science Translational Medicine 6(234) \u201cPotent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein\u201d.",
                    "Lu et al. (2013) Nature 500:227-232 \u201cMolecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26\u201d.",
                    "Mou et al. (2013) Journal of Virology 87(16):9379-9383 \u201cThe Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies\u201d.",
                    "Muller et al. (2012) Mbio. 3(6) Pii: e00515-12 \u201cHuman coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines\u201d.",
                    "Murphy et al. (2014) Proc. Natl. Acad. Sci. USA 111(14):5153-5158 \u201cMice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice\u201d.",
                    "Pascal et al. (2015) PNAS 112(28) \u201cPre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection\u201d.",
                    "Raj et al. (2013) Nature 495:251-256 \u201cDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC\u201d.",
                    "SinoBiological.com (Jun. 15, 2012) MERS-Cov (NCoV/Novel coronavirus) Spike Antibody, Mouse Mab. Cat. # 40070-MM04; [Online] Available Website: http://www.sinobiologicalcdn.com/reagent/40070-R723.pdf; Last Update: unknown; Accessed on: Apr. 4, 2017.",
                    "SinoBiological.com (Jun. 15, 2012) MERS-Cov (NCoV/Novel coronavirus) Spike Antibody, Rabbit Mab. Cat. # 40069-R723; [Online] Available Website: http://www.sinobiologicalcdn.com/reagent/40069-R723.pdf; Last Update: unknown; Accessed on Apr. 4, 2017.",
                    "Tang and Marasco (2015) Immunotherapy 7(6):591-594 \u201cHuman neutralizing antibodies against MERS coronavirus: implications for future immunotherapy\u201d.",
                    "Tang et al. (2014) PNAS 111(19):2022-2024 \u201cIdentification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution\u201d.",
                    "Van Boheemen et al. (2012) GenBank Acc. No. AFS88936.1 Dec. 4, 2012 \u201cS protein [Human betacoronavirus 2c EMC/2012]\u201d.",
                    "Van Boheemen et al. (2012) MBio. 3(6):e00473-12 \u201cGenomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans\u201d.",
                    "Ying et al. (2015) Microbes Infect. 17(2):142-8, Epub Nov. 29, 2014 \u201cDevelopment of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV Infections\u201d.",
                    "Ying et al. (2014) Journal of Virology 88(14):7796-7805 \u201cExceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies\u201d.",
                    "Zaki et al. (2012) The New England Journal of Medicine 367(19):1814-1820 \u201cIsolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia\u201d.",
                    "Reusken (2013) The Lancet 13(10); 859-86 \u201cMiddle East Respiratory Syndrome Coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study\u201d doi: 10.1016/S1473-3099(13)70164-6. Epub Aug. 9, 2013."
                ],
                "nplResolvedCount": 24,
                "nplResolvedLensIDs": [
                    "043-796-756-301-37X",
                    "067-540-921-290-283",
                    "027-877-315-782-213",
                    "043-286-403-135-353",
                    "035-760-912-363-624",
                    "067-884-443-627-767",
                    "048-188-266-680-461",
                    "027-359-098-622-423",
                    "025-246-608-570-632",
                    "055-005-586-964-518",
                    "026-513-003-919-117",
                    "023-939-052-489-028",
                    "020-009-029-407-493",
                    "003-376-346-248-551",
                    "145-146-407-738-040",
                    "095-041-202-864-526",
                    "016-741-112-113-368",
                    "073-586-665-992-024",
                    "034-994-634-633-262",
                    "043-148-481-331-661",
                    "073-682-937-516-081",
                    "009-507-053-935-564",
                    "023-671-383-084-282",
                    "079-080-784-051-77X"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3256278",
                    "10.3410/f.725599658.793535757",
                    "pmc4547275",
                    "10.1073/pnas.1513441112",
                    "10.1128/jvi.01277-13",
                    "10.1128/mbio.00473-12",
                    "10.1016/j.jinf.2012.10.002",
                    "pmc3648152",
                    "10.1128/mbio.00515-12",
                    "10.1073/pnas.1513935112",
                    "10.1128/jvi.00128-13",
                    "10.1016/s1473-3099(13)70164-6",
                    "10.1126/science.2315699",
                    "pmc4577199",
                    "pmc3852489",
                    "23785207",
                    "pmc4507189",
                    "24706856",
                    "23831647",
                    "10.2807/ese.17.49.20334-en",
                    "23468491",
                    "pmc4024880",
                    "10.1371/journal.pone.0081587",
                    "10.1128/jvi.00912-14",
                    "pmc3807362",
                    "23170002",
                    "21905149",
                    "26098703",
                    "23486063",
                    "10.1073/pnas.1510830112",
                    "23824801",
                    "23075143",
                    "26318165",
                    "26318164",
                    "26216974",
                    "10.1128/jvi.01048-13",
                    "23231891",
                    "10.1073/pnas.1402074111",
                    "pmc4308519",
                    "10.1056/nejmoa1211721",
                    "2315699",
                    "10.1073/pnas.1510199112",
                    "pmc3754068",
                    "10.1016/j.micinf.2014.11.008",
                    "10.1038/nature12005",
                    "24778221",
                    "pmc4577136",
                    "10.1038/nature12328",
                    "25456101",
                    "24789777",
                    "10.1073/pnas.1324022111",
                    "10.1126/scitranslmed.3008140",
                    "pmc3986188",
                    "10.2217/imt.15.33",
                    "pmc4097770",
                    "24324708",
                    "26124093",
                    "23072791",
                    "23933067",
                    "24778414",
                    "10.1002/rmv.706",
                    "pmc3754113",
                    "23232719"
                ]
            },
            {
                "index": "55",
                "publicationKey": "US_2015_0337029_A1",
                "lensId": "193-479-168-095-776",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2015/0337029 A1",
                "publicationDate": "2015-11-26",
                "filingNumber": "US 201514717760 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome - Coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2016-04-11"
                    }
                ],
                "url": "https://lens.org/193-479-168-095-776",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 13,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/395",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 11,
                "nplCitations": [
                    "Coughlin MM, Prabhakar BS. Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential. Rev Med Virol. 2012 Jan;22(1):2-17. Epub 2011 Sep 8.",
                    "Ying T, Li H, Lu L, Dimitrov DS, Jiang S. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections. Microbes Infect. 2015 Feb;17(2):142-8. Epub 2014 Nov 29.",
                    "MERS-CoV (NCoV / Novel coronavirus) Spike Antibody, Mouse MAb. Cat. #. 40070-MM04. Sino Biological Inc. 06/15/2012.",
                    "van Boheemen S et. al. S protein [Human betacoronavirus 2c EMC/2012]. GenBank Acc. No: AFS88936.1. 12/04/2012.",
                    "van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012 Nov 20;3(6). pii: e00473-12.",
                    "M\u00c3\u00bcller MA, Raj VS, Muth D, Meyer B, Kallies S, Smits SL, Wollny R et. al. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio. 2012 Dec 11;3(6). pii: e00515-12.",
                    "Chan JF, Li KS, To KK, Cheng VC, Chen H, Yuen KY. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect. 2012 Dec;65(6):477-89. Epub 2012 Oct 13.",
                    "Corman VM, M\u00c3\u00bcller MA, Costabel U, Timm J, Binger T, Meyer B, Kreher P, Lattwein E, Eschbach-Bludau M, Nitsche A, Bleicker T, Landt O, Schweiger B, Drexler JF, Osterhaus AD, Haagmans BL, Dittmer U, Bonin F, Wolff T, Drosten C. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012 Dec 6;17(49). pii:",
                    "Bowie JU, Reidhaar-Olson JF, Lim WA, Sauer RT. Deciphering the message in protein sequences: tolerance to amino acid substitutions. Science. 1990 Mar16;247(4948):1306-10.",
                    "MERS-CoV (NCoV / Novel coronavirus) Spike Antibody, Rabbit MAb. Cat. #. 40069-R723. Sino Biological Inc. 06/15/2012. http://www.sinobiologicalcdn.com/reagent/40069-R723.pdf.",
                    "Murphy AJ, et. al. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5153-8."
                ],
                "nplResolvedCount": 8,
                "nplResolvedLensIDs": [
                    "043-796-756-301-37X",
                    "048-188-266-680-461",
                    "027-359-098-622-423",
                    "026-513-003-919-117",
                    "023-939-052-489-028",
                    "095-041-202-864-526",
                    "016-741-112-113-368",
                    "034-994-634-633-262"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3256278",
                    "25456101",
                    "10.1073/pnas.1324022111",
                    "24706856",
                    "10.1128/mbio.00473-12",
                    "10.2807/ese.17.49.20334-en",
                    "pmc3986188",
                    "10.1016/j.jinf.2012.10.002",
                    "23231891",
                    "pmc4308519",
                    "10.1128/mbio.00515-12",
                    "23072791",
                    "23170002",
                    "21905149",
                    "2315699",
                    "10.1002/rmv.706",
                    "23232719",
                    "10.1016/j.micinf.2014.11.008",
                    "10.1126/science.2315699"
                ]
            },
            {
                "index": "56",
                "publicationKey": "US_2017_0157219_A1",
                "lensId": "045-786-744-480-837",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0157219 A1",
                "publicationDate": "2017-06-08",
                "filingNumber": "US 201715429046 A",
                "filingDate": "2017-02-09",
                "priorityFilingKeysActive": [
                    "US 201715429046 A 20170209",
                    "US 201514736170 A 20150610",
                    "US 201514667282 A 20150324",
                    "US 201414316893 A 20140627",
                    "US 201414247723 A 20140408",
                    "US 201662295842 P 20160216",
                    "US 201562147209 P 20150414",
                    "US 201562102671 P 20150113",
                    "US 201462063551 P 20141014",
                    "US 201462040885 P 20140822"
                ],
                "earliestPriorityDate": "2014-04-08",
                "title": "Methods Of Treating Zika Virus, Mers-cov, Chikungunya, Venezuelan Equine Encephalitus, And Rhinovirus In Mammalian Patients",
                "applicants": [
                    "TAMIR BIOTECHNOLOGY INC"
                ],
                "inventors": [
                    "HODGE III THOMAS W"
                ],
                "owners": [
                    {
                        "name": "TAMIR BIOTECHNOLOGY INC",
                        "executionDate": "2017-02-15"
                    }
                ],
                "url": "https://lens.org/045-786-744-480-837",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 1,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/46"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "57",
                "publicationKey": "US_2017_0340728_A1",
                "lensId": "083-658-496-756-065",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0340728 A1",
                "publicationDate": "2017-11-30",
                "filingNumber": "US 201715633589 A",
                "filingDate": "2017-06-26",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome - Coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2016-04-11"
                    }
                ],
                "url": "https://lens.org/083-658-496-756-065",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K38/00",
                    "C07K14/165",
                    "C12N7/00",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "58",
                "publicationKey": "WO_2018_115527_A2",
                "lensId": "015-503-809-635-588",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2018/115527 A2",
                "publicationDate": "2018-06-28",
                "filingNumber": "EP 2017084564 W",
                "filingDate": "2017-12-22",
                "priorityFilingKeysActive": [
                    "EP 2016082669 W 20161223"
                ],
                "earliestPriorityDate": "2016-12-23",
                "title": "Mers Coronavirus Vaccine",
                "applicants": [
                    "CUREVAC AG"
                ],
                "inventors": [
                    "RAUCH SUSANNE"
                ],
                "owners": [],
                "url": "https://lens.org/015-503-809-635-588",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 4756,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 17,
                "nplCitations": [
                    "STEPINSKI ET AL., RNA, vol. 7, no. 10, 2001, pages 1486 - 95",
                    "KORE ET AL., BIOORG. MED. CHEM., vol. 21, no. 15, 2013, pages 4570 - 4",
                    "URRY ET AL.: \"Modern Physical Methods in Biochemistry\", 1985, ELSEVIER, article \"Absorption, Circular Dichroism and ORD of Polypeptides\"",
                    "KARLIN ET AL., PNAS USA, vol. 90, 1993, pages 5873 - 5877",
                    "ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402",
                    "GEALL ET AL., SEMIN. IMMUNOL., vol. 25, no. 2, 2013, pages 152 - 159",
                    "BRUNELLE ET AL., METHODS ENZYMOL., vol. 530, 2013, pages 101 - 14",
                    "AKASHI, CURR. OPIN. GENET. DEV., vol. 11, no. 6, 2001, pages 660 - 666",
                    "CAPUT ET AL., PROC. NATL. ACAD. SCI. USA, vol. 83, 1986, pages 1670 - 1674",
                    "BINDER ET AL., EMBO J., vol. 13, 1994, pages 1969 - 1980",
                    "SEMPLE ET AL., NATURE BIOTECH., vol. 28, 2010, pages 172 - 176",
                    "BASHA ET AL., MOL THER., vol. 19, 2011, pages 2186 - 2200",
                    "INT J NANOMEDICINE, vol. 9, 2014, pages 1833 - 1843",
                    "FRONT PHARMACOL., vol. 6, 1 December 2015 (2015-12-01), pages 286",
                    "LANDEN ET AL., CANCER BIOLOGY & THERAPY, vol. 5, no. 12, 2006, pages 1708 - 1713",
                    "ADV DRUG DELIV REV., vol. 66, February 2014 (2014-02-01), pages 110 - 116",
                    "LOVE ET AL., PNAS, vol. 107, no. 5, 2010, pages 1864 - 1869"
                ],
                "nplResolvedCount": 10,
                "nplResolvedLensIDs": [
                    "005-784-007-379-413",
                    "019-779-601-634-917",
                    "114-655-611-675-834",
                    "069-994-674-145-394",
                    "117-773-259-938-012",
                    "020-667-110-629-952",
                    "179-474-415-281-518",
                    "021-258-833-896-500",
                    "028-862-168-091-90X",
                    "095-536-434-459-399"
                ],
                "nplResolvedExternalIDs": [
                    "9254694",
                    "10.1038/mt.2011.190",
                    "pmc46825",
                    "10.1016/s0959-437x(00)00250-1",
                    "23777824",
                    "pmc3242662",
                    "10.1016/j.bmc.2013.05.041",
                    "10.1016/b978-0-12-420037-1.00005-1",
                    "10.1073/pnas.90.12.5873",
                    "10.1073/pnas.83.6.1670",
                    "24034317",
                    "pmc1370192",
                    "10.1002/j.1460-2075.1994.tb06466.x",
                    "21971424",
                    "17106249",
                    "2419912",
                    "pmc395039",
                    "7909515",
                    "11680853",
                    "10.4161/cbt.5.12.3468",
                    "10.1093/nar/25.17.3389",
                    "pmc323145",
                    "8390686",
                    "11682310",
                    "pmc146917"
                ]
            },
            {
                "index": "59",
                "publicationKey": "US_2019_0351048_A1",
                "lensId": "075-391-010-665-180",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0351048 A1",
                "publicationDate": "2019-11-21",
                "filingNumber": "US 201716471539 A",
                "filingDate": "2017-12-22",
                "priorityFilingKeysActive": [
                    "EP 2016082669 W 20161223"
                ],
                "earliestPriorityDate": "2016-12-23",
                "title": "Mers Coronavirus Vaccine",
                "applicants": [
                    "CUREVAC AG"
                ],
                "inventors": [
                    "RAUCH SUSANNE"
                ],
                "owners": [
                    {
                        "name": "CUREVAC AG",
                        "executionDate": "2019-10-01"
                    }
                ],
                "url": "https://lens.org/075-391-010-665-180",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 2378,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "C07K14/165",
                    "C12N15/86"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "60",
                "publicationKey": "WO_2017_205460_A1",
                "lensId": "077-848-145-856-574",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/205460 A1",
                "publicationDate": "2017-11-30",
                "filingNumber": "US 2017/0034164 W",
                "filingDate": "2017-05-24",
                "priorityFilingKeysActive": [
                    "US 201662340624 P 20160524"
                ],
                "earliestPriorityDate": "2016-05-24",
                "title": "Metabalomics And Viral Diagnostics Suite",
                "applicants": [
                    "EXCISION BIOTHERAPEUTICS INC"
                ],
                "inventors": [
                    "MALCOLM THOMAS"
                ],
                "owners": [],
                "url": "https://lens.org/077-848-145-856-574",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 7,
                "familySize": 7,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "G01N33/573",
                    "G01N33/574"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "WHITE ET AL.: \"The CRISPR/Cas9 genome editing methodology as a weapon against human viruses\", DISCOV MED., vol. 19, no. 105, April 2015 (2015-04-01), pages 255 - 262, XP055335246",
                    "BALZARINI ET AL.: \"Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir\", ANTIVIR CHEM CHEMOTHER., vol. 12, no. 5, September 2001 (2001-09-01), pages 301 - 306, XP055440976",
                    "ZHANG ET AL.: \"Urinary Metabolic Biomarker and Pathway Study of Hepatitis B Virus Infected Patients Based on UPLC-MS System\", METABOLIC BIOMARKER AND PATHWAY STUDY OF HBV. PLOS ONE, vol. 8, no. 5, May 2013 (2013-05-01), pages 1 - 8, XP055440978, Retrieved from the Internet <URL:www.plosone.org>"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "166-982-863-126-49X",
                    "035-513-653-697-292",
                    "004-058-602-303-760"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3655955",
                    "25977188",
                    "10.1371/journal.pone.0064381",
                    "11900349",
                    "10.1177/095632020101200505",
                    "pmc4445958",
                    "23696887"
                ]
            },
            {
                "index": "61",
                "publicationKey": "WO_2018_145075_A1",
                "lensId": "120-812-090-506-157",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/145075 A1",
                "publicationDate": "2018-08-09",
                "filingNumber": "US 2018/0017027 W",
                "filingDate": "2018-02-06",
                "priorityFilingKeysActive": [
                    "US 201762455245 P 20170206"
                ],
                "earliestPriorityDate": "2017-02-06",
                "title": "Compositions And Methods For Augmenting Antibody Mediated Receptor Signaling",
                "applicants": [
                    "DANA FARBER CANCER INST INC"
                ],
                "inventors": [
                    "MARASCO WAYNE A",
                    "ZHU QUAN KAREN"
                ],
                "owners": [],
                "url": "https://lens.org/120-812-090-506-157",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 5,
                "familySize": 5,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/42",
                    "A61K39/395"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "LIU ET AL.: \"Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies\", JOURNAL BIOL CHEM, vol. 289, no. 6, 7 February 2014 (2014-02-07), pages 3571 - 3590, XP055170896"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "086-009-917-433-387"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3916558",
                    "24311787",
                    "10.1074/jbc.m113.513366"
                ]
            },
            {
                "index": "62",
                "publicationKey": "WO_2019_135003_A1",
                "lensId": "196-818-672-803-21X",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/135003 A1",
                "publicationDate": "2019-07-11",
                "filingNumber": "EP 2019050266 W",
                "filingDate": "2019-01-07",
                "priorityFilingKeysActive": [
                    "GB 201800274 A 20180108"
                ],
                "earliestPriorityDate": "2018-01-08",
                "title": "Peptides Having Protease Activity For Use In The Treatment Or Prevention Of Coronavirus Infection",
                "applicants": [
                    "ENZYMATICA AB"
                ],
                "inventors": [
                    "GU\u00d0MUNDSD\u00d3TTIR \u00c1G\u00daSTA",
                    "STEF\u00c1NSSON BJARKI",
                    "SANDHOLT GUNNAR BIRGIR"
                ],
                "owners": [],
                "url": "https://lens.org/196-818-672-803-21X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 23,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/48",
                    "A61K9/00",
                    "A61K9/20",
                    "A61K9/68",
                    "A61K31/407",
                    "A61K31/43",
                    "A61K31/47",
                    "A61K31/545",
                    "A61K31/7036",
                    "A61K31/7048",
                    "A61K38/06",
                    "A61K47/10",
                    "A61P11/00",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 66,
                "nplCitations": [
                    "SZELAZEK BOZENA ET AL: \"Structural Characterization of Human Coronavirus NL63 N Protein.\", JOURNAL OF VIROLOGY 01 06 2017, vol. 91, no. 11, 1 June 2017 (2017-06-01), XP009512578, ISSN: 1098-5514",
                    "BERTRAM STEPHANIE ET AL: \"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.\", JOURNAL OF VIROLOGY DEC 2011, vol. 85, no. 24, December 2011 (2011-12-01), pages 13363 - 13372, XP009512575, ISSN: 1098-5514",
                    "GRALINSKI; BARIC, J. PATHOL., vol. 235, 2015, pages 185 - 195",
                    "CAVANAGH: \"Coronaviruses with Special Emphasis on First Insights Concerning SARS 1\", 2005, BIRKHAUSER VERLAG BASEL, article \"Coronaviridae: a review of coronaviruses and toroviruses\"",
                    "STEFANSSON ET AL., COMPARATIVE BIOCHEM. PHYSIOL: PART B - BIOCHEM. & MOI. BIOL., vol. 155, no. 2, 2010, pages 186 - 194",
                    "ASGEIRSSON ET AL., EUR. J. BIOCHEM., vol. 180, 1989, pages 85 - 94",
                    "\"GenBank\", Database accession no. AC090397",
                    "STEFANSSON ET AL., COMP. BIOCHEM. PHYSIOL. B, BIOCHEM. MOL. BIOL., vol. 155, no. 2, 2010, pages 186 - 194",
                    "ASGEIRSSON; BJARNASON, COMP. BIOCHEM. PHYSIOL. B, vol. 998, 1991, pages 327 - 335",
                    "\"GenBank\", Database accession no. CAA55242.1",
                    "GU6MUNDSD6FTIR ET AL., EUR J BIOCHEM., vol. 217, no. 3, 1993, pages 1091 - 7",
                    "STEFANSSON, COMP. BIOCHEM. PHYSIOL. B, BIOCHEM. MOL. BIOL., vol. 155, no. 2, 2010, pages 186 - 194",
                    "STEFANSSON ET AL., BIOCHIM BIOPHYS ACTA., vol. 1865, no. 1, 2017, pages 11 - 19",
                    "GUDMUNDSDOTTIR, FOOD CHEM., vol. 111, no. 2, 2008, pages 408 - 14",
                    "ASGEIRSSON, EUR. J. BIOCHEM., vol. 180, 1989, pages 85 - 94",
                    "\"Genbank\", Database accession no. AC090397.1",
                    "\"Genbank\", Database accession no. AOX15769.1",
                    "\"Genbank\", Database accession no. AOX15770.1",
                    "\"Genbank\", Database accession no. AOX15771.1",
                    "\"Genbank\", Database accession no. CAD30563.1",
                    "STEFANSSON ET AL., COMP BIOCHEM PHYSIOL B BIOCHEM MOL BIOL., vol. 155, no. 2, 2010, pages 186 - 94",
                    "GREEN; SAMBROOK: \"Molecular Cloning: a Laboratory Manua\", 2012, COLD SPRING HARBOR LABORATORY PRESS",
                    "THOMPSON ET AL., NUC. ACID RES., vol. 22, 1994, pages 4673 - 4680",
                    "MEZIERE ET AL., J. IMMUNOL., vol. 159, 1997, pages 3230 - 3237",
                    "VEBER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 75, 1978, pages 2636",
                    "THORSETT, BIOCHEM. BIOPHYS. RES. COMM., vol. 111, 1983, pages 166",
                    "GREEN; SAMBROOK: \"Molecular Cloning, A Laboratory Manual\", 2012, COLD SPRING HARBOR",
                    "\"Remington's Pharmaceutical Sciences\", 1990, MACK PUBLISHING COMPANY",
                    "\"handbook of Pharmaceutical Excipients\", 2000, PHARMACEUTICAL PRESS",
                    "ASGEIRSSON, B.; P. CEKAN: \"Microscopic rate-constants for substrate binding and acylation in cold-adaptation of trypsin I from Atlantic cod\", FEBS LETT, vol. 580, no. 19, 2006, pages 4639 - 4644, XP028061322, DOI: doi:10.1016/j.febslet.2006.07.043",
                    "ASGEIRSSON, B.; J. W. FOX; J. B. BJARNASON: \"Purification and characterization of trypsin from the poikilotherm Gadus morhua\", EUR J BIOCHEM, vol. 180, no. 1, 1989, pages 85 - 94, XP001105360, DOI: doi:10.1111/j.1432-1033.1989.tb14618.x",
                    "ASGEIRSSON; BJARNASON: \"Structural and kinetic properties of chymotrypsin from Atlantic cod (Gadus morhua). Comparison with bovine chymotrypsin\", COMP. BIOCHEM. PHYSIOL. B, vol. 998, 1991, pages 327 - 335, XP025794920, DOI: doi:10.1016/0305-0491(91)90050-N",
                    "BACHOFEN, C.; B. BOLLINGER; E. PETERHANS; H. STALDER; M. SCHWEIZER: \"Diagnostic gap in Bovine viral diarrhea virus serology during the periparturient period in cattle\", J VET DIAON INVEST, vol. 25, no. 5, 2013, pages 655 - 661",
                    "BELOUZARD, S.; J. K. MILLET; B. N. LICITRA; G. R. WHITTAKER: \"Mechanisms of coronavirus cell entry mediated by the viral spike protein\", VIRUSES, vol. 4, no. 6, 2012, pages 1011 - 1033",
                    "BRADBURNE, A. F.; M. L. BYNOE; D. A. TYRRELL: \"Effects of a ''new'' human respiratory virus in volunteers\", BR MED J, vol. 3, no. 5568, 1967, pages 767 - 769",
                    "FEHR, A. R.; S. PERLMAN: \"Coronaviruses: an overview of their replication and pathogenesis\", METHODS MOL BIOL, vol. 1282, 2015, pages 1 - 23",
                    "FORNBACKE, M.; M. CLARSUND: \"Cold-adapted proteases as an emerging class of therapeutics\", INFECT DIS THER, vol. 2, no. 1, 2013, pages 15 - 26, XP055249597, DOI: doi:10.1007/s40121-013-0002-x",
                    "GALLAHER, W. R.; R. F. GARRY: \"Modeling of the Ebola virus delta peptide reveals a potential lytic sequence motif\", VIRUSES, vol. 7, no. 1, 2015, pages 285 - 305",
                    "GRAHAM, R. L.; R. S. BARIC: \"Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission\", J VIROL, vol. 84, no. 7, 2010, pages 3134 - 3146",
                    "GRALINSKI, L. E.; R. S. BARIC: \"Molecular pathology of emerging coronavirus infections\", J PATHOL, vol. 235, no. 2, 2015, pages 185 - 195",
                    "GREEN; SAMBROOK: \"Molecular Cloning: a Laboratory Manual\", 2012, COLD SPRING HARBOR LABORATORY PRESS",
                    "GUDMUNDSDOTTIR, A.; E. GUDMUNDSDOTTIR; S. OSKARSSON; B. BJARNASON; A. K. EAKIN; C. S. CRAIK: \"Isolation and characterization of cDNAs from Atlantic cod encoding two different forms of trypsinogen\", EUR J BIOCHEM, vol. 217, no. 3, 1993, pages 1091 - 1097, XP055200930, DOI: doi:10.1111/j.1432-1033.1993.tb18341.x",
                    "GUDMUNDSDOTTIR, A.; H. HILMARSSON; B. STEFANSSON: \"Potential use of Atlantic cod trypsin in biomedicine\", BIOMED RES INT, 2013, pages 749078",
                    "HEIKKINEN, T.; A. JARVINEN: \"The common cold\", LANCET, vol. 361, no. 9351, 2003, pages 51 - 59, XP004772755, DOI: doi:10.1016/S0140-6736(03)12162-9",
                    "HULL, D.; P. RENNIE; A. NORONHA; C. POORE; N. HARRINGTON; V. FEARNLEY; D. PASSALI: \"Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of common cold\", ACTA OTORHINOLARVNQOL ITAL, vol. 27, no. 2, 2007, pages 73 - 77",
                    "JIANG, J.; W. CUN; X. WU; Q. SHI; H. TANG; G. LUO: \"Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate\", J VIROL, vol. 86, no. 13, 2012, pages 7256 - 7267",
                    "JONSDOTTIR, H. R.; R. DIJKMAN: \"Coronaviruses and the human airway: a universal system for virus-host interaction studies\", VIROLOGY JOURNAL, vol. 13, no. 1, 2016, pages 24",
                    "KARBER, G.: \"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche\", NAUNVN-SCHMIEDEBERA'S ARCHIVES OF PHARMACOLOGY, vol. 162, no. 4, 1931, pages 480 - 483",
                    "KRAAIJEVELD, C. A.; S. E. REED; M. R. MACNAUGHTON: \"Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E\", J CLIN MICROBIOL, vol. 12, no. 4, 1980, pages 493 - 497",
                    "LIM, X. Y.; L. Y. NG; P. J. TAM; X. D. LIU: \"Human Coronaviruses: A Review of Virus-Host Interactions\", DISEASES, vol. 4, no. 3, 2016",
                    "LO, Y. S.; S. Y. LIN; S. M. WANG; C. T. WANG; Y. L. CHIU; T. H. HUANG; M. H. HOU: \"Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein\", FEBS LETT, vol. 587, no. 2, 2013, pages 120 - 127, XP028975221, DOI: doi:10.1016/j.febslet.2012.11.016",
                    "MACKAY, I. M.; K. E. ARDEN: \"MERS coronavirus: diagnostics, epidemiology and transmission\", VIROL J, vol. 12, 2015, pages 222",
                    "MEZIERE ET AL.: \"In vivo T helper cell response to retro-inverso peptidomimetics\", J. IMMUNOL., vol. 159, 1997, pages 3230 - 3237",
                    "PARK, J. E.; K. LI; A. BARLAN; A. R. FEHR; S. PERLMAN; P. B. MCCRAY, JR.; T. GALLAGHER: \"Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism\", PROC NATL ACAD SCI U S A, vol. 113, no. 43, 2016, pages 12262 - 12267",
                    "SOKALINGAM, S.; G. RAGHUNATHAN; N. SOUNDRARAJAN; G. LEE: \"A study on the effect of surface lysine to arginine mutagenesis on protein stability and structure using green fluorescent protein\", PLOS ONE, vol. 7, no. 7, 2012, pages e40410, XP055215573, DOI: doi:10.1371/journal.pone.0040410",
                    "SPILLIAERT, R.; A. GUDMUNDSDOTTIR: \"Atlantic Cod Trypsin Y-Member of a Novel Trypsin Group\", MAR BIOTECHNOL (NY), vol. 1, no. 6, 1999, pages 598 - 607, XP009187291, DOI: doi:10.1007/PL00011815",
                    "STEFANSSON, B.; L. HELGADOTTIR; S. OLAFSDOTTIR; A. GUDMUNDSDOTTIR; J. B. BJARNASON: \"Characterization of cold-adapted Atlantic cod (Gadus morhua) trypsin I--kinetic parameters, autolysis and thermal stability\", COMP BIOCHEM PHYSIOL B BIOCHEM MOL BIOL, vol. 155, no. 2, 2010, pages 186 - 194, XP026805399",
                    "STEFANSSON, B.; G. B. SANDHOLT; A. GUDMUNDSDOTTIR: \"Elucidation of different cold-adapted Atlantic cod (Gadus morhua) trypsin X isoenzymes\", BIOCHIM BIOPHVS ACTA, vol. 1865, no. 1, 2017, pages 11 - 19, XP029823711, DOI: doi:10.1016/j.bbapap.2016.10.005",
                    "SUZUKI, T.; Y. ORBA; Y. OKADA; Y. SUNDEN; T. KIMURA; S. TANAKA; K. NAGASHIMA; W. W. HALL; H. SAWA: \"The human polyoma JC virus agnoprotein acts as a viroporin\", PLOS PATHOQ, vol. 6, no. 3, 2010, pages e1000801, XP055030303, DOI: doi:10.1371/journal.ppat.1000801",
                    "THOMPSON ET AL.: \"CLUSTAL W.- improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice\", NUC. ACID RES., vol. 22, 1994, pages 4673 - 4680, XP002956304",
                    "THORSETT ET AL.: \"Dipeptide mimics. Conformationally restricted inhibitors of angiotensin-converting enzyme\", BIOCHEM. BIOPHYS. RES. COMM., vol. 111, 1983, pages 166",
                    "VAN DEN WORM, S. H.; K. K. ERIKSSON; J. C. ZEVENHOVEN; F. WEBER; R. ZUST; T. KURI; R. DIJKMAN; G. CHANG; S. G. SIDDELL; E. J. SNIJ: \"Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination\", PLOS ONE, vol. 7, no. 3, 2012, pages e32857",
                    "VEBER ET AL.: \"Conformationally restricted bicyclic analogs of somatostatin\", PROC. NATL. ACAD. SCI. USA, vol. 75, 1978, pages 2636",
                    "WENTWORTH, D. E.; K. V. HOLMES: \"Molecular Determinants of Species Specificity in the Coronavirus Receptor Aminopeptidase N (CD13): Influence of N-Linked Glycosylation\", J VIROL, vol. 75, no. 20, 2001, pages 9741 - 9752",
                    "\"Emergencies preparedness, response\", 2 February 2017, WHO",
                    "\"Handbook of Pharmaceutical Excipients\", 2000, PHARMACEUTICAL PRESS"
                ],
                "nplResolvedCount": 39,
                "nplResolvedLensIDs": [
                    "057-617-477-665-56X",
                    "032-633-432-127-883",
                    "143-637-150-196-867",
                    "067-532-215-506-788",
                    "161-942-130-898-961",
                    "017-851-353-982-04X",
                    "048-846-919-926-759",
                    "031-351-858-715-648",
                    "026-138-206-058-685",
                    "021-198-619-647-595",
                    "015-612-844-356-616",
                    "074-662-924-798-380",
                    "033-934-211-822-909",
                    "057-513-762-851-111",
                    "113-776-925-274-042",
                    "034-833-383-609-032",
                    "075-063-539-295-009",
                    "045-663-293-601-301",
                    "108-122-357-047-04X",
                    "029-666-470-349-041",
                    "058-162-564-855-431",
                    "039-999-294-190-112",
                    "024-131-624-258-052",
                    "050-493-438-089-604",
                    "084-421-794-573-313",
                    "039-676-361-532-623",
                    "058-574-297-802-044",
                    "133-941-163-537-695",
                    "048-900-900-160-102",
                    "090-394-117-460-967",
                    "082-697-398-764-817",
                    "072-136-312-024-533",
                    "043-583-211-795-307",
                    "043-145-118-781-736",
                    "111-490-138-888-022",
                    "000-665-541-106-905",
                    "147-663-448-487-24X",
                    "059-057-550-173-191",
                    "037-018-560-207-842"
                ],
                "nplResolvedExternalIDs": [
                    "10.1073/pnas.75.6.2636",
                    "28933406",
                    "10.1016/s0006-291x(83)80131-4",
                    "11559807",
                    "10.1128/jvi.02503-16",
                    "10.1093/nar/22.22.4673",
                    "10.1073/pnas.1608147113",
                    "10.1177/1040638713501172",
                    "17608134",
                    "26047443",
                    "10.1016/j.foodchem.2008.04.005",
                    "pmc4306839",
                    "10.1007/3-7643-7339-3_1",
                    "10.1007/bf01863914",
                    "21994442",
                    "pmc4687373",
                    "22816037",
                    "10.1016/j.febslet.2006.07.043",
                    "10.1128/jcm.12.4.493-497.1980",
                    "pmc2640010",
                    "24029404",
                    "26695637",
                    "10.1016/j.febslet.2012.11.016",
                    "10.1007/s40121-013-0002-x",
                    "pmc1843247",
                    "pmc114546",
                    "10.1016/0305-0491(91)90050-n",
                    "pmc3392243",
                    "pmc5456285",
                    "pmc3233180",
                    "10.1128/jvi.75.20.9741-9752.2001",
                    "10.3390/diseases4030026",
                    "10.1128/jvi.05300-11",
                    "20300659",
                    "19913635",
                    "pmc2838128",
                    "22792305",
                    "25270030",
                    "10.1111/j.1432-1033.1993.tb18341.x",
                    "10.1136/bmj.3.5568.767",
                    "10.1371/journal.ppat.1000801",
                    "pmc3416335",
                    "10.1371/journal.pone.0032857",
                    "10.1002/path.4454",
                    "23178926",
                    "10.3390/v4061011",
                    "12517470",
                    "10.1016/j.bbapap.2016.10.005",
                    "pmc2837404",
                    "26852031",
                    "27742554",
                    "10.1155/2013/749078",
                    "pmc4744394",
                    "1764912",
                    "10.1186/s12985-016-0479-5",
                    "pmc392617",
                    "10.1007/978-1-4939-2438-7_1",
                    "25609303",
                    "7984417",
                    "10.1186/s12985-015-0439-5",
                    "23555095",
                    "10.3390/v7010285",
                    "pmc3296753",
                    "pmc308517",
                    "pmc4108096",
                    "28331093",
                    "6252244",
                    "10.1007/pl00011815",
                    "22412934",
                    "pmc4369385",
                    "16879823",
                    "10.1016/j.cbpb.2009.11.004",
                    "pmc273622",
                    "9317121",
                    "208068",
                    "pmc3397359",
                    "pmc4267971",
                    "25135820",
                    "10.1016/s0140-6736(03)12162-9",
                    "10.1111/j.1432-1033.1989.tb14618.x",
                    "10.1371/journal.pone.0040410",
                    "10612685",
                    "27791014",
                    "10.1128/jvi.07222-11",
                    "6043624",
                    "22532692",
                    "25720466",
                    "6299286",
                    "2707266",
                    "10.1128/jvi.01394-09",
                    "pmc3600245",
                    "8223632",
                    "19906932"
                ]
            },
            {
                "index": "63",
                "publicationKey": "WO_2018_160977_A1",
                "lensId": "125-530-271-842-025",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/160977 A1",
                "publicationDate": "2018-09-07",
                "filingNumber": "US 2018/0020678 W",
                "filingDate": "2018-03-02",
                "priorityFilingKeysActive": [
                    "US 201762466779 P 20170303"
                ],
                "earliestPriorityDate": "2017-03-03",
                "title": "Coronaviruses, Vaccines Comprising The Same, And Methods For Preventing Disease",
                "applicants": [
                    "LOYOLA UNIV CHICAGO"
                ],
                "inventors": [
                    "BAKER SUSAN",
                    "DENG XUFANG",
                    "HACKBART MATTHEW",
                    "METTELMAN ROBERT",
                    "MIELECH ANNA",
                    "O'BRIEN AMORNRAT",
                    "FAABERG KAY",
                    "LAGER KELLY MILTON"
                ],
                "owners": [],
                "url": "https://lens.org/125-530-271-842-025",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N7/00",
                    "A61K39/00",
                    "A61K39/215",
                    "C12N9/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "KANG, H. ET AL.: \"Biochemical and genetic analyses of murine hepatitis virus Nsp15 endoribonuclease\", JOURNAL OF VIROLOGY, vol. 81, no. 24, December 2007 (2007-12-01), pages 13587 - 13597, XP055569173",
                    "ATHMER, J. ET AL.: \"4 and\", MBIO, vol. 8, no. 1, 31 January 2017 (2017-01-31), pages 1 - 14, XP055569198",
                    "DENG, X. ET AL.: \"Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 114, no. 21, pages E4251 - E4260, XP055569217"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "016-304-870-832-876",
                    "033-307-697-300-525"
                ],
                "nplResolvedExternalIDs": [
                    "17898055",
                    "pmc2168834",
                    "28484023",
                    "10.1128/jvi.00547-07",
                    "10.1073/pnas.1618310114"
                ]
            },
            {
                "index": "64",
                "publicationKey": "US_2018_0333482_A1",
                "lensId": "052-906-398-451-415",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0333482 A1",
                "publicationDate": "2018-11-22",
                "filingNumber": "US 201815910617 A",
                "filingDate": "2018-03-02",
                "priorityFilingKeysActive": [
                    "US 201762466779 P 20170303"
                ],
                "earliestPriorityDate": "2017-03-03",
                "title": "Coronaviruses, Vaccines Comprising The Same, And Methods For Preventing Disease",
                "applicants": [
                    "LOYOLA UNIV CHICAGO"
                ],
                "inventors": [
                    "BAKER SUSAN",
                    "DENG XUFANG",
                    "HACKBART MATTHEW",
                    "METTELMAN ROBERT",
                    "MIELECH ANNA",
                    "O'BRIEN AMORNRAT",
                    "FAABERG KAY",
                    "LAGER KELLY MILTON"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE",
                        "executionDate": "2018-07-09"
                    },
                    {
                        "name": "LOYOLA UNIVERSITY CHICAGO",
                        "executionDate": "2018-04-06"
                    }
                ],
                "url": "https://lens.org/052-906-398-451-415",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 15,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "65",
                "publicationKey": "US_2019_0307722_A1",
                "lensId": "052-547-072-220-471",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0307722 A1",
                "publicationDate": "2019-10-10",
                "filingNumber": "US 201716340346 A",
                "filingDate": "2017-10-20",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "Antiviral Compositions For The Treatment Of Infections Linked To Coronaviruses",
                "applicants": [
                    "UNIV CLAUDE BERNARD LYON",
                    "INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE INSERM",
                    "CENTRE NAT RECH SCIENT"
                ],
                "inventors": [
                    "ROSA-CALATRAVA MANUEL",
                    "TERRIER OLIVIER",
                    "PROUST ANA\u00cfS",
                    "MOULES VINCENT"
                ],
                "owners": [
                    {
                        "name": "CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)",
                        "executionDate": "2019-07-19"
                    },
                    {
                        "name": "INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM}",
                        "executionDate": "2019-07-19"
                    },
                    {
                        "name": "UNIVERSITE CLAUDE BERNARD LYON 1",
                        "executionDate": "2019-07-19"
                    }
                ],
                "url": "https://lens.org/052-547-072-220-471",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/353",
                    "A61K9/00",
                    "A61K31/35",
                    "A61K31/4375",
                    "A61K31/7056",
                    "A61K38/21",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "66",
                "publicationKey": "WO_2017_085692_A1",
                "lensId": "112-852-812-241-32X",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/085692 A1",
                "publicationDate": "2017-05-26",
                "filingNumber": "IB 2016056981 W",
                "filingDate": "2016-11-18",
                "priorityFilingKeysActive": [
                    "US 201562256868 P 20151118"
                ],
                "earliestPriorityDate": "2015-11-18",
                "title": "Pharmaceutical Compositions Of Ribavirin",
                "applicants": [
                    "GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD",
                    "LIQUIDIA TECH INC"
                ],
                "inventors": [
                    "DELL'ORCO PHILIP CHARLES",
                    "FARRER BRIAN T",
                    "HONG ZHI",
                    "ROBERTS CHRISTOPHER D",
                    "SAVAGE JOHN ROBERT",
                    "SPRAGUE JACOB J",
                    "WANG YONGCAI"
                ],
                "owners": [],
                "url": "https://lens.org/112-852-812-241-32X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 10,
                "familySize": 10,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K9/14",
                    "A61K9/50",
                    "A61K31/7056"
                ],
                "usClassifications": [],
                "nplCitationCount": 7,
                "nplCitations": [
                    "KURAI ET AL.: \"Virus-Induced exacerbations in asthma and COPD\", FRONT. MICROBIOL., vol. 4, 2013, pages 293",
                    "VENTURA, F. ET AL.: \"Is the use of ribavirin aerosols in respiratory syncytial virus infections justified? Clinical and economic evaluation\", ARCH PEDIATR., vol. 5, no. 2, February 1998 (1998-02-01), pages 123 - 31",
                    "WALSH, B. ET AL.: \"Characterization of Ribavirin Aerosol With Small Particle Aerosol Generator and Vibrating Mesh Micropump Aerosol Technologies\", RESPIR CARE, vol. 61, 2016, pages 577 - 585",
                    "WITKOWSKI J.T ET AL.: \"Design, synthesis, and broad spectrum antiviral activity of 1 -?-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides\", J. MED. CHEM., vol. 15, no. 11, November 1972 (1972-11-01), pages 1150 - 1154",
                    "ROLLAND J. ET AL.: \"Direct Fabrication and Harvesting of Monodisperse, Shape-Specific Nanobiomaterials\", J. AM. CHEM. SOC., vol. 127, 2005, pages 10096 - 10100",
                    "PRUSINER, P. ET AL.: \"The crystal and molecular structures of two polymorphic crystalline forms of virazole (1-?-D-ribofuranosyl-1,2,4-triazole-3-carboxamide). A new synthetic broad spectrum antiviral agent\", ACTA CRYST., vol. B32, 1976, pages 419 - 426",
                    "\"British Pharmacopaeia\", APPENDIX XVII C, 1988, pages A204 - 207"
                ],
                "nplResolvedCount": 6,
                "nplResolvedLensIDs": [
                    "014-554-401-161-757",
                    "063-034-014-553-003",
                    "096-151-652-277-998",
                    "099-378-176-297-386",
                    "086-255-221-244-215",
                    "005-607-300-043-831"
                ],
                "nplResolvedExternalIDs": [
                    "24098299",
                    "10.1021/jm00281a014",
                    "10.1107/s0567740876003154",
                    "10223131",
                    "10.4187/respcare.04383",
                    "10.3389/fmicb.2013.00293",
                    "10.1021/ja051977c",
                    "16011375",
                    "10.1016/s0929-693x(97)86824-8",
                    "pmc3787546",
                    "4347550",
                    "26932383"
                ]
            },
            {
                "index": "67",
                "publicationKey": "US_9460268_B2",
                "lensId": "102-288-835-385-29X",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9460268 B2",
                "publicationDate": "2016-10-04",
                "filingNumber": "US 201414479245 A",
                "filingDate": "2014-09-05",
                "priorityFilingKeysActive": [
                    "US 201361874976 P 20130906",
                    "US 201361885462 P 20131001",
                    "US 201462001039 P 20140520",
                    "US 201462001053 P 20140521",
                    "US 201462010382 P 20140610"
                ],
                "earliestPriorityDate": "2013-09-06",
                "title": "Systems And Methods For Detecting Infectious Diseases",
                "applicants": [
                    "THERANOS INC"
                ],
                "inventors": [
                    "HOLMES ELIZABETH A",
                    "BELHOCINE KAMILA",
                    "LEE JOSEPHINE",
                    "PATEL PRANAV",
                    "RICHARDSON AARON",
                    "TABAKMAN SCOTT"
                ],
                "owners": [
                    {
                        "name": "THERANOS IP COMPANY LLC",
                        "executionDate": "2017-12-11"
                    },
                    {
                        "name": "THERANOS INC",
                        "executionDate": "2015-09-28"
                    }
                ],
                "url": "https://lens.org/102-288-835-385-29X",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 26,
                "familySize": 47,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "G06F19/00",
                    "C12Q1/68",
                    "C12Q1/70",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 36,
                "nplCitations": [
                    "Hung IF, To KK, Lee CK, Lin CK, Chan JF, Tse H, Cheng VC, Chen H, Ho PL, Tse CW, Ng TK, Que TL, Chan KH, Yuen KY. Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin Infect Dis. Aug. 1, 2010;51(3):274-9.",
                    "Zimmerman O, Rogowski O, Aviram G, Mizrahi M, Zeltser D, Justo D, Dahan E, Arad R, Touvia O, Tau L, Tarabeia J, Berliner S, Paran Y. C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infect Dis. Oct. 4, 2010;10:288.",
                    "AppliedBiosystems StepOne(TM) Real-Time PCR System Manual, Rev. 2010.",
                    "Li P. (2012) Microfluidics for IVD: In Pursuit of the Holy Grail. J Bioengineer & Biomedical Sci S8:e001.",
                    "Dapat IC, Dapat C, Baranovich T, Suzuki Y, Kondo H, Shobugawa Y, Saito R, Suzuki H; Japanese Influenza Collaborative Study Group. Genetic characterization of human influenza viruses in the pandemic (2009-2010) and post-pandemic (2010-2011) periods in Japan. PLoS One. 2012;7(6):e36455.Epub Jun. 27, 2012.",
                    "Luk FO, Chan CK, Lai TY. A case of dengue maculopathy with spontaneous recovery. Case Rep Ophthalmol. Jun. 8, 2013;4(2):28-33. Print May 2013.",
                    "Sahni AK, Grover N, Sharma A, Khan ID, Kishore J. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) for diagnosis of dengue. Med J Armed Forces India. Jul. 2013;69(3):246-53. doi: 10.1016/j.mjafi.2012.07.017. Epub Dec. 1, 2012.",
                    "Rodriguez-Sanchez B, et. al. Improved diagnosis for nine viral diseases considered as notifiable by the world organization for animal health. Transbound Emerg Dis. Aug. 2008;55(5-6):215-25.",
                    "Gill P, Ghaemi A. Nucleic acid isothermal amplification technologies: a review. Nucleosides Nucleotides Nucleic Acids. Mar. 2008;27(3):224-43.",
                    "Roskos K, Hickerson AI, Lu HW, Ferguson TM, Shinde DN, Klaue Y, Niemz A. Simple system for isothermal DNA amplification coupled to lateral flow detection. PLoS One. Jul. 26, 2013;8(7):e69355. Print 2013.",
                    "Kimura Y, Oguchi-Katayama A, Kawai Y, Naito K, Mitani Y, Morlighem JE, Hayashizaki Y, Lezhava A. Tail variation of the folding primer affects the SmartAmp2 process differently. Biochem Biophys Res Commun. Jun. 12, 2009;383(4):455-9.",
                    "Diamandis EP. Theranos phenomenon: promises and fallacies. Clin Chem Lab Med. Jun. 2015;53(7):989-93.",
                    "Plebani M. Evaluating and using innovative technologies: a lesson from Theranos? Clin Chem Lab Med. Jun. 2015;53(7):961-2.",
                    "Rappleye E. \"Theranos gets extension to fix issues following CMS investigation.\" Becker's Hospital Review. Feb. 8, 2016. http://www.beckershospitalreview.com/hospital-management-administration/theranos-gets-extension-to-fix-issues-following-cms-investigation.html.",
                    "Ramsey L. \"Theranos has a week to respond to the searing report about its business.\" Business Insider. Feb. 5, 2016. http://www.businessinsider.com/theranos-response-to-cms-2016-2.",
                    "Loria K. \"'More skeptical than ever': Experts respond to the government's warning letter to Theranos.\" Jan. 28, 2016. Tech Insider. http://www.techinsider.io/how-bad-the-cms-letter-to-theranos-really-is-2016-1.",
                    "Fuller K. Centers for Medicare and Medicaid Services (CMS). Condition Level Deficiencies Notic-Immediate Jeopardy. Notice to Theranos, Inc. director Dr. Sunil Dhawan. Jan. 25, 2016. https://cdn2.vox-cdn.com/uploads/chorus-asset/file/5969923/Theranos-Inc-Cover-Letter-01-25-2016.0.pdf.",
                    "Havl\u00edckov\u00e1 M, Pljusnin AZ, Tmov\u00e1 B. Influenza virus detection in clinical specimens. Acta Virol. Sep. 1990;34(5):449-56.",
                    "Metzgar D, et. al. Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variants. PLoS One. Feb. 3, 2010;5(2):e8995.",
                    "Jannetto PJ, Buchan BW, Vaughan KA, Ledford JS, Anderson DK, Henley DC, Quigley NB, Ledeboer NA. Real-time detection of influenza a, influenza B, and respiratory syncytial virus a and B in respiratory specimens by use of nanoparticle probes. J Clin Microbiol. Nov. 2010;48(11):3997-4002. Epub Sep. 8, 2010.",
                    "Mahony JB, Petrich A, Smieja M. Molecular diagnosis of respiratory virus infections. Crit Rev Clin Lab Sci. Sep.-Dec. 2011;48(5-6):217-49.",
                    "Chin CD, Chin SY, Laksanasopin T, Sia SK. \"Chapter 1: Low-Cost Microdevices for Point-of-Care Testing.\" Biological and Medical Physics, Biomedical Engineering pp. 3-21. Oct. 12, 2012.",
                    "U.S. Appl. No. 14/479,190, filed Sep. 5, 2014.",
                    "U.S. Appl. No. 14/479,241, filed Sep. 5, 2014.",
                    "Written Opinion and International Search Report dated Dec. 18, 2014 for PCT/US2014/054424.",
                    "Anders et al., Am Journal Med Hyg 87(1), 2012, pp. 165-170.",
                    "Kautner et al., Journal of Pediatrics, 1997, 131, pp. 516-524.",
                    "Lounsbury et al., Lab Chip, 2013, 13, pp. 1384-1393.",
                    "Office Action dated Jan. 29, 2015 for U.S. Appl. No. 14/479,241.",
                    "Office Action dated Feb. 12, 2015 for U.S. Appl. No. 14/479,190.",
                    "U.S. Appl. 14/604,194, filed Jan. 23, 2015.",
                    "Voudoukis et al., 2011, Med Sci Monit, 17(4), pp, 185-188.",
                    "World Health Organization (WHO) Guide to Field Operations, Oct. 2006, pp. 1-80.",
                    "Office Action dated Jul. 8, 2015 for U.S. Appl. No. 14/479,241.",
                    "Advisory Action dated Sep. 25, 2015 for U.S. Appl. No. 14/479,241.",
                    "Office Action dated Nov. 19, 2015 for U.S. Appl. No. 14/604,194."
                ],
                "nplResolvedCount": 20,
                "nplResolvedLensIDs": [
                    "041-164-594-381-566",
                    "033-684-769-494-634",
                    "017-357-555-017-666",
                    "006-717-818-600-296",
                    "055-691-444-317-721",
                    "035-576-903-166-928",
                    "024-381-743-890-001",
                    "007-463-586-614-953",
                    "041-851-513-374-802",
                    "058-125-883-994-620",
                    "055-617-498-113-550",
                    "074-132-963-233-333",
                    "009-877-806-763-516",
                    "042-708-210-232-211",
                    "033-640-893-712-104",
                    "122-810-893-296-361",
                    "103-852-169-195-558",
                    "025-353-957-592-93X",
                    "015-173-776-212-116",
                    "105-763-401-360-684"
                ],
                "nplResolvedExternalIDs": [
                    "10.12659/msm.881713",
                    "9386651",
                    "pmc2959060",
                    "25996487",
                    "18666965",
                    "10.1007/978-3-642-29268-2_1",
                    "10.1186/1471-2334-10-288",
                    "20140251",
                    "20575664",
                    "10.1128/jcm.01118-10",
                    "pmc3391044",
                    "10.1111/j.1865-1682.2008.01037.x",
                    "10.1371/journal.pone.0008995",
                    "22185616",
                    "23922706",
                    "1981455",
                    "23389252",
                    "10.1159/000353224",
                    "21455103",
                    "23898289",
                    "20920320",
                    "10.1016/j.mjafi.2012.07.017",
                    "pmc3862550",
                    "10.1016/j.bbrc.2009.04.033",
                    "10.1515/cclm-2015-0411",
                    "10.1515/cclm-2015-0356",
                    "10.1086/653940",
                    "10.1371/journal.pone.0069355",
                    "pmc3020893",
                    "10.1016/s0022-3476(97)70054-4",
                    "pmc2815781",
                    "18260008",
                    "10.3109/10408363.2011.640976",
                    "19371726",
                    "20826644",
                    "22764309",
                    "pmc3724848",
                    "24600118",
                    "22761651",
                    "10.1039/c3lc41326h",
                    "pmc3539528",
                    "10.1371/journal.pone.0036455",
                    "26030792",
                    "pmc3384667",
                    "10.1080/15257770701845204",
                    "10.4269/ajtmh.2012.11-0713"
                ]
            },
            {
                "index": "68",
                "publicationKey": "WO_2016_116398_A1",
                "lensId": "109-746-392-442-207",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2016/116398 A1",
                "publicationDate": "2016-07-28",
                "filingNumber": "EP 2016050888 W",
                "filingDate": "2016-01-18",
                "priorityFilingKeysActive": [
                    "EP 15151594 A 20150119"
                ],
                "earliestPriorityDate": "2015-01-19",
                "title": "A Novel Vaccine Against The Middle East Respiratory Syndrome Coronavirus (mers-cov)",
                "applicants": [
                    "LUDWIG MAXIMILIANS UNIVERSIT\u00c4T M\u00dcNCHEN",
                    "PHILIPPS UNIVERSIT\u00c4T MARBURG"
                ],
                "inventors": [
                    "SUTTER GERD",
                    "SONG FEI",
                    "FUX ROBERT",
                    "VOLZ ASISA",
                    "BECKER STEPHAN",
                    "EICKMANN MARKUS"
                ],
                "owners": [],
                "url": "https://lens.org/109-746-392-442-207",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 14,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "C07K14/005"
                ],
                "usClassifications": [],
                "nplCitationCount": 6,
                "nplCitations": [
                    "ARWEN ALTENBURG ET AL: \"Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases\", VIRUSES, vol. 6, no. 7, 17 July 2014 (2014-07-17), pages 2735 - 2761, XP055200206, DOI: 10.3390/v6072735",
                    "F. SONG ET AL: \"Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies\", JOURNAL OF VIROLOGY, vol. 87, no. 21, 1 November 2013 (2013-11-01), pages 11950 - 11954, XP055157123, ISSN: 0022-538X, DOI: 10.1128/JVI.01672-13",
                    "RACHEL L. GRAHAM ET AL: \"A decade after SARS: strategies for controlling emerging coronaviruses\", NATURE REVIEWS MICROBIOLOGY, vol. 11, no. 12, 11 November 2013 (2013-11-11), pages 836 - 848, XP055200225, ISSN: 1740-1526, DOI: 10.1038/nrmicro3143",
                    "S. VAN BOHEEMEN ET AL: \"Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans\", MBIO, vol. 3, no. 6, 20 November 2012 (2012-11-20), pages e00473 - 12, XP055128733, ISSN: 2150-7511, DOI: 10.1128/mBio.00473-12",
                    "RUTH MCBRIDE ET AL: \"The Coronavirus Nucleocapsid Is a Multifunctional Protein\", VIRUSES, vol. 6, no. 8, 7 August 2014 (2014-08-07), pages 2991 - 3018, XP055200197, DOI: 10.3390/v6082991",
                    "ASISA VOLZ ET AL: \"Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein\", JOURNAL OF VIROLOGY., vol. 89, no. 16, 27 May 2015 (2015-05-27), US, pages 8651 - 8656, XP055257600, ISSN: 0022-538X, DOI: 10.1128/JVI.00614-15"
                ],
                "nplResolvedCount": 6,
                "nplResolvedLensIDs": [
                    "032-514-877-351-077",
                    "168-768-264-462-518",
                    "027-043-089-978-283",
                    "007-348-479-567-414",
                    "114-114-185-080-165",
                    "023-939-052-489-028"
                ],
                "nplResolvedExternalIDs": [
                    "25105276",
                    "pmc3807317",
                    "10.3390/v6082991",
                    "10.1128/mbio.00473-12",
                    "pmc4524222",
                    "pmc4113791",
                    "10.1128/jvi.00614-15",
                    "25036462",
                    "23986586",
                    "26018172",
                    "23170002",
                    "10.1128/jvi.01672-13",
                    "10.3390/v6072735",
                    "24217413",
                    "pmc4147684",
                    "10.1038/nrmicro3143"
                ]
            },
            {
                "index": "69",
                "publicationKey": "WO_2018_222983_A1",
                "lensId": "028-351-109-227-884",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/222983 A1",
                "publicationDate": "2018-12-06",
                "filingNumber": "US 2018/0035587 W",
                "filingDate": "2018-06-01",
                "priorityFilingKeysActive": [
                    "US 201762514091 P 20170602"
                ],
                "earliestPriorityDate": "2017-06-02",
                "title": "Phenotypically Wild-type And Genetically Attenuated Viruses",
                "applicants": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "inventors": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "owners": [],
                "url": "https://lens.org/028-351-109-227-884",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/21",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "WANG ET AL.: \"Construction of a live-attenuated HIV-1 vaccine through genetic code expansion\", ANGEW CHEM INT ED ENGL., vol. 53, no. 19, 5 May 2014 (2014-05-05), pages 4867 - 4871, XP055563251",
                    "THE GENETIC CODES, 15 March 2017 (2017-03-15), Retrieved from the Internet <URL:hftps://web.archive.org/web/20170315234037/https://www.ncbi.nlm.nih.gov/Taxonomy/Utils/wprintgc.cgi> [retrieved on 20180730]"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "008-764-941-717-89X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1002/anie.201402092",
                    "pmc4984542",
                    "24715496"
                ]
            },
            {
                "index": "70",
                "publicationKey": "WO_2018_222986_A1",
                "lensId": "192-721-416-364-258",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/222986 A1",
                "publicationDate": "2018-12-06",
                "filingNumber": "US 2018/0035591 W",
                "filingDate": "2018-06-01",
                "priorityFilingKeysActive": [
                    "US 201762514096 P 20170602"
                ],
                "earliestPriorityDate": "2017-06-02",
                "title": "Genetically Attenuated Nucleic Acid Vaccine",
                "applicants": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "inventors": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "owners": [],
                "url": "https://lens.org/192-721-416-364-258",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N15/66",
                    "C12N15/10",
                    "C12N15/11",
                    "C12N15/33"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "WANG ET AL.: \"Expanding the Genetic Code\", ANGEW. CHEM. INT. ED., vol. 44, no. 1, 17 December 2004 (2004-12-17), pages 34 - 66, XP055562040"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "71",
                "publicationKey": "US_2019_0290749_A1",
                "lensId": "120-926-310-472-207",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0290749 A1",
                "publicationDate": "2019-09-26",
                "filingNumber": "US 201716345699 A",
                "filingDate": "2017-10-30",
                "priorityFilingKeysActive": [
                    "KR 20160142703 A 20161031",
                    "KR 20170079762 A 20170623"
                ],
                "earliestPriorityDate": "2016-10-31",
                "title": "Immune Modulator And Vaccine Composition Containing The Same",
                "applicants": [
                    "EYEGENE INC"
                ],
                "inventors": [
                    "CHO YANG JE",
                    "KIM KWANGSUNG",
                    "LEE NA GYONG",
                    "PARK SHIN AE"
                ],
                "owners": [
                    {
                        "name": "EYEGENE INC",
                        "executionDate": "2019-05-08"
                    }
                ],
                "url": "https://lens.org/120-926-310-472-207",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 19,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/002",
                    "A61K39/39",
                    "A61P31/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "72",
                "publicationKey": "EP_2950817_B1",
                "lensId": "091-218-378-511-199",
                "jurisdiction": "EP",
                "kindCode": "B1",
                "displayKey": "EP 2950817 B1",
                "publicationDate": "2019-08-07",
                "filingNumber": "EP 14745410 A",
                "filingDate": "2014-01-31",
                "priorityFilingKeysActive": [
                    "US 201361759131 P 20130131"
                ],
                "earliestPriorityDate": "2013-01-31",
                "title": "Immunogenic Compositions Comprising Silicified Virus And Methods Of Use",
                "applicants": [
                    "PORTLAND STATE UNIV",
                    "PROVIDENCE HEALTH & SERVICES OREGON"
                ],
                "inventors": [
                    "STEDMAN KENNETH M",
                    "LAIDLER JAMES R",
                    "BAHJAT KEITH"
                ],
                "owners": [],
                "url": "https://lens.org/091-218-378-511-199",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "ANONYMOUS: \"Dr. Kenneth Stedman - Publications\", 1 January 2017 (2017-01-01), XP055400262, Retrieved from the Internet <URL:http://web.pdx.edu/~kstedman/Publications/allpubs.html> [retrieved on 20170822]",
                    "J E KYLE ET AL: \"PRESERVATION POTENTIAL OF LIPID-CONTAINING VIRUSES UNDER SILICIFYING CONDITIONS\", 43RD LUNAR AND PLANETARY SCIENCE CONFERENCE, 2012, pages 356 - 361, XP055400235, Retrieved from the Internet <URL:http://www.lpi.usra.edu/meetings/lpsc2012/pdf/2228.pdf>"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "73",
                "publicationKey": "US_9993543_B2",
                "lensId": "006-662-478-152-128",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9993543 B2",
                "publicationDate": "2018-06-12",
                "filingNumber": "US 201414763947 A",
                "filingDate": "2014-01-31",
                "priorityFilingKeysActive": [
                    "US 201361759131 P 20130131"
                ],
                "earliestPriorityDate": "2013-01-31",
                "title": "Immunogenic Compositions Comprising Silicified Virus And Methods Of Use",
                "applicants": [
                    "PORTLAND STATE UNIV",
                    "PROVIDENCE HEALTH & SERVICES\u2014OREGON"
                ],
                "inventors": [
                    "STEDMAN KENNETH M",
                    "LAIDLER JAMES R",
                    "BAHJAT KEITH"
                ],
                "owners": [
                    {
                        "name": "PORTLAND STATE UNIVERSITY",
                        "executionDate": "2015-04-29"
                    },
                    {
                        "name": "PROVIDENCE HEALTH & SERVICES - OREGON",
                        "executionDate": "2014-02-28"
                    },
                    {
                        "name": "OREGON STATE BOARD OF HIGHER EDUCATION ACTING BY AND THROUGH PORTLAND STATE UNIVERSITY",
                        "executionDate": "2014-02-22"
                    }
                ],
                "url": "https://lens.org/006-662-478-152-128",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/00",
                    "A61K39/125",
                    "A61K39/13",
                    "A61K39/145",
                    "A61K39/15",
                    "A61K39/21",
                    "A61K39/215",
                    "A61K39/235",
                    "A61K39/285",
                    "A61K39/29",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 8,
                "nplCitations": [
                    "Wang et al., \u201cHydrated Silica Exterior Produced by Biomimetic Silicification Confers Viral Vaccine Heat-Resistance,\u201d ACS Nano 9(1):799-808, 2015.",
                    "Alcock et al., \u201cLong-Term Thermo stabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass,\u201d Vaccines, vol. 2, 8 pages, 2010.",
                    "Kyle et al., \u201cPreservation Potential of Lipid-Containing Viruses under Silicifying Conditions,\u201d 43rd Lunar and Planetary Science Conference, 2012.",
                    "Laidler et al., \u201cDifferential Activation, Reactivation and Des sication Tolerance of Silicified Viruses,\u201d abstract presented at the Astrobiology Science Conference, Apr. 17, 2012, Atlanta, Georgia.",
                    "Laidler et al., \u201cVirus Silicification under Simulated Hot Spring Conditions,\u201d Astrobiology, vol. 10:569-576, 2010.",
                    "Laidler et al., \u201cReversible Inactivation and Desiccation Tolerance of Silicified Viruses,\u201d J. Virol., vol. 87:13927-13929, 2013.",
                    "Orange et al., \u201cExperimental fossilisation of Viruses from extremophilic Archaea,\u201d Biogeosciences, vol. 8:1465-1475, 2011.",
                    "Royston et al., \u201cCharacterization of Silica-Coated Tobacco Mosaic Virus,\u201d J. Colloid Interface Sci., vol. 298:706-712, 2006."
                ],
                "nplResolvedCount": 6,
                "nplResolvedLensIDs": [
                    "109-976-226-332-33X",
                    "045-732-946-166-420",
                    "095-022-123-251-744",
                    "041-843-275-763-991",
                    "092-852-588-703-636",
                    "052-341-743-573-427"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/j.jcis.2005.12.068",
                    "16426631",
                    "24109222",
                    "10.1089/ast.2010.0463",
                    "pmc3838281",
                    "25574563",
                    "10.1021/nn5063276",
                    "10.1126/scitranslmed.3000490",
                    "20371486",
                    "10.1128/jvi.02825-13",
                    "20735248",
                    "10.5194/bg-8-1465-2011"
                ]
            },
            {
                "index": "74",
                "publicationKey": "WO_2014_121132_A1",
                "lensId": "096-017-478-969-915",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2014/121132 A1",
                "publicationDate": "2014-08-07",
                "filingNumber": "US 2014/0014284 W",
                "filingDate": "2014-01-31",
                "priorityFilingKeysActive": [
                    "US 201361759131 P 20130131"
                ],
                "earliestPriorityDate": "2013-01-31",
                "title": "Immunogenic Compositions Comprising Silicified Virus And Methods Of Use",
                "applicants": [
                    "OREGON STATE",
                    "PROVIDENCE HEALTH & SERVICES OREGON"
                ],
                "inventors": [
                    "STEDMAN KENNETH M",
                    "LAIDLER JAMES R",
                    "BAHJAT KEITH"
                ],
                "owners": [],
                "url": "https://lens.org/096-017-478-969-915",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 8,
                "nplCitations": [
                    "LAIDLER ET AL.: \"Virus Silicification under Simulated Hot Spring Conditions\", ASTROBIOLOGY, vol. 10, no. 6, 24 August 2008 (2008-08-24), pages 569 - 576, XP055269930, DOI: 10.1089/AST.2010.0463",
                    "See also references of EP 2950817A4",
                    "SMITH ET AL., AEROBIOLOGIA, vol. 26, 2010, pages 35",
                    "DING ET AL., GYNECOL ONCOL, vol. 121, 2011, pages 148",
                    "FOGARTY ET AL., VIRUS RES, vol. 132, 2008, pages 140",
                    "NAKANO ET AL., FISH PATHOL, vol. 33, 1998, pages 65",
                    "LAIDLER; STEDMAN, ASTROBIOLOGY, vol. 10, 2010, pages 569",
                    "ORANGE ET AL., BIOGEOSCIENCES, vol. 8, 2011, pages 1465"
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "109-976-226-332-33X",
                    "124-513-861-219-056",
                    "045-732-946-166-420",
                    "022-833-502-043-217"
                ],
                "nplResolvedExternalIDs": [
                    "18166242",
                    "pmc3610175",
                    "10.1016/j.ygyno.2010.11.040",
                    "10.1089/ast.2010.0463",
                    "10.1016/j.virusres.2007.11.010",
                    "20735248",
                    "21208649",
                    "10.5194/bg-8-1465-2011"
                ]
            },
            {
                "index": "75",
                "publicationKey": "US_2015_0359871_A1",
                "lensId": "128-748-858-313-991",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2015/0359871 A1",
                "publicationDate": "2015-12-17",
                "filingNumber": "US 201414763947 A",
                "filingDate": "2014-01-31",
                "priorityFilingKeysActive": [
                    "US 201361759131 P 20130131"
                ],
                "earliestPriorityDate": "2013-01-31",
                "title": "Immunogenic Compositions Comprising Silicified Virus And Methods Of Use",
                "applicants": [
                    "UNIV PORTLAND STATE",
                    "PROVIDENCE HEALTH & SERVICES OREGON"
                ],
                "inventors": [
                    "STEDMAN KENNETH M",
                    "LAIDLER JAMES R",
                    "BAHJAT KEITH"
                ],
                "owners": [
                    {
                        "name": "PORTLAND STATE UNIVERSITY",
                        "executionDate": "2015-04-29"
                    },
                    {
                        "name": "PROVIDENCE HEALTH & SERVICES - OREGON",
                        "executionDate": "2014-02-28"
                    },
                    {
                        "name": "OREGON STATE BOARD OF HIGHER EDUCATION ACTING BY AND THROUGH PORTLAND STATE UNIVERSITY",
                        "executionDate": "2014-02-22"
                    }
                ],
                "url": "https://lens.org/128-748-858-313-991",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/125",
                    "A61K39/13",
                    "A61K39/145",
                    "A61K39/15",
                    "A61K39/21",
                    "A61K39/215",
                    "A61K39/235",
                    "A61K39/285",
                    "A61K39/29",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "76",
                "publicationKey": "WO_2016_059161_A1",
                "lensId": "057-743-123-300-202",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2016/059161 A1",
                "publicationDate": "2016-04-21",
                "filingNumber": "EP 2015073892 W",
                "filingDate": "2015-10-15",
                "priorityFilingKeysActive": [
                    "EP 14306633 A 20141015"
                ],
                "earliestPriorityDate": "2014-10-15",
                "title": "Composition With Reduced Immunogenicity",
                "applicants": [
                    "XENOTHERA"
                ],
                "inventors": [
                    "DUVAUX ODILE",
                    "SOULILLOU JEAN-PAUL"
                ],
                "owners": [],
                "url": "https://lens.org/057-743-123-300-202",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 9,
                "familySize": 9,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/08",
                    "A01K67/027",
                    "C07K16/10",
                    "C07K16/12",
                    "C07K16/14",
                    "C12N9/02",
                    "C12N9/10",
                    "C12N9/22",
                    "C12N9/40"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "ANDREW J. LUTZ ET AL: \"Double knockout pigs deficient in N-glycolylneuraminic acid and Galactose [alpha]-1,3-Galactose reduce the humoral barrier to xenotransplantation\", XENOTRANSPLANTATION, vol. 20, no. 1, 5 January 2013 (2013-01-05), pages 27 - 35, XP055069928, ISSN: 0908-665X, DOI: 10.1111/xen.12019",
                    "VERED PADLER-KARAVANI ET AL: \"Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk\", XENOTRANSPLANTATION, vol. 18, no. 1, 1 January 2011 (2011-01-01), pages 1 - 5, XP055176955, ISSN: 0908-665X, DOI: 10.1111/j.1399-3089.2011.00622.x",
                    "RAJU T S ET AL: \"Species-specific variation in glycosylation of IgG: evidence for species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics\", GLYCOBIOLOGY, OXFORD UNIVERSITY PRESS, US, vol. 10, no. 5, 1 January 2000 (2000-01-01), pages 477 - 486, XP002964086, ISSN: 0959-6658, DOI: 10.1093/GLYCOB/10.5.477",
                    "TANGVORANUNTAKUL PAM ET AL: \"Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 100, no. 21, 14 October 2003 (2003-10-14), pages 12045 - 12050, XP002443576, ISSN: 0027-8424, DOI: 10.1073/PNAS.2131556100"
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "040-154-701-721-55X",
                    "128-605-834-274-686",
                    "043-516-092-302-134",
                    "017-055-848-106-562"
                ],
                "nplResolvedExternalIDs": [
                    "10764836",
                    "14523234",
                    "10.1111/j.1399-3089.2011.00622.x",
                    "10.1073/pnas.2131556100",
                    "10.1093/glycob/10.5.477",
                    "pmc218710",
                    "23384142",
                    "21342282",
                    "10.1111/xen.12019"
                ]
            },
            {
                "index": "77",
                "publicationKey": "WO_2018_170347_A1",
                "lensId": "022-222-952-841-90X",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/170347 A1",
                "publicationDate": "2018-09-20",
                "filingNumber": "US 2018/0022777 W",
                "filingDate": "2018-03-16",
                "priorityFilingKeysActive": [
                    "US 201762473202 P 20170317",
                    "US 201762473174 P 20170317",
                    "US 201762473219 P 20170317"
                ],
                "earliestPriorityDate": "2017-03-17",
                "title": "Zoonotic Disease Rna Vaccines",
                "applicants": [
                    "MODERNATX INC"
                ],
                "inventors": [
                    "CIARAMELLA GIUSEPPE",
                    "HIMANSU SUNNY",
                    "PRESNYAK VLADIMIR",
                    "BENENATO KERRY",
                    "KUMARASINGHE ELLALAHEWAGE"
                ],
                "owners": [],
                "url": "https://lens.org/022-222-952-841-90X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 10,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 30,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/7105",
                    "A61K31/7115",
                    "A61K39/12",
                    "A61P37/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 6,
                "nplCitations": [
                    "GREER, C.E ET AL.: \"Long-term Protection in Hamsters against Human Parainfluenza Virus Type 3 Following Mucosal or Combinations of Mucosal and Systemic Immunizations with Chimeric Alphavirus-based Replicon Particles\", SCAND J IMMUNOL, vol. 66, no. 6, 2007, pages 645 - 653, XP002537662",
                    "\"Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential\", INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol. 47, 2016, pages 5 - 9, XP029667941",
                    "ANONYMOUS: \"Prevention and Treatment\", 9 November 2017 (2017-11-09), pages 1 - 1, XP055636630, Retrieved from the Internet <URL:https://www.cdc.gov/coronavirus/about/prevention.html>",
                    "ANONYMOUS: \"Lassa Fever\", 25 March 2014 (2014-03-25), XP055636631, Retrieved from the Internet <URL:https://www.cdc.gov/vhf/lassa/prevention/index.html>",
                    "ANONYMOUS: \"Nipah Virus (NiV)\", 20 March 2014 (2014-03-20), XP055636632, Retrieved from the Internet <URL:https://www.cdc.gov/vhf/nipah/prevention/index.html>",
                    "CHAHAL, J.S ET AL.: \"Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose\", PNAS, 2016, pages E4133 - E4142, XP055329399"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "015-770-990-151-890",
                    "016-819-513-559-042",
                    "066-375-759-866-375"
                ],
                "nplResolvedExternalIDs": [
                    "10.1111/j.1365-3083.2007.02019.x",
                    "17944814",
                    "27321961",
                    "10.1073/pnas.1600299113",
                    "10.1016/j.ijid.2016.06.012",
                    "27382155"
                ]
            },
            {
                "index": "78",
                "publicationKey": "US_2017_0240616_A1",
                "lensId": "101-625-965-925-678",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0240616 A1",
                "publicationDate": "2017-08-24",
                "filingNumber": "US 201515516742 A",
                "filingDate": "2015-10-15",
                "priorityFilingKeysActive": [
                    "EP 14306633 A 20141015"
                ],
                "earliestPriorityDate": "2014-10-15",
                "title": "Composition With Reduced Immunogenicity",
                "applicants": [
                    "XENOTHERA"
                ],
                "inventors": [
                    "DUVAUX ODILE",
                    "SOULILLOU JEAN-PAUL"
                ],
                "owners": [
                    {
                        "name": "XENOTHERA",
                        "executionDate": "2017-04-12"
                    }
                ],
                "url": "https://lens.org/101-625-965-925-678",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 9,
                "familySize": 9,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A01K67/027",
                    "C07K16/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "79",
                "publicationKey": "US_2019_0255171_A1",
                "lensId": "052-714-468-165-099",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0255171 A1",
                "publicationDate": "2019-08-22",
                "filingNumber": "US 201716346401 A",
                "filingDate": "2017-10-30",
                "priorityFilingKeysActive": [
                    "KR 20160142703 A 20161031",
                    "KR 20170107420 A 20170824",
                    "KR 20170107421 A 20170824"
                ],
                "earliestPriorityDate": "2016-10-31",
                "title": "Composition For Enhancing Immunity Comprising Immune Modulator And Cationic Liposome, And Use Of Same",
                "applicants": [
                    "EYEGENE INC"
                ],
                "inventors": [
                    "CHO YANG JE",
                    "KIM KWANGSUNG",
                    "LEE NA GYONG",
                    "PARK SHIN AE"
                ],
                "owners": [
                    {
                        "name": "EYEGENE INC",
                        "executionDate": "2019-05-08"
                    }
                ],
                "url": "https://lens.org/052-714-468-165-099",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 19,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/25",
                    "A61K9/127",
                    "A61K9/19",
                    "A61K31/739"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "80",
                "publicationKey": "US_2020_0030432_A1",
                "lensId": "113-299-974-915-089",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2020/0030432 A1",
                "publicationDate": "2020-01-30",
                "filingNumber": "US 201816494988 A",
                "filingDate": "2018-03-16",
                "priorityFilingKeysActive": [
                    "US 201762473174 P 20170317",
                    "US 201762473202 P 20170317",
                    "US 201762473219 P 20170317"
                ],
                "earliestPriorityDate": "2017-03-17",
                "title": "Zoonotic Disease Rna Vaccines",
                "applicants": [
                    "MODERNATX INC"
                ],
                "inventors": [
                    "CIARAMELLA GIUSEPPE",
                    "HIMANSU SUNNY",
                    "PRESNYAK VLADIMIR",
                    "BENENATO KERRY",
                    "KUMARASINGHE ELLALAHEWAGE SATHYAJITH"
                ],
                "owners": [],
                "url": "https://lens.org/113-299-974-915-089",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 30,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K31/7115",
                    "A61P31/14",
                    "C12N15/86"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "81",
                "publicationKey": "WO_2015_081155_A1",
                "lensId": "156-468-487-892-558",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/081155 A1",
                "publicationDate": "2015-06-04",
                "filingNumber": "US 2014/0067537 W",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/156-468-487-892-558",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 4,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "SONG ET AL.: \"Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies.\", JOURNAL OF VIROLOGY, vol. 87, no. 21, 28 August 2013 (2013-08-28), pages 11950 - 11954, XP055157123",
                    "DATABASE GENBANK [online] 4 December 2012 (2012-12-04), VAN BOHEEMEN: \"Human betacoronavirus 2c EMC/2012, complete genome.\", XP055295836, accession no. NCBI Database accession no. JX869059.2",
                    "DATABASE GENBANK [online] 10 June 2013 (2013-06-10), COTTEN M: \"Middle East respiratory syndrome coronavirus isolate Al-Hasa_4_2013, complete genome.\", XP055295837, accession no. NCBI Database accession no. KF186564.1",
                    "See also references of EP 3074051A4"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "114-114-185-080-165"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3807317",
                    "23986586",
                    "10.1128/jvi.01672-13"
                ]
            },
            {
                "index": "82",
                "publicationKey": "US_10016497_B2",
                "lensId": "131-281-667-701-571",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10016497 B2",
                "publicationDate": "2018-07-10",
                "filingNumber": "US 201415039672 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC",
                    "THE TRUSTEES OF THE UNIVERSTIY OF PENNSYLVANIA"
                ],
                "inventors": [
                    "WEINER DAVID",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [
                    {
                        "name": "THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA",
                        "executionDate": "2015-01-12"
                    },
                    {
                        "name": "INOVIO PHARMACEUTICALS INC",
                        "executionDate": "2014-12-16"
                    }
                ],
                "url": "https://lens.org/131-281-667-701-571",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 13,
                "nplCitations": [
                    "Van Boheemen et al. Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans. MBio. Nov. 20, 2012;3(6). pii: e00473-12.",
                    "GenBank: JX869059.2 Human betacoronavirus 2c EMC/2012, complete genome. Dated Dec. 4, 2012.",
                    "Zhou et al. Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins. Biochemical and Biophysical Research Communications 387 (2009) 326-329.",
                    "Lokugamage et al. Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV. Vaccine (2008) 26, 797-808.",
                    "Song F, et al., \u2018Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies,\u2019 Journal of Virology, (2013) vol. 87, No. 21, pp. 11950-11954.",
                    "GenBank: JX869059.2 Human betacoronavirus 2c EMC/2012, complete genome. Dec. 4, 2012. [online] Retrieved from internet Nov. 2, 2016. URL:https://www.ncbi.nlm.nih.gov/nuccore/JX869059.",
                    "GenBank: KF186564.1 Middle East respiratory syndrome coronavirus isolate Al-Hasa_4_2013 complete genome. Jun. 10, 2013. [online]. Retrieved from internet Nov. 2, 2016. URL:https://www.ncbi.nlm.nih.gov/nuccore/KF186564.",
                    "Falzarano et al., \u201cInterferon-\u03b12b and ribavirin treatment improves outcome in MERS-CoV-infected rhesus macaques\u201d, Nat Med, vol. 19(10): pp. 1313-1317 (2013).",
                    "Cotten et al., \u201cTransmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study\u201d, Lancet, 2013, 382:1993-2002.",
                    "Cotten et al., \u201cSpread, Circulation, and Evolution of the Middle East Respiratory Syndrome Coronavirus,\u201d mBio, 2014, 5(1):e01062-13.",
                    "[online] 25 March 2013 (2013-03-25), \"Human betacoronavirus 2c Jordan-N3/2012, complete genome\", XP002764824",
                    "DATABASE GenBank [online] 30 April 2013 (2013-04-30), \"Human betacoronavirus 2c England-Qatar/2012, complete genome\", XP002764825",
                    "Van Boheemen et al., \u201cGenomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans,\u201d mBio, 2012, 3(6):e00473-12, Accession No. JX869059."
                ],
                "nplResolvedCount": 6,
                "nplResolvedLensIDs": [
                    "109-155-880-448-590",
                    "105-955-717-757-57X",
                    "015-077-926-384-053",
                    "114-114-185-080-165",
                    "023-939-052-489-028",
                    "016-772-377-304-76X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/j.vaccine.2007.11.092",
                    "pmc3807317",
                    "10.1016/s0140-6736(13)61887-5",
                    "24549846",
                    "24055451",
                    "10.1016/j.bbrc.2009.07.025",
                    "10.1128/mbio.00473-12",
                    "19595990",
                    "23986586",
                    "pmc3898949",
                    "23170002",
                    "10.1128/jvi.01672-13",
                    "18191004",
                    "10.1128/mbio.01062-13",
                    "pmc2267761"
                ]
            },
            {
                "index": "83",
                "publicationKey": "WO_2019_202285_A1",
                "lensId": "119-630-893-222-702",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/202285 A1",
                "publicationDate": "2019-10-24",
                "filingNumber": "GB 2019000061 W",
                "filingDate": "2019-04-23",
                "priorityFilingKeysActive": [
                    "GB 201806460 A 20180420"
                ],
                "earliestPriorityDate": "2018-04-20",
                "title": "Pharmaceutical Compositions And Associated Kits And Uses",
                "applicants": [
                    "SECR DEFENCE",
                    "PROXIMA CONCEPTS LTD",
                    "THE UNIV OF STRATHCLYDE"
                ],
                "inventors": [
                    "WILLIAMSON ETHEL",
                    "MOORE BARRY",
                    "NEW ROGER"
                ],
                "owners": [],
                "url": "https://lens.org/119-630-893-222-702",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K9/00",
                    "A61K39/00",
                    "A61K39/02",
                    "A61K39/12",
                    "A61P31/04",
                    "A61P31/14",
                    "C07K16/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 20,
                "nplCitations": [
                    "JONES SARAH ET AL: \"Protein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity\", VACCINE, vol. 32, no. 33, 10 October 2013 (2013-10-10), pages 4234 - 4242, XP028859762, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2013.09.061",
                    "M. DOMINGOS ET AL: \"A New Oil-Based Antigen Delivery Formulation for both Oral and Parenteral Vaccination\", THE OPEN DRUG DELIVERY JOURNAL, 24 July 2008 (2008-07-24), pages 52 - 60, XP055606363, Retrieved from the Internet <URL:https://benthamopen.com/contents/pdf/TODDJ/TODDJ-2-52.pdf> DOI: 10.2174/1874126600802010052",
                    "B.D. MOORE ET AL: \"Dual route vaccination for plague with emergency use applications\", VACCINE, vol. 36, no. 34, 1 August 2018 (2018-08-01), AMSTERDAM, NL, pages 5210 - 5217, XP055606086, ISSN: 0264-410X, DOI: 10.1016/j.vaccine.2018.06.039",
                    "NEW R R C ET AL: \"Antibody-mediated protection against MERS-CoV in the murine model\", VACCINE, vol. 37, no. 30, 6 June 2019 (2019-06-06), pages 4094 - 4102, XP085722628, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2019.05.074",
                    "MURDAN S ET AL.: \"Immobilisation of vaccines onto micro-crystals for enhanced thermal stability\", INT J PHARM., vol. 296, 2005, pages 117 - 21, XP004882228, DOI: doi:10.1016/j.ijpharm.2005.02.022",
                    "NEW R.R.C., KIRBY C.J. SOLUBILISATION OF HYDROPHILIC DRUGS IN OILY FORMULATIONS. ADVANCED DRUG DELIVERY REVIEWS, vol. 25, 1997, pages 59 - 69",
                    "NEW R.R.C.KIRBY C.J.: \"Solubilisation of hydrophilic drugs in oily formulations\", ADVANCED DRUG DELIVERY REVIEWS, vol. 25, 1997, pages 59 - 69",
                    "M. DE O. DOMINGOS ET AL.: \"A new Oil-Based Antigen Delivery Formulation for both Oral and Parenteral Vaccination\", THE OPEN DRUG DELIVERY JOURNAL, vol. 2, 2008, pages 52 - 60",
                    "OKBA NMA ET AL.: \"Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches\", CURRENT OPINION IN VIROLOGY, vol. 23, 2017, pages 49 - 58, XP055499799, DOI: doi:10.1016/j.coviro.2017.03.007",
                    "DU ET AL.: \"A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implications for Developing Therapeutics and Vaccines\", PLOS ONE, vol. 8, 2013, pages e81587, XP009182022, DOI: doi:10.1371/journal.pone.0081587",
                    "JONES S. M. ET AL.: \"Protection conferred by a fully recombinant subunit vaccine against Yersinia pestis in male and female mice of four inbred strains\", VACCINE, vol. 19, 2001, pages 358 - 366",
                    "\"GenBank\", Database accession no. CAA43966.1",
                    "\"UniProtKB\", Database accession no. P23994.1",
                    "\"GenBank\", Database accession no. AFS88936.1",
                    "JONES ET AL.: \"Protein coated microcrystals formulated with model antigens and nodified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity\", VACCINE, vol. 32, 2014, pages 4234 - 4242, XP028859762, DOI: doi:10.1016/j.vaccine.2013.09.061",
                    "DOMINGOS M ET AL.: \"A New Oil-Based antigen Delivery Formulation for both Oral and Parenteral Vaccination\", THE OPEN DRUG DELIVERY JOURNAL, vol. 2, 2008, pages 52 - 60",
                    "PRABAKARAN M ET AL.: \"Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice\", ANTIVIRAL RESEARCH, vol. 86, no. 2, 2010, pages 180 - 187",
                    "\"GenBank\", Database accession no. KC164505.2",
                    "\"GenBank\", Database accession no. JX869059",
                    "LU ET AL.: \"Real-time Reverse Transcription-PCR Assay Panel for Middle East Respiratory Syndrome Coronavirus\", J. CLIN. MICRO., vol. 52, no. 1, 2014, pages 67 - 75, XP055334610, DOI: doi:10.1128/JCM.02533-13"
                ],
                "nplResolvedCount": 11,
                "nplResolvedLensIDs": [
                    "005-125-761-114-32X",
                    "040-763-407-420-581",
                    "073-767-167-739-23X",
                    "182-729-334-400-060",
                    "063-216-973-208-325",
                    "029-976-274-417-370",
                    "154-382-202-363-485",
                    "003-376-346-248-551",
                    "048-402-430-106-694",
                    "022-561-232-465-826",
                    "093-100-816-721-33X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/s0169-409x(96)00491-7",
                    "15885463",
                    "10.1016/s0264-410x(00)00108-0",
                    "20153776",
                    "pmc3911421",
                    "pmc3852489",
                    "pmc4101235",
                    "10.1128/jcm.02533-13",
                    "30017148",
                    "10.1016/j.vaccine.2019.05.074",
                    "10.1016/j.antiviral.2010.02.315",
                    "10.1016/j.ijpharm.2005.02.022",
                    "31178378",
                    "24120484",
                    "10.1016/j.coviro.2017.03.007",
                    "10.1371/journal.pone.0081587",
                    "24324708",
                    "24153118",
                    "10930691",
                    "10.2174/1874126600802010052",
                    "28412285",
                    "10.1016/j.vaccine.2013.09.061",
                    "10.1016/j.vaccine.2018.06.039"
                ]
            },
            {
                "index": "84",
                "publicationKey": "US_2017_0258893_A1",
                "lensId": "113-283-191-957-868",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0258893 A1",
                "publicationDate": "2017-09-14",
                "filingNumber": "US 201415039672 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [
                    {
                        "name": "THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA",
                        "executionDate": "2015-01-12"
                    },
                    {
                        "name": "INOVIO PHARMACEUTICALS INC",
                        "executionDate": "2014-12-16"
                    }
                ],
                "url": "https://lens.org/113-283-191-957-868",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "85",
                "publicationKey": "US_2019_0022213_A1",
                "lensId": "095-044-150-527-23X",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0022213 A1",
                "publicationDate": "2019-01-24",
                "filingNumber": "US 201816022839 A",
                "filingDate": "2018-06-29",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/095-044-150-527-23X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "86",
                "publicationKey": "WO_2015_184164_A1",
                "lensId": "184-629-420-435-520",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/184164 A1",
                "publicationDate": "2015-12-03",
                "filingNumber": "US 2015/0033024 W",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462005476 P 20140530",
                    "US 201462051626 P 20140917",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [],
                "url": "https://lens.org/184-629-420-435-520",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027"
                ],
                "usClassifications": [],
                "nplCitationCount": 16,
                "nplCitations": [
                    "LUCA SIMEONI ET AL: \"Human CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution\", HUMAN IMMUNOLOGY, vol. 63, no. 9, September 2002 (2002-09-01), pages 719 - 730, XP055211847, ISSN: 0198-8859, DOI: 10.1016/S0198-8859(02)00433-0",
                    "SARA REARDON: \"Biologists make first mouse model for MERS : Nature News & Comment\", NATURE NEWS, 30 January 2014 (2014-01-30), XP055212045, Retrieved from the Internet <URL:http://www.nature.com/news/biologists-make-first-mouse-model-for-mers-1.14634> [retrieved on 20150908], DOI: 10.1038/nature.2014.14634",
                    "ABBOTT C A ET AL: \"GENOMIC ORGANIZATION, EXACT LOCALIZATION, AND TISSUE EXPRESSION OF THE HUMAN CD26 (DIPEPTIDYL PEPTIDASE IV) GENE\", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE, vol. 40, no. 5, 1994, pages 331 - 338, XP001026517, ISSN: 0093-7711, DOI: 10.1007/BF01246674",
                    "ANNE-MARIE BERNARD ET AL: \"Structure of the mouse dipeptidyl peptidase IV (CD26) gene\", BIOCHEMISTRY, vol. 33, no. 50, December 1994 (1994-12-01), US, pages 15204 - 15214, XP055212119, ISSN: 0006-2960, DOI: 10.1021/bi00254a032",
                    "GERICH: \"Pathogenesis and Management of Postpandrial Hyperglycemia: Role of Incretin-Based Therapies\", INTL. J. GEN. MED., vol. 6, 2013, pages 877 - 895",
                    "RAJ ET AL.: \"Dipeptidyl Peptidase 4 is a Functional Receptor for the Emerging Human Coronovirus-EMC\", NATURE, vol. 495, no. 7440, 2013, pages 251 - 254, XP055302115, DOI: doi:10.1038/nature12005",
                    "FESTING ET AL.: \"Revised nomenclature for strain 129 mice\", MAMMALIAN GENOME, vol. 10, 1999, pages 836, XP055344303, DOI: doi:10.1007/s003359901099",
                    "VALENZUELA ET AL., NATURE BIOTECH, vol. 21.6, 2003, pages 652 - 659",
                    "PAGE ET AL.: \"Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection\", J VIROL, vol. 86, 2012, pages 13334 - 13349",
                    "VALENZUELA ET AL.: \"High-throughput engineering of the mouse genome coupled with high-resolution expression analysis\", NATURE BIOTECH, vol. 21, no. 6, 2003, pages 652 - 659",
                    "POUEYMIROU ET AL.: \"FO generation mice that are essentially fully derived from the donor gene-targeted ES cells allowing immediate phenotypic analyses\", NATURE BIOTECH., vol. 25, no. 1, 2007, pages 91 - 99",
                    "RAJ ET AL.: \"Dipeptidyl Peptidase 4 is a Functional Receptor for the Emerging Human Coronavirus-EMC\", NATUERE, vol. 495, no. 7440, 2013, pages 251 - 254, XP055302115, DOI: doi:10.1038/nature12005",
                    "COCKRELL ET AL.: \"Mouse Dipeptidyl Peptidase is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection\", J. VIROL., vol. 88, no. 9, 2014, pages 5195 - 5199",
                    "COLEMAN ET AL.: \"Wild-Type and Innate Immune-Deficient Mice are Not Susceptible to the Middle East Respiratory Syndrome Coronavirus\", J. GEN. VIROL., vol. 95, no. 2, 2014, pages 408 - 412",
                    "LU ET AL.: \"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26\", NATURE, vol. 500, no. 7461, 2013, pages 227 - 31, XP055162686, DOI: doi:10.1038/nature12328",
                    "ZHAO ET AL.: \"Rapid Generation of a Mouse Model for Middle East Respiratory Syndrome\", PROC. NATL. ACAD. SCI. USA, vol. 111, no. 13, 2014, pages 4970 - 4975, XP055212024, DOI: doi:10.1073/pnas.1323279111"
                ],
                "nplResolvedCount": 15,
                "nplResolvedLensIDs": [
                    "118-660-215-665-839",
                    "113-247-817-446-456",
                    "015-091-157-711-697",
                    "085-122-255-782-470",
                    "077-654-442-397-567",
                    "144-694-712-972-15X",
                    "046-419-902-381-810",
                    "054-391-011-603-49X",
                    "037-334-759-900-091",
                    "122-156-759-782-023",
                    "020-009-029-407-493",
                    "145-146-407-738-040",
                    "000-667-406-763-514",
                    "068-538-867-072-00X",
                    "172-177-240-760-035"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3884108",
                    "pmc3993820",
                    "7927537",
                    "10.1021/bi00254a032",
                    "24574399",
                    "10.1128/jvi.03764-13",
                    "23015710",
                    "12730667",
                    "24403842",
                    "17187059",
                    "7999781",
                    "10.1038/nbt1263",
                    "10430671",
                    "pmc3917065",
                    "10.1038/nbt822",
                    "10.1038/nature12005",
                    "10.1128/jvi.01689-12",
                    "pmc3503056",
                    "10.1007/bf01246674",
                    "12175726",
                    "10.1038/nature12328",
                    "10.2147/ijgm.s51665",
                    "23831647",
                    "10.1099/vir.0.060640-0",
                    "24197535",
                    "24599590",
                    "10.1007/s003359901099",
                    "10.1073/pnas.1323279111",
                    "pmc3977243",
                    "10.1016/s0198-8859(02)00433-0",
                    "23486063",
                    "10.1038/nature.2014.14634"
                ]
            },
            {
                "index": "87",
                "publicationKey": "US_9497945_B2",
                "lensId": "051-073-552-319-915",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9497945 B2",
                "publicationDate": "2016-11-22",
                "filingNumber": "US 201514723855 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462005476 P 20140530",
                    "US 201462051626 P 20140917",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2015-09-14"
                    }
                ],
                "url": "https://lens.org/051-073-552-319-915",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/00",
                    "A01K67/027",
                    "C12Q1/68",
                    "C12Q1/70",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 35,
                "nplCitations": [
                    "Mullins et al. Journal of Clinical Investigation, 1996.",
                    "Moreadith et al., J. Mol. Med., 1997;75:208-16.",
                    "Pera et al. Journal of Cell Science 2000; 113: 5-10.",
                    "Kuroiwa et al. Nature Genetics 2004;36:775-80.",
                    "Simenoi et al. Hum Immunol 2002;63:719-30.",
                    "Lu et al. Nature 2013;500:227-32.",
                    "Auerbach, W. et al. (Nov. 2000). \"Establishment and Chimera Analysis of 129/SvEv- and C57BL/6-Derived Mouse Embryonic Stem Cells,\" BioTechniques 29(5): 1024-1032.",
                    "Cockrell, A.S. et al. (May 2014, e-published Feb. 26, 2014). \"Mouse Dipeptidyl Peptidase is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection,\" J. Virol. 88(9):5195-5199.",
                    "Coleman, C.M. et al. (Feb. 2014, e-published Nov. 6, 2013). \"Wild-Type and Innate Immune-Deficient Mice are Not Susceptible to the Middle East Respiratory Syndrome Coronavirus,\" J. Gen. Virol. 95(Pt 2):408-412.",
                    "Festing, M.F. et al. (Aug. 1999). \"Revised Nomenclature for Strain 129 Mice,\" Mamm Genome 10(8):836.",
                    "GenBank Accession No. KC776174.1, located at , last visited Aug. 10, 2015, 12 pages.",
                    "GenBank Accession No. JX869059.2 located at , last visited Aug. 10, 2015, 13 pages.",
                    "Gerich, J. (Dec. 4, 2013). \"Pathogenesis and Management of Postpandrial Hyperglycemia: Role of Incretin-Based Therapies,\" Intl. J. Gen. Med. 6:877-895.",
                    "Lu, G. et al. (Aug. 8, 2013, e-published Jul. 7, 2013). \"Molecular Basis of Binding Between Novel Human Coronavirus MERS-CoV and Its Receptor CD26,\" Nature 500(7461):227-231.",
                    "Page, C. et al. (Dec. 2012). \"Induction of Alternatively Activated Macrophages Enhances Pathogenesis During Severe Acute Respiratory Syndrome Coronavirus Infection,\" J Virol 86(24):13334-13349.",
                    "Pascal, K.E. et al. (Jul. 14, 2015, e-published Jun. 29, 2015). \"Pre- and Postexposure Efficacy of Fully Human Antibodies Against Spike Protein in a Novel Humanized Mouse Model of MERS-CoV Infection,\" Proc. Natl. Acad. Sci. USA 112(28):8738-8743.",
                    "Pascal, K.E. et al. (2015). \"Supporting Information,\" Proc. Natl. Acad. Sci. USA, 10 pages.",
                    "Poueymirou, W.T. et al. (Jan. 2007, e-published Dec. 24, 2006). F0 Generation Mice Fully Derived From Gene-Targeted Embryonic Stem Cells Allowing Immediate Phenotypic Analyses, Nat Biotechnol 25(1):91-99.",
                    "Raj, V.S. et al. (Mar. 14, 2013). \"Dipeptidyl Peptidase 4 is a Functional Receptor for the Emerging Human Coronavirus-EMC,\" Nature 495(7440):251-254.",
                    "Valenzuela, D.M. et al. (Jun. 2003, e-published May 5, 2003). High-Throughput Engineering of the Mouse Genome Coupled with High-Resolution Expression Analysis, Nature Biotechnology 21(6):652-659.",
                    "Zhao, J. et al. (Apr. 1, 2014). Rapid Generation of a Mouse Model for Middle East Respiratory Syndrome, Proc. Natl. Acad. Sci. USA 111(13):4970-4975.",
                    "Abbott, C.A. et al. (1994). \"Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene,\" Immunogenetics 40(5):331-338.",
                    "Bernard, A.M. et al. (Dec. 20, 1994). \"Structure of the mouse dipeptidyl peptidase IV (CD26) gene,\" Biochemistry 33(50):15204-15214.",
                    "International Search Report mailed on Sep. 18, 2015, for PCT Application No. PCT/US2015/033024, filed May 28, 2015, 7 pages.",
                    "Reardon, S. (Jan. 30, 2014). \"Biologists Make First Mouse Model for MERS,\" Nature News located at http://www.nature.com/news/biologists-make-first-mouse-model-for-mers-1.14634, last visited Sep. 8, 2015.",
                    "Simeoni, L. et al. (Sep. 2002). \"Human CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution,\" Human Immunology 63(9):719-730.",
                    "Written Opinion mailed on Sep. 18, 2015, for PCT Application No. PCT/US2015/033024, filed May 28, 2015, 7 pages.",
                    "Center for Disease Control and Prevention (Oct. 4, 2012). \"Severe Respiratory Illness Associated with a Novel Coronavirus-Saudi Arabia and Qatar, 2012,\" Morbidity and Mortality Weekly Report (MMWR), MMWR Early Release, located at , last visited on Apr. 23, 2016, 3 pages.",
                    "Gama Sosa, M.A. et al. (Mar. 2010, e-published Nov. 25, 2009). \"Animal transgenesis: an overview,\" Brain Struct Funct 214(2-3):91-109.",
                    "Mulvihill, E.E. et al. (Dec. 2014, e-published Sep. 12, 2014). \"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors,\" Endocr Rev 35(6):992-1019.",
                    "Ristevski, S. (Feb. 2005). \"Making better transgenic models: conditional, temporal, and spatial approaches,\" Mol Biotechnol 29(2):153-163.",
                    "Sigmund, C.D. (Jun. 2000). \"Viewpoint: are studies in genetically altered mice out of control?\" Arteroscler Throm Vasc Biol 20(6):1425-1429.",
                    "Smith, K.R. (Oct. 9, 2002). \"Gene transfer in higher animals: theoretical considerations and key concepts,\" J Biotechnol 99(1):1-22.",
                    "Tong, C. et al. (Sep. 9, 2010). \"Production of p53 gene knockout rats by homologous recombination in embryonic stem cells,\" Nature 467(7312):211-213.",
                    "Van Der Weyden L. et al. (Dec. 3, 2002, e-published Dec. 3, 2002). \"Tools for targeted manipulation of the mouse genome,\" Physiol Genomics 11(3):133-164."
                ],
                "nplResolvedCount": 27,
                "nplResolvedLensIDs": [
                    "044-217-677-312-406",
                    "104-556-161-839-355",
                    "035-760-912-363-624",
                    "024-385-617-574-946",
                    "051-508-475-126-991",
                    "118-660-215-665-839",
                    "113-247-817-446-456",
                    "015-091-157-711-697",
                    "085-122-255-782-470",
                    "077-654-442-397-567",
                    "144-694-712-972-15X",
                    "046-419-902-381-810",
                    "080-586-043-504-747",
                    "134-958-999-769-59X",
                    "054-391-011-603-49X",
                    "037-334-759-900-091",
                    "122-156-759-782-023",
                    "020-379-126-711-305",
                    "023-154-204-899-879",
                    "020-009-029-407-493",
                    "145-146-407-738-040",
                    "000-667-406-763-514",
                    "079-521-739-746-928",
                    "002-305-399-176-585",
                    "068-538-867-072-00X",
                    "006-727-147-254-300",
                    "172-177-240-760-035"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3884108",
                    "10.3410/f.725599658.793535757",
                    "pmc2937076",
                    "pmc3993820",
                    "24574399",
                    "10.2144/00295st04",
                    "10.1038/ng1373",
                    "10845854",
                    "19937345",
                    "10.1038/nbt1263",
                    "10.1210/er.2014-1035",
                    "10.1152/physiolgenomics.00074.2002",
                    "10.1007/s001090050105",
                    "12175726",
                    "pmc4507189",
                    "10.2147/ijgm.s51665",
                    "23831647",
                    "11084865",
                    "9106077",
                    "10.1016/s0168-1656(02)00105-0",
                    "24197535",
                    "10.1007/s00429-009-0230-8",
                    "12464689",
                    "10.1007/s003359901099",
                    "23486063",
                    "10.1073/pnas.1510830112",
                    "25216328",
                    "7927537",
                    "20703227",
                    "10591620",
                    "10.1038/nature09368",
                    "10.1021/bi00254a032",
                    "10.1128/jvi.03764-13",
                    "23015710",
                    "12730667",
                    "24403842",
                    "17187059",
                    "7999781",
                    "10430671",
                    "pmc3917065",
                    "12204554",
                    "10.1038/nbt822",
                    "10.1038/nature12005",
                    "10.1128/jvi.01689-12",
                    "pmc3503056",
                    "15184897",
                    "10.1007/bf01246674",
                    "10.1038/nature12328",
                    "10.1161/01.atv.20.6.1425",
                    "10.1385/mb:29:2:153",
                    "10.1099/vir.0.060640-0",
                    "24599590",
                    "26124093",
                    "10.1073/pnas.1323279111",
                    "15699570",
                    "pmc3977243",
                    "10.1016/s0198-8859(02)00433-0",
                    "10.1038/nature.2014.14634"
                ]
            },
            {
                "index": "88",
                "publicationKey": "WO_2020_006494_A1",
                "lensId": "171-554-584-429-551",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2020/006494 A1",
                "publicationDate": "2020-01-02",
                "filingNumber": "US 2019/0039952 W",
                "filingDate": "2019-06-28",
                "priorityFilingKeysActive": [
                    "US 201862692398 P 20180629"
                ],
                "earliestPriorityDate": "2018-06-29",
                "title": "Cell-stored Barcoded Deep Mutational Scanning Libraries And Uses Of The Same",
                "applicants": [
                    "HUTCHINSON FRED CANCER RES",
                    "UNIV WASHINGTON"
                ],
                "inventors": [
                    "BLOOM JESSE",
                    "DINGENS ADAM S",
                    "DUSENBURY KATHARINE",
                    "RADFORD CAELAN"
                ],
                "owners": [],
                "url": "https://lens.org/171-554-584-429-551",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 56,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/005",
                    "C07K14/155",
                    "C12N15/10",
                    "C40B20/04",
                    "C40B40/02",
                    "C40B40/08",
                    "C40B50/10",
                    "C40B70/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 5,
                "nplCitations": [
                    "DINGENS, AS ET AL.: \"Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody\", CELL HOST AND MICROBE, vol. 21, no. 6, 1 June 2017 (2017-06-01), pages 777 - 791, XP085072737, DOI: 10.1016/j.chom.2017.05.003",
                    "DOUD, MB ET AL.: \"Complete mapping of viral escape from neutralizing antibodies\", PLOS PATHOGENS, vol. 13, no. 3, 13 March 2017 (2017-03-13), pages e1006271, XP055666997",
                    "BEHERA, V ET AL.: \"Exploiting genetic variation to uncover rules of transcription factor binding and chromatin accessibility\", NATURE COMMUNICATIONS, vol. 9, no. 1, 22 February 2018 (2018-02-22), pages 1 - 15, XP055666998",
                    "DOUD, MB ET AL.: \"Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin\", VIRUSES, vol. 8, no. 6, 3 June 2016 (2016-06-03), pages 155, XP055667000",
                    "THYAGARAJAN, B ET AL.: \"The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin\", ELIFE, vol. 3, 8 July 2014 (2014-07-08), pages 1 - 26, XP055667006"
                ],
                "nplResolvedCount": 5,
                "nplResolvedLensIDs": [
                    "051-273-441-645-917",
                    "008-619-103-971-468",
                    "025-200-772-459-094",
                    "008-420-266-376-77X",
                    "038-824-069-847-148"
                ],
                "nplResolvedExternalIDs": [
                    "29472540",
                    "10.1016/j.chom.2017.05.003",
                    "10.1371/journal.ppat.1006271",
                    "10.7554/elife.03300",
                    "pmc4109307",
                    "10.1038/s41467-018-03082-6",
                    "28579254",
                    "25006036",
                    "10.3390/v8060155",
                    "pmc4926175",
                    "27271655",
                    "28288189"
                ]
            },
            {
                "index": "89",
                "publicationKey": "US_10548971_B2",
                "lensId": "048-312-099-134-978",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10548971 B2",
                "publicationDate": "2020-02-04",
                "filingNumber": "US 201816022839 A",
                "filingDate": "2018-06-29",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/048-312-099-134-978",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "A61K39/12",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 15,
                "nplCitations": [
                    "Van Boheemen S, et al. 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3(6): e00473-12. doi:10.1128/mBio.00473-12.",
                    "Lokugamage et al. Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV. Vaccine (2008) 26, 797-808.",
                    "Zhou et al. Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins. Biochemical and Biophysical Research Communications 387 (2009) 326-329.",
                    "Gen Bank: JX869059.2. Human betacoronavirus 2c EMC/2012, complete genome. Date Dec. 4, 2012.",
                    "[online] 25 March 2013 (2013-03-25), \"Human betacoronavirus 2c Jordan-N3/2012, complete genome\", XP002764824",
                    "Corrected Notice of Allowability dated Mar. 15, 2018 for U.S. Appl. No. 15/039,672 (pp. 1-2).",
                    "Corrected Notice of Allowability dated Mar. 26, 2018 for U.S. Appl. No. 15/039,672 (pp. 1-3).",
                    "DATABASE GenBank [online] 30 April 2013 (2013-04-30), \"Human betacoronavirus 2c England-Qatar/2012, complete genome\", XP002764825",
                    "Cotten et al., \u201cSpread, Circulation, and Evolution of the Middle East Respiratory Syndrome Coronavirus,\u201d mBio, 2014, 5(1):e01062-13.",
                    "Cotten et al., \u201cTransmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study\u201d, Lancet, 2013, 382:1993-2002.",
                    "Cotten M, \u201cMiddle East respiratory syndrome coronavirus isolate Al-HASA_4_2013, complete genome.\u201d, Database Genbank, (Jun. 10, 2013), Database accession No. KF186564.1, XP055295837, 17 pages.",
                    "Falzarano et al., \u201cInterferon-a2b and ribavirin treatment improves outcome in MERS-CoV-infected rhesus macaques\u201d, Mat Med, vol. 19(10): pp. 1313-1317 (2013).",
                    "Gen Bank: AFS88936. S protein, Human betacoronavirus 2c EMC/2012. Date Dec. 4, 2012, 2 pages.",
                    "Notice of Allowance dated Mar. 5, 2018 for U.S. Appl. No. 15/039,672 (pp. 1-8).",
                    "Song F, et al., \u2018Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies,\u2019 Journal of Virology, (2013) vol. 87, No. 21, pp. 11950-11954."
                ],
                "nplResolvedCount": 7,
                "nplResolvedLensIDs": [
                    "109-155-880-448-590",
                    "105-955-717-757-57X",
                    "018-702-914-707-986",
                    "015-077-926-384-053",
                    "114-114-185-080-165",
                    "023-939-052-489-028",
                    "016-772-377-304-76X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/j.vaccine.2007.11.092",
                    "pmc3807317",
                    "10.1016/s0140-6736(13)61887-5",
                    "24549846",
                    "24055451",
                    "10.1016/j.bbrc.2009.07.025",
                    "10.1128/mbio.00473-12",
                    "10.1038/nm.3362",
                    "19595990",
                    "24013700",
                    "23986586",
                    "pmc3898949",
                    "23170002",
                    "10.1128/jvi.01672-13",
                    "18191004",
                    "10.1128/mbio.01062-13",
                    "pmc2267761",
                    "pmc4093902"
                ]
            },
            {
                "index": "90",
                "publicationKey": "US_2015_0351372_A1",
                "lensId": "191-443-415-367-584",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2015/0351372 A1",
                "publicationDate": "2015-12-10",
                "filingNumber": "US 201514824475 A",
                "filingDate": "2015-08-12",
                "priorityFilingKeysActive": [
                    "US 201462005476 P 20140530",
                    "US 201462051626 P 20140917",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2015-09-14"
                    }
                ],
                "url": "https://lens.org/191-443-415-367-584",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 5,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027",
                    "C12Q1/68",
                    "C12Q1/70"
                ],
                "usClassifications": [],
                "nplCitationCount": 8,
                "nplCitations": [
                    "Abbott et al Immunogenetics, 1994, 331-338",
                    "Bernard et al Biochemistry, 33(50), 1994, 15204-15214",
                    "Reardon et al (Nature NEWS, 30 January 2014, 1-4",
                    "Gama Sosa et al Brain Struct Funct (2010) 214:91\u2013109",
                    "Smith, et al Journal of Biotechnology 99 (2002) 1-22",
                    "Ristevski, Molecular Biotechnology, 2005, 153-163",
                    "Sigmund Arteroscler Throm Vasc Biol 20: 2000, 1425-1429",
                    "Mulvihill et al Endocr Rev. 2014 Dec;35(6):992-1019"
                ],
                "nplResolvedCount": 7,
                "nplResolvedLensIDs": [
                    "051-508-475-126-991",
                    "015-091-157-711-697",
                    "134-958-999-769-59X",
                    "122-156-759-782-023",
                    "023-154-204-899-879",
                    "079-521-739-746-928",
                    "002-305-399-176-585"
                ],
                "nplResolvedExternalIDs": [
                    "10.1007/bf01246674",
                    "25216328",
                    "7927537",
                    "10.1161/01.atv.20.6.1425",
                    "10.1385/mb:29:2:153",
                    "10.1021/bi00254a032",
                    "10.1016/s0168-1656(02)00105-0",
                    "10845854",
                    "10.1007/s00429-009-0230-8",
                    "7999781",
                    "19937345",
                    "10.1210/er.2014-1035",
                    "15699570",
                    "12204554"
                ]
            },
            {
                "index": "91",
                "publicationKey": "US_2016_0007579_A1",
                "lensId": "161-746-608-598-59X",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2016/0007579 A1",
                "publicationDate": "2016-01-14",
                "filingNumber": "US 201514723855 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462005476 P 20140530",
                    "US 201462051626 P 20140917",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2015-09-14"
                    }
                ],
                "url": "https://lens.org/161-746-608-598-59X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 4,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027",
                    "C12Q1/70",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 6,
                "nplCitations": [
                    "Mullins et al. Journal of Clinical Investigation, 1996.",
                    "Moreadith et al., J. Mol. Med., 1997;75:208-16.",
                    "Pera et al. Journal of Cell Science 2000; 113: 5-10.",
                    "Kuroiwa et al. Nature Genetics 2004;36:775-80.",
                    "Simenoi et al. Hum Immunol 2002;63:719-30.",
                    "Lu et al. Nature 2013;500:227-32."
                ],
                "nplResolvedCount": 5,
                "nplResolvedLensIDs": [
                    "104-556-161-839-355",
                    "024-385-617-574-946",
                    "037-334-759-900-091",
                    "020-379-126-711-305",
                    "145-146-407-738-040"
                ],
                "nplResolvedExternalIDs": [
                    "15184897",
                    "12175726",
                    "10.1038/nature12328",
                    "10591620",
                    "23831647",
                    "10.1007/s001090050105",
                    "9106077",
                    "10.1016/s0198-8859(02)00433-0",
                    "10.1038/ng1373"
                ]
            },
            {
                "index": "92",
                "publicationKey": "EP_3045181_B1",
                "lensId": "100-419-349-516-121",
                "jurisdiction": "EP",
                "kindCode": "B1",
                "displayKey": "EP 3045181 B1",
                "publicationDate": "2018-11-14",
                "filingNumber": "EP 15151594 A",
                "filingDate": "2015-01-19",
                "priorityFilingKeysActive": [
                    "EP 15151594 A 20150119"
                ],
                "earliestPriorityDate": "2015-01-19",
                "title": "A Novel Vaccine Against The Middle East Respiratory Syndrome Coronavirus (mers-cov)",
                "applicants": [
                    "UNIV MUENCHEN LUDWIG MAXIMILIANS",
                    "PHILIPPS UNIV MARBURG"
                ],
                "inventors": [
                    "SUTTER GERD",
                    "FUX ROBERT",
                    "VOLZ ASISA",
                    "SONG FEI",
                    "BECKER STEPHAN",
                    "EICKMANN MARKUS"
                ],
                "owners": [],
                "url": "https://lens.org/100-419-349-516-121",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "ZHAO JINCUN ET AL: \"Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.\", IMMUNITY 21 JUN 2016, vol. 44, no. 6, 21 June 2016 (2016-06-21), pages 1379 - 1391, XP029619108, ISSN: 1097-4180, DOI: doi:10.1016/j.immuni.2016.05.006",
                    "ZHAO JINCUN ET AL: \"Rapid generation of a mouse model for Middle East respiratory syndrome.\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 01 APR 2014, vol. 111, no. 13, 1 April 2014 (2014-04-01), pages 4970 - 4975, XP055212024, ISSN: 1091-6490, DOI: doi:10.1073/pnas.1323279111"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "054-391-011-603-49X",
                    "028-241-381-303-519"
                ],
                "nplResolvedExternalIDs": [
                    "27287409",
                    "24599590",
                    "10.1016/j.immuni.2016.05.006",
                    "10.1073/pnas.1323279111",
                    "pmc3977243"
                ]
            },
            {
                "index": "93",
                "publicationKey": "WO_2015_026958_A1",
                "lensId": "061-716-056-821-059",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/026958 A1",
                "publicationDate": "2015-02-26",
                "filingNumber": "US 2014/0051914 W",
                "filingDate": "2014-08-20",
                "priorityFilingKeysActive": [
                    "US 201361867971 P 20130820"
                ],
                "earliestPriorityDate": "2013-08-20",
                "title": "Methods For Improving Respiratory System Health And Increasing The Concentration Of Hypothiocyanate Ion In Vertebrate Lungs",
                "applicants": [
                    "LEE JAMES D"
                ],
                "inventors": [
                    "LEE JAMES D"
                ],
                "owners": [],
                "url": "https://lens.org/061-716-056-821-059",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 8,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61L2/20"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "BLOCK SEYMOUR: \"Disinfection, sterilization, and preservation\", 1 January 2001, DISINFECTION, STERILIZATION AND PRESERVATION, XX, XX, PAGE(S) 187-191,344, XP002503889"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "94",
                "publicationKey": "US_2019_0336526_A1",
                "lensId": "003-192-299-100-485",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0336526 A1",
                "publicationDate": "2019-11-07",
                "filingNumber": "US 201916431032 A",
                "filingDate": "2019-06-04",
                "priorityFilingKeysActive": [
                    "US 201361867971 P 20130820"
                ],
                "earliestPriorityDate": "2013-08-20",
                "title": "Methods For Improving Respiratory System Health And Increasing The Concentration Of Hypothiocyanate Ion In Vertebrate Lungs",
                "applicants": [
                    "LEE JAMES D"
                ],
                "inventors": [
                    "LEE JAMES D"
                ],
                "owners": [],
                "url": "https://lens.org/003-192-299-100-485",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K33/40",
                    "A61L2/20",
                    "A61L9/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "95",
                "publicationKey": "US_2019_0256585_A1",
                "lensId": "174-156-700-336-404",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0256585 A1",
                "publicationDate": "2019-08-22",
                "filingNumber": "US 201615570734 A",
                "filingDate": "2016-06-10",
                "priorityFilingKeysActive": [
                    "KR 20150082132 A 20150610"
                ],
                "earliestPriorityDate": "2015-06-10",
                "title": "Antibody Specifically Binding To An Isolated Peptide Derived From Vimentin Or A Fragment Binding To The Peptide",
                "applicants": [
                    "IMMUNEMED INC"
                ],
                "inventors": [
                    "KIM YOON WON",
                    "KIM YOUNG JIN",
                    "HONG HYO JEONG",
                    "PARK SANG JIN",
                    "KIM MIN WOO",
                    "PARK SUNG MAN"
                ],
                "owners": [
                    {
                        "name": "IMMUNEMED INC",
                        "executionDate": "2017-11-14"
                    }
                ],
                "url": "https://lens.org/174-156-700-336-404",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 15,
                "familySize": 16,
                "seqCount": 162,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/18",
                    "A61P29/00",
                    "A61P31/12",
                    "A61P31/16",
                    "A61P31/20"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "96",
                "publicationKey": "AU_2017_269336_A1",
                "lensId": "052-189-838-573-469",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2017/269336 A1",
                "publicationDate": "2018-09-27",
                "filingNumber": "AU 2017/269336 A",
                "filingDate": "2017-05-24",
                "priorityFilingKeysActive": [
                    "US 201662340624 P 20160524"
                ],
                "earliestPriorityDate": "2016-05-24",
                "title": "Metabalomics And Viral Diagnostics Suite",
                "applicants": [
                    "EXCISION BIOTHERAPEUTICS INC"
                ],
                "inventors": [
                    "MALCOLM THOMAS"
                ],
                "owners": [],
                "url": "https://lens.org/052-189-838-573-469",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 7,
                "familySize": 7,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "G01N33/573",
                    "G01N33/574"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "97",
                "publicationKey": "AU_2016_357651_A1",
                "lensId": "040-428-257-126-193",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2016/357651 A1",
                "publicationDate": "2018-05-17",
                "filingNumber": "AU 2016/357651 A",
                "filingDate": "2016-11-18",
                "priorityFilingKeysActive": [
                    "US 201562256868 P 20151118"
                ],
                "earliestPriorityDate": "2015-11-18",
                "title": "Pharmaceutical Compositions Of Ribavirin",
                "applicants": [
                    "GLAXOSMITHKLINE IP NO 2 LTD",
                    "LIQUIDIA TECHNOLOGIES INC"
                ],
                "inventors": [
                    "DELL'ORCO PHILIP CHARLES",
                    "FARRER BRIAN T",
                    "HONG ZHI",
                    "ROBERTS CHRISTOPHER D",
                    "SAVAGE JOHN ROBERT",
                    "SPRAGUE JACOB J",
                    "WANG YONGCAI"
                ],
                "owners": [],
                "url": "https://lens.org/040-428-257-126-193",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 10,
                "familySize": 10,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K9/14",
                    "A61K9/50",
                    "A61K31/7056"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "98",
                "publicationKey": "AU_2015_264189_A1",
                "lensId": "132-408-086-125-619",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2015/264189 A1",
                "publicationDate": "2016-11-17",
                "filingNumber": "AU 2015/264189 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462051717 P 20140917",
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome -coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [],
                "url": "https://lens.org/132-408-086-125-619",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/08",
                    "A61K39/00",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "99",
                "publicationKey": "AU_2018_275267_A1",
                "lensId": "077-879-273-568-536",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2018/275267 A1",
                "publicationDate": "2019-12-19",
                "filingNumber": "AU 2018/275267 A",
                "filingDate": "2018-06-01",
                "priorityFilingKeysActive": [
                    "US 201762514091 P 20170602"
                ],
                "earliestPriorityDate": "2017-06-02",
                "title": "Phenotypically Wild-type And Genetically Attenuated Viruses",
                "applicants": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "inventors": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "owners": [],
                "url": "https://lens.org/077-879-273-568-536",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/21",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "100",
                "publicationKey": "AU_2018_275790_A1",
                "lensId": "146-235-512-758-263",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2018/275790 A1",
                "publicationDate": "2019-12-19",
                "filingNumber": "AU 2018/275790 A",
                "filingDate": "2018-06-01",
                "priorityFilingKeysActive": [
                    "US 201762514096 P 20170602"
                ],
                "earliestPriorityDate": "2017-06-02",
                "title": "Genetically Attenuated Nucleic Acid Vaccine",
                "applicants": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "inventors": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "owners": [],
                "url": "https://lens.org/146-235-512-758-263",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N15/66",
                    "C12N15/10",
                    "C12N15/11",
                    "C12N15/33"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "101",
                "publicationKey": "AU_2014_212104_B2",
                "lensId": "098-617-620-673-245",
                "jurisdiction": "AU",
                "kindCode": "B2",
                "displayKey": "AU 2014/212104 B2",
                "publicationDate": "2018-02-15",
                "filingNumber": "AU 2014/212104 A",
                "filingDate": "2014-01-31",
                "priorityFilingKeysActive": [
                    "US 201361759131 P 20130131"
                ],
                "earliestPriorityDate": "2013-01-31",
                "title": "Immunogenic Compositions Comprising Silicified Virus And Methods Of Use",
                "applicants": [
                    "PORTLAND STATE UNIV",
                    "PROVIDENCE HEALTH & SERVICES OREGON"
                ],
                "inventors": [
                    "STEDMAN KENNETH M",
                    "LAIDLER JAMES R",
                    "BAHJAT KEITH"
                ],
                "owners": [],
                "url": "https://lens.org/098-617-620-673-245",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "LAIDLER et al., \"Virus Silicification under Simulated Hot Spring Conditions\", Astrobiology, 2010, Vol. 10, No. 6, pages 569-576"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "045-732-946-166-420"
                ],
                "nplResolvedExternalIDs": [
                    "10.1089/ast.2010.0463",
                    "20735248"
                ]
            },
            {
                "index": "102",
                "publicationKey": "AU_2015_332634_A1",
                "lensId": "167-220-684-585-24X",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2015/332634 A1",
                "publicationDate": "2017-04-27",
                "filingNumber": "AU 2015/332634 A",
                "filingDate": "2015-10-15",
                "priorityFilingKeysActive": [
                    "EP 14306633 A 20141015"
                ],
                "earliestPriorityDate": "2014-10-15",
                "title": "Composition With Reduced Immunogenicity",
                "applicants": [
                    "XENOTHERA"
                ],
                "inventors": [
                    "SOULILLOU JEAN-PAUL",
                    "DUVAUX ODILE"
                ],
                "owners": [],
                "url": "https://lens.org/167-220-684-585-24X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 9,
                "familySize": 9,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/08",
                    "A01K67/027",
                    "C07K16/10",
                    "C07K16/12",
                    "C07K16/14",
                    "C12N9/02",
                    "C12N9/10",
                    "C12N9/22",
                    "C12N9/40"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "103",
                "publicationKey": "AU_2014_354797_B2",
                "lensId": "038-520-559-056-952",
                "jurisdiction": "AU",
                "kindCode": "B2",
                "displayKey": "AU 2014/354797 B2",
                "publicationDate": "2017-10-26",
                "filingNumber": "AU 2014/354797 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "INOVIO PHARMACEUTICALS INC",
                    "UNIV PENNSYLVANIA"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/038-520-559-056-952",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "SONG F, et al., 'Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies,' Journal of Virology, (2013) vol 87 No 21, pp 11950-11954"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "114-114-185-080-165"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3807317",
                    "23986586",
                    "10.1128/jvi.01672-13"
                ]
            },
            {
                "index": "104",
                "publicationKey": "AU_2014_354797_C1",
                "lensId": "049-291-082-842-755",
                "jurisdiction": "AU",
                "kindCode": "C1",
                "displayKey": "AU 2014/354797 C1",
                "publicationDate": "2018-02-01",
                "filingNumber": "AU 2014/354797 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "INOVIO PHARMACEUTICALS INC",
                    "UNIV PENNSYLVANIA"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/049-291-082-842-755",
                "docType": "Amended Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "SONG F, et al., 'Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies,' Journal of Virology, (2013) vol 87 No 21, pp 11950-11954"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "114-114-185-080-165"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3807317",
                    "23986586",
                    "10.1128/jvi.01672-13"
                ]
            },
            {
                "index": "105",
                "publicationKey": "AU_2014_354797_A1",
                "lensId": "117-582-520-419-776",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2014/354797 A1",
                "publicationDate": "2016-07-07",
                "filingNumber": "AU 2014/354797 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "INOVIO PHARMACEUTICALS INC",
                    "UNIV PENNSYLVANIA"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/117-582-520-419-776",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "106",
                "publicationKey": "AU_2015_266841_C1",
                "lensId": "086-878-343-453-999",
                "jurisdiction": "AU",
                "kindCode": "C1",
                "displayKey": "AU 2015/266841 C1",
                "publicationDate": "2018-06-07",
                "filingNumber": "AU 2015/266841 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462051626 P 20140917",
                    "US 201462005476 P 20140530",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [],
                "url": "https://lens.org/086-878-343-453-999",
                "docType": "Amended Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "SIMEONI L. et al., Human Immunology, 2002, Vol. 63, pages 719-730"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "037-334-759-900-091"
                ],
                "nplResolvedExternalIDs": [
                    "12175726",
                    "10.1016/s0198-8859(02)00433-0"
                ]
            },
            {
                "index": "107",
                "publicationKey": "AU_2015_266841_B2",
                "lensId": "039-850-836-515-474",
                "jurisdiction": "AU",
                "kindCode": "B2",
                "displayKey": "AU 2015/266841 B2",
                "publicationDate": "2017-04-13",
                "filingNumber": "AU 2015/266841 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462051626 P 20140917",
                    "US 201462005476 P 20140530",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [],
                "url": "https://lens.org/039-850-836-515-474",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "108",
                "publicationKey": "AU_2015_266841_A1",
                "lensId": "022-640-834-554-75X",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2015/266841 A1",
                "publicationDate": "2016-12-08",
                "filingNumber": "AU 2015/266841 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462051626 P 20140917",
                    "US 201462005476 P 20140530",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [],
                "url": "https://lens.org/022-640-834-554-75X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "SIMEONI L. et al., Human Immunology, 2002, Vol. 63, pages 719-730"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "037-334-759-900-091"
                ],
                "nplResolvedExternalIDs": [
                    "12175726",
                    "10.1016/s0198-8859(02)00433-0"
                ]
            },
            {
                "index": "109",
                "publicationKey": "AU_2014_308878_B2",
                "lensId": "166-694-962-816-115",
                "jurisdiction": "AU",
                "kindCode": "B2",
                "displayKey": "AU 2014/308878 B2",
                "publicationDate": "2018-07-26",
                "filingNumber": "AU 2014/308878 A",
                "filingDate": "2014-08-20",
                "priorityFilingKeysActive": [
                    "US 201361867971 P 20130820"
                ],
                "earliestPriorityDate": "2013-08-20",
                "title": "Methods For Improving Respiratory System Health And Increasing The Concentration Of Hypothiocyanate Ion In Vertebrate Lungs",
                "applicants": [
                    "LEE JAMES D"
                ],
                "inventors": [
                    "LEE JAMES D"
                ],
                "owners": [],
                "url": "https://lens.org/166-694-962-816-115",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61L2/20"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "110",
                "publicationKey": "AU_2019_204638_A1",
                "lensId": "066-616-123-539-541",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2019/204638 A1",
                "publicationDate": "2019-07-18",
                "filingNumber": "AU 2019/204638 A",
                "filingDate": "2019-06-28",
                "priorityFilingKeysActive": [
                    "KR 20150082132 A 20150610"
                ],
                "earliestPriorityDate": "2015-06-10",
                "title": "Antibody Binding Specifically Isolated Vimentin-derived Peptide, Or Binding Fragment Of The Peptide",
                "applicants": [
                    "IMMUNEMED INC"
                ],
                "inventors": [
                    "KIM YOON",
                    "KIM YOUNG",
                    "HONG HYO JEONG",
                    "PARK SANG",
                    "KIM MIN",
                    "PARK SUNG"
                ],
                "owners": [],
                "url": "https://lens.org/066-616-123-539-541",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 15,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/18",
                    "A61K39/00",
                    "A61K39/395"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            }
        ]
    }
}
